Citrus Sinensis ID: 048219
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 183 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FLV4 | 872 | G-type lectin S-receptor- | yes | no | 0.836 | 0.175 | 0.506 | 2e-40 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.781 | 0.171 | 0.513 | 8e-38 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.825 | 0.182 | 0.487 | 9e-38 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.814 | 0.179 | 0.487 | 2e-34 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.863 | 0.193 | 0.469 | 2e-33 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.781 | 0.211 | 0.489 | 2e-31 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.781 | 0.212 | 0.489 | 4e-31 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.825 | 0.183 | 0.4 | 6e-31 | |
| Q9LFV3 | 436 | Probable leucine-rich rep | no | no | 0.814 | 0.341 | 0.443 | 6e-31 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.825 | 0.162 | 0.464 | 1e-30 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 164 bits (416), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 79/156 (50%), Positives = 103/156 (66%), Gaps = 3/156 (1%)
Query: 16 TPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEI 75
+P SF+Y +L+ T+ F + +G G GTVYKG + LVAV RL++ L EREF TE+
Sbjct: 516 SPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEV 575
Query: 76 KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPN---WIERTGIAR 132
IG HH NLVRL GY E S ++LVYEYM NGSL +F++E+ N W R IA
Sbjct: 576 NTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAV 635
Query: 133 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A+GI Y H++C +IIHCDIKP+NIL+D+N C K
Sbjct: 636 ATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPK 671
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 156 bits (394), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 76/148 (51%), Positives = 106/148 (71%), Gaps = 5/148 (3%)
Query: 20 FSYAELKKITDGFKEKVGRGSSGTVYKG----AMINRQLVAVNRLEKVLDEREREFQTEI 75
F+Y EL + T F E++GRG+ G VYKG A + VAV +L+++ + E+EF+ E+
Sbjct: 521 FTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEV 580
Query: 76 KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIA 135
KVIG+ HH+NLVRL+G+ E +++VYE++ G+LA+ LF +P+W +R IA IA
Sbjct: 581 KVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFR-RPRPSWEDRKNIAVAIA 639
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDE 163
RGILYLH+EC QIIHCDIKPQNIL+DE
Sbjct: 640 RGILYLHEECSEQIIHCDIKPQNILLDE 667
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (394), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 75/154 (48%), Positives = 105/154 (68%), Gaps = 3/154 (1%)
Query: 17 PFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIK 76
P F+Y EL++ T FKEK+G G GTVY+G + NR +VAV +LE + ++ E++F+ E+
Sbjct: 471 PVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI-EQGEKQFRMEVA 529
Query: 77 VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF--NAEKQPNWIERTGIARDI 134
I THH NLVRL+G+ + ++LVYE+M NGSL + LF ++ K W R IA
Sbjct: 530 TISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGT 589
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A+GI YLH+EC I+HCDIKP+NIL+D+N AK
Sbjct: 590 AKGITYLHEECRDCIVHCDIKPENILVDDNFAAK 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 145 bits (365), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 75/154 (48%), Positives = 98/154 (63%), Gaps = 5/154 (3%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVI 78
+FSY EL+ T F +K+G G G+V+KGA+ + +AV RLE + + E++F+TE+ I
Sbjct: 482 AFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGI-SQGEKQFRTEVVTI 540
Query: 79 GRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP----NWIERTGIARDI 134
G H NLVRL G+ E SKK+LVY+YM NGSL LF + + W R IA
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
ARG+ YLHDEC IIHCDIKP+NIL+D C K
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPK 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 141 bits (356), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 76/162 (46%), Positives = 106/162 (65%), Gaps = 4/162 (2%)
Query: 5 YKIDSNYSTLTTPFS-FSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKV 63
+ + Y +T+ F +SY EL K T FK ++GRG SGTVYKG + + + VAV +LE V
Sbjct: 508 WASEKGYKAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENV 567
Query: 64 LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQ-- 121
+E FQ E+ VIGR +H NLVR+ G+ E S ++LV EY+ NGSLA+ILF+
Sbjct: 568 RQGKE-VFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNIL 626
Query: 122 PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 163
+W R IA +A+G+ YLH EC +IHCD+KP+NIL+D+
Sbjct: 627 LDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQ 668
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 135 bits (339), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 72/147 (48%), Positives = 95/147 (64%), Gaps = 4/147 (2%)
Query: 22 YAELKKITDGFKE--KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIG 79
Y ++ T+ F E K+GRG G VYKG N + VAV RL K + E EF+TE+ V+
Sbjct: 343 YRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVA 402
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP--NWIERTGIARDIARG 137
+ HRNLVRLLG+SL+ ++ILVYEYM N SL +LF+ KQ +W++R I IARG
Sbjct: 403 KLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARG 462
Query: 138 ILYLHDECETQIIHCDIKPQNILMDEN 164
ILYLH + IIH D+K NIL+D +
Sbjct: 463 ILYLHQDSRLTIIHRDLKASNILLDAD 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (337), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 72/147 (48%), Positives = 95/147 (64%), Gaps = 4/147 (2%)
Query: 22 YAELKKITDGFKE--KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIG 79
Y ++ T+ F E K+GRG G VYKG N + VAV RL K + E EF+TE+ V+
Sbjct: 341 YRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVA 400
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEK--QPNWIERTGIARDIARG 137
+ HRNLVRLLG+SL+ ++ILVYEYM N SL +LF+ K Q +W++R I IARG
Sbjct: 401 KLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLDWMQRYNIIGGIARG 460
Query: 138 ILYLHDECETQIIHCDIKPQNILMDEN 164
ILYLH + IIH D+K NIL+D +
Sbjct: 461 ILYLHQDSRLTIIHRDLKASNILLDAD 487
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 133 bits (335), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 62/155 (40%), Positives = 102/155 (65%), Gaps = 4/155 (2%)
Query: 17 PFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIK 76
P F+Y +L+ T+ F K+G+G G+VY+G + + +AV +LE + + ++EF+ E+
Sbjct: 480 PIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGI-GQGKKEFRAEVS 538
Query: 77 VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF---NAEKQPNWIERTGIARD 133
+IG HH +LVRL G+ E + ++L YE++S GSL +F + + +W R IA
Sbjct: 539 IIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALG 598
Query: 134 IARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A+G+ YLH++C+ +I+HCDIKP+NIL+D+N AK
Sbjct: 599 TAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAK 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 133 bits (335), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 67/151 (44%), Positives = 95/151 (62%), Gaps = 2/151 (1%)
Query: 20 FSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIG 79
++Y +++K T F +G+GS G VYK M N +L A + +REFQTE+ ++G
Sbjct: 104 YNYKDIQKATQNFTTVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLLG 163
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP--NWIERTGIARDIARG 137
R HHRNLV L GY ++ S ++L+YE+MSNGSL ++L+ E NW ER IA DI+ G
Sbjct: 164 RLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLLYGGEGMQVLNWEERLQIALDISHG 223
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK 168
I YLH+ +IH D+K NIL+D + AK
Sbjct: 224 IEYLHEGAVPPVIHRDLKSANILLDHSMRAK 254
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 132 bits (333), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 71/153 (46%), Positives = 93/153 (60%), Gaps = 2/153 (1%)
Query: 18 FSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKV 77
+ S L++ TD F +KVGRGS G+VY G M + + VAV R+F TE+ +
Sbjct: 594 YFISLPVLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVAL 653
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAE--KQPNWIERTGIARDIA 135
+ R HHRNLV L+GY E ++ILVYEYM NGSL D L + K +W+ R IA+D A
Sbjct: 654 LSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAA 713
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+G+ YLH C IIH D+K NIL+D N AK
Sbjct: 714 KGLEYLHTGCNPSIIHRDVKSSNILLDINMRAK 746
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 183 | ||||||
| 359477044 | 768 | PREDICTED: G-type lectin S-receptor-like | 0.819 | 0.195 | 0.728 | 3e-59 | |
| 359477040 | 774 | PREDICTED: G-type lectin S-receptor-like | 0.819 | 0.193 | 0.721 | 1e-57 | |
| 225431551 | 768 | PREDICTED: G-type lectin S-receptor-like | 0.819 | 0.195 | 0.695 | 5e-57 | |
| 224078930 | 488 | predicted protein [Populus trichocarpa] | 0.890 | 0.334 | 0.672 | 7e-57 | |
| 255582007 | 783 | ATP binding protein, putative [Ricinus c | 0.836 | 0.195 | 0.655 | 2e-54 | |
| 255582003 | 817 | ATP binding protein, putative [Ricinus c | 0.836 | 0.187 | 0.662 | 2e-54 | |
| 296088600 | 623 | unnamed protein product [Vitis vinifera] | 0.841 | 0.247 | 0.649 | 7e-53 | |
| 225431567 | 762 | PREDICTED: G-type lectin S-receptor-like | 0.841 | 0.202 | 0.649 | 8e-53 | |
| 359477046 | 798 | PREDICTED: G-type lectin S-receptor-like | 0.814 | 0.186 | 0.673 | 8e-53 | |
| 147782422 | 762 | hypothetical protein VITISV_038481 [Viti | 0.841 | 0.202 | 0.649 | 9e-53 |
| >gi|359477044|ref|XP_002275760.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 233 bits (594), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 110/151 (72%), Positives = 131/151 (86%), Gaps = 1/151 (0%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQ-LVAVNRLEKVLDEREREFQTEIKV 77
SF+Y EL+K+T+GFKE++G+G+SGTVYKGA+ N Q +VAV +LEKVL E +REFQ E+KV
Sbjct: 472 SFTYMELEKVTNGFKEEIGKGASGTVYKGAISNSQRIVAVKKLEKVLAEGQREFQNELKV 531
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARG 137
IGRTHHRNLVRLLGY LE ++LVYEYMSNGSLAD+LF KQP WIER GIA ++ARG
Sbjct: 532 IGRTHHRNLVRLLGYCLEGPNRLLVYEYMSNGSLADLLFTPGKQPCWIERMGIALNVARG 591
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+LYLH+ECETQIIHCDIKPQNILMDE + AK
Sbjct: 592 VLYLHEECETQIIHCDIKPQNILMDEYKRAK 622
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477040|ref|XP_002275651.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 227 bits (579), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 109/151 (72%), Positives = 126/151 (83%), Gaps = 1/151 (0%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQ-LVAVNRLEKVLDEREREFQTEIKV 77
SF+Y EL+K+T+GF E++G+G+SGTVYKGA N Q +VAV +LEKVL E E EFQ E+KV
Sbjct: 478 SFTYMELEKVTNGFMEEIGKGASGTVYKGATSNGQRIVAVKKLEKVLAEGEIEFQNELKV 537
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARG 137
IGRTHHRNLVRLLGY L+ ++LVYEYMSNGSLAD LF KQP W ER GIA ++ARG
Sbjct: 538 IGRTHHRNLVRLLGYCLDGPNRLLVYEYMSNGSLADWLFTPGKQPRWSERMGIALNVARG 597
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK 168
ILYLH+ECET IIHCDIKPQNILMDE RCAK
Sbjct: 598 ILYLHEECETCIIHCDIKPQNILMDEYRCAK 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431551|ref|XP_002275615.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 225 bits (574), Expect = 5e-57, Method: Compositional matrix adjust.
Identities = 105/151 (69%), Positives = 129/151 (85%), Gaps = 1/151 (0%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQ-LVAVNRLEKVLDEREREFQTEIKV 77
SF+Y EL+K+T+ FKE++G+G+SGTVYKGA+ N Q +VAV + EKVL E +REFQ E+KV
Sbjct: 472 SFTYMELEKVTNCFKEEIGKGASGTVYKGAISNGQRIVAVKKQEKVLAEWQREFQNELKV 531
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARG 137
+GRTHHRNLVRLLGY L+ ++LVYEYMSNGSLAD+LF KQP W+ER IA ++A+G
Sbjct: 532 LGRTHHRNLVRLLGYCLDGRNRLLVYEYMSNGSLADLLFTPAKQPCWVERVRIALNVAKG 591
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+LYLH+ECETQIIHCDIKPQNILMDE RCAK
Sbjct: 592 VLYLHEECETQIIHCDIKPQNILMDEYRCAK 622
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224078930|ref|XP_002335729.1| predicted protein [Populus trichocarpa] gi|222834660|gb|EEE73123.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 225 bits (573), Expect = 7e-57, Method: Compositional matrix adjust.
Identities = 113/168 (67%), Positives = 137/168 (81%), Gaps = 5/168 (2%)
Query: 6 KIDSNYSTLT----TPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRL 60
K+ SN ST P +F+YAEL+ +T GFKE++GRGS GTVYKG + N+++VAV RL
Sbjct: 175 KVPSNDSTGLNEEFAPRAFTYAELENVTGGFKEEIGRGSFGTVYKGIISSNQKVVAVKRL 234
Query: 61 EKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEK 120
EKVL E EREFQ E+KVIG+THHRNLVRLLGY + ++LVYEYMSNGSLADILF+ EK
Sbjct: 235 EKVLAEGEREFQNEMKVIGKTHHRNLVRLLGYCHDGHHRLLVYEYMSNGSLADILFSLEK 294
Query: 121 QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+P + ER IAR+IARGI+YLH+ECETQIIHCDIKPQNIL+DE+RC K
Sbjct: 295 RPCFPERLEIARNIARGIVYLHEECETQIIHCDIKPQNILIDESRCPK 342
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582007|ref|XP_002531801.1| ATP binding protein, putative [Ricinus communis] gi|223528567|gb|EEF30589.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 217 bits (553), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 101/154 (65%), Positives = 127/154 (82%), Gaps = 1/154 (0%)
Query: 16 TPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQ-LVAVNRLEKVLDEREREFQTE 74
P SF+YAEL+++TDGFKE++GRGS GTVYKG + Q +VAV +LE+VL + +REFQTE
Sbjct: 483 APLSFTYAELERVTDGFKEEIGRGSFGTVYKGLLSRSQKVVAVKKLERVLADGDREFQTE 542
Query: 75 IKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDI 134
+K IG+THH+NLVRLLGY E ++LVYE+MSNGSL+D+LF+ E +P + ER IAR+I
Sbjct: 543 MKAIGKTHHKNLVRLLGYCNEGPNRLLVYEFMSNGSLSDVLFSPENRPCFAERIEIARNI 602
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
ARGILYLH+ECETQIIHCDIKP+NILMD C K
Sbjct: 603 ARGILYLHEECETQIIHCDIKPENILMDAYMCPK 636
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582003|ref|XP_002531799.1| ATP binding protein, putative [Ricinus communis] gi|223528565|gb|EEF30587.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 217 bits (553), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 102/154 (66%), Positives = 129/154 (83%), Gaps = 1/154 (0%)
Query: 16 TPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQ-LVAVNRLEKVLDEREREFQTE 74
P SF+YAEL+++TDGFKE++GRGS GTVYKG + + Q +VAV +LE+VL + +REFQTE
Sbjct: 483 APLSFTYAELERVTDGFKEEIGRGSFGTVYKGLLSSSQKVVAVKKLERVLADGDREFQTE 542
Query: 75 IKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDI 134
+KVIG+THHRNLV LLGY E ++LVY++MSNGSL+D+LF+ EK+P + ER IAR+I
Sbjct: 543 MKVIGKTHHRNLVCLLGYCNEGLNRLLVYDFMSNGSLSDVLFSPEKRPCFTERIEIARNI 602
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
ARGILYLH+ECETQIIHCDIKP+NILMD C K
Sbjct: 603 ARGILYLHEECETQIIHCDIKPENILMDAYMCPK 636
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088600|emb|CBI37591.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 211 bits (538), Expect = 7e-53, Method: Compositional matrix adjust.
Identities = 102/157 (64%), Positives = 126/157 (80%), Gaps = 3/157 (1%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKV 77
SFSY +L+K TDGF+E++GRG G VYKG + Q +AV RLEKV++E EREFQ E+ +
Sbjct: 256 SFSYNDLEKATDGFREELGRGPFGAVYKGTIAQGNQTIAVKRLEKVVEEGEREFQAEMTI 315
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARG 137
IGRTHHRNLVRLLG+ ++ SKK+LVYEYMSNGSLAD+LFN EK+P W ER IA D+ARG
Sbjct: 316 IGRTHHRNLVRLLGFCMQGSKKLLVYEYMSNGSLADLLFNGEKRPIWRERVRIALDVARG 375
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK--NFRL 172
I YLH+ECE IIH DIKP+NIL+D++ AK +FRL
Sbjct: 376 IFYLHEECEVHIIHGDIKPKNILLDDSWTAKLSDFRL 412
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431567|ref|XP_002276274.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 211 bits (538), Expect = 8e-53, Method: Compositional matrix adjust.
Identities = 102/157 (64%), Positives = 126/157 (80%), Gaps = 3/157 (1%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKV 77
SFSY +L+K TDGF+E++GRG G VYKG + Q +AV RLEKV++E EREFQ E+ +
Sbjct: 466 SFSYNDLEKATDGFREELGRGPFGAVYKGTIAQGNQTIAVKRLEKVVEEGEREFQAEMTI 525
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARG 137
IGRTHHRNLVRLLG+ ++ SKK+LVYEYMSNGSLAD+LFN EK+P W ER IA D+ARG
Sbjct: 526 IGRTHHRNLVRLLGFCMQGSKKLLVYEYMSNGSLADLLFNGEKRPIWRERVRIALDVARG 585
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK--NFRL 172
I YLH+ECE IIH DIKP+NIL+D++ AK +FRL
Sbjct: 586 IFYLHEECEVHIIHGDIKPKNILLDDSWTAKLSDFRL 622
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477046|ref|XP_002275786.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 211 bits (538), Expect = 8e-53, Method: Compositional matrix adjust.
Identities = 101/150 (67%), Positives = 124/150 (82%), Gaps = 1/150 (0%)
Query: 20 FSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVI 78
FSY EL + T GFKE++G+GS G VYKG + +++LVAV RLEK+++E EREFQ E++ I
Sbjct: 504 FSYKELIRATSGFKEELGKGSFGAVYKGFLYKSKKLVAVKRLEKIVEEGEREFQAEMRAI 563
Query: 79 GRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGI 138
GRTHHRNLVRL+GY E S+++LVYEYMSNGSLA++LFNA +P+W ER IA D+ARGI
Sbjct: 564 GRTHHRNLVRLMGYCAENSRRLLVYEYMSNGSLANLLFNAGTRPHWNERVRIALDVARGI 623
Query: 139 LYLHDECETQIIHCDIKPQNILMDENRCAK 168
LYLH+ECET IIHCDIKPQNILMDE AK
Sbjct: 624 LYLHEECETPIIHCDIKPQNILMDEFLNAK 653
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147782422|emb|CAN72833.1| hypothetical protein VITISV_038481 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 211 bits (537), Expect = 9e-53, Method: Compositional matrix adjust.
Identities = 102/157 (64%), Positives = 126/157 (80%), Gaps = 3/157 (1%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKV 77
SFSY +L+K TDGF+E++GRG G VYKG + Q +AV RLEKV++E EREFQ E+ +
Sbjct: 466 SFSYNDLEKATDGFREELGRGPFGAVYKGTIAQGNQTIAVKRLEKVVEEGEREFQAEMTI 525
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARG 137
IGRTHHRNLVRLLG+ ++ SKK+LVYEYMSNGSLAD+LFN EK+P W ER IA D+ARG
Sbjct: 526 IGRTHHRNLVRLLGFCMQGSKKLLVYEYMSNGSLADLLFNGEKRPIWRERVRIALDVARG 585
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK--NFRL 172
I YLH+ECE IIH DIKP+NIL+D++ AK +FRL
Sbjct: 586 IFYLHEECEVHIIHGDIKPKNILLDDSWTAKLSDFRL 622
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 183 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.879 | 0.194 | 0.464 | 4e-35 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.814 | 0.179 | 0.493 | 1.4e-31 | |
| TAIR|locus:2172149 | 440 | CRLK1 "calcium/calmodulin-regu | 0.874 | 0.363 | 0.434 | 8.8e-31 | |
| TAIR|locus:2143166 | 436 | CRLK2 "calcium/calmodulin-regu | 0.814 | 0.341 | 0.443 | 3e-30 | |
| TAIR|locus:2090634 | 663 | AT3G19300 [Arabidopsis thalian | 0.814 | 0.224 | 0.453 | 1.5e-29 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.770 | 0.208 | 0.496 | 2e-29 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.781 | 0.152 | 0.465 | 4.9e-29 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.825 | 0.162 | 0.464 | 7e-29 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.825 | 0.183 | 0.4 | 1.1e-28 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.890 | 0.171 | 0.426 | 1.2e-28 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 4.0e-35, P = 4.0e-35
Identities = 78/168 (46%), Positives = 110/168 (65%)
Query: 7 IDSNYSTLT----TPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEK 62
+ S+Y+ L P F+Y EL++ T FKEK+G G GTVY+G + NR +VAV +LE
Sbjct: 457 LSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEG 516
Query: 63 VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAE--K 120
+ ++ E++F+ E+ I THH NLVRL+G+ + ++LVYE+M NGSL + LF + K
Sbjct: 517 I-EQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAK 575
Query: 121 QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
W R IA A+GI YLH+EC I+HCDIKP+NIL+D+N AK
Sbjct: 576 FLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAK 623
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 356 (130.4 bits), Expect = 1.4e-31, P = 1.4e-31
Identities = 76/154 (49%), Positives = 99/154 (64%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVI 78
+FSY EL+ T F +K+G G G+V+KGA+ + +AV RLE + + E++F+TE+ I
Sbjct: 482 AFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGI-SQGEKQFRTEVVTI 540
Query: 79 GRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF-NAEKQP---NWIERTGIARDI 134
G H NLVRL G+ E SKK+LVY+YM NGSL LF N ++ W R IA
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
ARG+ YLHDEC IIHCDIKP+NIL+D C K
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPK 634
|
|
| TAIR|locus:2172149 CRLK1 "calcium/calmodulin-regulated receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 339 (124.4 bits), Expect = 8.8e-31, P = 8.8e-31
Identities = 70/161 (43%), Positives = 101/161 (62%)
Query: 9 SNYSTLTTPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERE 68
SN + + +SY +L+K T F +G+G+ G VYK M ++VAV L + E
Sbjct: 92 SNVISASGILEYSYRDLQKATCNFTTLIGQGAFGPVYKAQMSTGEIVAVKVLATDSKQGE 151
Query: 69 REFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIER 127
+EFQTE+ ++GR HHRNLV L+GY E + +L+Y YMS GSLA L++ + +P +W R
Sbjct: 152 KEFQTEVMLLGRLHHRNLVNLIGYCAEKGQHMLIYVYMSKGSLASHLYSEKHEPLSWDLR 211
Query: 128 TGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
IA D+ARG+ YLHD +IH DIK NIL+D++ A+
Sbjct: 212 VYIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 252
|
|
| TAIR|locus:2143166 CRLK2 "calcium/calmodulin-regulated receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 334 (122.6 bits), Expect = 3.0e-30, P = 3.0e-30
Identities = 67/151 (44%), Positives = 95/151 (62%)
Query: 20 FSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIG 79
++Y +++K T F +G+GS G VYK M N +L A + +REFQTE+ ++G
Sbjct: 104 YNYKDIQKATQNFTTVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLLG 163
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP--NWIERTGIARDIARG 137
R HHRNLV L GY ++ S ++L+YE+MSNGSL ++L+ E NW ER IA DI+ G
Sbjct: 164 RLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLLYGGEGMQVLNWEERLQIALDISHG 223
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK 168
I YLH+ +IH D+K NIL+D + AK
Sbjct: 224 IEYLHEGAVPPVIHRDLKSANILLDHSMRAK 254
|
|
| TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 335 (123.0 bits), Expect = 1.5e-29, P = 1.5e-29
Identities = 68/150 (45%), Positives = 94/150 (62%)
Query: 20 FSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIG 79
FSY E++K T+ F +GRG GTVYK N + AV ++ K ++ E EF EI+++
Sbjct: 316 FSYKEIRKATEDFNAVIGRGGFGTVYKAEFSNGLVAAVKKMNKSSEQAEDEFCREIELLA 375
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGI 138
R HHR+LV L G+ + +++ LVYEYM NGSL D L + EK P +W R IA D+A +
Sbjct: 376 RLHHRHLVALKGFCNKKNERFLVYEYMENGSLKDHLHSTEKSPLSWESRMKIAIDVANAL 435
Query: 139 LYLHDECETQIIHCDIKPQNILMDENRCAK 168
YLH C+ + H DIK NIL+DE+ AK
Sbjct: 436 EYLHFYCDPPLCHRDIKSSNILLDEHFVAK 465
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 334 (122.6 bits), Expect = 2.0e-29, P = 2.0e-29
Identities = 72/145 (49%), Positives = 94/145 (64%)
Query: 22 YAELKKITDGFKE--KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIG 79
Y ++ T+ F E K+GRG G VYKG N + VAV RL K + E EF+TE+ V+
Sbjct: 343 YRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVA 402
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP--NWIERTGIARDIARG 137
+ HRNLVRLLG+SL+ ++ILVYEYM N SL +LF+ KQ +W++R I IARG
Sbjct: 403 KLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARG 462
Query: 138 ILYLHDECETQIIHCDIKPQNILMD 162
ILYLH + IIH D+K NIL+D
Sbjct: 463 ILYLHQDSRLTIIHRDLKASNILLD 487
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 322 (118.4 bits), Expect = 4.9e-29, Sum P(2) = 4.9e-29
Identities = 68/146 (46%), Positives = 94/146 (64%)
Query: 20 FSYAELKKITDGFKEK--VGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKV 77
FS+ EL T+GF +GRGS G VYKG + N+ VA+ R E+ + E+EF EI +
Sbjct: 602 FSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDL 661
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF-NAEKQPNWIERTGIARDIAR 136
+ R HHRNLV L+GYS ++ +++LVYEYM NG++ D L NA ++ R+ +A A+
Sbjct: 662 LSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAK 721
Query: 137 GILYLHDECETQIIHCDIKPQNILMD 162
GILYLH E +IH DIK NIL+D
Sbjct: 722 GILYLHTEANPPVIHRDIKTSNILLD 747
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 7.0e-29, P = 7.0e-29
Identities = 71/153 (46%), Positives = 96/153 (62%)
Query: 18 FSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKV 77
+ S L++ TD F +KVGRGS G+VY G M + + VAV R+F TE+ +
Sbjct: 594 YFISLPVLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVAL 653
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF-NAEKQP-NWIERTGIARDIA 135
+ R HHRNLV L+GY E ++ILVYEYM NGSL D L +++ +P +W+ R IA+D A
Sbjct: 654 LSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAA 713
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+G+ YLH C IIH D+K NIL+D N AK
Sbjct: 714 KGLEYLHTGCNPSIIHRDVKSSNILLDINMRAK 746
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 329 (120.9 bits), Expect = 1.1e-28, P = 1.1e-28
Identities = 62/155 (40%), Positives = 101/155 (65%)
Query: 17 PFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIK 76
P F+Y +L+ T+ F K+G+G G+VY+G + + +AV +LE + + ++EF+ E+
Sbjct: 480 PIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGI-GQGKKEFRAEVS 538
Query: 77 VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP---NWIERTGIARD 133
+IG HH +LVRL G+ E + ++L YE++S GSL +F + +W R IA
Sbjct: 539 IIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALG 598
Query: 134 IARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A+G+ YLH++C+ +I+HCDIKP+NIL+D+N AK
Sbjct: 599 TAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAK 633
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 330 (121.2 bits), Expect = 1.2e-28, P = 1.2e-28
Identities = 73/171 (42%), Positives = 107/171 (62%)
Query: 6 KIDSNYSTLTTPF-----SFSYAELKKITDGFKEK--VGRGSSGTVYKGAMINRQLVAVN 58
K D++ S++ P +F++ ELKK TD F E VG G G VY+G + N QL+A+
Sbjct: 600 KWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIK 659
Query: 59 RLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNA 118
R ++ + EF+TEI+++ R HH+N+VRLLG+ + ++++LVYEY+SNGSL D L
Sbjct: 660 RAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGK 719
Query: 119 EK-QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ +W R IA +G+ YLH+ + IIH DIK NIL+DEN AK
Sbjct: 720 SGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAK 770
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 183 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-27 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-17 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-04 | |
| PRK00485 | 464 | PRK00485, fumC, fumarate hydratase; Reviewed | 4e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.001 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.001 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.001 | |
| cd01362 | 455 | cd01362, Fumarase_classII, Class II fumarases | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.002 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.002 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.002 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.002 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.002 | |
| COG0114 | 462 | COG0114, FumC, Fumarase [Energy production and con | 0.002 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.003 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.003 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.003 | |
| cd01596 | 450 | cd01596, Aspartase_like, aspartase (L-aspartate am | 0.003 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-29
Identities = 44/131 (33%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 36 VGRGSSGTVYKG-AMINRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRLLGYS 93
+G G GTVY + VA+ ++K E EI+++ + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 94 LEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCD 153
+ + LV EY GSL D+L E + + E I I G+ YLH IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 154 IKPQNILMDEN 164
+KP+NIL+D +
Sbjct: 118 LKPENILLDSD 128
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-27
Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRN 85
+K+G G+ G VYKG + + VAV L++ E++ EF E +++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+V+LLG E +V EYM G L L + + + A IARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
IH D+ +N L+ EN K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVK 142
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-27
Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 10/144 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRN 85
+K+G G+ G VYKG + VAV L++ E++ EF E +++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADIL-FNAEKQPNWIERTGIARDIARGILYLHDE 144
+V+LLG E ++V EYM G L D L N K+ + + A IARG+ YL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
IH D+ +N L+ EN K
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVK 143
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-27
Identities = 49/140 (35%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRL 89
EK+G GS G VY +LVA+ ++K +++RE EIK++ + H N+VRL
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 90 LGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
E K+ LV EY G L D+L + R R I + YLH +
Sbjct: 63 YD-VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLHSK---G 117
Query: 149 IIHCDIKPQNILMDENRCAK 168
I+H D+KP+NIL+DE+ K
Sbjct: 118 IVHRDLKPENILLDEDGHVK 137
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-25
Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 32 FKEKVGRGSSGTVYKG-----AMINRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRN 85
+K+G G+ G VYKG VAV L++ E ER EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+VRLLG + +V EYM G L D L ++ + +A IA+G+ YL +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+H D+ +N L+ EN K
Sbjct: 122 --NFVHRDLAARNCLVTENLVVK 142
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-25
Identities = 51/136 (37%), Positives = 71/136 (52%), Gaps = 7/136 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVR 88
K+G GS GTVYK ++VAV L+K ++++ + EI+++ R H N+VR
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L+ + LV EY G L D L + E IA I RG+ YLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 149 IIHCDIKPQNILMDEN 164
IIH D+KP+NIL+DEN
Sbjct: 119 IIHRDLKPENILLDEN 134
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 6e-25
Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 13/142 (9%)
Query: 34 EKVGRGSSGTVYKGAMINR--QLVAVN--RLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
E +GRGS G+VY A+ +L+AV L +E + EI+++ H N+VR
Sbjct: 6 ELLGRGSFGSVYL-ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 90 LGYSLEVSKK-ILVY-EYMSNGSLADILFNAEK-QPNWIERTGIARDIARGILYLHDECE 146
G + K + ++ EY+S GSL+ +L K I + R I G+ YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK--YTRQILEGLAYLHSN-- 120
Query: 147 TQIIHCDIKPQNILMDENRCAK 168
I+H DIK NIL+D + K
Sbjct: 121 -GIVHRDIKGANILVDSDGVVK 141
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 6e-22
Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 16/148 (10%)
Query: 34 EKVGRGSSGTVYKGAMINRQ----LVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNLVR 88
+K+G G+ G VYKG + + VAV L++ E ER +F E +V+ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADIL--------FNAEKQPNWIERTGIARDIARGILY 140
LLG E LV EYM G L D L + + + A IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 141 LHDECETQIIHCDIKPQNILMDENRCAK 168
L + +H D+ +N L+ E+ K
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVK 145
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-20
Identities = 40/133 (30%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMINR-QLVAVNR--LEKVLDEREREFQTEIKVIGRTHHRNLVR 88
+ +GRG+ G VYKG + VA+ + LEK+ +E + EI ++ H N+V+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
+G ++ EY NGSL I+ P + + + + +G+ YLH++
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-VLQGLAYLHEQ---G 119
Query: 149 IIHCDIKPQNILM 161
+IH DIK NIL
Sbjct: 120 VIHRDIKAANILT 132
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-19
Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 6/138 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+G+G G V G ++ VAV L+ + F E V+ H NLV+LLG
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLG 67
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQII 150
L+ + +V EYM+ GSL D L + + ++ G A D+ G+ YL E +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 151 HCDIKPQNILMDENRCAK 168
H D+ +N+L+ E+ AK
Sbjct: 125 HRDLAARNVLVSEDLVAK 142
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-17
Identities = 47/141 (33%), Positives = 72/141 (51%), Gaps = 15/141 (10%)
Query: 35 KVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNLVRLL 90
+G+GSSG VYK ++ ++ A+ ++ DE R + E+K + +V+
Sbjct: 8 VLGQGSSGVVYKV--RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 91 GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIARGILYLHDECET 147
G + +I +V EYM GSLAD+L +K E IAR I +G+ YLH +
Sbjct: 66 G-AFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHTK--R 119
Query: 148 QIIHCDIKPQNILMDENRCAK 168
IIH DIKP N+L++ K
Sbjct: 120 HIIHRDIKPSNLLINSKGEVK 140
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-17
Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 8/135 (5%)
Query: 33 KEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
EK+G+G G VYK + VA+ ++ E++ + EI+++ + H N+V+ G
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 92 YSLEVSKKILVYEYMSNGSLADIL--FNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
L+ + +V E+ S GSL D+L N + I + +++ +G+ YLH I
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI--AYVCKELLKGLEYLHSN---GI 119
Query: 150 IHCDIKPQNILMDEN 164
IH DIK NIL+ +
Sbjct: 120 IHRDIKAANILLTSD 134
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-17
Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 8/140 (5%)
Query: 34 EKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNLVR 88
+ +G G G V +G + VA+ L+ +++R +F TE ++G+ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L G + +++ EYM NGSL L + + + G+ R IA G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 149 IIHCDIKPQNILMDENRCAK 168
+H D+ +NIL++ N K
Sbjct: 127 YVHRDLAARNILVNSNLVCK 146
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-16
Identities = 49/138 (35%), Positives = 72/138 (52%), Gaps = 17/138 (12%)
Query: 34 EKVGRGSSGTVYKGAMINR--QLVAVNR--LEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
E +G+GS G VYK R Q+VA+ LE+ DE E + Q EI+ + + + +
Sbjct: 7 ECIGKGSFGEVYKAI-DKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKY 64
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDECE 146
G L+ SK ++ EY GS D+L +P ++ T IA R++ G+ YLH+E
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE-- 117
Query: 147 TQIIHCDIKPQNILMDEN 164
IH DIK NIL+ E
Sbjct: 118 -GKIHRDIKAANILLSEE 134
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-16
Identities = 42/137 (30%), Positives = 71/137 (51%), Gaps = 11/137 (8%)
Query: 32 FKEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVR 88
EK+G G+SG VYK +R + VA+ ++ ++ + + EI ++ H N+V
Sbjct: 23 NLEKIGEGASGEVYKA--TDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
S V ++ +V EYM GSL DI+ + N + + R++ +G+ YLH
Sbjct: 80 YYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQ 135
Query: 148 QIIHCDIKPQNILMDEN 164
+IH DIK NIL+ ++
Sbjct: 136 NVIHRDIKSDNILLSKD 152
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 8e-16
Identities = 47/146 (32%), Positives = 70/146 (47%), Gaps = 21/146 (14%)
Query: 33 KEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERERE--FQT---EIKVIGRTHHR 84
EK+G G+ G VYK ++ ++VA L+K+ + E E T EI ++ H
Sbjct: 4 LEKLGEGTYGVVYKA--RDKKTGEIVA---LKKIRLDNEEEGIPSTALREISLLKELKHP 58
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQ--PNWIERTGIARDIARGILYLH 142
N+V+LL K LV+EY L L PN I+ I + RG+ Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCH 115
Query: 143 DECETQIIHCDIKPQNILMDENRCAK 168
+I+H D+KPQNIL++ + K
Sbjct: 116 SH---RILHRDLKPQNILINRDGVLK 138
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 72.5 bits (176), Expect = 2e-15
Identities = 48/140 (34%), Positives = 70/140 (50%), Gaps = 11/140 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERERE---FQTEIKVIGR-THHRNLV 87
K+G GS G VY +R+LVA+ L K L+ + +E F EI+++ H N+V
Sbjct: 4 ILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIARGILYLHDEC 145
+L + + LV EY+ GSL D+L ++ E I I + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--- 118
Query: 146 ETQIIHCDIKPQNILMDENR 165
IIH DIKP+NIL+D +
Sbjct: 119 SKGIIHRDIKPENILLDRDG 138
|
Length = 384 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-15
Identities = 47/141 (33%), Positives = 77/141 (54%), Gaps = 15/141 (10%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLLGY 92
E VG G+ G VYKG + +A ++ V ++ E E + EI ++ + +HHRN+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 93 SLEVS------KKILVYEYMSNGSLADILFNAEK---QPNWIERTGIARDIARGILYLHD 143
++ S + LV E+ GS+ D++ N + + +WI I R+I RG+ +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 144 ECETQIIHCDIKPQNILMDEN 164
++IH DIK QN+L+ EN
Sbjct: 140 H---KVIHRDIKGQNVLLTEN 157
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-15
Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
+++G G+ G VYK I +LVA+ ++ + Q EI ++ H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDECET 147
G L K +V EY GSL DI + + P + IA R+ +G+ YLH ET
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDI-YQVTRGP--LSELQIAYVCRETLKGLAYLH---ET 120
Query: 148 QIIHCDIKPQNILMDENRCAK 168
IH DIK NIL+ E+ K
Sbjct: 121 GKIHRDIKGANILLTEDGDVK 141
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 8e-15
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 21/146 (14%)
Query: 33 KEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGR-THHRNLV 87
E +G G+ G VYK QLVA+ K++D + E E + E ++ + ++H N+
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAI----KIMDIIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 88 RLLGYSLEVSKKI------LVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGI 138
G ++ + LV E GS+ D++ K+ ++ IA R+ RG+
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 139 LYLHDECETQIIHCDIKPQNILMDEN 164
YLH+ ++IH DIK QNIL+ +N
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKN 149
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-14
Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 7/133 (5%)
Query: 35 KVGRGSSGTVYKGAMINR-QLVAVN--RLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
K+G G+ G VY ++ +L+AV R++ + +E E+KV+ H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
+ K + EY S G+L ++L + + R + G+ YLH I+H
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLH---SHGIVH 122
Query: 152 CDIKPQNILMDEN 164
DIKP NI +D N
Sbjct: 123 RDIKPANIFLDHN 135
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-14
Identities = 39/145 (26%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRN 85
F +++G G G V + VAV L +E+ R +F+ EI+++ H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 86 LVRLLGYSLEVSKKI--LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
+V+ G + + L+ EY+ +GSL D L Q N + I +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 144 ECETQIIHCDIKPQNILMDENRCAK 168
+ + IH D+ +NIL++ K
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVK 149
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-14
Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 10/140 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQ---LVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVR 88
EK+G GS G+VYK I+++ +VA+ + ++E +E EI ++ + +V+
Sbjct: 7 ILEKLGEGSYGSVYKA--IHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
G + + +V EY GS++DI+ K E I +G+ YLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---K 119
Query: 149 IIHCDIKPQNILMDENRCAK 168
IH DIK NIL++E AK
Sbjct: 120 KIHRDIKAGNILLNEEGQAK 139
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-14
Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 4/136 (2%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGY 92
EK+G+G+ G VYKG + VAV L + +R+F E +++ + H N+V+L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
++ +V E + GSL L + + + ++ D A G+ YL + IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 153 DIKPQNILMDENRCAK 168
D+ +N L+ EN K
Sbjct: 118 DLAARNCLVGENNVLK 133
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-14
Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVR 88
+++G G G V+ G + ++ VA+ K + E E +F E +V+ + H LV+
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAI----KTIREGAMSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L G E S LV+E+M +G L+D L + + G+ D+ G+ YL
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 149 IIHCDIKPQNILMDENRCAK 168
+IH D+ +N L+ EN+ K
Sbjct: 121 VIHRDLAARNCLVGENQVVK 140
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-14
Identities = 46/141 (32%), Positives = 76/141 (53%), Gaps = 15/141 (10%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLLGY 92
E VG G+ G VYKG + +A ++ V + E E + EI ++ + +HHRN+ G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 93 SLEVS------KKILVYEYMSNGSLADILFNAEK---QPNWIERTGIARDIARGILYLHD 143
++ + + LV E+ GS+ D++ N + + WI I R+I RG+ +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH- 128
Query: 144 ECETQIIHCDIKPQNILMDEN 164
+ ++IH DIK QN+L+ EN
Sbjct: 129 --QHKVIHRDIKGQNVLLTEN 147
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-14
Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 14/143 (9%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLD-----EREREFQTEIKVIGRTHHRNLV 87
E +G GS G+VY+G + + AV + D E ++ + EI ++ + H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADIL--FNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ LG E + E + GSLA +L + + +P T R I G+ YLHD
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT---RQILLGLEYLHDR- 121
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+H DIK NIL+D N K
Sbjct: 122 --NTVHRDIKGANILVDTNGVVK 142
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 8e-14
Identities = 43/139 (30%), Positives = 75/139 (53%), Gaps = 14/139 (10%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLE-----KVLDERE-REFQTEIKVIGRTHHRNLV 87
E +G+G+ GTVY G QL+AV ++E + E+E + Q E+ ++ H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADIL--FNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ LG L+ + + E++ GS++ IL F +P + + T + I G+ YLH+ C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYT---KQILDGVAYLHNNC 122
Query: 146 ETQIIHCDIKPQNILMDEN 164
++H DIK N+++ N
Sbjct: 123 ---VVHRDIKGNNVMLMPN 138
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-13
Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 4/136 (2%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
K+G G G V++G NR VA+ L+ ++++FQ E++ + R H++L+ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 94 LEVSKKILVYEYMSNGSLADILFNAEKQPNWIER-TGIARDIARGILYLHDECETQIIHC 152
++ E M GSL L + E Q + +A +A G+ YL ++ IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHR 128
Query: 153 DIKPQNILMDENRCAK 168
D+ +NIL+ E+ K
Sbjct: 129 DLAARNILVGEDLVCK 144
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-13
Identities = 50/136 (36%), Positives = 76/136 (55%), Gaps = 15/136 (11%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVN--RLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
E++G+GS G VYKG +++VA+ LE+ DE E + Q EI V+ + + R
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYY 68
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDECET 147
G L+ +K ++ EY+ GS D+L +P +E T IA R+I +G+ YLH E
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSE--- 120
Query: 148 QIIHCDIKPQNILMDE 163
+ IH DIK N+L+ E
Sbjct: 121 RKIHRDIKAANVLLSE 136
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-13
Identities = 38/140 (27%), Positives = 69/140 (49%), Gaps = 13/140 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQT---EIKVIGRTHHRNLV 87
E +G G++ VY + N + VA+ R++ L++ + E++ + + +H N+V
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADIL---FNAEKQPNWIERTGIARDIARGILYLHDE 144
+ + + LV Y+S GSL DI+ + I T + +++ +G+ YLH
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT-VLKEVLKGLEYLHSN 121
Query: 145 CETQIIHCDIKPQNILMDEN 164
IH DIK NIL+ E+
Sbjct: 122 ---GQIHRDIKAGNILLGED 138
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-13
Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 27/168 (16%)
Query: 9 SNYSTLTTPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVL- 64
S+ S + S +EL+++ ++G G+ GTVYK +I+R +L A+ KV+
Sbjct: 60 SSASGSAPSAAKSLSELERV-----NRIGSGAGGTVYK--VIHRPTGRLYAL----KVIY 108
Query: 65 ----DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEK 120
D R+ EI+++ +H N+V+ + ++ E+M GSL E+
Sbjct: 109 GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ 168
Query: 121 QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+AR I GI YLH I+H DIKP N+L++ + K
Sbjct: 169 F-----LADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVK 208
|
Length = 353 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-13
Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 33 KEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNLV 87
+E +G G G V +G + VA+ L+ E++R +F +E ++G+ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
L G + +++ E+M NG+L L + Q I+ G+ R IA G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125
Query: 148 QIIHCDIKPQNILMDENRCAK 168
+H D+ +NIL++ N K
Sbjct: 126 NYVHRDLAARNILVNSNLVCK 146
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 5e-13
Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 19/139 (13%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDERERE-F-QT---EIKVIGRTHHRNLV 87
++G G+ G VYK +LVA L+K+ E E+E F T EIK++ + H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 88 RLLGYSLEVSKKI----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
RL + SK +V+EYM + L +L + E + + + + G+ YLH
Sbjct: 62 RL--KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 144 ECETQIIHCDIKPQNILMD 162
I+H DIK NIL++
Sbjct: 119 N---GILHRDIKGSNILIN 134
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-13
Identities = 42/138 (30%), Positives = 74/138 (53%), Gaps = 9/138 (6%)
Query: 33 KEKV-GRGSSGTVYKGAMI----NRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNL 86
K+KV G G G V++G + VA+ L+ E++R +F +E ++G+ H N+
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
+RL G + +++ EYM NG+L L + + + + + G+ R IA G+ YL D
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD--- 125
Query: 147 TQIIHCDIKPQNILMDEN 164
+H D+ +NIL++ N
Sbjct: 126 MNYVHRDLAARNILVNSN 143
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-12
Identities = 50/138 (36%), Positives = 79/138 (57%), Gaps = 17/138 (12%)
Query: 34 EKVGRGSSGTVYKGAMINR--QLVAVN--RLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
EK+G+GS G V+KG + NR ++VA+ LE+ DE E + Q EI V+ + + +
Sbjct: 10 EKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKY 67
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDECE 146
G L+ +K ++ EY+ GS D+L +P ++ T IA R+I +G+ YLH E
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE-- 120
Query: 147 TQIIHCDIKPQNILMDEN 164
+ IH DIK N+L+ E+
Sbjct: 121 -KKIHRDIKAANVLLSEH 137
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-12
Identities = 38/135 (28%), Positives = 70/135 (51%), Gaps = 12/135 (8%)
Query: 35 KVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNLVRLL 90
++G G+SG V K +++R +++AV + ++E + + E+ ++ + + +V
Sbjct: 8 ELGAGNSGVVSK--VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT--GIARDIARGILYLHDECETQ 148
G + EYM GSL IL + + ER IA + +G+ YLH++ +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLHEK--HK 121
Query: 149 IIHCDIKPQNILMDE 163
IIH D+KP NIL++
Sbjct: 122 IIHRDVKPSNILVNS 136
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-12
Identities = 45/140 (32%), Positives = 62/140 (44%), Gaps = 11/140 (7%)
Query: 33 KEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRL 89
+ K+G G G V+ G VAV K L F E +++ + H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAV----KTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQ 148
E +V EYMS GSL D L + E K+ + +A IA G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRN 123
Query: 149 IIHCDIKPQNILMDENRCAK 168
IH D+ +NIL+ EN K
Sbjct: 124 YIHRDLAARNILVGENLVCK 143
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-12
Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 34 EKVGRGSSGTVYKGAMINR-QLVAVNR--LEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
++G G+ G V+K + VA+ + L ++ + EIK + H +V+LL
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
S +LV EYM L+++L + E+ + R + +G+ Y+H I+
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIM 121
Query: 151 HCDIKPQNILMDENRCAK 168
H D+KP N+L+ + K
Sbjct: 122 HRDLKPANLLISADGVLK 139
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-12
Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 16/139 (11%)
Query: 36 VGRGSSGTVYKGAMINR------QLVAVNRLEKVLDER-EREFQTEIKVIGRTHHRNLVR 88
+G G+ G VY+G R VAV L + E+ E +F E ++ + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPN------WIERTGIARDIARGILYLH 142
L+G S E + ++ E M+ G L L +P + ARD+A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 143 DECETQIIHCDIKPQNILM 161
E IH DI +N L+
Sbjct: 134 ---ENHFIHRDIAARNCLL 149
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-12
Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 21/145 (14%)
Query: 34 EKVGRGSSGTVYKGAMINR-QLVAVNR-LEKVLDEREREFQT-EIKVIGRTHHRNLVRLL 90
VG GS G V K Q+VA+ + LE D+ ++ EI+++ + H NLV L+
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 91 GYSLEVSKK----ILVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGILYLHD 143
EV ++ LV+E++ + L D+ EK PN ++ + + + I RGI + H
Sbjct: 67 ----EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 144 ECETQIIHCDIKPQNILMDENRCAK 168
IIH DIKP+NIL+ ++ K
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVK 140
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-11
Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 8/138 (5%)
Query: 36 VGRGSSGTVYKGAMI---NRQL-VAVNRLEKVLDERER-EFQTEIKVIGRTHHRNLVRLL 90
+G G G V G + R++ VA+ L+ E++R +F +E ++G+ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
G + ++V EYM NGSL L + Q I+ G+ R IA G+ YL D +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYV 128
Query: 151 HCDIKPQNILMDENRCAK 168
H D+ +NIL++ N K
Sbjct: 129 HRDLAARNILVNSNLVCK 146
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-11
Identities = 50/146 (34%), Positives = 76/146 (52%), Gaps = 10/146 (6%)
Query: 24 ELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH 83
L+K+T G E +G G G V +G Q VAV ++ D + F E V+ + HH
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEYTG-QKVAVKNIK--CDVTAQAFLEETAVMTKLHH 58
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLH 142
+NLVRLLG L I V E MS G+L + L + + I+ + D+A G+ YL
Sbjct: 59 KNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 143 DECETQIIHCDIKPQNILMDENRCAK 168
+ +++H D+ +NIL+ E+ AK
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAK 140
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-11
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 23/153 (15%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHR 84
K ++G G+ G V+ G + ++LVAV L E ++ ++F+ E +++ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILF-------------NAEKQPNWIERTGIA 131
N+V+ G E I+V+EYM +G L L + + + IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
IA G++YL + +H D+ +N L+ +
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-11
Identities = 46/137 (33%), Positives = 70/137 (51%), Gaps = 14/137 (10%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLE-----KVLDERERE----FQTEIKVIGRTHHRN 85
+G GS G+VY G + +L+AV ++E +R+R EI ++ H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+V+ LG SL+ + EY+ GS+A +L N + R + R I +G+ YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFV-RQILKGLNYLHNR- 125
Query: 146 ETQIIHCDIKPQNILMD 162
IIH DIK NIL+D
Sbjct: 126 --GIIHRDIKGANILVD 140
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-11
Identities = 39/124 (31%), Positives = 67/124 (54%), Gaps = 12/124 (9%)
Query: 41 SGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100
+GT+ M +Q+ V +E + EI+++ R +H +++R+LG + E S
Sbjct: 24 TGTL----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79
Query: 101 LVYEYMSNGSLADIL--FNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQN 158
L E+M+ GS++ +L + A K+ I T + RG+ YLH+ QIIH D+K N
Sbjct: 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYT---EQLLRGLSYLHEN---QIIHRDVKGAN 133
Query: 159 ILMD 162
+L+D
Sbjct: 134 LLID 137
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-11
Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 17/143 (11%)
Query: 34 EKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERE--REFQTEIKVIGRTHHRNLVR 88
VG G+ G V K N+ ++VA+ + ++ D+ + + E+KV+ + H N+V
Sbjct: 7 GVVGEGAYGVVLKCR--NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDI---ARGILYLHDEC 145
L + LV+EY+ +L ++L E P + + I + I Y H
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH--- 117
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
IIH DIKP+NIL+ E+ K
Sbjct: 118 SHNIIHRDIKPENILVSESGVLK 140
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-11
Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 35 KVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-----FQTEIKVIGRTHHRNLVR 88
++G G+ G VY+ + ++VA L+KV + ER+ EI ++ H N+V
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLLNLRHPNIVE 70
Query: 89 LL----GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
L G L+ LV EY LA +L N + + + + RG+ YLH+
Sbjct: 71 LKEVVVGKHLD--SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
IIH D+K N+L+ + C K
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLK 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-11
Identities = 44/140 (31%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVR 88
F +++G G G V G + VA+ K++ E E EF E KV+ + H LV+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAI----KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L G + +V EYMSNG L + L K+ + + +D+ G+ YL + Q
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---Q 120
Query: 149 IIHCDIKPQNILMDENRCAK 168
IH D+ +N L+D+ C K
Sbjct: 121 FIHRDLAARNCLVDDQGCVK 140
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 8e-11
Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 18/149 (12%)
Query: 34 EKVGRGSSGTVYKGAMINR----QLVAVNRLE-KVLDEREREFQT-EIKVIGRTHHRNLV 87
E +G+GS GTV K + R +++ ++ + E+E++ E+ ++ H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 88 RLLGYSLEVSKKIL--VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
R ++ S + L V EY G LA ++ +K+ +IE I R + + +L L+ EC
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY-EC 121
Query: 146 ------ETQIIHCDIKPQNILMDENRCAK 168
++H D+KP NI +D N K
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVK 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-11
Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 8/139 (5%)
Query: 29 TDGFKEKV--GRGSSGTVYKGAMINRQL-VAVNRLEKVLDEREREFQTEIKVIGRTHHRN 85
D E+V G+G+ G VY ++ Q+ +A+ + + + EI + HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGI--ARDIARGILYLHD 143
+V+ LG E + E + GSL+ +L + E+T I + I G+ YLHD
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 144 ECETQIIHCDIKPQNILMD 162
QI+H DIK N+L++
Sbjct: 127 N---QIVHRDIKGDNVLVN 142
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-11
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 21/155 (13%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN 85
K ++G G+ G V+ N + LVAV L+ D ++F E +++ H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSL--------ADILFNAEKQP----NWIERTGIARD 133
+V+ G +E I+V+EYM +G L D + AE + IA+
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 134 IARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
IA G++YL + +H D+ +N L+ EN K
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-10
Identities = 47/147 (31%), Positives = 70/147 (47%), Gaps = 6/147 (4%)
Query: 24 ELKKITDGFKEKVGRGSSGTVYKGAMINRQL-VAVNRLEKVLDEREREFQTEIKVIGRTH 82
E+++ K K+G G G VY+G L VAV L++ E E EF E V+
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYL 141
H NLV+LLG ++ E+M+ G+L D L +Q N + +A I+ + YL
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 142 HDECETQIIHCDIKPQNILMDENRCAK 168
+ IH D+ +N L+ EN K
Sbjct: 121 E---KKNFIHRDLAARNCLVGENHLVK 144
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-10
Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 17/160 (10%)
Query: 36 VGRGSSGTVYKGAMIN-------RQLVAVNRLEK-VLDEREREFQTEIKVIGRTHHRNLV 87
+G G+ G VY+G + VAV L K D+ ++EF E ++ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNW------IERTGIARDIARGILYL 141
+LLG L + ++ E M G L L +A + E I D+A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 142 HDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181
IH D+ +N L+ E + + IG AR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-10
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 20 FSYAELKKITDGFKEKVGRGSSGTVYKGA-MINRQLVAVNRLE---KVLDEREREFQTEI 75
FS + +K+ +E +G GS G VY + ++VA+ ++ K +E+ ++ E+
Sbjct: 8 FSKDDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 76 KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIA 135
+ + + H N + G L LV EY GS +DIL +K +E I
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGAL 125
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+G+ YLH IH DIK NIL+ E K
Sbjct: 126 QGLAYLHSHER---IHRDIKAGNILLTEPGTVK 155
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-10
Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 19/145 (13%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERERE-----FQTEIKVIGRTHHRNLVR 88
EK+G G+ G VYKG N++ + ++K+ E E E EI ++ H N+V
Sbjct: 6 EKIGEGTYGVVYKGR--NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP--NWIERTGIAR---DIARGILYLHD 143
L ++ S+ L++E++S D+ + P +++ + I +GIL+ H
Sbjct: 64 LQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 144 ECETQIIHCDIKPQNILMDENRCAK 168
+++H D+KPQN+L+D K
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIK 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-10
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 10/140 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVR 88
F +++G G G V+ G + VA+ K++ E E +F E KV+ + H NLV+
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAI----KMIREGAMSEDDFIEEAKVMMKLSHPNLVQ 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L G + +V EYM+NG L + L + + + D+ + YL
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNG 120
Query: 149 IIHCDIKPQNILMDENRCAK 168
IH D+ +N L+ E+ K
Sbjct: 121 FIHRDLAARNCLVGEDNVVK 140
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 2e-10
Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 21/144 (14%)
Query: 33 KEKVGRGSSGTVYKGAMI-NRQLVAVNRLE-KVLDEREREF-QTEIKVIGRTHHRNLVRL 89
+++G+GS G VY + +L + ++ + E+ERE E+K++ + +H N+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 90 LGYSLEVSKKILVYEYMSNGSLADIL--FNAEKQP-------NWIERTGIARDIARGILY 140
E K +V EY G L+ + E +P +W + + Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF------VQLCLALKY 118
Query: 141 LHDECETQIIHCDIKPQNILMDEN 164
LH +I+H DIKPQNI + N
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSN 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-10
Identities = 46/136 (33%), Positives = 75/136 (55%), Gaps = 13/136 (9%)
Query: 34 EKVGRGSSGTVYKGAMINR--QLVAVN--RLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
E++G+GS G V+KG + NR Q+VA+ LE+ DE E + Q EI V+ + + +
Sbjct: 10 ERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKY 67
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQ 148
G L+ +K ++ EY+ GS D+L P + + + ++I +G+ YLH E +
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSE---K 121
Query: 149 IIHCDIKPQNILMDEN 164
IH DIK N+L+ E
Sbjct: 122 KIHRDIKAANVLLSEQ 137
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-10
Identities = 39/141 (27%), Positives = 68/141 (48%), Gaps = 15/141 (10%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQ---TEIKVIGR-THHRNL 86
F + +G GS TV + A+ L+K +E++ + E +V+ R H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 87 VRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG--IARDIARGILYLHD 143
++L Y+ + + + V EY NG L + K + E+ A +I + YLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 144 ECETQIIHCDIKPQNILMDEN 164
+ IIH D+KP+NIL+D++
Sbjct: 121 K---GIIHRDLKPENILLDKD 138
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-10
Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 20/147 (13%)
Query: 34 EKVGRGSSGTVYKGAMINRQLV----AVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
++G G+ G+V K + N ++ + + +++ E+++ +V+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKY 64
Query: 90 LG-YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG------IARDIARGILYL 141
G + E S I + EY GSL I +K+ R G IA + +G+ YL
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG---RIGEKVLGKIAESVLKGLSYL 121
Query: 142 HDECETQIIHCDIKPQNILMDENRCAK 168
H +IIH DIKP NIL+ K
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVK 145
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-10
Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 6/129 (4%)
Query: 34 EKVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
EK+G+G+SGTVY + Q VA+ ++ ++ EI V+ H N+V L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L + +V EY++ GSL D++ E + + + R+ + + +LH Q+IH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139
Query: 153 DIKPQNILM 161
DIK NIL+
Sbjct: 140 DIKSDNILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-10
Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 9/141 (6%)
Query: 34 EKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVR 88
+G+G G VY G +I + AV L ++ D E E F E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 89 LLGYSL-EVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
LLG L ++V YM +G L + + + P + G +A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 148 QIIHCDIKPQNILMDENRCAK 168
+ +H D+ +N ++DE+ K
Sbjct: 118 KFVHRDLAARNCMLDESFTVK 138
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-10
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 37/155 (23%)
Query: 23 AELKKITDGFKEKV-GRGSSGTVYKGAMI-----NRQLVAVNRLEKVLDERE-----REF 71
EL+KI KV G G+ GTVYKG I + VA+ KVL E +E
Sbjct: 7 TELEKI------KVLGSGAFGTVYKGVWIPEGEKVKIPVAI----KVLREETSPKANKEI 56
Query: 72 QTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNAEKQPNWI 125
E V+ H ++VRLLG L S+ L+ + M G L D + ++ NW
Sbjct: 57 LDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW- 114
Query: 126 ERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160
IA+G+ YL E +++H D+ +N+L
Sbjct: 115 -----CVQIAKGMSYLE---EKRLVHRDLAARNVL 141
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-09
Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 17/158 (10%)
Query: 31 GFK--EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV----LDEREREFQ-TEIKVIGRTH 82
FK +K+G+GS G+VYK + + Q A L++V + ++ERE EI+++ +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYA---LKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGIL 139
H N++ L+ +K +V EY G L+ + +K+ I I R + RG+
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 140 YLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177
LH++ +I+H D+K NIL+ N K L I KV
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-09
Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 26/142 (18%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLEKVLDE--------REREFQTEIKVIGRTHHRNL 86
+G G+ GTVYK + + VA+ ++ L E RE +K + H N+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL---LKQLESFEHPNI 63
Query: 87 VRLL----GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQ---PNWIERTGIARDIARGI 138
VRLL G + K+ LV+E++ LA L K P I+ + R + RG+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD--LMRQLLRGV 120
Query: 139 LYLHDECETQIIHCDIKPQNIL 160
+LH I+H D+KPQNIL
Sbjct: 121 DFLHSHR---IVHRDLKPQNIL 139
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-09
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 32 FKEKVGRGSSGTVYKGAMI--NRQLVAVNRLEKVLDER-----EREFQTEIKVIGRTHHR 84
F E++G G+ G VYKG + N +L A + K L E ++EF+ E +++ H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILF----NAEKQPNWIERTG----------- 129
N+V LLG + +++EY+++G L + L +++ + T
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 130 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
IA IA G+ YL +H D+ +N L+ E K
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-09
Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-----FQTEIKVIGRTHHRNLV 87
EK+G G+ G VYK + + +A L+K+ E+E E EI ++ H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIAR----DIARGILYLHD 143
RL + LV+EY+ D+ + + P++ + + + I RGI Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 144 ECETQIIHCDIKPQNILMDENR 165
+++H D+KPQN+L+D
Sbjct: 121 H---RVLHRDLKPQNLLIDRRT 139
|
Length = 294 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-09
Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 21/145 (14%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREF-----QTEIKVIGRTHHRNLV 87
K+G G+ G VYK I ++VA L+K+L E++ EIK++ + H N+V
Sbjct: 14 GKLGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKILKKLKHPNVV 70
Query: 88 RLLGYSLEVSKKI--------LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGIL 139
L+ ++E K +V YM + L+ +L N + + + GI
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGIN 129
Query: 140 YLHDECETQIIHCDIKPQNILMDEN 164
YLH E I+H DIK NIL+D
Sbjct: 130 YLH---ENHILHRDIKAANILIDNQ 151
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-09
Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
+K+G G G V+ G VA+ L++ E F E ++ + H LVRL Y+
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRL--YA 68
Query: 94 LEVSKKI-LVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIH 151
+ + I ++ EYM NGSL D L E + + +A IA G+ ++ IH
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 152 CDIKPQNILMDENRCAK 168
D++ NIL+ E C K
Sbjct: 126 RDLRAANILVSETLCCK 142
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-09
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 23/157 (14%)
Query: 32 FKEKVGRGSSGTVYKGAMIN---RQLVAVNRLEKVLDERE-REFQTEIKVIGRT-HHRNL 86
F++ +G G+ G V K + R A+ R+++ + + R+F E++V+ + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNA---EKQPNW--IERTG----------IA 131
+ LLG L EY +G+L D L + E P + T A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
D+ARG+ YL + Q IH D+ +NIL+ EN AK
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 164
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-09
Identities = 37/134 (27%), Positives = 68/134 (50%), Gaps = 7/134 (5%)
Query: 36 VGRGSSGTVYKGAMIN-RQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
VGRG+ G V+ ++LV + ++ E++ + Q E +V+ H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPN-WIERTGIARDIARGILYLHDECETQIIH 151
LE ++V EY G+LA+ + +K+ N ++ I + +L LH I+H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 152 CDIKPQNILMDENR 165
D+K QNIL+D+++
Sbjct: 125 RDLKTQNILLDKHK 138
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-09
Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 19 SFSYAELKKITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDER-EREF 71
+F + L++IT +GRG G V+ LV V L+K DE + EF
Sbjct: 1 AFPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF 55
Query: 72 QTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNAEKQPNW- 124
+ E+ + + H+N+VRLLG E ++ EY G L L K P
Sbjct: 56 RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 125 -IERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
++ + IA G+ +L + + +H D+ +N L+ R K
Sbjct: 116 TKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVK 157
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-09
Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 5/132 (3%)
Query: 34 EKVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
+++G G+ G VYK +N +L A+ ++ E Q EI ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L K + E+ GSL DI ++ + + ++R+ +G+ YLH + + +H
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 153 DIKPQNILMDEN 164
DIK NIL+ +N
Sbjct: 131 DIKGANILLTDN 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-09
Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 28/143 (19%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVN--RLEKVLDEREREFQT---EIKVIGRTHHRNLV 87
EK+G G+ G VYK + ++VA+ RLE E E T EI ++ +H N+V
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLE---TEDEGVPSTAIREISLLKELNHPNIV 61
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARD--------IARGIL 139
RLL +K LV+E++ + +K + TG+ + +GI
Sbjct: 62 RLLDVVHSENKLYLVFEFLD--------LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 140 YLHDECETQIIHCDIKPQNILMD 162
Y H +++H D+KPQN+L+D
Sbjct: 114 YCHSH---RVLHRDLKPQNLLID 133
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 5e-09
Identities = 40/129 (31%), Positives = 64/129 (49%), Gaps = 6/129 (4%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
EK+G+G+SGTVY I Q VA+ ++ ++ EI V+ + N+V L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L + +V EY++ GSL D++ I + R+ + + +LH Q+IH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALDFLH---SNQVIHR 139
Query: 153 DIKPQNILM 161
DIK NIL+
Sbjct: 140 DIKSDNILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 7e-09
Identities = 39/129 (30%), Positives = 64/129 (49%), Gaps = 6/129 (4%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
EK+G+G+SGTVY + Q VA+ ++ ++ EI V+ + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L + +V EY++ GSL D++ I + R+ + + +LH Q+IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLH---SNQVIHR 140
Query: 153 DIKPQNILM 161
DIK NIL+
Sbjct: 141 DIKSDNILL 149
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 8e-09
Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 6/129 (4%)
Query: 34 EKVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
EK+G+G+SGTV+ + Q VA+ ++ ++ EI V+ + N+V L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L + +V EY++ GSL D++ E + + + R+ + + +LH Q+IH
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQVIHR 139
Query: 153 DIKPQNILM 161
DIK N+L+
Sbjct: 140 DIKSDNVLL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-09
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 18 FSFSYAELKKITDGFKEK--VGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEI 75
S S + I KE+ + RG G YKG I + + K +++ +EI
Sbjct: 679 VSKSIT-INDILSSLKEENVISRGKKGASYKGKSIKNG---MQFVVKEINDVNSIPSSEI 734
Query: 76 KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIA 135
+G+ H N+V+L+G L++EY+ +L+++L N +W R IA IA
Sbjct: 735 ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL----SWERRRKIAIGIA 790
Query: 136 RGILYLHDECETQIIHCDIKPQNILMD 162
+ + +LH C ++ ++ P+ I++D
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 9e-09
Identities = 34/142 (23%), Positives = 75/142 (52%), Gaps = 12/142 (8%)
Query: 29 TDGFK--EKVGRGSSGTVYKGA-MINRQLVAVNRLE--KVLDERERE-FQTEIKVIGRTH 82
FK +K+G+G VYK +++ ++VA+ +++ +++D + R+ EI ++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGIL 139
H N+++ L +E ++ +V E G L+ ++ + +KQ I I + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 140 YLHDECETQIIHCDIKPQNILM 161
++H +I+H DIKP N+ +
Sbjct: 121 HMH---SKRIMHRDIKPANVFI 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-08
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 23/157 (14%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN 85
K ++G G+ G V+ N + LVAV L++ + ++FQ E +++ H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSL----------ADILFNAEKQP----NWIERTGIA 131
+VR G E ++V+EYM +G L A IL E + IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
IA G++YL +H D+ +N L+ + K
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVK 162
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-08
Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 25/158 (15%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE-----REREFQTEIKVIGRT-HHRN 85
F++ +G G+ G V + AMI + + +N K+L E R+F E++V+ + HH N
Sbjct: 6 FEDVIGEGNFGQVIR-AMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNA---EKQPNWIERTGIAR---------- 132
++ LLG + EY G+L D L + E P + + G A
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 133 --DIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
D+A G+ YL ++ Q IH D+ +N+L+ EN +K
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASK 159
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-08
Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 6/116 (5%)
Query: 53 QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG--YSLEVSKKILVYEYMSNGS 110
++VAV +L+ E R+F+ EI+++ H N+V+ G YS LV EY+ GS
Sbjct: 34 EVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93
Query: 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENR 165
L D L ++ + + A I +G+ YL + +H D+ +NIL++ ENR
Sbjct: 94 LRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENR 146
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-08
Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 36 VGRGSSGTVYKGAMIN--RQLVAVNRLEK--VLDEREREF-QTEIKVIGRTHHRNLVRLL 90
+G+GS G V +L A+ L+K ++ +E E TE ++ R +H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 91 GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
Y+ + +K+ LV EY G L L + R A +I + YLH I
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHSL---GI 114
Query: 150 IHCDIKPQNILMDE 163
I+ D+KP+NIL+D
Sbjct: 115 IYRDLKPENILLDA 128
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-08
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 4/126 (3%)
Query: 37 GRGSSGTVYKGAMINRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRLLGYSLE 95
G G+ G VYK L A ++ ++ E E E F EI ++ H N+V L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 96 VSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIK 155
+K ++ E+ G+L I+ E+ + + R + + +LH ++IH D+K
Sbjct: 74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLK 130
Query: 156 PQNILM 161
NIL+
Sbjct: 131 AGNILL 136
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-08
Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 15/138 (10%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKV-LDEREREFQT----EIKVIGRTHHRNLVR 88
EK+G G+ GTV+K NR+ + L++V LD+ + + EI ++ H+N+VR
Sbjct: 6 EKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADIL--FNAEKQPNWIERTGIARDIARGILYLHDECE 146
L K LV+EY + L N + P ++ + +G+ + H
Sbjct: 64 LYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVK--SFMFQLLKGLAFCHSH-- 118
Query: 147 TQIIHCDIKPQNILMDEN 164
++H D+KPQN+L+++N
Sbjct: 119 -NVLHRDLKPQNLLINKN 135
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-08
Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 14/136 (10%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQT---EIKVIGRTHHRNLVRL 89
EK+G G+ TVYKG ++VA+ + LD E T EI ++ H N+VRL
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIH--LDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEK---QPNWIERTGIARDIARGILYLHDECE 146
+K +LV+EYM + + + PN ++ + +GI + H E
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCH---E 118
Query: 147 TQIIHCDIKPQNILMD 162
+++H D+KPQN+L++
Sbjct: 119 NRVLHRDLKPQNLLIN 134
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-08
Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 35 KVGRGSSGTVY--KGAMINRQLVAVNRLE---KVLDEREREFQTEIKVIGRTHHRNLVRL 89
++G GS G VY + N ++VAV ++ K +E+ ++ E+K + + H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTN-EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
G L+ LV EY GS +D+L +K +E I +G+ YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 150 IHCDIKPQNILMDE 163
IH DIK NIL+ E
Sbjct: 143 IHRDIKAGNILLTE 156
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-08
Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 4/136 (2%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGY 92
E +G+G+ G V+KG + ++ VAV ++ L E + +F +E +++ + H N+V+L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
+ +V E + G L + + + A D A G+ YL + IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHR 117
Query: 153 DIKPQNILMDENRCAK 168
D+ +N L+ EN K
Sbjct: 118 DLAARNCLVGENNVLK 133
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-08
Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLE---KVLDEREREFQTEIKVIGRTHHRNLVRLL 90
++G GS G VY + N ++VA+ ++ K +E+ ++ E++ + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
G L LV EY GS +D+L +K +E + +G+ YLH +I
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMI 137
Query: 151 HCDIKPQNILMDE 163
H D+K NIL+ E
Sbjct: 138 HRDVKAGNILLSE 150
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-08
Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 18/144 (12%)
Query: 34 EKVGRGSSGTVYKGAMINR---QLVAVNRLEKVL---DE--REREFQTEIKVIGRTHHRN 85
+++G G+ G+VY N+ +LVA+ +++K +E RE ++ K+ H N
Sbjct: 5 KQLGDGTFGSVYLA--RNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL---NEHPN 59
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLHDE 144
+V+L E + V+EYM G+L ++ + + +P I I +G+ ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK- 117
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
H D+KP+N+L+ K
Sbjct: 118 --HGFFHRDLKPENLLVSGPEVVK 139
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-08
Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 30/164 (18%)
Query: 32 FKEKVGRGSSGTV----------YKGAMINRQ-----LVAVNRLEKVLDERER-EFQTEI 75
KEK+G G G V + G LVAV L + + R +F EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 76 KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGI----- 130
K++ R + N++RLLG + ++ EYM NG L L E + + I
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 131 ------ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A IA G+ YL +H D+ +N L+ + K
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIK 169
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-08
Identities = 40/134 (29%), Positives = 68/134 (50%), Gaps = 9/134 (6%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREF---QTEIKVIGRTHHRNLVRLL 90
++VG G+ G VYK ++ +A ++ K+ E +F Q EI ++ H N+V
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
G L K + EY GSL DI ++ + ++ + R+ +G+ YLH + + +
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 151 HCDIKPQNILMDEN 164
H DIK NIL+ +N
Sbjct: 129 HRDIKGANILLTDN 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-08
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 25/154 (16%)
Query: 32 FKEKVGRGSSGTVYKG-----AMINRQLVAVNRLEKVLDERE-REFQTEIKVIGRTHHRN 85
F E++G + G +YKG M + QLVA+ L+ + + ++ EFQ E ++ HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILF----------------NAEKQPNWIERTG 129
+V LLG + +++EY++ G L + L + + +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 130 IARDIARGILYLHDECETQIIHCDIKPQNILMDE 163
IA IA G+ YL +H D+ +NIL+ E
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-08
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 35/163 (21%)
Query: 36 VGRGSSGTVYK----GAMINRQ--LVAVNRL-EKVLDEREREFQTEIKVIGRTHHRNLVR 88
+G+G+ G V++ G + +VAV L E+ + + +FQ E ++ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTG------------------- 129
LLG L++EYM+ G L + L + P
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFL--RHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 130 ----IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
IA+ +A G+ YL E + +H D+ +N L+ EN K
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVK 170
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-08
Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 15/140 (10%)
Query: 34 EKVGRGSSGTVYKGAMINR-QLVAVNRLE--KVLDEREREFQ--------TEIKVIGRTH 82
E +G+G+ G VY + +++AV ++E + R Q +EI+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
H N+V+ LG+ + EY+ GS+ L + + R + G+ YLH
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FTEQVLEGLAYLH 125
Query: 143 DECETQIIHCDIKPQNILMD 162
+ I+H D+K N+L+D
Sbjct: 126 SK---GILHRDLKADNLLVD 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-08
Identities = 40/161 (24%), Positives = 60/161 (37%), Gaps = 31/161 (19%)
Query: 32 FKEKVGRGSSGTVY---------------KGAMINRQ--LVAVNRLEKVLDERER-EFQT 73
F EK+G G G V+ LVAV L + R +F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 74 EIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTG---- 129
E+K++ R N+ RLLG ++ EYM NG L L + + +
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 130 ------IARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
+A IA G+ YL +H D+ +N L+ +N
Sbjct: 129 FSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKN 166
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-08
Identities = 36/136 (26%), Positives = 57/136 (41%), Gaps = 12/136 (8%)
Query: 36 VGRGSSGTVY------KGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
+G+G+ G VY G + + V + + + EI+++ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 90 LGYSLEVSKKILVY-EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
G L + + ++ EYM GS+ D L + R R I G+ YLH
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK-YTRQILEGVEYLHSN---M 124
Query: 149 IIHCDIKPQNILMDEN 164
I+H DIK NIL D
Sbjct: 125 IVHRDIKGANILRDSA 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-08
Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 7/147 (4%)
Query: 24 ELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH 83
E+ + + K+G G G V++G N VAV L K ++F E +++ + H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN-AEKQPNWIERTGIARDIARGILYLH 142
L++L +V E M GSL + L A + + +A +A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL- 119
Query: 143 DECETQ-IIHCDIKPQNILMDENRCAK 168
E Q IH D+ +N+L+ EN K
Sbjct: 120 ---EAQNYIHRDLAARNVLVGENNICK 143
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-08
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 25/154 (16%)
Query: 36 VGRGSSGTVYKGAMINRQLVAVNRLEKVLDE-----REREFQTEIKVIGRT-HHRNLVRL 89
+G G+ G V K A I + + ++ K + E R+F E++V+ + HH N++ L
Sbjct: 3 IGEGNFGQVLK-ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNA---EKQPNWIERTG------------IARDI 134
LG L EY +G+L D L + E P + A D+
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
ARG+ YL + Q IH D+ +NIL+ EN AK
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-08
Identities = 32/135 (23%), Positives = 62/135 (45%), Gaps = 6/135 (4%)
Query: 35 KVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
K+G GS+G V + + VAV +++ +R E+ ++ H N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 94 LEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCD 153
L + +V E++ G+L DI+ + I + + + + +LH + +IH D
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI--ATVCLAVLKALSFLHAQ---GVIHRD 140
Query: 154 IKPQNILMDENRCAK 168
IK +IL+ + K
Sbjct: 141 IKSDSILLTSDGRVK 155
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 8e-08
Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLE---KVLDEREREFQTEIKVIGRTHHRNLVRLL 90
++G GS G VY + ++VA+ ++ K +E+ ++ E+K + R H N +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
G L LV EY GS +D+L +K +E I +G+ YLH +I
Sbjct: 92 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMI 147
Query: 151 HCDIKPQNILMDE 163
H DIK NIL+ E
Sbjct: 148 HRDIKAGNILLTE 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-07
Identities = 47/173 (27%), Positives = 73/173 (42%), Gaps = 39/173 (22%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQ-----------------LVAVNRLEKVLDERER-EFQT 73
FKEK+G G G V+ ++N Q LVAV L ++ R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 74 EIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---AEKQPNWIERTG- 129
E+K++ R N++RLLG ++ ++ EYM NG L L + +K+ N +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 130 --------------IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+A IA G+ YL +H D+ +N L+ EN K
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIK 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-07
Identities = 44/140 (31%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
+K+G G G V+ G VAV L+ E F E +++ + H LV+L Y+
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQL--YA 68
Query: 94 LEVSKKI-LVYEYMSNGSLADILFNAE----KQPNWIERTGIARDIARGILYLHDECETQ 148
+ + I +V EYMS GSL D L + E K PN ++ +A +A G+ Y+
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD---MAAQVAAGMAYIE---RMN 122
Query: 149 IIHCDIKPQNILMDENRCAK 168
IH D++ NIL+ + K
Sbjct: 123 YIHRDLRSANILVGDGLVCK 142
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-07
Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 35 KVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-FQT----EIKVIGRTHHRNLVR 88
K+G+G+ G V+K +Q+VA L+KVL E E+E F EIK++ H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 89 LL--------GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILY 140
L+ Y+ LV+E+ + LA +L N + E + + + G+ Y
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 141 LHDECETQIIHCDIKPQNILMDEN 164
+H +I+H D+K NIL+ ++
Sbjct: 135 IH---RNKILHRDMKAANILITKD 155
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-07
Identities = 38/152 (25%), Positives = 64/152 (42%), Gaps = 25/152 (16%)
Query: 36 VGRGSSGTVYKGAMINRQLVAVNRLEKV----------LDEREREFQTEIKVIGRTHHRN 85
+G+GS G VY+G + + +V +V + ER EF E V+ + +
Sbjct: 14 LGQGSFGMVYEG--LAKGVVKGEPETRVAIKTVNENASMRER-IEFLNEASVMKEFNCHH 70
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADIL---------FNAEKQPNWIERTGIARDIAR 136
+VRLLG ++V E M+ G L L P + +A +IA
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 137 GILYLHDECETQIIHCDIKPQNILMDENRCAK 168
G+ YL + +H D+ +N ++ E+ K
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVK 159
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-07
Identities = 36/140 (25%), Positives = 60/140 (42%), Gaps = 10/140 (7%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-----DEREREFQTEIKVIGRTHHRNLVR 88
+++G G+ G+V KG + + V K L ++EF E V+ + H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L+G +LV E G L L + P + +A +A G+ YL
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV-SDLKELAHQVAMGMAYLE---SKH 115
Query: 149 IIHCDIKPQNILMDENRCAK 168
+H D+ +N+L+ AK
Sbjct: 116 FVHRDLAARNVLLVNRHQAK 135
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-07
Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 24/139 (17%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDERERE---FQT--EIKVIGRTHHRNLV 87
EK+G GS TVYKG + IN QLVA+ KV+ + E F E ++ H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVAL----KVISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 88 RLLGYSLEVSKKIL--VYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGILYLH 142
L + + +K+ L V+EYM D+ + P + + + RG+ Y+H
Sbjct: 67 LL--HDIIHTKETLTFVFEYMH----TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 143 DECETQIIHCDIKPQNILM 161
+ I+H D+KPQN+L+
Sbjct: 121 GQ---HILHRDLKPQNLLI 136
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-07
Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 15/129 (11%)
Query: 38 RGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV 96
+ S+G +Y +I + ++ N++++VL ER+ ++ + +V+L YS +
Sbjct: 14 KKSTGDIYAIKVIKKADMIRKNQVDQVLTERD--------ILSQAQSPYVVKLY-YSFQG 64
Query: 97 SKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIK 155
K + LV EY+ G LA +L N + R IA +I + YLH IIH D+K
Sbjct: 65 KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH---SNGIIHRDLK 120
Query: 156 PQNILMDEN 164
P NIL+D N
Sbjct: 121 PDNILIDSN 129
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-07
Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 19/141 (13%)
Query: 34 EKVGRGSSGTVY--KGAMINRQLVAVN-RLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
+K+G GS G +Y K + V L K+ + + + E+ ++ + H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 91 GYSLEVSKKILVYEYMSNGSLAD-------ILFNAEKQPNWIERTGIARDIARGILYLHD 143
E + +V EY G L +LF+ ++ +W + I+ G+ ++HD
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIHD 119
Query: 144 ECETQIIHCDIKPQNILMDEN 164
+I+H DIK QNI + +N
Sbjct: 120 R---KILHRDIKSQNIFLSKN 137
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-07
Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 8/138 (5%)
Query: 36 VGRGSSGTVYKGAMI---NRQL-VAVNRL-EKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
+G G G + +G + R+L VA++ L D++ R F E +G+ H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
G + ++V EYMSNG+L L E Q + G+ +A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYV 129
Query: 151 HCDIKPQNILMDENRCAK 168
H + +L++ + K
Sbjct: 130 HKGLAAHKVLVNSDLVCK 147
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-07
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 24/158 (15%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN 85
K ++G G+ G V+ N + LVAV L+ ++FQ E +++ H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSL--------ADILFNAEKQP-------NWIERTGI 130
+V+ G + I+V+EYM +G L D + + QP + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 131 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A IA G++YL + +H D+ +N L+ N K
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 3e-07
Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 26/151 (17%)
Query: 32 FKEKVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREF----QT---EIKVIGRTHH 83
+K+G G+ VYK ++VA+ +++ L ER+ T EIK++ H
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKDGINFTALREIKLLQELKH 61
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSL------ADILFNAEKQPNWIERTGIARDIARG 137
N++ LL S LV+E+M L I+ +++ T RG
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------LRG 114
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ YLH I+H D+KP N+L+ + K
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLK 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-07
Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 17/139 (12%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNR-LEKVLDEREREFQT-EIKVIGRTHHRNLVRLL 90
K+G GS G V+K Q+VA+ + +E D ++ EI+++ + H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 91 GYSLEVSKKI----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
EV ++ LV+EY + L ++ EK P + I + I L + C
Sbjct: 67 ----EVFRRKRKLHLVFEYCDHTVLNEL----EKNPRGVPEHLI-KKIIWQTLQAVNFCH 117
Query: 147 TQ-IIHCDIKPQNILMDEN 164
IH D+KP+NIL+ +
Sbjct: 118 KHNCIHRDVKPENILITKQ 136
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-07
Identities = 35/119 (29%), Positives = 61/119 (51%), Gaps = 8/119 (6%)
Query: 53 QLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRLLGYSLEVSKKI--LVYEYMSNG 109
++VAV L++ ++ ++ EI ++ +H N+V+ G E K L+ EY+ G
Sbjct: 34 EMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93
Query: 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
SL D L + + N + A+ I G+ YLH + IH D+ +N+L+D +R K
Sbjct: 94 SLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVK 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-07
Identities = 37/137 (27%), Positives = 68/137 (49%), Gaps = 11/137 (8%)
Query: 33 KEKVGRGSSGTVYKGA-MINRQLVAVNRLE-KVLDERER-EFQTEIKVIGRTHHRNLVRL 89
K+G+GS G V+K ++++ A+ +++ ++ RER E E +V+ + ++R
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGILYLHDECE 146
L+ K +V EY NG L +L +P + + R I G+ +LH +
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP--LPEDQVWRFFIQILLGLAHLHSK-- 120
Query: 147 TQIIHCDIKPQNILMDE 163
+I+H DIK N+ +D
Sbjct: 121 -KILHRDIKSLNLFLDA 136
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-07
Identities = 40/144 (27%), Positives = 69/144 (47%), Gaps = 26/144 (18%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKV-LD-EREREFQT---EIKVIGRTHHRNLVR 88
EK+G G+ G VYK N+ V L+K+ LD E E T EI ++ +H N+V+
Sbjct: 6 EKIGEGTYGVVYKAR--NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR--------GILY 140
LL +K LV+E++ + +K + +GI + + G+ +
Sbjct: 64 LLDVIHTENKLYLVFEFLHQ--------DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 141 LHDECETQIIHCDIKPQNILMDEN 164
H +++H D+KPQN+L++
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTE 136
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-07
Identities = 35/137 (25%), Positives = 62/137 (45%), Gaps = 5/137 (3%)
Query: 34 EKVGRGSSGTVYKGAM-INRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLG 91
E++GRG+ G V+ G + + VAV + L + + +F E +++ + H N+VRL+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
+ +V E + G L + E + + A G+ YL + IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117
Query: 152 CDIKPQNILMDENRCAK 168
D+ +N L+ E K
Sbjct: 118 RDLAARNCLVTEKNVLK 134
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-07
Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 21/147 (14%)
Query: 34 EKVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDERERE-----FQTEIKVIGRTHHRN-L 86
EK+G G+ G VYK N +LVA L+K E + E EI ++ +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVA---LKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 87 VRLLG--YSLEVSKKI---LVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGI 138
VRLL + E + K LV+EY+ + + N + I + +G+
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 139 LYLHDECETQIIHCDIKPQNILMDENR 165
+ H ++H D+KPQN+L+D+ +
Sbjct: 124 AHCHKH---GVMHRDLKPQNLLVDKQK 147
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 5e-07
Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 14/136 (10%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQT--EIKVIGRTHHRNLVRLL 90
EK+G GS TVYKG + +N +LVA+ ++ ++ +E F E ++ H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVAL-KVIRLQEEEGTPFTAIREASLLKGLKHANIVLLH 69
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGILYLHDECET 147
LV+EY+ D+ +K P + + + RG+ Y+H +
Sbjct: 70 DIIHTKETLTLVFEYVH----TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QR 122
Query: 148 QIIHCDIKPQNILMDE 163
I+H D+KPQN+L+ +
Sbjct: 123 YILHRDLKPQNLLISD 138
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-07
Identities = 42/141 (29%), Positives = 58/141 (41%), Gaps = 10/141 (7%)
Query: 34 EKVGRGSSGTVYKGAMIN----RQLVAVNRLEK-VLDEREREFQTEIKVIGRTHHRNLVR 88
+K+G GS G V +G VAV L+ L + +F E ++ H NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIER-TGIARDIARGILYLHDECET 147
L G L +V E GSL D L I A IA G+ YL
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 148 QIIHCDIKPQNILMDENRCAK 168
+ IH D+ +NIL+ + K
Sbjct: 117 RFIHRDLAARNILLASDDKVK 137
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-07
Identities = 34/151 (22%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 33 KEKVGRGSSGTVYKGA-MINRQLVAVNRLE--KVLDERERE-FQTEIKVIGRTHHRNLVR 88
++K+GRG VY+ +++R+ VA+ +++ +++D + R+ EI ++ + +H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGILYLHDEC 145
L +E ++ +V E G L+ ++ +KQ I + + + + ++H
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR- 125
Query: 146 ETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176
+++H DIKP N+ + K L +G+
Sbjct: 126 --RVMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 7e-07
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 14/137 (10%)
Query: 35 KVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDEREREFQT---EIKVIGRTHHRNLVR 88
+GRG+ G VYK N + A+ + + ++ Q+ EI ++ H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 89 LLGYSLE-VSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGILYLHD 143
L+ LE K + L+++Y + I F+ + + I + + I G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH- 125
Query: 144 ECETQIIHCDIKPQNIL 160
++H D+KP NIL
Sbjct: 126 --SNWVLHRDLKPANIL 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 8e-07
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 17/148 (11%)
Query: 35 KVGRGSSG----TVYKGAMINRQLVAVNR--LEKVLDEREREFQTEIKVIGRTHHRNLVR 88
+G+ + K LVAV + L+ E + Q EI + H N++
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDEC 145
+ + S+ +V M+ GS D+L P + IA +D+ + Y+H +
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSK- 120
Query: 146 ETQIIHCDIKPQNILMDENRCAK--NFR 171
IH +K +IL+ + R
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLR 146
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-06
Identities = 34/123 (27%), Positives = 56/123 (45%), Gaps = 11/123 (8%)
Query: 59 RLEKVLDERER-EFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL--VYEYMSNGSLADIL 115
R + +E +R F+ E + R +H N+V LL S E +L V+EY+ +L ++L
Sbjct: 12 RTDAPEEEHQRARFRRETALCARLYHPNIVALLD-SGEAPPGLLFAVFEYVPGRTLREVL 70
Query: 116 FNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKNFRL 172
P E + + + H++ I+H D+KPQNI++ AK
Sbjct: 71 AADGALPA-GETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDF 126
Query: 173 WIG 175
IG
Sbjct: 127 GIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-06
Identities = 32/136 (23%), Positives = 62/136 (45%), Gaps = 11/136 (8%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQT----EIKVIGRTHHRNLVR 88
K+G G+ G VYK + ++VA+ +++ L EIK++ +H N+++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
LL LV+E+M I P + ++ + +G+ + H
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKS-YLYQLLQGLAFCH---SHG 118
Query: 149 IIHCDIKPQNILMDEN 164
I+H D+KP+N+L++
Sbjct: 119 ILHRDLKPENLLINTE 134
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-06
Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
+ +G+G G V G + VAV ++ D + F E V+ + H NLV+LLG
Sbjct: 12 QTIGKGEFGDVMLGDYRGNK-VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 94 LEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIER-TGIARDIARGILYLHDECETQIIH 151
+E + +V EYM+ GSL D L + + + + D+ + YL +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 152 CDIKPQNILMDENRCAK 168
D+ +N+L+ E+ AK
Sbjct: 126 RDLAARNVLVSEDNVAK 142
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-06
Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 35 KVGRGSSGTVYKGAMINRQ---LVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
++G G+ G VYK N++ L A +E +E ++ EI+++ +H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
K ++ E+ G++ I+ ++ + I R + + YLH +IIH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 152 CDIKPQNILM 161
D+K N+L+
Sbjct: 134 RDLKAGNVLL 143
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 31/165 (18%)
Query: 32 FKEKVGRGSSGTVY-----------------KGAMINRQLVAVNRLEKVLDERER-EFQT 73
FKEK+G G G V+ + LVAV L + ++ R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 74 EIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNAEKQPNWIERTGI- 130
EIK++ R N++RLL + ++ EYM NG L L ++ + I
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 131 -------ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A IA G+ YL +H D+ +N L+ +N K
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIK 170
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-06
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 27/150 (18%)
Query: 24 ELKKITDGFKEKVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDER-----EREFQTEIKV 77
ELK++ + +G G+ GTVYKG + + V + K+L+E EF E +
Sbjct: 8 ELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNAEKQPNWIERTGIA 131
+ H +LVRLLG L + + LV + M +G L D + ++ NW +
Sbjct: 63 MASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ---- 117
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILM 161
IA+G++YL E +++H D+ +N+L+
Sbjct: 118 --IAKGMMYLE---ERRLVHRDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 20/146 (13%)
Query: 24 ELKKITDGFKEKVGRGSSGTVYK------GAMINRQLVAVNRLEKVLDEREREFQTEIKV 77
+L+ I+D +G G+ G+V K G ++ +++V + V + RE Q +
Sbjct: 6 DLETISD-----LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----I 56
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTG-IARDIAR 136
+ +V G L + + E+M GSL I + P +E G IA +
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVE 114
Query: 137 GILYLHDECETQIIHCDIKPQNILMD 162
G+ YL++ +I+H DIKP NIL++
Sbjct: 115 GLTYLYNV--HRIMHRDIKPSNILVN 138
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 33/133 (24%), Positives = 62/133 (46%), Gaps = 13/133 (9%)
Query: 36 VGRGSSG--TVYKGAMINRQLV--AVNRLEKVLDEREREF-QTEIKVIGRTHHRNLVRLL 90
+G+G+ G T+Y+ + +V VN L E+ER EI ++ H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTR--LSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIAR--DIARGILYLHDECETQ 148
+ ++ + ++ EY + G+L D + +K + E + I + Y+H +
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121
Query: 149 IIHCDIKPQNILM 161
I+H DIK NI +
Sbjct: 122 ILHRDIKTLNIFL 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-06
Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 32/145 (22%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVN--RLEKVLDE-------REREFQTEIKVIGRTHH 83
+K+G GS TVYKG + + QLVA+ RLE +E RE ++K H
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLK------H 62
Query: 84 RNLVRLLGYSLEVSKKIL--VYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGI 138
N+V L + + +KK L V+EY+ D+ + + + + RG+
Sbjct: 63 ANIVTL--HDIIHTKKTLTLVFEYLDT----DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 139 LYLHDECETQIIHCDIKPQNILMDE 163
Y H +++H D+KPQN+L+ E
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISE 138
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-06
Identities = 35/129 (27%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRLL-GY 92
++G G+ G VYK ++A ++ E E E + EI ++ H N+V+LL +
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
E + IL+ E+ + G++ ++ E+ + + + + YLH E +IIH
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127
Query: 153 DIKPQNILM 161
D+K NIL
Sbjct: 128 DLKAGNILF 136
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-06
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 20 FSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQ---LVAVNRLEKVLDERE-REFQTEI 75
F+ +LK ++GRG+ GTV K M+++ ++AV R+ +DE+E + ++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 76 KVIGRTHH-RNLVRLLGYSLEVSKKILVYEYM--SNGSLADILFNAEKQPNWIERT--GI 130
V+ R+ +V+ G + E M S ++ K E I
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKS-VIPEEILGKI 112
Query: 131 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A + + YL +E +IIH D+KP NIL+D N K
Sbjct: 113 AVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIK 148
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-06
Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 14/139 (10%)
Query: 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSL 94
K+G+G G V+ G VA+ L+ E F E +V+ + H LV+L Y++
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 95 EVSKKI-LVYEYMSNGSLADILFNAE----KQPNWIERTGIARDIARGILYLHDECETQI 149
+ I +V EYMS GSL D L + P ++ +A IA G+ Y+
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIASGMAYVE---RMNY 123
Query: 150 IHCDIKPQNILMDENRCAK 168
+H D++ NIL+ EN K
Sbjct: 124 VHRDLRAANILVGENLVCK 142
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-06
Identities = 34/128 (26%), Positives = 62/128 (48%), Gaps = 6/128 (4%)
Query: 35 KVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
K+G GS+G V + + VAV +++ +R E+ ++ HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 94 LEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCD 153
L + +V E++ G+L DI+ + I + + R + YLH++ +IH D
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI--ATVCLSVLRALSYLHNQ---GVIHRD 143
Query: 154 IKPQNILM 161
IK +IL+
Sbjct: 144 IKSDSILL 151
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-06
Identities = 39/160 (24%), Positives = 71/160 (44%), Gaps = 30/160 (18%)
Query: 34 EKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDERE-REFQTEI---KVIGRTHH 83
+ +G G+ G V K + VAV L+ E++ + +E+ K+IG+ H
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 75
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNAEKQPNWIERT 128
+N++ LLG + +V EY ++G+L D L E+ +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 129 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A +ARG+ +L + + IH D+ +N+L+ E+ K
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMK 172
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-06
Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 10/133 (7%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQT--EIKVIGRTHHRNLVRLLGY 92
VG G+ G V + Q VA+ ++ K +T E+K++ H N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 93 SLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
+ + I V E + L +L + + +I+ I RG+ Y+H ++H
Sbjct: 78 FISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY--FLYQILRGLKYVH---SAGVVH 131
Query: 152 CDIKPQNILMDEN 164
D+KP NIL++EN
Sbjct: 132 RDLKPSNILINEN 144
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-06
Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 30/143 (20%)
Query: 36 VGRGSSGTVYK---------GAM--INRQL-VAVNRLEKVLDEREREFQTEIKVIGRTHH 83
+G+G+ G V AM +N+Q V + VL ER E+ H
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL--NERRILQELN------H 59
Query: 84 RNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG--IARDIARGILY 140
LV L YS + + + LV + + G D+ ++ ++ + E +I + Y
Sbjct: 60 PFLVNLW-YSFQDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 141 LHDECETQIIHCDIKPQNILMDE 163
LH IIH DIKP NIL+DE
Sbjct: 116 LH---SKGIIHRDIKPDNILLDE 135
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-06
Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 5/62 (8%)
Query: 104 EYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD 162
E+M GSL +L A + P N + + IA + RG+ YL ++ +I+H D+KP NIL++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREK--HKIMHRDVKPSNILVN 134
Query: 163 EN 164
Sbjct: 135 SR 136
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-06
Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 29/146 (19%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-FQT----EIKVIGRTHHRNLVRL 89
+G G+ G VYK +LVA L+KV + E+E F EIK++ + +HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVA---LKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 90 LGY------SLEVSKK----ILVYEYMSN---GSLADILFNAEKQPNWIERTGIARDIAR 136
+L+ K LV+EYM + G L L + + + +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI----KSFMKQLLE 127
Query: 137 GILYLHDECETQIIHCDIKPQNILMD 162
G+ Y H +H DIK NIL++
Sbjct: 128 GLNYCHK---KNFLHRDIKCSNILLN 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-06
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 49/173 (28%)
Query: 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREF-QTEIKVIGRTHHRNLVR----- 88
K+G G+ G VYK +++N+Q + K + ++ E+ EI + R VR
Sbjct: 139 KLGEGAFGVVYKASLVNKQS---KKEGKYVLKKATEYGAVEIWMNER------VRRACPN 189
Query: 89 -----LLGYSLEVSKK-----ILVYEYMSNGSLADIL------FNAEK--------QPNW 124
+ G+ VS K LV+ Y +LAD++ +N E P
Sbjct: 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG 249
Query: 125 IERTG-IARDIARGILY----LHDECETQIIHCDIKPQNILMDENRCAKNFRL 172
+ER I + I R IL+ LH T I+H D+KPQNI+ E + +F++
Sbjct: 250 LERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEG--SGSFKI 297
|
Length = 566 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-06
Identities = 40/134 (29%), Positives = 59/134 (44%), Gaps = 11/134 (8%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
+K+G G G V+ G N VAV L K + F E ++ H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 94 LEVSKKILVYEYMSNGSLADILFNAEKQ----PNWIERTGIARDIARGILYLHDECETQI 149
+ ++ EYM+ GSL D L + E P I+ + IA G+ Y+
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID---FSAQIAEGMAYIE---RKNY 124
Query: 150 IHCDIKPQNILMDE 163
IH D++ N+L+ E
Sbjct: 125 IHRDLRAANVLVSE 138
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-06
Identities = 33/128 (25%), Positives = 62/128 (48%), Gaps = 6/128 (4%)
Query: 35 KVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
K+G GS+G V + + +LVAV +++ +R E+ ++ H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 94 LEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCD 153
L + +V E++ G+L DI+ + I +A + + + LH + +IH D
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLKALSVLHAQ---GVIHRD 141
Query: 154 IKPQNILM 161
IK +IL+
Sbjct: 142 IKSDSILL 149
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-06
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 20/148 (13%)
Query: 34 EKVGRGSSGTVYK-------GAMINRQLVAVNRLEKVLDERERE-----FQTEIKVIGRT 81
E +G G+ G VYK ++ + + V+ D+RER+ +E+ +I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 82 -HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNA--EKQPNWIERT--GIARDIAR 136
H N+VR LE + +V + + L + FN+ EK+ + E I +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 137 GILYLHDECETQIIHCDIKPQNILMDEN 164
+ YLH E +I+H D+ P NI++ E+
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGED 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-05
Identities = 37/156 (23%), Positives = 69/156 (44%), Gaps = 22/156 (14%)
Query: 36 VGRGSSGTVYKGAM----INRQLVAVNRLE-KVLDERE-REFQTEIKVIGRTHHRNLVRL 89
+G G G+V +G + ++ VAV ++ + E EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 90 LGYSLEVSKK------ILVYEYMSNGSLADILFNA--EKQPNWIERTGIAR---DIARGI 138
+G E S +++ +M +G L L + P + + + DIA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 139 LYLHDECETQIIHCDIKPQNILMDENR--CAKNFRL 172
YL + IH D+ +N ++ E+ C +F L
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-05
Identities = 37/135 (27%), Positives = 62/135 (45%), Gaps = 8/135 (5%)
Query: 34 EKVGRGSSGTVYK-GAMINRQLVAVNRLEKVLDEREREFQTEIKVI-GRTHHRNLVRLLG 91
E +G+G+ G V+K N AV L+ + D E E + E ++ + H N+V+ G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYG 82
Query: 92 YSLEVSKKI-----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
+ K LV E + GS+ D++ K+ +E IA + ++ L
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 147 TQIIHCDIKPQNILM 161
+ IH D+K NIL+
Sbjct: 143 NKTIHRDVKGNNILL 157
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-05
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 14/140 (10%)
Query: 32 FKEKVGRGSSGTV----YKGAMINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHR 84
F + +G GS G V +KG + + A+ L K ++ ++ E E +++ H
Sbjct: 5 FIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
LV L G + S LV EY+ G L L + + P + R A + + YLH
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA-QVVLALEYLHSL 120
Query: 145 CETQIIHCDIKPQNILMDEN 164
I++ D+KP+N+L+D +
Sbjct: 121 ---DIVYRDLKPENLLLDSD 137
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-05
Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 14/139 (10%)
Query: 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSL 94
K+G+G G V+ G VA+ L+ E F E +++ + H LV L Y++
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 95 EVSKKI-LVYEYMSNGSLADILFNAE----KQPNWIERTGIARDIARGILYLHDECETQI 149
+ I +V E+M GSL D L + K P ++ +A IA G+ Y+
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD---MAAQIADGMAYIE---RMNY 123
Query: 150 IHCDIKPQNILMDENRCAK 168
IH D++ NIL+ +N K
Sbjct: 124 IHRDLRAANILVGDNLVCK 142
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 45/153 (29%)
Query: 36 VGRGSSGTVYKGAMINR--QLVAVNRLEKVLDERE---REFQTEIKVIGRTHHRNLVRLL 90
+G G+ G V A+ R + VA+ ++ V D+ R + EIK++ H N++ LL
Sbjct: 8 IGSGAYGVVCS-AVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLL 65
Query: 91 -----GYSLEVSKKILVYEYM---------SNGSLAD-----ILFNAEKQPNWIERTGIA 131
+ + +V E M S L D L+
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ-------------- 111
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
I RG+ YLH +IH D+KP NIL++ N
Sbjct: 112 --ILRGLKYLH---SANVIHRDLKPSNILVNSN 139
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 47/162 (29%)
Query: 25 LKKITDGFKEKVGRGSSGTVY-----------------KGAMINRQLVAVNRLEKVLDER 67
KKI + +G+G G V+ K MI R N++++VL E+
Sbjct: 3 FKKI-----KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR-----NKVKRVLTEQ 52
Query: 68 EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIE 126
E ++ H L L S + + LV +Y G L +L ++QP
Sbjct: 53 E--------ILATLDHPFLPTLYA-SFQTETYLCLVMDYCPGGELFRLL---QRQPGKCL 100
Query: 127 RTGIARDIARGIL----YLHDECETQIIHCDIKPQNILMDEN 164
+AR A +L YLH I++ D+KP+NIL+ E+
Sbjct: 101 SEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHES 139
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-05
Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 35 KVGRGSSGTVYK------GAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVR 88
++G G+ G V K G ++ R+L+ + + ++ RE Q V+ + +V
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECNSPYIVG 67
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWI-ERTGIARDIARGILYLHDECET 147
G + + E+M GSL +L A++ P I + IA + RG+ YL ++
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK--H 123
Query: 148 QIIHCDIKPQNILMD 162
QI+H D+KP NIL++
Sbjct: 124 QIMHRDVKPSNILVN 138
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-05
Identities = 37/155 (23%), Positives = 70/155 (45%), Gaps = 21/155 (13%)
Query: 36 VGRGSSGTVYKGAMINRQL---VAVNRLEKVLDERER--EFQTEIKVIGRTHHRNLVRLL 90
+G G G+V +G + VAV ++ + R +F +E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 91 GYSLEVSKK------ILVYEYMSNGSLADILFNAE--KQPNWIERTGIAR---DIARGIL 139
G L+ + +++ +M +G L L + P ++ + + DIA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 140 YLHDECETQIIHCDIKPQNILMDENR--CAKNFRL 172
YL + IH D+ +N +++EN C +F L
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-05
Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVR 88
F +++G G G V+ G + VA+ K ++E E +F E KV+ + H LV+
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAI----KAINEGAMSEEDFIEEAKVMMKLSHPKLVQ 63
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L G + +V E+M NG L + L + + + + +D+ G+ YL
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNS 120
Query: 149 IIHCDIKPQNILMDE 163
IH D+ +N L+
Sbjct: 121 FIHRDLAARNCLVSS 135
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 36/137 (26%), Positives = 68/137 (49%), Gaps = 12/137 (8%)
Query: 36 VGRGSSGTVYKGAM-INRQLVAVNRLEKVLDEREREFQ---TEIKVIGRTHHRNLVRLLG 91
+G+G G V M +L A +L K ++ + ++ E +++ + H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 92 YSLEVSKKI-LVYEYMSNGSLADILFNA-EKQPNWIERTGI--ARDIARGILYLHDECET 147
Y+ + + LV M+ G L ++N E+ P + E I G+ +LH +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116
Query: 148 QIIHCDIKPQNILMDEN 164
+II+ D+KP+N+L+D +
Sbjct: 117 RIIYRDLKPENVLLDND 133
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-05
Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 35 KVGRGSSGTVYKGA---MINRQL---VAVNRLEKVLDERER-EFQTEIKVIGRTHHRNLV 87
++G+GS G VY+G +I + VAV + + RER EF E V+ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILF----NAEKQ-----PNWIERTGIARDIARGI 138
RLLG + ++V E M++G L L AE P E +A +IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 139 LYLHDECETQIIHCDIKPQNILMDENRCAK 168
YL+ + + +H D+ +N ++ + K
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVK 159
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 33/138 (23%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLE------KVLDEREREFQTEI----KVIGRTHH 83
E +G+G+ ++KG I R++ L KVLD+ R + ++ + H
Sbjct: 1 ESLGQGTFTKIFKG--IRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH 58
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
++LV G + + I+V EY+ GSL L + N + +A+ +A + +L D
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 144 ECETQIIHCDIKPQNILM 161
+ + H ++ +N+L+
Sbjct: 119 K---GLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-05
Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 34 EKVGRGSSGTVYKGAMINRQ---LVAVNRLEKVLDEREREFQTEIKVI-GRTHHRNLVRL 89
E +G+G+ G VYK + N++ L AV L+ + D E E + E ++ +H N+V+
Sbjct: 28 ETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKF 84
Query: 90 LGYSLEVSKKI-----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
G + K + LV E + GS+ +++ ++ I+ + +L L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 145 CETQIIHCDIKPQNILM 161
+IIH D+K NIL+
Sbjct: 145 HNNRIIHRDVKGNNILL 161
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-05
Identities = 32/148 (21%), Positives = 73/148 (49%), Gaps = 4/148 (2%)
Query: 33 KEKVGRGSSGTVYKGA-MINRQLVAVNRLE--KVLDERER-EFQTEIKVIGRTHHRNLVR 88
++K+GRG VY+ +++ VA+ +++ ++D + R + EI ++ + +H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
+E ++ +V E G L+ ++ + +KQ I + + + L +
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 149 IIHCDIKPQNILMDENRCAKNFRLWIGK 176
++H DIKP N+ + K L +G+
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-05
Identities = 32/136 (23%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDERE-REFQTEIKVIGRTHH---RNLVR 88
E +GRG+ G VY+G + ++VA+ + + + + Q E+ ++ + N+ +
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDEC 145
G L+ + ++ EY GS+ ++ + I I+ R++ + Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVLVALKYIH--- 118
Query: 146 ETQIIHCDIKPQNILM 161
+ +IH DIK NIL+
Sbjct: 119 KVGVIHRDIKAANILV 134
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-05
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 26 KKITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKVI 78
+KIT ++G+GS G VY+G VA+ + + RER EF E V+
Sbjct: 6 EKIT--MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 79 GRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN---------AEKQPNWIERTG 129
+ ++VRLLG + +++ E M+ G L L + + P+ +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 130 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+A +IA G+ YL+ + +H D+ +N ++ E+ K
Sbjct: 124 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-05
Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 24 ELKKITDGFKE--KVGRGSSGTVYK------GAMINRQLVAVNRLEKVLDEREREFQTEI 75
ELK D F++ ++G G+ G V+K G ++ R+L+ + + ++ RE Q
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ--- 55
Query: 76 KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWI-ERTGIARDI 134
V+ + +V G + + E+M GSL +L A + P I + IA +
Sbjct: 56 -VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--V 112
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMD 162
+G+ YL ++ +I+H D+KP NIL++
Sbjct: 113 IKGLTYLREK--HKIMHRDVKPSNILVN 138
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 1e-04
Identities = 34/138 (24%), Positives = 63/138 (45%), Gaps = 15/138 (10%)
Query: 34 EKVGRGSSGTVYKG---AMINRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNLVRL 89
+++G G G V G +++ V V L E+ F E++ +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 90 LGYSLEVSKKILVYEYMSNGSLADIL------FNAEKQPNWIERTGIARDIARGILYLHD 143
LG +E +LV E+ G L + L Q + ++R +A ++A G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLH- 117
Query: 144 ECETQIIHCDIKPQNILM 161
+ IH D+ +N +
Sbjct: 118 --QADFIHSDLALRNCQL 133
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 1e-04
Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 34 EKVGRGSSGTVYKGAM---INRQLVAVNRLE---KVLDEREREFQTEIKVIGRTHHRNLV 87
+++G G G V G + V V L V ++ + F E + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK--FLEEAQPYRSLQHSNLL 58
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEK------QPNWIERTGIARDIARGILYL 141
+ LG EV+ +LV E+ G L L + K P ++R +A +IA G+L+L
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHL 116
Query: 142 HDECETQIIHCDIKPQNILMDEN 164
H + IH D+ +N L+ +
Sbjct: 117 H---KNNFIHSDLALRNCLLTAD 136
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 1e-04
Identities = 33/129 (25%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 35 KVGRGSSGTV--YKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
K+G GS+G V + RQ VAV ++ +R E+ ++ H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQ-VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L + ++ E++ G+L DI+ ++ + N + + + + + YLH + +IH
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHR 141
Query: 153 DIKPQNILM 161
DIK +IL+
Sbjct: 142 DIKSDSILL 150
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 1e-04
Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 32/146 (21%)
Query: 33 KEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLD------EREREFQTEIKVIGR-TH 82
+K+G+G+ G V+K I+R ++VA L+K+ D + +R F+ EI +
Sbjct: 12 LQKLGKGAYGIVWKA--IDRRTKEVVA---LKKIFDAFRNATDAQRTFR-EIMFLQELGD 65
Query: 83 HRNLVRLLG-YSLEVSKKI-LVYEYM----SNGSLADILFNAEKQPNWIERTGIARDIAR 136
H N+V+LL E K I LV+EYM A+IL + K+ I + +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR-------YIMYQLLK 118
Query: 137 GILYLHDECETQIIHCDIKPQNILMD 162
+ Y+H +IH D+KP NIL++
Sbjct: 119 ALKYIH---SGNVIHRDLKPSNILLN 141
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 32/133 (24%), Positives = 71/133 (53%), Gaps = 10/133 (7%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLE-KVLDEREREFQTEIKVIGRTHHRNLVRL 89
++E +G G+ GTVYK ++ R+++AV + + E +++ +E++++ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
G ++ + E+M GSL D+ + + R +A + +G+ YL +I
Sbjct: 65 YGAFFVENRISICTEFMDGGSL-DVYRKIPEHV--LGRIAVA--VVKGLTYLWS---LKI 116
Query: 150 IHCDIKPQNILMD 162
+H D+KP N+L++
Sbjct: 117 LHRDVKPSNMLVN 129
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 15/135 (11%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRT-HHRNLVRLL 90
+G+GS G V + AV L+K +L ++E+ E V+ + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 91 GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG--IARDIARGILYLHDECET 147
YS + ++K+ V +Y++ G L F+ +++ ++E A ++A I YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHSL--- 115
Query: 148 QIIHCDIKPQNILMD 162
II+ D+KP+NIL+D
Sbjct: 116 NIIYRDLKPENILLD 130
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 20/144 (13%)
Query: 32 FKEKVGRGSSGTVYKG-------AMINRQLVAVNRLEKVLDERE-REFQTEIKVIGRTHH 83
+++G+G+ G+VYK M +++ RLE LDE + + E+ ++ +
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEI----RLE--LDESKFNQIIMELDILHKAVS 58
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR---GILY 140
+V G + EYM GSL D L+ I + R G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 141 LHDECETQIIHCDIKPQNILMDEN 164
L +E IIH D+KP N+L++ N
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGN 139
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 39/163 (23%), Positives = 69/163 (42%), Gaps = 33/163 (20%)
Query: 36 VGRGSSGTVYKGAMINRQ------LVAVNRLEKVLDERE-REFQTEIKVIGRTHHRNLVR 88
+G G G V K + VAV L++ E R+ +E ++ + +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEK-QPNWIERTG------------------ 129
L G + +L+ EY GSL L + K P+++ G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 130 ----IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A I+RG+ YL E +++H D+ +N+L+ E R K
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMK 167
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 2e-04
Identities = 39/136 (28%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 36 VGRGSSGTVY--KGAMINRQLVAVNRLEKVLDERERE-----FQTEIKVIGRTHHRNLVR 88
+G+G+ G VY A R+L AV +++ + E + EI+++ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGREL-AVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 89 LLGYSLEVSKKIL--VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
G + ++ L E+M GS+ D L + + R R I G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK-YTRQILEGVSYLH---S 124
Query: 147 TQIIHCDIKPQNILMD 162
I+H DIK NIL D
Sbjct: 125 NMIVHRDIKGANILRD 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 15/135 (11%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLEK--VLDERE-REFQTEIKV-IGRTHHRNLVRLL 90
+G+GS G V + + AV L+K +L ++E + E V + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 91 GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG--IARDIARGILYLHDECET 147
YS + + K+ V +Y++ G L F+ +++ ++ E A +IA + YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLH---SL 115
Query: 148 QIIHCDIKPQNILMD 162
II+ D+KP+NIL+D
Sbjct: 116 NIIYRDLKPENILLD 130
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 2e-04
Identities = 38/134 (28%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQT---EIKVIGRTHHRNLVRL 89
+K+G G+ TV+KG + + LVA+ + L+ E T E+ ++ H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
LV+EY+ + L L N + + RG+ Y H + +I
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124
Query: 150 IHCDIKPQNILMDE 163
+H D+KPQN+L++E
Sbjct: 125 LHRDLKPQNLLINE 138
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 2e-04
Identities = 38/134 (28%), Positives = 63/134 (47%), Gaps = 10/134 (7%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQT---EIKVIGRTHHRNLVRL 89
+K+G G+ TVYKG + + LVA+ + L+ E T E+ ++ H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
LV+EY+ + L L + N + RG+ Y H ++
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 150 IHCDIKPQNILMDE 163
+H D+KPQN+L++E
Sbjct: 126 LHRDLKPQNLLINE 139
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 36/135 (26%), Positives = 67/135 (49%), Gaps = 12/135 (8%)
Query: 36 VGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQ---TEIKVIGRTHHRNLVRLLG 91
+G+G G V + ++ A +L+K ++ + Q E K++ + R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 92 YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGI--ARDIARGILYLHDECETQ 148
Y+ E + LV M+ G L ++N +P + E I A I G+ +LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---R 115
Query: 149 IIHCDIKPQNILMDE 163
I++ D+KP+N+L+D+
Sbjct: 116 IVYRDLKPENVLLDD 130
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 35/139 (25%), Positives = 67/139 (48%), Gaps = 8/139 (5%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDERE-REFQTEIKVIGRTHH-RNLVRLL 90
++G G+ G VYK ++AV ++ + ++ E + ++ V+ ++H +V+
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTG-IARDIARGILYLHDECETQI 149
GY + S + E MS + D L + P + G + I + + YL ++ +
Sbjct: 81 GYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGV 136
Query: 150 IHCDIKPQNILMDENRCAK 168
IH D+KP NIL+D + K
Sbjct: 137 IHRDVKPSNILLDASGNVK 155
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 3e-04
Identities = 43/136 (31%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 36 VGRGSSGTVY--KGAMINRQLVAVNRLEKVLDERERE-----FQTEIKVIGRTHHRNLVR 88
+GRG+ G VY A R+L AV ++ D +E + EI+++ H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGREL-AVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 89 LLGYSLEVSKKIL--VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
G + +K L EYM GS+ D L + R R I +G+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR-YTRQILQGVSYLHS--- 124
Query: 147 TQIIHCDIKPQNILMD 162
I+H DIK NIL D
Sbjct: 125 NMIVHRDIKGANILRD 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|234779 PRK00485, fumC, fumarate hydratase; Reviewed | Back alignment and domain information |
|---|
Score = 39.7 bits (94), Expect = 4e-04
Identities = 17/51 (33%), Positives = 23/51 (45%), Gaps = 9/51 (17%)
Query: 40 SSGTVYKGAM-------INRQLV-AVNRLEKVLDEREREFQTEIKVIGRTH 82
SS + AM I +L+ A+ L L + EF +K IGRTH
Sbjct: 139 SSNDTFPTAMHIAAVLAIVERLLPALEHLRDTLAAKAEEFADIVK-IGRTH 188
|
Length = 464 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 4e-04
Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 10/134 (7%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQT---EIKVIGRTHHRNLVRL 89
EK+G G+ TV+KG + + LVA+ + L+ E T E+ ++ H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
LV+EY+ + L + + + I RG+ Y H ++
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 150 IHCDIKPQNILMDE 163
+H D+KPQN+L++E
Sbjct: 126 LHRDLKPQNLLINE 139
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 28/140 (20%)
Query: 36 VGRGSSGTVYKG-AMINRQLVAVNRLEKVLDERE-------REFQTEIKVIGRTHHRNLV 87
+ RG+ G VY G N +L AV KV+ + + + Q E + + +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAV----KVVKKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 88 RLLGYSLEVSKKI-LVYEYMSNGSLADIL-----FNAEKQPNWIERTGIARDIARGILYL 141
L YSL+ + + LV EY+ G + +L F+ E +I +A D YL
Sbjct: 68 HLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YL 120
Query: 142 HDECETQIIHCDIKPQNILM 161
H IIH D+KP N+L+
Sbjct: 121 H---RHGIIHRDLKPDNMLI 137
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 5e-04
Identities = 37/174 (21%), Positives = 69/174 (39%), Gaps = 31/174 (17%)
Query: 6 KIDSNYSTLTTPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEK--- 62
+++ N+ T ++ E K +G+G+ + KG + R V R+ K
Sbjct: 311 RVNPNFRTDEVEVTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYR 370
Query: 63 --VLDEREREFQT--EIKVIGRTHHRNLVRLLG------YSLEVSKKILVYEYMSNGSLA 112
LDER R +T E +++ + R G Y ++ +K +V EY+ L
Sbjct: 371 HPELDERLRTERTRAEARLL------SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLK 424
Query: 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC 166
D+L + R + + LH I+H D+ N ++ ++R
Sbjct: 425 DVLEG---------NPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIVRDDRL 466
|
Length = 535 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 5e-04
Identities = 37/134 (27%), Positives = 70/134 (52%), Gaps = 13/134 (9%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLEK--VLDERE-REFQTEIKVIGRTHHRNLVRLLG 91
+G+GS G V ++ + AV L+K VL+ +E + E V+ + + L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 92 YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG--IARDIARGILYLHDECETQ 148
YS + ++K+ V ++++ G L F+ +++ ++ E A +IA + YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLH---SIN 116
Query: 149 IIHCDIKPQNILMD 162
I++ D+KP+NIL+D
Sbjct: 117 IVYRDLKPENILLD 130
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 5e-04
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 20/109 (18%)
Query: 75 IKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-----------FNAEKQPN 123
+K+IG+ H+N++ LLG + ++ EY S G+L + L F+ K P
Sbjct: 71 MKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 124 ----WIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ + A +ARG+ YL + + IH D+ +N+L+ E+ K
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMK 174
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 5e-04
Identities = 31/119 (26%), Positives = 54/119 (45%), Gaps = 10/119 (8%)
Query: 55 VAVNRLEKVLDERERE-FQTEIKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNGS 110
VAV L+ ERE +E+K++ +H H N+V LLG +++ EY G
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIM--SHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 111 LADILF-NAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
L + L E + + +A+G+ +L + IH D+ +N+L+ + K
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 5e-04
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 23/127 (18%)
Query: 58 NRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN 117
+ EK L + E + +K+IG+ H+N++ LLG + ++ EY S G+L + L
Sbjct: 58 DATEKDLSDLVSEMEM-MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-R 113
Query: 118 AEKQPNWIERTGIAR----------------DIARGILYLHDECETQIIHCDIKPQNILM 161
A + P IAR +ARG+ YL + + IH D+ +N+L+
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170
Query: 162 DENRCAK 168
EN K
Sbjct: 171 TENNVMK 177
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 6e-04
Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 34 EKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL----DEREREFQTEIKVIGRTHHRNLVR 88
+VG+G G V+ + ++VA+ R++K L +E R TE ++ T LV+
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV-RHVLTERDILTTTKSEWLVK 65
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
LL Y+ + + + L EY+ G +L N R +A + LH E
Sbjct: 66 LL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---EL 120
Query: 148 QIIHCDIKPQNILMD 162
IH D+KP+N L+D
Sbjct: 121 GYIHRDLKPENFLID 135
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 6e-04
Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 11/90 (12%)
Query: 82 HHRNLVRLLGYSLEVSKKILV-YEYMSNGSLADILFNAEKQPNWIERTGIARD------- 133
H+N++ +L +E + V Y YM+ G+L L + +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 134 IARGILYLHDECETQIIHCDIKPQNILMDE 163
IA G+ YLH + +IH DI +N ++DE
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDE 152
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 6e-04
Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 101 LVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQIIHCDIKPQNI 159
LV EY++ G A ++ P +W + IA ++ G+ LH IIH DIKP+N+
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDWA-KQYIA-EVVLGVEDLHQR---GIIHRDIKPENL 128
Query: 160 LMDEN 164
L+D+
Sbjct: 129 LIDQT 133
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 8e-04
Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 7/136 (5%)
Query: 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQT--EIKVIGRTHHRNLVRLLGY 92
VG G+ G V K +++VA+ + + + E + T E+K++ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
K LV+EY+ L + E+ PN + + I + I +H + I+H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELL----EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR 124
Query: 153 DIKPQNILMDENRCAK 168
DIKP+N+L+ N K
Sbjct: 125 DIKPENLLISHNDVLK 140
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 8e-04
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 27/150 (18%)
Query: 24 ELKKITDGFKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVLDER-EREFQTEIKV 77
E KKI + +G G+ GTVYKG I + VA+ L + + +E E V
Sbjct: 8 EFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNAEKQPNWIERTGIA 131
+ + ++ RLLG L S L+ + M G L D + ++ NW +
Sbjct: 63 MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ---- 117
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILM 161
IA+G+ YL E +++H D+ +N+L+
Sbjct: 118 --IAKGMNYLE---ERRLVHRDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 9e-04
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 31/163 (19%)
Query: 24 ELKKITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRL-EKVLDEREREFQTEIK 76
E+ T F E++G G VYKG + Q VA+ L +K EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 77 VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF------------------NA 118
+ R H N+V LLG + +++ Y S+ L + L +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 119 EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM 161
+ +++ I IA G+ +L ++H D+ +N+L+
Sbjct: 121 LEPADFVH---IVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.001
Identities = 36/135 (26%), Positives = 60/135 (44%), Gaps = 12/135 (8%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+G G G V K L V + V ++ +E +++ +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 92 Y-SLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
Y + + K I ++ EY G L IL + + R IA + YLH+ I
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNR---GI 114
Query: 150 IHCDIKPQNILMDEN 164
I+ D+KP+N+L+D N
Sbjct: 115 IYRDLKPENLLLDSN 129
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 23/143 (16%)
Query: 35 KVGRGSSGTVYKGAMINR--QLVAVNRLEKVLDEREREFQT--EIKVIGRTH---HRNLV 87
++G G+ G V+K + + VA+ R+ E T E+ V+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 88 RL-----LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIA----RGI 138
RL + + +K LV+E++ D+ +K P T +D+ RG+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 139 LYLHDECETQIIHCDIKPQNILM 161
+LH +++H D+KPQNIL+
Sbjct: 124 DFLHSH---RVVHRDLKPQNILV 143
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.001
Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 32/160 (20%)
Query: 36 VGRGSSGTVYKGAMINRQLVAVNRLEKVL------DEREREFQTEI------KVIGRTHH 83
+G G G V I NR+ KV D E++ I K+IG+ H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--H 83
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNAEKQPNWIERT 128
+N++ LLG + ++ EY S G+L + L E+Q ++ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 129 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A +ARG+ YL + + IH D+ +N+L+ E+ K
Sbjct: 144 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 33/131 (25%), Positives = 62/131 (47%), Gaps = 8/131 (6%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLE--KVLDERERE-FQTEIKVIGRTHHRNLVRLLG 91
VG G+ G V+ I+ A+ + +V+ ++ + E +V+ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
+ ++ EY+ G L L N+ + N A +I + YLH + +I++
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLHSK---EIVY 124
Query: 152 CDIKPQNILMD 162
D+KP+NIL+D
Sbjct: 125 RDLKPENILLD 135
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.001
Identities = 33/104 (31%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 71 FQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV--YEYMSNGSLADILFNAEKQPNWIERT 128
+ EI+++ H +V+ G + ++K L EYM GS+ D L + R
Sbjct: 51 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK 110
Query: 129 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRL 172
R I G+ YLH I+H DIK NIL D A N +L
Sbjct: 111 -YTRQILEGMSYLHS---NMIVHRDIKGANILRDS---AGNVKL 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|176465 cd01362, Fumarase_classII, Class II fumarases | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.001
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 9/51 (17%)
Query: 40 SSGTVYKGAM-------INRQLV-AVNRLEKVLDEREREFQTEIKVIGRTH 82
SS + AM + +L+ A+ L LD + EF+ +K IGRTH
Sbjct: 135 SSNDTFPTAMHIAAALALQERLLPALKHLIDALDAKADEFKDIVK-IGRTH 184
|
This subgroup contains Escherichia coli fumarase C, human mitochondrial fumarase, and related proteins. It is a member of the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. Fumarase catalyzes the reversible hydration/dehydration of fumarate to L-malate during the Krebs cycle. Length = 455 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.002
Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 25/146 (17%)
Query: 30 DGFK--EKVGRGSSGTVYKGAMINR--QLVAVNRLEKVLDERERE-FQT----EIKVIGR 80
D ++ ++ G+ G VY+ A + ++VA L+K+ E+E+E F EI ++ +
Sbjct: 5 DEYEKLNRIEEGTYGVVYR-ARDKKTGEIVA---LKKLKMEKEKEGFPITSLREINILLK 60
Query: 81 THHRNLVRL----LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWI-ERTGIARDIA 135
H N+V + +G +L+ K +V EY+ + L ++ KQP E + +
Sbjct: 61 LQHPNIVTVKEVVVGSNLD--KIYMVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLL 116
Query: 136 RGILYLHDECETQIIHCDIKPQNILM 161
G+ +LHD I+H D+K N+L+
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLL 139
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 31/162 (19%), Positives = 66/162 (40%), Gaps = 11/162 (6%)
Query: 10 NYSTLTTPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERE- 68
N T + E I + ++YKG N + V + +K +
Sbjct: 2 NIITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKV 60
Query: 69 --REFQTEIKVIGRTHHRNLVRLLGYSLEVS----KKILVYEYMSNGSLADILFNAEKQP 122
+ EIK + R N++++ G+ +++ + L+ EY + G L ++L EK
Sbjct: 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDL 119
Query: 123 NWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
++ + +A D +G+ L+ + ++ + L+ EN
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN 159
|
Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.002
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 22/156 (14%)
Query: 36 VGRGSSGTVYKGAMINR----QLVAVNRLEKVLDERE--REFQTEIKVIGRTHHRNLVRL 89
+G+G G+V + + + Q VAV L+ + EF E + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 90 LGYSLEVSKK------ILVYEYMSNGSLADILFNAE--KQPNWIERTGIAR---DIARGI 138
+G SL K +++ +M +G L L + ++P + + R DIA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 139 LYLHDECETQIIHCDIKPQNILMDENR--CAKNFRL 172
YL + IH D+ +N +++EN C +F L
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.002
Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 20/109 (18%)
Query: 75 IKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA---------------DILFNAE 119
+K+IG+ H+N++ LLG + ++ EY + G+L DI E
Sbjct: 71 MKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 120 KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+Q ++ + A +ARG+ YL + IH D+ +N+L+ E+ K
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMK 174
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 35/134 (26%), Positives = 68/134 (50%), Gaps = 13/134 (9%)
Query: 36 VGRGSSGTVYKGA-MINRQLVAVNRLEK--VLDERE-REFQTEIKVIGRTHHRNLVRLLG 91
+G+GS G V + AV L+K +L ++E + +E V+ + + L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 92 YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG--IARDIARGILYLHDECETQ 148
+S + + K+ V +Y++ G L ++ +++ ++E A +IA + YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLH---SLN 116
Query: 149 IIHCDIKPQNILMD 162
I++ D+KP+NIL+D
Sbjct: 117 IVYRDLKPENILLD 130
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.002
Identities = 39/142 (27%), Positives = 65/142 (45%), Gaps = 22/142 (15%)
Query: 35 KVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQT--EIKVIGRTH---HRNLVR 88
++G G+ GTVYK + VA+ + +E T E+ ++ R H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 89 LLGYSLEV-----SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR----GIL 139
L+ +K LV+E++ D+ +K P +D+ R G+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ----DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 140 YLHDECETQIIHCDIKPQNILM 161
+LH C I+H D+KP+NIL+
Sbjct: 123 FLHANC---IVHRDLKPENILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.002
Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQL--VAVNRLEKVLDEREREFQ---TEIKVIGRTHHRNL 86
F +G GS G V N VA+ R EK ++++ +E K++ +H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
V L G + S LV E++ G L ++ PN + A I YL
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-CFYAAQIVLIFEYLQ---S 149
Query: 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEARS 182
I++ D+KP+N+L+D++ K KV + R+
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185
|
Length = 340 |
| >gnl|CDD|223192 COG0114, FumC, Fumarase [Energy production and conversion] | Back alignment and domain information |
|---|
Score = 37.2 bits (87), Expect = 0.002
Identities = 17/51 (33%), Positives = 24/51 (47%), Gaps = 9/51 (17%)
Query: 40 SSGTVYKGAM-------INRQLV-AVNRLEKVLDEREREFQTEIKVIGRTH 82
SS + AM + +L+ A+ L K L + EF +K IGRTH
Sbjct: 138 SSNDTFPTAMHIAAVLAVVNRLIPALKHLIKTLAAKAEEFADVVK-IGRTH 187
|
Length = 462 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.003
Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 5/77 (6%)
Query: 90 LGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLHDECET 147
L Y+ E + LV M+ G L ++N ++ +ER + I GIL+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 148 QIIHCDIKPQNILMDEN 164
I++ D+KP+N+L+D+
Sbjct: 115 DIVYRDMKPENVLLDDQ 131
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.003
Identities = 32/144 (22%), Positives = 61/144 (42%), Gaps = 15/144 (10%)
Query: 33 KEKVGRGSSGTVYKGAMINRQ----LVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLV 87
+G G G VY+G ++ + VAV + RE F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIE-RTGI--ARDIARGILYLHDE 144
+L+G + + +V E G L L + ++ + I + ++ + YL
Sbjct: 71 KLIGV-ITENPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLES- 125
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
+ +H DI +N+L+ C K
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVK 147
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 36.8 bits (85), Expect = 0.003
Identities = 37/137 (27%), Positives = 68/137 (49%), Gaps = 13/137 (9%)
Query: 36 VGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQ---TEIKVIGRTHHRNLVRLLG 91
+G+G+ G VY+ + R++ A+ L K ++E E ++ RT ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 92 --YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIAR-DIARGILYLHDECET 147
+S + + LV +YMS G L ++ +K+ + E A+ IA +L L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDR--AKFYIAELVLALEHLHKY 115
Query: 148 QIIHCDIKPQNILMDEN 164
I++ D+KP+NIL+D
Sbjct: 116 DIVYRDLKPENILLDAT 132
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|176468 cd01596, Aspartase_like, aspartase (L-aspartate ammonia-lyase) and fumarase class II enzymes | Back alignment and domain information |
|---|
Score = 37.0 bits (87), Expect = 0.003
Identities = 13/35 (37%), Positives = 21/35 (60%), Gaps = 2/35 (5%)
Query: 49 MINRQLV-AVNRLEKVLDEREREFQTEIKVIGRTH 82
+ +L+ A+ +L+ LD + EF +K IGRTH
Sbjct: 150 ALLERLLPALEQLQDALDAKAEEFADIVK-IGRTH 183
|
This group contains aspartase (L-aspartate ammonia-lyase), fumarase class II enzymes, and related proteins. It is a member of the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. Aspartase catalyzes the reversible deamination of aspartic acid. Fumarase catalyzes the reversible hydration/dehydration of fumarate to L-malate during the Krebs cycle. Length = 450 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 36.7 bits (85), Expect = 0.004
Identities = 37/145 (25%), Positives = 68/145 (46%), Gaps = 27/145 (18%)
Query: 36 VGRGSSGTVYKGAMINRQL---VAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL--- 89
+G GS+G V+ + ++ VAV ++ + + EIK+I R H N+V++
Sbjct: 13 LGCGSNGLVF--SAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 90 -----------LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGI-ARDIARG 137
+G E++ +V EYM LA++L E+ P E + + RG
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLSEEHARLFMYQLLRG 126
Query: 138 ILYLHDECETQIIHCDIKPQNILMD 162
+ Y+H ++H D+KP N+ ++
Sbjct: 127 LKYIH---SANVLHRDLKPANVFIN 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 183 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.98 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.94 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.94 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.94 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.93 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.92 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.92 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.92 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.92 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.92 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.92 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.92 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.92 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.92 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.92 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.92 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.92 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.92 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.92 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.92 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.91 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.91 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.91 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.91 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.91 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.91 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.91 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.91 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.91 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.91 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.91 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.91 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.91 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.91 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.91 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.9 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.9 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.9 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.9 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.9 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.9 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.9 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.9 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.89 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.89 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.89 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.89 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.89 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.89 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.88 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.88 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.88 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.88 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.88 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.88 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.88 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.88 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.88 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.88 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.88 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.88 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.87 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.87 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.87 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.87 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.87 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.87 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.87 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.86 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.86 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.86 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.86 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.85 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.85 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.85 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.84 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.84 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.84 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.84 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.84 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.84 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.81 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.8 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.78 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.76 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.58 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.2 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.14 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.99 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.94 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.9 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.74 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.48 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.12 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.88 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.82 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.64 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.46 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.4 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.97 | |
| PLN02236 | 344 | choline kinase | 96.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.62 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.57 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.16 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.16 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.06 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.66 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 95.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.39 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.69 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.62 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.52 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 94.22 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.83 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.81 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.75 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.56 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 91.23 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 90.23 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=212.84 Aligned_cols=147 Identities=27% Similarity=0.378 Sum_probs=129.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||.|+|++||+|+.+ .+..||||.+.+. .....+.+..|+.+|+.++|+|||++.+++.+.+.+|+|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 445567999999999999966 4788999998876 4455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC------Ccccccceeccccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN------RCAKNFRLWIGKVDEA 180 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~------~~~~i~dfg~a~~~~~ 180 (183)
.||+|..++...+ .+++.....++.|++.|+.+||++ +|+||||||+|||++.. -.+||+|||+|++.+.
T Consensus 92 ~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 92 NGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999997654 577888888999999999999998 99999999999999875 3589999999998753
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=216.34 Aligned_cols=164 Identities=46% Similarity=0.725 Sum_probs=146.6
Q ss_pred CCceeCHHHHHHHHhchh--cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceE
Q 048219 16 TPFSFSYAELKKITDGFK--EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93 (183)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~--~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (183)
....+++.+++..+++|. ..||+|+||.||+|...++..+|+|++..........+.+|+.++.+++|||++++.|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 345589999999999998 589999999999999988889999988764322145599999999999999999999999
Q ss_pred EeCC-eEEEEEeccCCCCHHHHHhcCCC-CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccc
Q 048219 94 LEVS-KKILVYEYMSNGSLADILFNAEK-QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFR 171 (183)
Q Consensus 94 ~~~~-~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~d 171 (183)
.+.+ ..++|+||+++|+|.+.+..... .++|..++.|+.+++.||.|||..+..+|+|||+|++|||+|++.++|++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9888 59999999999999999976555 789999999999999999999998767899999999999999999999999
Q ss_pred eecccccc
Q 048219 172 LWIGKVDE 179 (183)
Q Consensus 172 fg~a~~~~ 179 (183)
||+|+...
T Consensus 221 FGLa~~~~ 228 (361)
T KOG1187|consen 221 FGLAKLGP 228 (361)
T ss_pred ccCcccCC
Confidence 99998764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=214.64 Aligned_cols=148 Identities=25% Similarity=0.347 Sum_probs=130.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 104 (183)
++-.++||+|+||.||+|++. +++.||+|++.-.. .....-+.+||.+|+++.||||+++.+..... +.+|+|+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 444568999999999999965 68899999985432 33344578899999999999999999998765 68999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
||++ ||.-++......+++..+..+++|++.||.|||++ +|+|||||.+|||+|.+|.+||+|||||+|++..
T Consensus 199 YMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred cccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9975 99999987777889999999999999999999998 9999999999999999999999999999998765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=205.83 Aligned_cols=148 Identities=25% Similarity=0.332 Sum_probs=125.8
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH-------HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE-------REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
-.|.+.+.||+|+||.|.+|..+ +++.+|+|++.+.... ......+|+++|++++||+||+++++|..+...
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 34566789999999999999855 6899999999753211 123367999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---Ccccccceeccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAKNFRLWIGK 176 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---~~~~i~dfg~a~ 176 (183)
|+||||+.||+|++.+.... .+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||.|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999986543 344455567899999999999998 99999999999999766 789999999999
Q ss_pred ccc
Q 048219 177 VDE 179 (183)
Q Consensus 177 ~~~ 179 (183)
+..
T Consensus 328 ~~g 330 (475)
T KOG0615|consen 328 VSG 330 (475)
T ss_pred ccc
Confidence 863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=209.57 Aligned_cols=149 Identities=25% Similarity=0.301 Sum_probs=135.1
Q ss_pred HHHhchhcccCcCcCceEEEEEE-cCCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+|...+.||+|+|..||.++. ..+..+|+|.+.+.. +.....+.+||++++.++|||||+++++|++.+++||+
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 35677778899999999999998 678999999997643 34456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
.|+|+.++|..+++ .++.+++..+..++.||+.|+.|||++ +|+|||||..|++++++.++||+|||+|....
T Consensus 97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999887 557788999999999999999999998 99999999999999999999999999998654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=209.58 Aligned_cols=150 Identities=22% Similarity=0.329 Sum_probs=132.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH-HHHHHHHHHHHhhcC-CCceeeeeceEEeCC-eEEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER-EREFQTEIKVIGRTH-HRNLVRLLGYSLEVS-KKILVY 103 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~ 103 (183)
.+|...++||.|+||.||+|... .+..||||++++....- .---++|+.-|++++ ||||+++++++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 46778889999999999999855 57889999998753221 122367999999998 999999999999887 899999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
|||+ +.|+++++.+++.+++..+..|+.||++||.|+|.+ |+.|||+||+|||+.....+||+|||+|+.....
T Consensus 90 E~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred Hhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 9995 699999998888999999999999999999999998 9999999999999999999999999999976544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=196.53 Aligned_cols=147 Identities=26% Similarity=0.289 Sum_probs=128.1
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
...++|+|++|.|++|+.+ +|+.||+|++.... +...+-.++|++.|++++|+|+|.+.++|......++|+|||+.
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 3457899999999999977 58999999986532 33345578999999999999999999999999999999999976
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEARS 182 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~~ 182 (183)
++-+-+...+...+...+..++.|++.|+.|+|++ +++|||+||+||++..++.+|+||||+|+...++.
T Consensus 86 -TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 86 -TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred -HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 56566666666777888888999999999999998 99999999999999999999999999999887653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=189.92 Aligned_cols=148 Identities=23% Similarity=0.311 Sum_probs=131.9
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.-.+.+|+|+||.||+|++. +++.||+|+++..... .....++||..|+.++|+||+.+.++|...+++.+|+||+
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 444568999999999999965 6889999998754322 2356789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
+ .+|+..+......+....+..++.+++.|+.|||++ .|+|||+||.|++++.+|.+||+|||+|+++.++
T Consensus 84 ~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 84 P-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred c-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 7 499999988777888889999999999999999998 9999999999999999999999999999988754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=201.64 Aligned_cols=151 Identities=23% Similarity=0.320 Sum_probs=136.0
Q ss_pred HHHHHhchhcccCcCcCceEEEEEE-cCCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..+.+|++.+.||.|+||.|-+|.. ..+..||+|.+.+.. ..+...+.+||++|..++||||+.++++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 3567899999999999999999985 578999999987643 334567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|||||..+|.|++++..+ ..+.+.....++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.
T Consensus 130 ivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999999765 4567788888999999999999998 99999999999999999999999999998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=200.91 Aligned_cols=145 Identities=35% Similarity=0.493 Sum_probs=129.1
Q ss_pred hhcccCcCcCceEEEEEEcCCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-eEEEEEeccCC
Q 048219 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVS-KKILVYEYMSN 108 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~ 108 (183)
+.+.+|+|+||.||++.+.....+++|.+..... .....+.+|+.+|.+++||||+++.|++..+. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3456999999999999988877799999876432 22568999999999999999999999998877 79999999999
Q ss_pred CCHHHHHhc-CCCCCChHHHHHHHHHHHHHHHHhhhCCCCC-ceecCCCCCCEEecCCC-cccccceecccccc
Q 048219 109 GSLADILFN-AEKQPNWIERTGIARDIARGILYLHDECETQ-IIHCDIKPQNILMDENR-CAKNFRLWIGKVDE 179 (183)
Q Consensus 109 ~~l~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~~ 179 (183)
|+|..++.. ....+++..++.++.+|+.|+.|||++ + |+|||||++|+|++.+. ++||+|||+++...
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999977 367788999999999999999999998 6 99999999999999997 99999999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=204.95 Aligned_cols=150 Identities=27% Similarity=0.401 Sum_probs=132.3
Q ss_pred HHHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 24 ELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 24 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
++......+.+.||+|.||.||.|.+.....+++|.++.. ......+.+|+.+|++++|++||++++++..+..++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3344444566789999999999999998888999998764 233457889999999999999999999999888999999
Q ss_pred eccCCCCHHHHHhc-CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 104 EYMSNGSLADILFN-AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 104 e~~~~~~l~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
||++.|+|.+++.. .+..+.....+.++.|||.|+.||.++ .+|||||.++|||++++..+||+|||+|+.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999986 445677778888999999999999998 999999999999999999999999999995
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=192.90 Aligned_cols=143 Identities=27% Similarity=0.384 Sum_probs=124.7
Q ss_pred cccCcCcCceEEEEEEcC-CcEEEEEEccc-hhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe-EEEEEeccCCCC
Q 048219 34 EKVGRGSSGTVYKGAMIN-RQLVAVNRLEK-VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK-KILVYEYMSNGS 110 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~ 110 (183)
..||+|+.|+||++.++. ++.+|+|.+.. ..+...+++.+|+++++..+||+||+++++|...+. +.|+||||.+|+
T Consensus 85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGS 164 (364)
T KOG0581|consen 85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGS 164 (364)
T ss_pred hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCC
Confidence 469999999999999774 67889999843 234556789999999999999999999999999885 999999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|..++...+ ..++...-.++.++++||.|||.. .+|+|||+||+|+|++..|.+||+|||.++...
T Consensus 165 Ld~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 165 LDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred HHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 999997653 356777778999999999999962 299999999999999999999999999998653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=194.09 Aligned_cols=146 Identities=25% Similarity=0.290 Sum_probs=128.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
...+.+.||+|+||.|++++.. +++.+|+|.+++..- ...+....|..+|..++||+|+.+...|++..++|+|+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 4556789999999999999866 478899999987532 234668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++||.|+..+.+.+ .+.+..+..++.+|+.||.|||+. +|+||||||+|||+|.+|+++|+|||+|+..
T Consensus 106 ~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 106 YLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred ccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999997654 456666777899999999999998 9999999999999999999999999999954
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=200.19 Aligned_cols=149 Identities=25% Similarity=0.269 Sum_probs=131.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH---HHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER---EREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.|.+.||+|+|++|++|+.. .++.+|+|.+.+..-.. ...+..|-..|..+ .||.|++++..|+++.++|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 3567789999999999999966 57899999998754322 24567788889888 7999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
||+++|+|.+++...+ .+++.....++.+|+.|++|||++ |||||||||+|||+|.++.++|.|||-|++.+..
T Consensus 154 e~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999997764 577777788999999999999998 9999999999999999999999999999987654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=190.21 Aligned_cols=154 Identities=22% Similarity=0.321 Sum_probs=127.3
Q ss_pred HHhchhcccCcCcCceEEEEEE-cCCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeec-eEEeCCe-EEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLG-YSLEVSK-KILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv 102 (183)
..+.+.++||+|+||.||++.. .++..+|.|.+.=. .......+..|+.+|++++||||+++++ .+...+. ++|+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3466778999999999999984 57888998887521 1223456889999999999999999988 4555555 8999
Q ss_pred EeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCC-CCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDEC-ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+|.+|+|.+.+.. ..+..++..++.+..|++.||..+|..- ...+.||||||.||+++.+|.+|++|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998853 3466889999999999999999999821 123899999999999999999999999999988
Q ss_pred ccc
Q 048219 179 EAR 181 (183)
Q Consensus 179 ~~~ 181 (183)
.+.
T Consensus 179 ~s~ 181 (375)
T KOG0591|consen 179 SSK 181 (375)
T ss_pred cch
Confidence 654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=183.70 Aligned_cols=146 Identities=27% Similarity=0.286 Sum_probs=128.4
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+...||.|+||.|.+++.+ ++.-+|+|.+++... .......+|..+|+.+.||+++++.+.+.+.++++++|||++
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 3468999999999999976 477889999987543 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
||.+++++...++ ++++....++.||+.|++|||+. .|++|||||+|||+|.+|.+||.|||+|+-...+
T Consensus 128 GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 128 GGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred CccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999977554 56677777999999999999998 9999999999999999999999999999965443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=192.63 Aligned_cols=144 Identities=19% Similarity=0.219 Sum_probs=126.8
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+.||+|+||.||+|+.+ +|..+|+|++.+.. ......+..|-.+|.....+.+|+++..|++..++||+|||+
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 34578999999999999966 58899999998753 233456788889998889999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|||++..++...+ .+++.....++.+++.|+.-+|+. +++||||||+|+|+|..|++||.|||||...
T Consensus 224 PGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 224 PGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999997654 566777777899999999999998 9999999999999999999999999999654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=196.07 Aligned_cols=145 Identities=30% Similarity=0.458 Sum_probs=128.8
Q ss_pred hhcccCcCcCceEEEEEEcC--C--cE-EEEEEccc---hhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 32 FKEKVGRGSSGTVYKGAMIN--R--QL-VAVNRLEK---VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~--~--~~-~~ik~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+.++||+|+||.||+|.... + .. ||+|..+. ........+..|+++++.++||||++++|+.....+++++|
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 44789999999999998543 2 23 78988874 23455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+|+||+|.+++.......+......++.+.+.||.|||++ .++||||.++|+|++.++.+||+|||+++.+.
T Consensus 241 El~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999987666678888888999999999999998 99999999999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=191.35 Aligned_cols=147 Identities=27% Similarity=0.371 Sum_probs=128.4
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch----hh-HHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV----LD-EREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 100 (183)
..|.+.+.||+|+||.|+.|... ++..+|+|.+.+. .. .....+.+|+.+++.+. ||||+++++++.....++
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 35667789999999999999865 5788999977653 11 22345668999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~~~ 178 (183)
+||||+.||+|++.+.. ...+.+.....++.|++.|+.|+|++ +|+||||||+|++++.+ +++||+|||+|...
T Consensus 97 ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999987 45566677788999999999999998 99999999999999999 99999999999976
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=182.89 Aligned_cols=147 Identities=31% Similarity=0.431 Sum_probs=126.1
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC--eEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS--KKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 106 (183)
+...+.||+|+||.||++...+ +...|+|.+..........+.+|+.+|..++|||||+++|...... .++++|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4455689999999999998664 7888999876542222556889999999999999999999754443 688999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~~ 179 (183)
++|+|.+++...+..+++..+..+..|++.||.|+|++ +++|+||||+|||++. ++.+||+|||+|+...
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999987654678899999999999999999998 9999999999999999 6999999999998654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=182.88 Aligned_cols=146 Identities=21% Similarity=0.301 Sum_probs=123.4
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--HHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEEEecc
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--REREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYM 106 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 106 (183)
....|++|+||.||+|++. +...||+|+++-.... ..-..++||.+|.+++|||||.+.++... .+.+|+|||||
T Consensus 80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 3457999999999999976 4678999998643211 11235789999999999999999999874 46799999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
+. +|.+++..-...+....+..++.|++.|+.|||++ .|+|||||++|+|+...|.+||+|||+|+-+...
T Consensus 160 Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 160 EH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred Hh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 75 99999987666777788888999999999999998 9999999999999999999999999999977543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=180.41 Aligned_cols=144 Identities=26% Similarity=0.389 Sum_probs=121.7
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--HHHHHHHHHHHHhhcCCCc-eeeeeceEEeCC------eEEE
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--REREFQTEIKVIGRTHHRN-LVRLLGYSLEVS------KKIL 101 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~l 101 (183)
..+++|+|+||.||+|+.+ +++.||+|.+.-.... ......+|+.+++.++|+| |+.+.+++.+.+ ..++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 3357999999999999965 5789999987543211 2234678999999999999 999999998766 7899
Q ss_pred EEeccCCCCHHHHHhcCC---CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAE---KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|++. -++..++.... ...+...+..++.|++.|+.|||++ +|+||||||+||++++.|.+||+|||+|+-+
T Consensus 95 vfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 95 VFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 999996 49999987755 3455567888999999999999998 9999999999999999999999999999965
Q ss_pred c
Q 048219 179 E 179 (183)
Q Consensus 179 ~ 179 (183)
.
T Consensus 171 ~ 171 (323)
T KOG0594|consen 171 S 171 (323)
T ss_pred c
Confidence 4
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=191.13 Aligned_cols=145 Identities=28% Similarity=0.402 Sum_probs=128.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.. ....+.+.+|+++++.++||||+..+++|++..+.++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 566789999999999999865 57889999987643 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
.| +|..++... ..+++..+..++.++..||.|||++ +|.|+|+||+||+++..+.+|++|||+|+.-.
T Consensus 84 ~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 84 VG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred hh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 76 999999764 4567777888999999999999998 99999999999999999999999999999654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=182.62 Aligned_cols=148 Identities=26% Similarity=0.328 Sum_probs=122.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--------------HHHHHHHHHHHHhhcCCCceeeeeceE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--------------REREFQTEIKVIGRTHHRNLVRLLGYS 93 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (183)
.|.+.+.||+|.||.|.+|+.. .++.+|+|++.+.... ....+.+||.+|+++.|+|+|++.++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 4667788999999999999965 5889999998753211 124678999999999999999999998
Q ss_pred EeC--CeEEEEEeccCCCCHHHHHhcCCCC-CChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccc
Q 048219 94 LEV--SKKILVYEYMSNGSLADILFNAEKQ-PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 94 ~~~--~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~ 170 (183)
.++ +.+|||+|||..|.+...- .... +.+.....|...+..||.|||.+ +|+||||||+|+|++.+|.+||+
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence 764 5799999999887664322 2233 66777888999999999999998 99999999999999999999999
Q ss_pred ceecccccccc
Q 048219 171 RLWIGKVDEAR 181 (183)
Q Consensus 171 dfg~a~~~~~~ 181 (183)
|||.+..+.+.
T Consensus 253 DFGVs~~~~~~ 263 (576)
T KOG0585|consen 253 DFGVSNEFPQG 263 (576)
T ss_pred ccceeeecccC
Confidence 99999977543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=190.41 Aligned_cols=145 Identities=26% Similarity=0.350 Sum_probs=128.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|++.+.||.|+.|.|.+|... +|+..|||++.+.. ......+-.||.+|+.+.|||+++++++|++...+|++.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 567789999999999999854 68999999987652 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.|++++...+ .+.+.....++.||+.|+.|+|.. +|+||||||+|+++|..+++||+|||+|.+.
T Consensus 94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc
Confidence 99999999997654 455677778999999999999997 9999999999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=176.91 Aligned_cols=149 Identities=29% Similarity=0.407 Sum_probs=124.6
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC-----------------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceee
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN-----------------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVR 88 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~-----------------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 88 (183)
+..+.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.++..++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4456778899999999999997432 2368899876542 233456889999999999999999
Q ss_pred eeceEEeCCeEEEEEeccCCCCHHHHHhcCC------------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCce
Q 048219 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAE------------------KQPNWIERTGIARDIARGILYLHDECETQII 150 (183)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 150 (183)
+++++.+.+..+++|||+++++|.+++.... ..+.+.....++.|++.||.|||+. +++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999899999999999999999885421 1245566778999999999999998 999
Q ss_pred ecCCCCCCEEecCCCcccccceeccccc
Q 048219 151 HCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 151 H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+||||+||+++.++.+||+|||+|+..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~ 188 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNL 188 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceec
Confidence 9999999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=181.87 Aligned_cols=145 Identities=19% Similarity=0.196 Sum_probs=125.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... +++.+++|.+.+.. ......+..|+.++..++|++++++++.+.+....+++|||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 345678999999999999865 57889999986532 12234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+|+..
T Consensus 83 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 83 LPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999988653 3567778888999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=178.46 Aligned_cols=140 Identities=21% Similarity=0.206 Sum_probs=122.5
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||++... +++.+++|.+.+.. ......+..|+.+++.++||||+++.+.+...+..+++|||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999865 57889999987542 2233567789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|.+.+... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 82 L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 82 LFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99888653 4567778888899999999999998 9999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=181.58 Aligned_cols=145 Identities=21% Similarity=0.215 Sum_probs=126.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++..++|+||+++++.+.+.+..+++|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 455678999999999999976 57889999987532 22335577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 83 ~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 83 LPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999988654 3467778888999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=195.43 Aligned_cols=144 Identities=31% Similarity=0.479 Sum_probs=126.5
Q ss_pred hchhcccCcCcCceEEEEEEc------CCcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+.||+|+||.||+|... ....||+|.++..... ...+|.+|++++..++|||||+++|+|...++.++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 345578999999999999733 3467999999865444 567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC---------CCC----CChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccc
Q 048219 103 YEYMSNGSLADILFNA---------EKQ----PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKN 169 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~---------~~~----~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i 169 (183)
+||+..|||-+++... ... ++....+.|+.||+.|+.||.++ .+|||||.++|+|++++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 9999999999999642 122 66778889999999999999998 9999999999999999999999
Q ss_pred cceeccc
Q 048219 170 FRLWIGK 176 (183)
Q Consensus 170 ~dfg~a~ 176 (183)
+|||+++
T Consensus 645 sDfGLsR 651 (774)
T KOG1026|consen 645 SDFGLSR 651 (774)
T ss_pred cccccch
Confidence 9999998
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-27 Score=181.52 Aligned_cols=145 Identities=20% Similarity=0.217 Sum_probs=124.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... ++..+++|.+.+.. ......+..|+.++..++|++|+++++++.+.+..+++|||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 345578999999999999865 47789999986532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++.... .+.+.....++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 83 ~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 83 IPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999886543 456677777889999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-27 Score=181.22 Aligned_cols=144 Identities=20% Similarity=0.189 Sum_probs=124.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|.+.+.||+|+||.||++... +++.+++|.+.+.. ......+.+|+.++..+.||||+++++++.+.+..+++|||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 455678999999999999865 57889999886532 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++++|.+.+... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||+|+.
T Consensus 83 ~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 83 LPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999988653 3466777777899999999999998 999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=181.21 Aligned_cols=144 Identities=19% Similarity=0.214 Sum_probs=124.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+...+.||+|+||.||+|... .+..+++|.+.+.. ......+..|+.+++.++|++|+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 345678999999999999865 57789999986542 12335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++++|.+.+... ..+++.....++.|++.||.|+|+. +|+||||||+||+++.++.++|+|||+|+.
T Consensus 83 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 83 IPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999988654 3456677777899999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=180.58 Aligned_cols=145 Identities=19% Similarity=0.194 Sum_probs=124.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|.+.+.||+|+||.||++... .++.+++|.+.+... .....+.+|+.++..++|++|+++++.+.+.+..+++|||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456678999999999999865 478899999865321 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+|..+
T Consensus 83 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 83 IPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999998654 3456667777889999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=179.67 Aligned_cols=145 Identities=20% Similarity=0.203 Sum_probs=124.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||++... +++.+++|.+.+.. ......+.+|+.+++.++|||++++++.+.+.+..+++||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 3555578999999999999976 46789999886532 1223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+++... .+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 124 y~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 124 YMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999988543 456777788899999999999998 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-27 Score=178.85 Aligned_cols=149 Identities=22% Similarity=0.336 Sum_probs=121.9
Q ss_pred HHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC-C
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV-S 97 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 97 (183)
..++.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++..+ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 445677889999999999999742 24578999886432 23345688999999999 899999999988764 4
Q ss_pred eEEEEEeccCCCCHHHHHhcCC----------------------------------------------------------
Q 048219 98 KKILVYEYMSNGSLADILFNAE---------------------------------------------------------- 119 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~---------------------------------------------------------- 119 (183)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5889999999999998886421
Q ss_pred ---CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 120 ---KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 120 ---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
..+.+.....++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~ 224 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeeccccccc
Confidence 1244556677889999999999998 9999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=187.22 Aligned_cols=151 Identities=29% Similarity=0.411 Sum_probs=129.2
Q ss_pred HHHHHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEcc--chhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 22 YAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLE--KVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 22 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
++++......+.+.||+|+||+||+|.+.. .||+|.++ ...++..+.|.+|+.++++-+|.||+-+.|++..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 344444444566789999999999999876 46666664 4445667889999999999999999999999987766
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.||+.||.|.+|+..+......+.-.....|+.|+++|+.|||++ +|+|+|||..||++.++++|||.|||+|.+-
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999987666677677788999999999999998 9999999999999999999999999999754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=176.31 Aligned_cols=140 Identities=22% Similarity=0.220 Sum_probs=121.9
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||++... ++..+++|.+.+.. ......+..|+.+++.++|||++++.+++...+..+++|||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5899999999999865 57889999987542 2233456789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|...+... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++..
T Consensus 82 L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 82 LFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 98887553 3567778888999999999999998 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=177.85 Aligned_cols=149 Identities=26% Similarity=0.258 Sum_probs=127.3
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC--CcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN--RQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
...+.+.+.||+|+||.||+|.... +..+++|.+.+.. ......+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3456777899999999999998543 3578999886532 1233467889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|||+++++|.+++... ..+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||+|+...
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999988654 3466777788999999999999998 99999999999999999999999999998643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=168.83 Aligned_cols=146 Identities=26% Similarity=0.348 Sum_probs=127.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.++.+.||+|.||.||.|+.+ ++-.+++|.+.+..-. ....+.+|+++...++||||++++++|.+...+|+++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 346678999999999999965 5778999998764321 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+.|+++..++... ..+++.....++.|++.|+.|+|.. +++|||+||+|+|++..+..|++|||-+...
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999997543 4577777788999999999999997 9999999999999999999999999988754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=184.35 Aligned_cols=141 Identities=31% Similarity=0.453 Sum_probs=128.5
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
+++|+|+.|.||.|... .++.||+|++....+...+.+.+|+.+|+..+|+|||.+++.|...+.++.||||++||+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 58999999999999854 57889999998766666677899999999999999999999999889999999999999999
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+.+.. ..+++..+..++.++++||.|||.+ +|+|||||.+||+++.++.+||.|||+|..+.
T Consensus 359 DvVt~--~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 359 DVVTK--TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred hhhhc--ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 98854 4578899999999999999999998 99999999999999999999999999998664
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-26 Score=174.44 Aligned_cols=139 Identities=20% Similarity=0.227 Sum_probs=121.3
Q ss_pred cCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 36 lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
||+|+||.||++... ++..+++|.+.+.. ......+..|+.++..++||||+++.+.+...+..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 46789999886532 22335677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+.+... ..+++.....++.|++.||.|||++ +++||||||+||+++.++.++|+|||+|+..
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 9988653 3467777788899999999999998 9999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=176.82 Aligned_cols=146 Identities=21% Similarity=0.221 Sum_probs=126.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... +++.+++|.+.+... .....+.+|+.++..++||||+++++.+...+..+++||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 4567789999999999999976 478899998865321 223467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+.+.... .+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 99 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 99 FVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred CCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 999999999886543 456666777889999999999998 9999999999999999999999999999854
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=176.56 Aligned_cols=145 Identities=25% Similarity=0.270 Sum_probs=126.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... .+..+++|.+.+... .....+..|+.++..++|+||+++++++...+..+++|||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456678999999999999976 478899999875422 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ..+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 83 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 83 VPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999998653 3466777778899999999999998 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=175.83 Aligned_cols=146 Identities=23% Similarity=0.195 Sum_probs=127.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||++... .++.+++|.+..... .....+.+|+.++..+.|++++++.+.+.+.+..+++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456678999999999999865 578899999875422 2334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++......+++.....++.|++.||.|+|+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 999999999976555677888888899999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=175.77 Aligned_cols=146 Identities=21% Similarity=0.177 Sum_probs=125.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||++... .++.+++|.+.+.. ......+.+|..++..+.|++|+++.+++.+.+..+++|||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456678999999999999866 46788999886532 12234477889999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++......+.+.....++.|++.||.|+|++ +|+|+||||+||+++.++.++|+|||+|+..
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 999999999976445567777778899999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=186.14 Aligned_cols=144 Identities=22% Similarity=0.273 Sum_probs=124.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
..+...||+|+||.|+++..+ +++.+|||.+++.. .++...+..|.+++... +||+++.++..|++..++|+|||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 456689999999999999976 46789999998743 33456678888888766 59999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+.||++.... ....+++..+..|+..|+.||.|||++ +|++||||.+|||+|.+|.+||+|||++|.+
T Consensus 450 y~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 450 YVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred ecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 99999944333 335678888888999999999999998 9999999999999999999999999999954
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=175.44 Aligned_cols=140 Identities=22% Similarity=0.224 Sum_probs=122.3
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||++... ++..+++|.+.+.. ......+.+|+.+++.+.|||++++.+.+...+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5899999999999865 57889999987542 2234567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+...+... ..+.+..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 82 L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 82 LFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 98887553 3567778888999999999999998 9999999999999999999999999998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=174.62 Aligned_cols=145 Identities=23% Similarity=0.245 Sum_probs=125.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 455678999999999999976 578899998864321 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ..+++.....++.|++.||.|+|++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 83 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 83 VPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999988654 3466777778899999999999998 9999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=176.00 Aligned_cols=146 Identities=23% Similarity=0.184 Sum_probs=126.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||++... .++.+++|.+.+.. ......+.+|..++..++|++++++++++.+.+..+++|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456678999999999999865 47889999986522 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|...
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 999999999866445577778888999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=173.04 Aligned_cols=145 Identities=25% Similarity=0.338 Sum_probs=123.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
|.+.+.||.|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|+|++++++++.+.+..+++||+++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 556678999999999999865 577899998764321 123456789999999999999999999998889999999997
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ ++.+.+......++......++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||+|+..
T Consensus 87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 5 89888866555567777888999999999999998 9999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=173.59 Aligned_cols=139 Identities=21% Similarity=0.203 Sum_probs=120.4
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||++... .+..+++|.+.+... .....+..|+.++..+.|+||+++.+.+...+..++||||+++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999865 578899999875421 223456789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|...+... ..+++.....++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||+|+.
T Consensus 82 L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 82 LFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 98887543 356777888899999999999997 5 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=177.50 Aligned_cols=139 Identities=29% Similarity=0.402 Sum_probs=113.8
Q ss_pred hhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--C---eEEEEEec
Q 048219 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--S---KKILVYEY 105 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~---~~~lv~e~ 105 (183)
-.+.+|.|+||.||+|...+ +..+|||++-.... .-..|..+|+.+.||||+++..+|... . ...+||||
T Consensus 28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 34679999999999998654 68899998754322 234589999999999999998887632 2 34589999
Q ss_pred cCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceeccccc
Q 048219 106 MSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~~~ 178 (183)
+|. +|++.+... +...+...+..+..|++.||.|||.. +||||||||+|+|+|.+ +.+||+|||.|+..
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 985 899888642 34566666777899999999999997 99999999999999977 99999999999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=173.73 Aligned_cols=148 Identities=24% Similarity=0.329 Sum_probs=130.7
Q ss_pred HHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
....|++.+.||.|..+.||+|+.. .+..|+||++.-. ...+...+..|+..+..+.||||++++..|.....+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3456888899999999999999954 5788999998632 2334577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 104 EYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 104 e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
.+|.+|++.+.+... ...+++..+..|.++++.||.|||.+ |.+|||+|+.|||++.+|.++|+|||.+-
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeee
Confidence 999999999998753 34578888999999999999999998 99999999999999999999999999875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=177.79 Aligned_cols=148 Identities=24% Similarity=0.332 Sum_probs=130.3
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhH---HHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDE---REREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 102 (183)
..|.+.+.||+|.||.||.|.... +..+|+|.+.+.... ....+.+|+.+|+.++ |||++.+.++|++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 457777899999999999999775 889999998765432 2357889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC----Ccccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN----RCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~----~~~~i~dfg~a~~~ 178 (183)
||++.||.|++.+... .+++.....++.|++.++.|+|+. +++|||+||+|+++... +.++++|||+|+..
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999999999765 378888889999999999999997 99999999999999644 37999999999977
Q ss_pred cc
Q 048219 179 EA 180 (183)
Q Consensus 179 ~~ 180 (183)
..
T Consensus 190 ~~ 191 (382)
T KOG0032|consen 190 KP 191 (382)
T ss_pred cC
Confidence 54
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=171.16 Aligned_cols=145 Identities=23% Similarity=0.224 Sum_probs=127.7
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.++.+.||.|.-|.||++.... +...|+|.+.+..-. ...++..|-++|..+.||.+++++..|+.....|++|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 3455689999999999999765 588999999875433 345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 106 MSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 106 ~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|+||+|..+..... +.+++..+..++.+++.||+|||.. |||+|||||+|||+.++|++-+.||-++.-
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999886543 5677888888999999999999998 999999999999999999999999998863
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=177.02 Aligned_cols=145 Identities=21% Similarity=0.197 Sum_probs=124.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||++... ++..+++|.+.+.. ......+.+|+.+++.++|||++++.+++.+.+..+++||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 3556678999999999999875 57789999986532 1223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+++... .+++.....++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+|+..
T Consensus 124 y~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 124 YMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999988543 456677777889999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=170.71 Aligned_cols=145 Identities=22% Similarity=0.226 Sum_probs=123.9
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
...+.||+|+||.||++... ++..+++|.+.+... .....+.+|+.++..+.|++++++.+.+.+.+..+++||++
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 45578999999999999864 678899998865321 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|...+.... ..+++.....++.|++.|+.|+|+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 9999988775432 3467778888899999999999998 9999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=168.33 Aligned_cols=149 Identities=26% Similarity=0.361 Sum_probs=127.6
Q ss_pred HHHhchhcccCcCcCceEEEEEEc----CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
...+.+.+.||+|+||.||+|... .+..+++|.++... ......+.+|+..+..++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 345667789999999999999753 35678899887542 2334568889999999999999999999998899999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|||+++++|.+++......+++.....++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999998876555677888889999999999999998 9999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=175.89 Aligned_cols=146 Identities=23% Similarity=0.226 Sum_probs=127.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|.+.+.||+|+||.||+|... .++.+++|.+..... .....+..|+.++..+.|++++++++++.+.+..+++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456778999999999999976 578899999875421 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++++|.+++... ..++......++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+|+...
T Consensus 83 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 83 MPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 9999999998664 4567777888999999999999997 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=181.27 Aligned_cols=147 Identities=16% Similarity=0.143 Sum_probs=125.3
Q ss_pred HhchhcccCcCcCceEEEEEEcC--CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN--RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||+|++|.||.|.... +..+++|.+..........+..|+.++..++||||+++++++...+..+++|||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 36777899999999999998543 5667777765443444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+.+... ...+.+.....++.|++.||.|+|++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999877532 23466777778899999999999998 9999999999999999999999999999865
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=175.17 Aligned_cols=145 Identities=19% Similarity=0.196 Sum_probs=124.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||++... .+..+++|.+.... ......+..|+.++..++|++++++++.+.+.+..+++|||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345578999999999999865 57889999886432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ..+++.....++.|++.||.|+|+. +++||||||+||+++.++.++|+|||+|+..
T Consensus 83 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 83 LPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred CCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999988654 3466777778999999999999998 9999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=171.72 Aligned_cols=146 Identities=25% Similarity=0.310 Sum_probs=124.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|+|++++.+++.+....+++|||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3566788999999999999976 578899998864322 12335678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ +++.+.+......+.+..+..++.|++.||.|+|++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 5 588887765555567777888999999999999998 9999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=191.05 Aligned_cols=143 Identities=27% Similarity=0.500 Sum_probs=127.7
Q ss_pred chhcccCcCcCceEEEEEEcC--Cc----EEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMIN--RQ----LVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~--~~----~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+...||+|+||.||.|...+ +. .|++|.+.+.. ......|+.|..+|+.+.||||+++.|++.+....+|++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 345689999999999998653 32 38899988764 334567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 104 EYMSNGSLADILFNA------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 104 e~~~~~~l~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
|||.+|+|..++... ...+.-.+.+.++.+|+.|+.||+++ ++|||||.++|+|+++...+||+|||+|+
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhH
Confidence 999999999999876 56677788889999999999999998 99999999999999999999999999999
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=181.10 Aligned_cols=152 Identities=29% Similarity=0.408 Sum_probs=131.7
Q ss_pred HHHHHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHH-HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 22 YAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDER-EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 22 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..++.+.+-.+.++||+|.||.|.+|......+||+|.+....... +..+..|+.+|.+++||||+.++++|...+.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3455566667789999999999999998888899999998765444 478999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCC-CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 101 LVYEYMSNGSLADILFNAEK-QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
+++||+++|+|-+++....- .........|+.||+.|+.||.+- .+||||+.++|+|+|.++++||+|||+|+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence 99999999999999976521 122233456999999999999986 99999999999999999999999999998
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=172.65 Aligned_cols=145 Identities=23% Similarity=0.196 Sum_probs=124.7
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||++.... +..+++|.+.+.. ......+.+|+.++..+.|++++++.+.+.+.+..+++|||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 4566789999999999998764 6778999886432 11233477889999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++++|.+++......+++.....++.|++.|+.|+|+. +++||||||+||+++.++.++|+|||+|+.
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchhee
Confidence 999999999976445567777788899999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=176.55 Aligned_cols=149 Identities=23% Similarity=0.328 Sum_probs=123.8
Q ss_pred HHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
...+.+.+.||+|+||.||+|... .+..+++|.++... ......+.+|+.++..+ .||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 344667789999999999999632 24578999886432 23345688899999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-----------------------------------------------------------
Q 048219 99 KILVYEYMSNGSLADILFNAE----------------------------------------------------------- 119 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~----------------------------------------------------------- 119 (183)
.+++|||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998885421
Q ss_pred ---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 120 ---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 120 ---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
..+++..+..++.|++.||.|+|+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceec
Confidence 1245556677899999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-26 Score=172.54 Aligned_cols=140 Identities=24% Similarity=0.254 Sum_probs=119.9
Q ss_pred cccCcCcCceEEEEEEc----CCcEEEEEEccchhh----HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 34 EKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLD----EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.||+|+||.||++... .++.+++|.+.+... .....+..|+.+++.++||||+++++.+...+..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 46899999999999753 467899999875321 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++++|.+.+... ..+.+.....++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9999999988654 3455666677889999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=175.13 Aligned_cols=146 Identities=21% Similarity=0.183 Sum_probs=125.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
..+.+.+.||+|+||.||++... .++.+++|.+.+... .....+.+|+.+++.++|||++++++.+.+.+..+++|
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45666788999999999999976 467889998764321 22345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+++++|.+++... .++......++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+|+..
T Consensus 123 Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 123 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999988653 356677777899999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=178.07 Aligned_cols=148 Identities=20% Similarity=0.256 Sum_probs=127.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe-EEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK-KILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~ 105 (183)
|...+++|+|+||.++..+.+ ..+.+++|.+.-. .........+|+.++.++.||||+.+.+.|+..+. .+|+|+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 556678999999999988855 4667888887532 22233468899999999999999999999988777 9999999
Q ss_pred cCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 106 MSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 106 ~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
|+||++.+.+...+ ..+.+..+..++.|++.|+.|||++ +|+|||||+.||++..++.++|.|||+|+..+.
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999997655 5677888889999999999999988 999999999999999999999999999998754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=158.61 Aligned_cols=144 Identities=25% Similarity=0.340 Sum_probs=124.6
Q ss_pred hcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 33 KEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.++||+|++|+|++|+.. +...|++|.+.-... ......++|+.+++.++|.||+++++.......+-+|+|+|..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 357999999999999865 467889998754321 1235678999999999999999999999999999999999964
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
++..+....+..++......++.|++.||.++|++ .+.|||+||.|.+++.+|..|++|||+|+-+..
T Consensus 86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 89888887777777777778899999999999998 999999999999999999999999999996543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=170.61 Aligned_cols=142 Identities=23% Similarity=0.351 Sum_probs=121.1
Q ss_pred hcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe-----CCeEEEEEe
Q 048219 33 KEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE-----VSKKILVYE 104 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e 104 (183)
.+.||.|++|.|+.|.+. ++..||+|++.+. .....++..+|+.+|+.++|+||+.+.+.+.. -+.+|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 357999999999999865 5788999998753 23446788999999999999999999988864 235899999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++ ..+|.+.+... ..++..-...++.|++.||.|+|+. +++||||||+|++++.++.+||+|||+|+...
T Consensus 107 lM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecc
Confidence 99 56999988664 3366666666889999999999998 99999999999999999999999999999774
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=171.04 Aligned_cols=148 Identities=24% Similarity=0.339 Sum_probs=124.2
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-Cc----EEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQ----LVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~----~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
..+...+.||+|+||.||+|.+.. +. .+++|.+.... ......+.+|+.+++.++|+|++++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 345666789999999999998542 22 37888876432 33456788899999999999999999988754 5678
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|++++|++.+.+......+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+|+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999876555677778888999999999999998 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=171.45 Aligned_cols=139 Identities=26% Similarity=0.266 Sum_probs=120.7
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||++... .+..+++|.+.+... .....+..|..++..+ +||||+++++++.+.+..+++|||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5899999999999865 578899999875421 2234577889999888 6999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+.
T Consensus 82 ~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 82 DLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 998877543 4577888888999999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=167.08 Aligned_cols=147 Identities=27% Similarity=0.393 Sum_probs=125.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-----CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (183)
.+.+.+.||+|+||.||++... .+..+++|.+..........+.+|+.++..++|+|++++.+++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 3456678999999999998742 467899999876554555678899999999999999999988754 346889
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++||+++++|.+++......+++.....++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++..
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999866545577788888999999999999998 9999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=171.31 Aligned_cols=142 Identities=23% Similarity=0.267 Sum_probs=120.4
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHH---hhcCCCceeeeeceEEeCCeEEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVI---GRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.||+|+||.||++... +++.+++|.+.+.. ......+..|+.++ +.++|||++++++++...+..+++|
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45678999999999999865 57889999987542 12234566666654 5668999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
||+++++|...+.. ..+++.....++.|++.|+.|+|+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 82 E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 82 EYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred cCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 99999999887743 4577888888999999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=170.63 Aligned_cols=141 Identities=25% Similarity=0.254 Sum_probs=121.7
Q ss_pred cccCcCcCceEEEEEEc----CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 34 EKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.||+|+||.||++... .+..+++|.+.+... .....+..|+.++..++|+||+++++++.+.+..+++|||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 46899999999998742 467899999875432 123456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+.+... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 99999988543 3467788888999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=179.63 Aligned_cols=148 Identities=28% Similarity=0.407 Sum_probs=127.6
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-C-----CceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-H-----RNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~ 100 (183)
-+|.+.+.||+|+||.|.+|.+. +++.||||++++. .........|+.+|..++ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 36778899999999999999976 5889999999765 345567788999999886 4 28999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC--Ccccccceecccc
Q 048219 101 LVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN--RCAKNFRLWIGKV 177 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~--~~~~i~dfg~a~~ 177 (183)
||+|.+. -+|+++++... +.++...+..++.||+.+|.+||.. +|||+||||+|||+... ..+|++|||.|.+
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999995 59999998754 4466778888999999999999987 99999999999999765 5799999999998
Q ss_pred ccc
Q 048219 178 DEA 180 (183)
Q Consensus 178 ~~~ 180 (183)
...
T Consensus 341 ~~q 343 (586)
T KOG0667|consen 341 ESQ 343 (586)
T ss_pred cCC
Confidence 654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=173.49 Aligned_cols=140 Identities=27% Similarity=0.393 Sum_probs=119.6
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.||+|+||.||++... +++.+++|.+.... ......+.+|+.+++.++|+||+++++++...+..+++|||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34568999999999999865 57889999885432 23345688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.... ...+..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++..
T Consensus 157 ~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 157 GSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred Ccccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 9885422 234566677899999999999998 9999999999999999999999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=170.86 Aligned_cols=139 Identities=27% Similarity=0.285 Sum_probs=119.6
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||++... ++..+++|.+.+.. ......+..|+.++..+ +||||+++++++...+..+++|||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5899999999999866 46789999987542 22334567888888766 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++.....++.|++.|+.|+|++ +++|+||||+||+++.++.++|+|||+|+.
T Consensus 82 ~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 82 DLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 998877543 4567778888999999999999998 999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=184.06 Aligned_cols=149 Identities=21% Similarity=0.262 Sum_probs=126.7
Q ss_pred HHhchhcccCcCcCceEEEEEEcCC-cEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceE-Ee---C---Ce
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINR-QLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYS-LE---V---SK 98 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~---~---~~ 98 (183)
....+.+.|.+|+|+.||+|.+..+ ..+|+|++-.........+.+|+++|+.|+ |+|||.+++.. .. . -.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3455667899999999999998765 899999976655566778999999999997 99999999843 21 1 23
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 99 KILVYEYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
..+.||||.++.|-+++..+ ...+++..++.|+.++++|+.+||.. +.+|+|||||.+|+|++.+++.||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 57899999999999999754 24488999999999999999999985 56899999999999999999999999999874
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=164.05 Aligned_cols=145 Identities=24% Similarity=0.336 Sum_probs=125.6
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
+.+.+.||+|+||.||++....+..+++|.+.... .....+.+|+.+++.++|||++++++++...+..+++|||++++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 45567899999999999988777788999876432 22346788999999999999999999999889999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|.+.+......+++.....++.|++.||.|+|++ +++|+||+|+||+++.++.++++|||.++..
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 99998865444567777888999999999999998 9999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=169.92 Aligned_cols=139 Identities=22% Similarity=0.287 Sum_probs=119.0
Q ss_pred ccCcCcCceEEEEEEcC-CcEEEEEEccchh---hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL---DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|.... +..+++|.+.+.. ......+..|..++..+ +||+|+++++++...+..+++|||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 58999999999998764 6789999987542 12234566788888765 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++.....++.|++.||.|||++ +++||||||+||+++.++.++|+|||+|+.
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 82 DLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 998888654 3466777788899999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=164.32 Aligned_cols=144 Identities=26% Similarity=0.347 Sum_probs=125.2
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
+.+.+.||+|+||.||++....+..+++|.+.+... ....+..|+.+++.++|+|++++++++...+..+++||+++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 456678999999999999877777788988764321 2345778999999999999999999998888999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|.+++......+++.....++.|++.|+.|+|+. +++|+|++|+||+++.++.++++|||+++.
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCccccee
Confidence 99998866545567888888999999999999998 999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=170.20 Aligned_cols=145 Identities=23% Similarity=0.199 Sum_probs=123.1
Q ss_pred hchhcccCcCcCceEEEEEEc----CCcEEEEEEccchhh----HHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLD----EREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 100 (183)
+.+.+.||+|+||.||++... .+..+++|.+.+... .....+..|+.++..++ |++++++.+++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456678999999999998753 467899998865321 12345778999999995 899999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|||++++++.+.+... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+|+..
T Consensus 82 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999999988653 3466777788899999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=165.65 Aligned_cols=140 Identities=24% Similarity=0.260 Sum_probs=119.8
Q ss_pred cCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 36 lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
||+|+||.||++... +++.+++|.+...... ....+..|+.+++.+.|++++++.+++...+..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 5778999988653221 224567899999999999999999999999999999999999999
Q ss_pred HHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 112 ADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 112 ~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
...+... ...+++.....++.|++.|+.|+|++ +++|+||+|+||+++.++.++|+|||+|+..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 8777432 23467788888999999999999998 9999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=163.49 Aligned_cols=146 Identities=29% Similarity=0.404 Sum_probs=127.1
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.+.||+|+||.||.+....+..+++|.+..... ....+.+|+.++..+.|||++++++++......+++||++++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 3566778999999999999877766799998865422 235678899999999999999999999888889999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.+++......+.+..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||.++..
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceec
Confidence 999998866444577888889999999999999998 9999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=174.13 Aligned_cols=151 Identities=23% Similarity=0.367 Sum_probs=125.1
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV 96 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (183)
+....+.+.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44556777889999999999998743 23579999886532 33345688899999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------------------------------------------------
Q 048219 97 SKKILVYEYMSNGSLADILFNAE--------------------------------------------------------- 119 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~--------------------------------------------------------- 119 (183)
+..+++|||+++++|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999998875321
Q ss_pred ------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 120 ------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 120 ------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
..+.+.....++.|++.||.|||++ +++||||||+||+++.++.++|+|||+|+..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence 1234556677899999999999998 9999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=162.37 Aligned_cols=141 Identities=25% Similarity=0.415 Sum_probs=123.3
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+|++++.+++......+++|||++++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999865 57788999875432 33446788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
.+++......+++.....++.|++.||.|+|++ +++|+||+|+||+++.++.++++|||+++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence 998865444567888888999999999999998 999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=177.37 Aligned_cols=152 Identities=24% Similarity=0.327 Sum_probs=132.9
Q ss_pred HHHHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 24 ELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 24 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
....-.+.+.++||.|.|+.|.++... ++..||+|.+++.. ......+.+|+.+|..++||||++++.+.+.+..+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 334455777889999999999999865 57889999988643 233456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+||||+.+|.+++++....+... .....+..|+..++.|||+. .|+|||||++|++++.+.++||+|||++.+++
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999987765544 66667889999999999998 99999999999999999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=168.88 Aligned_cols=140 Identities=24% Similarity=0.266 Sum_probs=117.5
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHH-HHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIK-VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|... ++..+++|.+.+... .....+..|.. +++.++||||+++++.+...+..+++|||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5899999999999865 578899999865321 12234444544 567789999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++...+... ..+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 82 ELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 998887543 3567777888999999999999998 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=168.89 Aligned_cols=139 Identities=23% Similarity=0.274 Sum_probs=116.7
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhh-cCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|... .+..+++|.+..... ........|..++.. ..||||+++++++...+..+++|||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999865 467899998875321 122344556666654 47999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||+|+.
T Consensus 82 ~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 82 DLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 999888654 3466777778899999999999998 999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=168.54 Aligned_cols=140 Identities=26% Similarity=0.273 Sum_probs=117.5
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHH-HHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIK-VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|... ++..+++|.+.+... .....+..|.. +++.++||||+++++.+...+..+++|||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5899999999999976 578899999865321 12233444544 567889999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|...+... ..+.+.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 82 ELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999888653 3466777778899999999999998 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=181.66 Aligned_cols=154 Identities=28% Similarity=0.412 Sum_probs=132.8
Q ss_pred eCHHHHHHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEcc---chhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe
Q 048219 20 FSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLE---KVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE 95 (183)
Q Consensus 20 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (183)
|...++++....+ ..||.|+||.||-|++. +...||||.+. +...+....++.|+.+|+.+.|||.+.+.|+|..
T Consensus 19 F~k~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 19 FFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HccCCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 3444455443333 46899999999999965 57789999875 3345566789999999999999999999999998
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 96 VSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 96 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
..-.|+|||||- |+..+++....+.+.+..+..|+.+.++||.|||++ +.+|||+|+.|||+.+.|.||++|||.|
T Consensus 98 e~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 98 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred cchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence 888999999995 599999988888888999999999999999999998 9999999999999999999999999999
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
.+.
T Consensus 174 si~ 176 (948)
T KOG0577|consen 174 SIM 176 (948)
T ss_pred hhc
Confidence 865
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=169.46 Aligned_cols=144 Identities=24% Similarity=0.267 Sum_probs=121.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCC-ceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHR-NLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+.+.||+|+||.||+|... .++.+++|.+.+.. ......+..|..++..+.|+ +++.+.+++...+..+++||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456678999999999999866 46789999987542 12334577888899888765 58888888888899999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|+++++|.+.+... ..+.+.....++.|++.||.|+|++ +++|+||||+||+++.++.++|+|||+|+.
T Consensus 82 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 82 YVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 99999999888553 3466777888899999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=168.86 Aligned_cols=139 Identities=26% Similarity=0.263 Sum_probs=115.5
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHH-HHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEI-KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|... ++..+++|.+.+... .....+..|. .+++.+.|+||+++++.+...+..+++|||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5899999999999976 467799998865321 1122344443 4567889999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
++.+.+... ..+.+.....++.|++.||.|+|++ +++||||||+||+++.++.++|+|||+|+.
T Consensus 82 ~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 82 ELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 999988654 3455666777899999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=164.65 Aligned_cols=148 Identities=23% Similarity=0.289 Sum_probs=125.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-----CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 99 (183)
..+.+.+.||+|+||.||.+... .+..+++|.+.... ......+.+|+.+++.++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34556678999999999998732 46779999886442 33345688999999999999999999988764 568
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|||+++++|.+++.......++..+..++.|++.+|.|+|++ +++|+||+|+||+++.++.++++|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 899999999999998865444567888888999999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=169.22 Aligned_cols=148 Identities=20% Similarity=0.254 Sum_probs=125.6
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
..|.+.+.||+|+||.||++... .+..+++|.+.... ......+.+|+.++..++|+||+++++++...+..+++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 45667788999999999999876 46677888765432 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ..+++.....++.+++.|+.|+|+. .+++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 85 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 9999999988653 3466777778899999999999974 27999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=168.57 Aligned_cols=139 Identities=26% Similarity=0.244 Sum_probs=116.5
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHH-HHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEI-KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|... ++..+++|.+.+... .....+..|. .+++.++|+||+++.+.+.+.+..+++|||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999976 477899998865321 1223344454 4678899999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+.+.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+|+.
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 82 ELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 998877543 3456667777899999999999998 999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=169.14 Aligned_cols=147 Identities=22% Similarity=0.260 Sum_probs=125.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+.+.||+|+||.||++... .+..+++|.+.... ......+.+|+.+++.++|+|++++++++...+..+++|||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 4556678999999999999976 46778888876432 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++... ..+++..+..++.|++.|+.|+|+. .+++|+||||+||+++.++.++|+|||+++..
T Consensus 86 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 86 DGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999988653 3466777888999999999999974 26999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=163.97 Aligned_cols=147 Identities=23% Similarity=0.340 Sum_probs=129.3
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..|.+.+.||+|+||.||++.... +..+++|.+..........+..|+.+++.++|+|++++.+.+...+..+++|||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 346677789999999999998764 7788999887655555677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++++...+......+++..+..++.|++.++.|+|++ +++|+|++|+||+++.++.++|+|||++..
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 99999887765555677888888999999999999998 999999999999999999999999998864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=162.13 Aligned_cols=146 Identities=21% Similarity=0.342 Sum_probs=126.9
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+.+.||+|+||.||++.... +..+++|.+..........+.+|+.+++.+.|+|++++.+.+...+..++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4566789999999999998764 667788887655444556788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++...+......+++..+..++.|++.||.|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 999887765445677888888999999999999998 9999999999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-25 Score=162.24 Aligned_cols=148 Identities=26% Similarity=0.370 Sum_probs=130.3
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.+.+.||.|+||.||+|....+..+++|.+..........+..|+.+++.++|+|++++++++.+....+++||+++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 34667788999999999999988888899999876655455678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++.... ..+.+..+..++.|++.|+.|+|++ +++|+|++|+||+++.++.++++|||.+...
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence 999999986532 3467777888999999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=163.62 Aligned_cols=147 Identities=25% Similarity=0.367 Sum_probs=127.9
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.+.+.||+|++|.||+|....+..+++|.+.... .....+.+|+.++++++|+|++++++++...+..+++||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 3466778999999999999987777789999886532 234567889999999999999999999998899999999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++.... ..+.+.....++.|++.|+.++|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 999999986543 4567788888999999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=168.06 Aligned_cols=145 Identities=24% Similarity=0.338 Sum_probs=123.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
|.+.+.||+|+||.||+|... .+..+++|.+..... .....+.+|+.+++.++|+|++++++++...+..+++|||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 556678999999999999865 467789998764321 122356789999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ ++.+.+......+.......++.|++.||.|+|++ +++||||+|+||+++.++.++|+|||+|+..
T Consensus 88 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 88 K-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceec
Confidence 5 88887766555567777788899999999999998 9999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=160.55 Aligned_cols=140 Identities=26% Similarity=0.419 Sum_probs=123.5
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHH
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD 113 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 113 (183)
.||+|+||.||++...++..+++|.+.... ......+.+|+.++..++|+|++++.+.+...+..+++||+++++++.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 589999999999987778889999876543 2334468889999999999999999999998899999999999999999
Q ss_pred HHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 114 ILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 114 ~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
++......+.+.....++.+++.++.|+|++ +++|+|++|+||+++.++.++++|||++..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence 8865545567788888999999999999998 999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=169.04 Aligned_cols=139 Identities=24% Similarity=0.302 Sum_probs=119.0
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|... ++..+++|.+.+... .....+..|..++..+ .|||++++++++...+..+++|||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5899999999999876 477899998875421 2234566788888766 6999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++.....++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 82 DLMFHIQKS-RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred hHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 999887654 3467777888999999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-25 Score=162.68 Aligned_cols=146 Identities=27% Similarity=0.460 Sum_probs=126.9
Q ss_pred hchhcccCcCcCceEEEEEEcC-C---cEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-R---QLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~---~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+.+.||+|+||.||+|.... + ..+++|.+.... ......+..|+.+++.++|||++++.+.+......+++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 5667889999999999998653 2 368999886542 3345678899999999999999999999988889999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++......+++.....++.|++.|+.|+|++ +++|+|++|+||+++.++.++++|||+++..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999998876555677888888999999999999998 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=161.91 Aligned_cols=147 Identities=29% Similarity=0.455 Sum_probs=126.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-C---CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-N---RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~---~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||+|... . ...+++|.+.... ......+.+|+.++..++|||++++.+++...+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4566788999999999999854 2 3368888876432 233457888999999999999999999998888999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++++|.+++......+.+.....++.|++.|+.++|+. +++|+|++|+||+++.++.++++|||+++..
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999876555567788888999999999999998 9999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=167.49 Aligned_cols=139 Identities=24% Similarity=0.296 Sum_probs=118.1
Q ss_pred ccCcCcCceEEEEEEcC-CcEEEEEEccchhh---HHHHHHHHHHHHHhh-cCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLD---EREREFQTEIKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|.... +..+++|.+.+... ........|..++.. +.||||+++++++.+.+..+++|||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 58999999999999764 67899999875421 223445667777765 58999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++.....++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||+|+.
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 82 DLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 999988653 3466777788999999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=167.72 Aligned_cols=139 Identities=22% Similarity=0.258 Sum_probs=118.1
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhh-cCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|... ++..+++|.+.+... ........|..++.. ..|++++++++++.+.+..+++|||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 5899999999999976 577899999875421 223445667777765 48999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++.....++.|++.||.|||++ +++||||||+||+++.++.++|+|||+++.
T Consensus 82 ~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 82 DLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 999888653 3466777788899999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=162.68 Aligned_cols=148 Identities=22% Similarity=0.320 Sum_probs=130.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..+.+.+.||+|++|.||++... ++..+++|.+..........+..|+.+++.++|+|++++.+.+......+++|||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 34667788999999999999865 57788999886554455567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++.+++......+++.....++.|++.++.|+|+. +++|+|++|+||+++.++.++|+|||++...
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 99999998876555677888888999999999999998 9999999999999999999999999988644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=165.43 Aligned_cols=146 Identities=23% Similarity=0.222 Sum_probs=124.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+...+.||+|+||.||++... ++..+++|.+..... .....+.+|+.+++.++|++++++.+.+.+.+..+++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 445678999999999999865 577899998865321 1224567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+.+.... ..+++.....++.|++.|+.|+|+. +++|+||+|+||++++++.++|+|||+++..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 99999988775432 3467778888899999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-25 Score=167.46 Aligned_cols=139 Identities=27% Similarity=0.268 Sum_probs=120.3
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||++... ++..+++|.+.+... .....+..|..++..+ .|++++++.+++...+..+++|||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999865 467899999875422 2234577888888887 5999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||+|+.
T Consensus 82 ~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 82 DLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 998877543 3577888888999999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=162.70 Aligned_cols=140 Identities=19% Similarity=0.301 Sum_probs=117.2
Q ss_pred ccCcCcCceEEEEEEcC-------------------------CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeee
Q 048219 35 KVGRGSSGTVYKGAMIN-------------------------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~-------------------------~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (183)
.||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999986321 13477888765544445567889999999999999999
Q ss_pred eceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC----
Q 048219 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR---- 165 (183)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~---- 165 (183)
++++...+..++||||++++++..++......+++..+..++.|++.|+.|+|+. +++|+||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999988865555667888888999999999999998 999999999999997643
Q ss_pred ---cccccceecccc
Q 048219 166 ---CAKNFRLWIGKV 177 (183)
Q Consensus 166 ---~~~i~dfg~a~~ 177 (183)
.++++|||++..
T Consensus 159 ~~~~~kl~d~g~~~~ 173 (274)
T cd05076 159 TSPFIKLSDPGVSFT 173 (274)
T ss_pred ccceeeecCCccccc
Confidence 379999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=172.63 Aligned_cols=139 Identities=19% Similarity=0.200 Sum_probs=120.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+|.+.+.||+|+||.||+|.+. .++.+++|.... ..+.+|+.+++.++||||+++++++......++++|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 4677789999999999999975 577888886432 346789999999999999999999999999999999985
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++..++... ..+++.....++.|++.||.|+|++ +|+||||||+||+++.++.++|+|||+|+..
T Consensus 167 -~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 167 -TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred -CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 6888877553 3467778888999999999999998 9999999999999999999999999999753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=168.83 Aligned_cols=144 Identities=22% Similarity=0.343 Sum_probs=120.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-----eEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS-----KKIL 101 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 101 (183)
|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++.+++...+ ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456788999999999999865 57889999886432 223346788999999999999999999886432 4799
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|||+. +++.+.+... ..+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 82 v~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 6888887543 3467778888999999999999998 9999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-25 Score=171.84 Aligned_cols=151 Identities=21% Similarity=0.330 Sum_probs=124.3
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchhh-HHHHHHHHHHHHHhhcC-CCceeeeeceEEeC
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLD-EREREFQTEIKVIGRTH-HRNLVRLLGYSLEV 96 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 96 (183)
+....+.+.+.||+|+||.||+|.... ...+++|.+..... .....+.+|+.++..+. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 334556677899999999999997532 24689998864322 23456889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------------------------------------------------
Q 048219 97 SKKILVYEYMSNGSLADILFNAE--------------------------------------------------------- 119 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~--------------------------------------------------------- 119 (183)
+..+++|||+++|+|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998875421
Q ss_pred --------------------------------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe
Q 048219 120 --------------------------------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM 161 (183)
Q Consensus 120 --------------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~ 161 (183)
..+.+..+..++.|++.|+.|+|++ +++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 1244556677899999999999998 99999999999999
Q ss_pred cCCCcccccceeccccc
Q 048219 162 DENRCAKNFRLWIGKVD 178 (183)
Q Consensus 162 ~~~~~~~i~dfg~a~~~ 178 (183)
+.++.++++|||+|+..
T Consensus 271 ~~~~~~kL~DfGla~~~ 287 (400)
T cd05105 271 AQGKIVKICDFGLARDI 287 (400)
T ss_pred eCCCEEEEEeCCcceec
Confidence 99999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-25 Score=162.02 Aligned_cols=140 Identities=23% Similarity=0.369 Sum_probs=118.4
Q ss_pred cccCcCcCceEEEEEEcCCc-----------EEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 34 EKVGRGSSGTVYKGAMINRQ-----------LVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~-----------~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
+.||+|+||.||+|...... .+++|.+...... ...+.+|+.+++.++|+|++++.+++.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 35899999999999865432 4566665543222 5678889999999999999999999887 778999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-------cccccceecc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-------CAKNFRLWIG 175 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-------~~~i~dfg~a 175 (183)
|||+++++|.+++......++...+..++.|++.||.|+|++ +++|+||||+||+++..+ .++++|||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999876554677888888999999999999998 999999999999999887 7999999999
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
...
T Consensus 156 ~~~ 158 (259)
T cd05037 156 ITV 158 (259)
T ss_pred ccc
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=164.05 Aligned_cols=144 Identities=35% Similarity=0.531 Sum_probs=123.5
Q ss_pred hhcccCcCcCceEEEEEEc-----CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-----~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.||.|+||.||+|... .+..|++|.+.... ......+.+|+..+.+++||||+++.+++...+..++++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4568999999999999876 25678999986532 33467889999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ...+++..+..++.|++.||.|||++ +++|++|+++||+++.++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999999876 45678888899999999999999998 9999999999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=163.71 Aligned_cols=149 Identities=27% Similarity=0.450 Sum_probs=127.3
Q ss_pred HHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
++..+.+.+.+|+|+||.||++... .+..+++|.+..........+.+|+.++..++|++++++.+++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3455667788999999999998742 2355788888765444556788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 100 ILVYEYMSNGSLADILFNAE------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
++++||+++++|.+++.... ..+++.....++.|++.+|.|+|++ +++|+||||+||+++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999886422 2367778888999999999999998 99999999999999999999
Q ss_pred cccceecccc
Q 048219 168 KNFRLWIGKV 177 (183)
Q Consensus 168 ~i~dfg~a~~ 177 (183)
+++|||+++.
T Consensus 160 kl~dfg~~~~ 169 (288)
T cd05093 160 KIGDFGMSRD 169 (288)
T ss_pred EeccCCcccc
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=161.22 Aligned_cols=148 Identities=28% Similarity=0.419 Sum_probs=127.1
Q ss_pred HhchhcccCcCcCceEEEEEEcC----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||+|.... ...+++|.+.... ......+..|+.++..++|+|++++.+.+...+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 35567889999999999998642 3568888876433 233456788999999999999999999999888999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|++++++|.+++......+++.....++.|++.|+.|||++ +++|+|++|+||+++.++.++++|||+++...
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999876555677888888999999999999998 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=162.00 Aligned_cols=140 Identities=22% Similarity=0.272 Sum_probs=118.9
Q ss_pred cCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 36 lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
||+|+||.||++... .++.+++|.+..... .....+..|+++++.++|||++++.+.+......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 578899998864321 1223456699999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 112 ADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 112 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
...+.... ....+.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 88775432 3466777778899999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=177.45 Aligned_cols=149 Identities=25% Similarity=0.341 Sum_probs=124.9
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEcc--c--hhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe--EEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLE--K--VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK--KILVY 103 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~--~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~ 103 (183)
++.+.||+|+|-+||+|.+. .|..||...++ . ..+....++.+|+.+|+.|+|+||++++.+|.+..+ +.+++
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999975 46667644433 1 224456789999999999999999999999998766 78999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceecccccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~~~~~~ 181 (183)
|.+..|+|..++.+.+ ..+...+..|++||+.||.|||++. .+|+|||||-+||+++.+ |.|||+|+|+|.+.+.+
T Consensus 123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999998764 3566788889999999999999974 599999999999999866 99999999999876543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-25 Score=165.12 Aligned_cols=149 Identities=28% Similarity=0.368 Sum_probs=124.3
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC---------------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeee
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN---------------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLL 90 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~---------------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (183)
+..+.+.+.||+|+||.||.+.... ...+++|.+.... ......+.+|+.++..++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4456777899999999999987532 2357888876542 23345688999999999999999999
Q ss_pred ceEEeCCeEEEEEeccCCCCHHHHHhcCC-----------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCE
Q 048219 91 GYSLEVSKKILVYEYMSNGSLADILFNAE-----------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNI 159 (183)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ni 159 (183)
+++...+..+++|||+++++|.+++.... ....+.....++.|++.|+.|||++ +++|+||+|+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999885421 1245667778899999999999998 999999999999
Q ss_pred EecCCCcccccceeccccc
Q 048219 160 LMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 160 l~~~~~~~~i~dfg~a~~~ 178 (183)
+++.++.++++|||+++..
T Consensus 161 ll~~~~~~kl~dfg~~~~~ 179 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNL 179 (295)
T ss_pred EEcCCCcEEeccccccccc
Confidence 9999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=161.23 Aligned_cols=147 Identities=26% Similarity=0.351 Sum_probs=127.0
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.+.+.||+|+||.||+|....+..+++|.+.... .....+.+|+.+++.++|+|++++++.+...+..++++|+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4456778999999999999997777789999876532 234578889999999999999999999988889999999999
Q ss_pred CCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++.+++... ........+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||+|+..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceec
Confidence 99999988653 23456677778899999999999998 9999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-25 Score=167.26 Aligned_cols=143 Identities=23% Similarity=0.263 Sum_probs=120.9
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEec
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
++.+.||+|+||.||+|... ++..+++|.+.+... .....+..|..++..+. |++++++.+++.+.+..+++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45678999999999999865 578899999875421 22345677888888776 56788899999889999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++++|...+... ..+++.....++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||+|+.
T Consensus 83 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 83 VNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 9999999888553 3467788888999999999999998 999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=165.79 Aligned_cols=139 Identities=26% Similarity=0.307 Sum_probs=119.5
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||++... ++..+++|.+.+.. ......+..|..++..+ .|||++++++++...+..+++|||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999876 46789999987542 12234566788888877 6999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|...+... ..+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 82 DLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 998887553 3467788888999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=165.89 Aligned_cols=144 Identities=23% Similarity=0.254 Sum_probs=120.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+.+.||+|+||.||+|... ++..+++|.+.+... ........|..++..+ .|++++++.+++...+..+++||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 345678999999999999876 467899998875421 1223456677777776 47889999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|+++++|...+... ..+.+..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||+|+.
T Consensus 82 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 82 YVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 99999999888553 3466778888999999999999998 999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-25 Score=164.24 Aligned_cols=145 Identities=22% Similarity=0.291 Sum_probs=122.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|+||.||++... ++..+++|.+.... ......+.+|+.+++.++|+|++++.+++...+..+++|||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456678999999999999976 46788999876432 222356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.+..+. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 83 ~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 83 EKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred CCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 886665443 3344567778888999999999999998 9999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-24 Score=160.25 Aligned_cols=146 Identities=27% Similarity=0.367 Sum_probs=126.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+.++..++|+|++++++.+...+..+++|||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 4667788999999999999864 577888988764433344567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++... ..+++.....++.|++.|+.|+|+. +++|+|++|+||+++.++.++++|||+++..
T Consensus 90 ~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 90 GGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceee
Confidence 99999988543 3466777888999999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=163.45 Aligned_cols=147 Identities=29% Similarity=0.448 Sum_probs=123.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-----CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
.+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++|+|++++.+++......+++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 3456678999999999999742 34678898886432 23345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCC----------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc
Q 048219 103 YEYMSNGSLADILFNAE----------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC 166 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~ 166 (183)
|||+++++|.+++.... ..+.+.....++.|++.|+.|+|++ +++|+|++|+||+++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 99999999999885321 2345666777899999999999998 9999999999999999999
Q ss_pred ccccceeccccc
Q 048219 167 AKNFRLWIGKVD 178 (183)
Q Consensus 167 ~~i~dfg~a~~~ 178 (183)
++++|||+++..
T Consensus 163 ~kl~dfg~~~~~ 174 (283)
T cd05090 163 VKISDLGLSREI 174 (283)
T ss_pred EEeccccccccc
Confidence 999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-25 Score=169.08 Aligned_cols=143 Identities=19% Similarity=0.211 Sum_probs=122.8
Q ss_pred HHHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
....+.+.+.||+|+||.||+|.... +..+++|...+. ....|+.+++.++|+||+++++++...+..++++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34457778899999999999999764 567888875432 23458999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++. +++.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++..+.++|+|||+|++.
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 995 588888866556678888888999999999999998 9999999999999999999999999999753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=180.66 Aligned_cols=146 Identities=31% Similarity=0.499 Sum_probs=130.7
Q ss_pred chhcccCcCcCceEEEEEEc----CCcEEEEEEccchhhHH-HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 31 GFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDER-EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.+.+.||.|.||.|++|+.+ ....||||.++-...+. ...|+.|+.+|.++.||||+++.|+........|++||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 34478999999999999854 24679999998766554 45799999999999999999999998888888999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|++|+|..++.....+++......+...|+.|+.||-++ +.|||||.++|||++.+-..|++|||++++..
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999988877788888888999999999999998 99999999999999999999999999999773
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=160.74 Aligned_cols=140 Identities=23% Similarity=0.319 Sum_probs=116.6
Q ss_pred ccCcCcCceEEEEEEcC---CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMIN---RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~---~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++|+||+++++.+...+..+++||++++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996433 3457777765432 2233567889999999999999999999998999999999999999
Q ss_pred HHHHHhcCCC----CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 111 LADILFNAEK----QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 111 l~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|.+++..... ...+.....++.|++.|+.|+|+. +++|+||||+||+++.++.+|++|||++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccc
Confidence 9999865432 234556677899999999999998 999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=159.10 Aligned_cols=145 Identities=30% Similarity=0.430 Sum_probs=127.3
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.+.||.|++|.||+|... ++.+++|.+..... ...++.+|+.+++.++|+|++++.+++.+.+..+++||++++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4556788999999999999765 67789999876543 456788899999999999999999999888999999999999
Q ss_pred CCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.+++.... ..+++..+..++.|++.|+.|+|++ +++|+||+|+||+++.++.++|+|||.++..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccc
Confidence 99999886543 3577888888999999999999998 9999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=159.67 Aligned_cols=146 Identities=26% Similarity=0.362 Sum_probs=126.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++|||++++.+.+...+..++++||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4566778999999999999865 577889988765433444567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++... ..+++.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 90 ~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 90 GGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 99999988543 3567788888999999999999998 9999999999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=179.62 Aligned_cols=147 Identities=24% Similarity=0.285 Sum_probs=126.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... .+..+++|.+.... ......+..|+.++..++|++|++++..+...+..++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3556788999999999999976 57889999886432 2223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+++++|.+++... ..+.+.....++.|++.||.|||.. +|+|+||||+||+++.++.++|+|||+|+...
T Consensus 85 y~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 85 YLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred CCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 99999999988653 3456777788999999999999997 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=159.33 Aligned_cols=142 Identities=20% Similarity=0.312 Sum_probs=118.8
Q ss_pred cccCcCcCceEEEEEEcC-------------CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 34 EKVGRGSSGTVYKGAMIN-------------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~-------------~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999997421 2247777776544444557788999999999999999999999888899
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc-------cccccee
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC-------AKNFRLW 173 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~-------~~i~dfg 173 (183)
++||+++++++..++......+++.....++.|++.|+.|+|+. +++|+||+|+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999888865555577888888999999999999998 9999999999999987654 8999999
Q ss_pred ccccc
Q 048219 174 IGKVD 178 (183)
Q Consensus 174 ~a~~~ 178 (183)
++...
T Consensus 158 ~~~~~ 162 (262)
T cd05077 158 IPITV 162 (262)
T ss_pred CCccc
Confidence 98754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=158.63 Aligned_cols=140 Identities=22% Similarity=0.345 Sum_probs=119.5
Q ss_pred ccCcCcCceEEEEEEc---CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMI---NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||+|... .+..+++|.+..... .....+.+|+.+++.++|+|++++.+++. ....+++|||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999998754 345688888865432 23456889999999999999999999875 457889999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|.+++......+++..+..++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||+++..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 145 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccc
Confidence 9998865555678888889999999999999998 9999999999999999999999999999744
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=165.66 Aligned_cols=138 Identities=25% Similarity=0.218 Sum_probs=115.9
Q ss_pred cCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhc---CCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRT---HHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 36 lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
||+|+||.||+|... .+..+++|.+.+.... .......|..++... .||+++++...+...+..+++|||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 4788999998653221 223344566666554 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
++|...+... ..+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.++|+|||+|+.
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 9998888653 4467778888999999999999998 999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=161.45 Aligned_cols=147 Identities=27% Similarity=0.443 Sum_probs=125.6
Q ss_pred HHhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..+.+.+.||+|+||.||+|.... +..+++|.+...... ....+.+|+.++..+.|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346677889999999999997532 467899988754333 3467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCC-------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 101 LVYEYMSNGSLADILFNAE-------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
++|||+++++|.+++.... ..+++.....++.|++.|+.++|++ +++|+||+|+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999986432 2355667778899999999999998 99999999999999999999
Q ss_pred cccceecccc
Q 048219 168 KNFRLWIGKV 177 (183)
Q Consensus 168 ~i~dfg~a~~ 177 (183)
+++|||+++.
T Consensus 162 kl~d~g~~~~ 171 (280)
T cd05049 162 KIGDFGMSRD 171 (280)
T ss_pred EECCccccee
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=160.05 Aligned_cols=147 Identities=27% Similarity=0.370 Sum_probs=125.3
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-C----cEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-R----QLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~----~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
..+.+.+.||+|+||.||+|.... + ..+++|.+.... ......+.+|+.+++.++|+|++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 345566789999999999998542 2 257888776543 3345678889999999999999999999877 78899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|+++++++.+.+......+++.....++.|++.|+.|+|++ +++|+|++|+||+++.++.++|+|||+|+..
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999876555678888889999999999999997 9999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-26 Score=165.90 Aligned_cols=145 Identities=28% Similarity=0.399 Sum_probs=130.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.-+.+.++||+|++|.||+|..+ .|+.+++|.+-- ..+...+..|+.++++...+.+|+++|.|.-...+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 33456678999999999999976 488899998743 245677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
-.|++.+.+..+++.+.+..+..+....+.||.|||.. .-+|||+|+.|||++.+|.+|++|||.|.-
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccch
Confidence 99999999988888899999999999999999999997 889999999999999999999999999863
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=163.29 Aligned_cols=147 Identities=29% Similarity=0.442 Sum_probs=122.4
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-Cc--EEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQ--LVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~--~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+.+.||+|+||.||+|.... +. .+++|.+.... ......+.+|+.++.++ +|+|++++++++...+..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 345677889999999999998653 33 45676665422 23345678899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 103 YEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
|||+++++|.+++.... ..+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999886432 2356777888999999999999998 99999999999999999999
Q ss_pred cccceecccc
Q 048219 168 KNFRLWIGKV 177 (183)
Q Consensus 168 ~i~dfg~a~~ 177 (183)
+|+|||+++.
T Consensus 164 kl~dfg~~~~ 173 (303)
T cd05088 164 KIADFGLSRG 173 (303)
T ss_pred EeCccccCcc
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=180.19 Aligned_cols=146 Identities=19% Similarity=0.236 Sum_probs=123.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|.+.+.||+|+||.||+|... .+..+++|.+.... .....++.+|+.++..++|||++++++++.+.+..+++|||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 556678999999999999876 47889999886432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC----------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 106 MSNGSLADILFNAE----------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 106 ~~~~~l~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
++|++|.+++.... ..........++.|++.||.|+|+. +++||||||+||+++.++.++|+|||+|
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999885421 1123445667889999999999998 9999999999999999999999999999
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
+..
T Consensus 161 k~i 163 (932)
T PRK13184 161 IFK 163 (932)
T ss_pred eec
Confidence 865
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=169.51 Aligned_cols=153 Identities=22% Similarity=0.355 Sum_probs=125.0
Q ss_pred HHHHHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcC-CCceeeeeceEE
Q 048219 23 AELKKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTH-HRNLVRLLGYSL 94 (183)
Q Consensus 23 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 94 (183)
.++....+.+.+.||+|+||.||+|+.. .+..+++|.+.... ......+..|+.++..+. |+||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344445666789999999999999853 24579999987542 223346888999999997 999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhcCC-------------------------------------------------------
Q 048219 95 EVSKKILVYEYMSNGSLADILFNAE------------------------------------------------------- 119 (183)
Q Consensus 95 ~~~~~~lv~e~~~~~~l~~~l~~~~------------------------------------------------------- 119 (183)
..+..+++|||+++|+|.+++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 8899999999999999999885421
Q ss_pred ------------------------------------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCC
Q 048219 120 ------------------------------------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQ 157 (183)
Q Consensus 120 ------------------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ 157 (183)
..+.+.....++.|++.||.|+|+. +++|+||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 1123445566888999999999997 9999999999
Q ss_pred CEEecCCCcccccceeccccc
Q 048219 158 NILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 158 nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+++.++.++++|||+++..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~ 289 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDI 289 (401)
T ss_pred eEEEeCCCEEEEEecCcceec
Confidence 999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=157.98 Aligned_cols=144 Identities=31% Similarity=0.466 Sum_probs=126.3
Q ss_pred cccCcCcCceEEEEEEcC----CcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.||+|+||.||+|.... +..+++|.+...... ....+..|+..+..++|++++++++++......+++||++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 358999999999998653 677889988754333 256788999999999999999999999998899999999999
Q ss_pred CCHHHHHhcC--------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 109 GSLADILFNA--------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 109 ~~l~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
++|.+++... ...+++.....++.|++.|+.++|++ +++|+|++|+||+++.++.++++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765 35678888899999999999999998 999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=163.41 Aligned_cols=146 Identities=25% Similarity=0.344 Sum_probs=124.4
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||.|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3556678999999999999865 57789999875322 222345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ +++.+.+......+++..+..++.|++.||.|+|++ +++|+||+|+||+++.++.++++|||+++..
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 7 588888866555677778888999999999999998 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=160.57 Aligned_cols=148 Identities=25% Similarity=0.388 Sum_probs=125.9
Q ss_pred HHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
..+.+...||+|+||.||.+... .+..+++|.+..........+.+|+.+++.++|+|++++.+++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34566678999999999998743 245578888776555555678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc
Q 048219 102 VYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC 166 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~ 166 (183)
+|||+++++|.+++.... ..+++..+..++.|++.|+.|+|++ +++|+||+|+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986422 2356777888999999999999998 9999999999999999999
Q ss_pred ccccceeccccc
Q 048219 167 AKNFRLWIGKVD 178 (183)
Q Consensus 167 ~~i~dfg~a~~~ 178 (183)
++++|||+|+..
T Consensus 162 ~~l~dfg~a~~~ 173 (291)
T cd05094 162 VKIGDFGMSRDV 173 (291)
T ss_pred EEECCCCccccc
Confidence 999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-26 Score=166.39 Aligned_cols=145 Identities=23% Similarity=0.231 Sum_probs=126.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
..+.+.||+|+||.|.+++.+ .++.+|+|++++.. .+.....+.|.++|+..+||.+..+...|++.+++|+||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 456688999999999999865 58899999997642 33456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+.||.|+-.+... +.+++.....+..+|..||.|||++ +|+.||+|.+|.++|.+|++||.|||+++..
T Consensus 250 anGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 250 ANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred ccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999998878654 4456666667889999999999998 9999999999999999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=169.84 Aligned_cols=143 Identities=24% Similarity=0.376 Sum_probs=121.0
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
+.||.|.||+||-|..+ +|+.||+|.+.+.. ......+.+|+.+|+.+.||.|+.+.-.|+++++++.|||-+.| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 68999999999999865 68999999998643 33446789999999999999999999999999999999999955 6
Q ss_pred HHHH-HhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---Ccccccceeccccccc
Q 048219 111 LADI-LFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAKNFRLWIGKVDEA 180 (183)
Q Consensus 111 l~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---~~~~i~dfg~a~~~~~ 180 (183)
..+. +..+..-+++.....++.||+.||.|||.. +|+|+||||+|+|+... -.+||||||+|++...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 5554 444445566766677889999999999998 99999999999999754 4799999999998754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=158.60 Aligned_cols=147 Identities=20% Similarity=0.326 Sum_probs=124.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|||++++.+.+.+.+..++++|+
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456778999999999999865 5788899876432 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++.+++.. ....++......++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||++....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999887753 223456677788999999999999998 99999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=160.12 Aligned_cols=148 Identities=24% Similarity=0.370 Sum_probs=122.8
Q ss_pred HHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
...+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++|+|++++++++......
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 345667789999999999998753 23568888875432 22345678899999999999999999999888899
Q ss_pred EEEEeccCCCCHHHHHhcCC---------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccc
Q 048219 100 ILVYEYMSNGSLADILFNAE---------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~ 170 (183)
+++|||+++++|.+++.... ....+.....++.|++.|+.|+|+. +++|+||||+||+++.++.++++
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999885422 1234566777899999999999998 99999999999999999999999
Q ss_pred ceecccc
Q 048219 171 RLWIGKV 177 (183)
Q Consensus 171 dfg~a~~ 177 (183)
|||+|+.
T Consensus 162 dfg~~~~ 168 (277)
T cd05062 162 DFGMTRD 168 (277)
T ss_pred CCCCccc
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=160.76 Aligned_cols=147 Identities=26% Similarity=0.397 Sum_probs=125.0
Q ss_pred HHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
....+.+.||+|+||.||++... .+..+++|.+..........+.+|+.+++.++|+|++++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34556789999999999998632 245678888766555555678899999999999999999999998899999
Q ss_pred EEeccCCCCHHHHHhcCC--------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 102 VYEYMSNGSLADILFNAE--------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
+||++++++|.+++.... ..+.+..+..++.|++.|+.|+|++ +++|+||+|+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 999999999999886532 2356777788899999999999998 99999999999999999999
Q ss_pred cccceecccc
Q 048219 168 KNFRLWIGKV 177 (183)
Q Consensus 168 ~i~dfg~a~~ 177 (183)
+|+|||+++.
T Consensus 162 kL~dfg~~~~ 171 (280)
T cd05092 162 KIGDFGMSRD 171 (280)
T ss_pred EECCCCceeE
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=162.01 Aligned_cols=146 Identities=27% Similarity=0.353 Sum_probs=127.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..+.+.+.||+|++|.||++... .++.+++|.+..........+.+|+.+++.++|+|++++.+.+...+..+++|||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 44666778999999999999864 57889999886544444566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++.+++.. ..+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++++|||++...
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 99999998854 3466777888999999999999998 9999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=167.36 Aligned_cols=143 Identities=24% Similarity=0.319 Sum_probs=121.2
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-----eEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS-----KKILV 102 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv 102 (183)
.+.+.||+|+||.||++... ++..+++|.+.... ......+.+|+.+++.++|+||+++++++...+ ..+++
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 35578999999999999865 57889999886432 223456889999999999999999999998766 78999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||+. +++.+.+.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 83 ~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 83 TELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99996 578777644 34567788888999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=160.71 Aligned_cols=141 Identities=21% Similarity=0.324 Sum_probs=119.5
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHH---HHHHHHHHHHHhhcCCCceeeeeceEEe----CCeEEEEEecc
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYM 106 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~ 106 (183)
..+++|+++.||+|.. ++..+++|.+....... ...+.+|+.++.+++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3689999999999987 57789999987542222 3567799999999999999999999876 34688999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|+|.+++... ..+++.....++.+++.|+.++|+. .+++||||+|+||+++.++.+|++|||+++..
T Consensus 105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 999999998654 3566777788999999999999973 27889999999999999999999999999853
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=157.78 Aligned_cols=147 Identities=29% Similarity=0.394 Sum_probs=128.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.+.+|+|+||.||++... .+..+++|.+..........+..|+.+++.++|+|++++++.+...+..+++||+++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 3556678999999999999865 467788888765544455678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++.+++......+++.....++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++...
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhh
Confidence 9999998866545677888888999999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=160.24 Aligned_cols=147 Identities=27% Similarity=0.370 Sum_probs=126.3
Q ss_pred hchhcccCcCcCceEEEEEEc-----CCcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKIL 101 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (183)
+.+.+.||+|+||.||++... .+..+++|.+...... ....+.+|+.+++.+.|+|++++.+++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 445578999999999999843 3578999988755433 45678899999999999999999998876 557899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+||+++++++.+++......+++.....++.|++.||.|+|+. +++|+|++|+||+++.++.++++|||++....
T Consensus 86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999976554577888888999999999999998 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=160.32 Aligned_cols=149 Identities=25% Similarity=0.346 Sum_probs=122.9
Q ss_pred HHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
...+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++|+|++++++.+...+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345677789999999999998643 24468898876432 22334578899999999999999999999888899
Q ss_pred EEEEeccCCCCHHHHHhcCC---------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccc
Q 048219 100 ILVYEYMSNGSLADILFNAE---------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~ 170 (183)
+++|||+++++|.+++.... ..........++.|++.|+.|+|++ +++|+||||+||+++.++.++++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999986421 1224456677899999999999998 99999999999999999999999
Q ss_pred ceeccccc
Q 048219 171 RLWIGKVD 178 (183)
Q Consensus 171 dfg~a~~~ 178 (183)
|||+|+..
T Consensus 162 Dfg~~~~~ 169 (288)
T cd05061 162 DFGMTRDI 169 (288)
T ss_pred cCCccccc
Confidence 99998743
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-26 Score=178.72 Aligned_cols=145 Identities=21% Similarity=0.317 Sum_probs=129.5
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcE-EEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQL-VAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~-~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.|++...||.|+||.||+|..+..+. .|.|.+.....+....++-||++|..+.||+|++++++|...+.++|..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35566679999999999998776444 45677777666777889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
||.+.-.+-..++.+++..+..++.|++.||+|||++ .|+|||||+.|||+.-+|.++++|||.+-
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccc
Confidence 9998888877788899999999999999999999998 99999999999999999999999999875
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=156.66 Aligned_cols=141 Identities=28% Similarity=0.440 Sum_probs=124.0
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHH
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD 113 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 113 (183)
.||+|+||.||++....++.+++|.+...... ....+..|+.+++.+.|++++++.+++......++++|+++++++.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 58999999999998766888999987754333 45678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 114 ILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 114 ~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++.......+......++.+++.++.|+|++ +++|+|++|+||+++.++.++|+|||+++..
T Consensus 82 ~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 143 (251)
T cd05041 82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREE 143 (251)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence 8865444566777788899999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=161.69 Aligned_cols=146 Identities=22% Similarity=0.249 Sum_probs=123.9
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||+|+||.||++... ++..+++|.+.... ......+.+|++++..++||||+++++.+...+..+++|||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 445678999999999999865 46778888775432 2334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++... ..+++.....++.|++.||.|+|+. .+++|+|++|+||+++.++.++++|||++...
T Consensus 83 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 83 GGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 99999998654 3466777788999999999999973 28999999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=159.23 Aligned_cols=146 Identities=25% Similarity=0.350 Sum_probs=122.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCc----EEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQ----LVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~----~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
.+.+.+.||+|+||.||+|... ++. .+++|.+... .......+.+|+.++..+.|+|++++.+++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence 3455678999999999999854 333 4788887643 23345678889999999999999999998864 456789
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++++++.+.+......+++.....++.|++.||.|+|++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999998866555677888888999999999999998 9999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-24 Score=157.91 Aligned_cols=140 Identities=26% Similarity=0.348 Sum_probs=117.2
Q ss_pred ccCcCcCceEEEEEEcC---CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMIN---RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~---~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++|+|++++++.+.+....+++|||+++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999997543 4567888876433 2333568889999999999999999999988888999999999999
Q ss_pred HHHHHhcCC----CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 111 LADILFNAE----KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 111 l~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|.+++.... ....+.....++.|++.|+.|+|+. +++|+|+||+||+++.++.++++|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccc
Confidence 999886422 1234555667889999999999998 999999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=172.73 Aligned_cols=150 Identities=23% Similarity=0.375 Sum_probs=130.2
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcC-----CcEEEEEEccc-hhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEK-VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~ik~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (183)
+.+....+...||.|.||-||+|.+.. .-.||+|..+. ..+++.+.++.|+.+|+.+.||||+++.|.+. ...
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccc
Confidence 344445566789999999999998542 34588999887 44666788999999999999999999999985 457
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+||||.++.|.|..++......+.......++.|++.+|.|||+. ++|||||.++||++.....+|++|||+++-.
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 8999999999999999988777777777778999999999999998 9999999999999999999999999999854
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=157.46 Aligned_cols=142 Identities=28% Similarity=0.320 Sum_probs=122.8
Q ss_pred cccCcCcCceEEEEEEcC----CcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.||+|++|.||+|.+.. ...+++|.+..... .....+..|+.++.+++|+|++++++.+.. ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999998643 23588998876544 455678899999999999999999999888 889999999999
Q ss_pred CCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 109 GSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 109 ~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|.+.+.... ..+.+.....++.|++.||.|+|++ +++|+||+|+||+++.++.++|+|||+++...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALP 148 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccc
Confidence 99999986644 4567788888999999999999998 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=161.41 Aligned_cols=146 Identities=23% Similarity=0.301 Sum_probs=125.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH-----HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE-----REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+.+.+.||+|++|.||+|... .+..+++|.+...... ....+..|+.++..++|+|++++.+++.+.+..+++|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 445678999999999999865 5788999998654322 2345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|++ +++|.+++......+++.....++.|++.||.|+|++ +++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 999 8899999865443577888888999999999999998 99999999999999999999999999998553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=158.14 Aligned_cols=147 Identities=27% Similarity=0.452 Sum_probs=125.4
Q ss_pred HhchhcccCcCcCceEEEEEEcC-C---cEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-R---QLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~---~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+...+.||+|+||.||+|.... + ..+++|.+.... ......+..|+.+++.++|+|++++.+++...+..+++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 34556789999999999998642 2 367888876542 233456888999999999999999999999889999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++++|.+++......+++.....++.|++.|+.|+|+. +++|+|++|+||+++.++.++++|||++...
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999998866555677778888999999999999998 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=161.45 Aligned_cols=144 Identities=27% Similarity=0.371 Sum_probs=125.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.+.||+|++|.||++... .+..+++|.+..........+.+|+.+++.+.|+|++++.+.+......+++|||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 4556678999999999999865 577899998765444445678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
++++.+++.. ..+++.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred CCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 9999998854 3467778888999999999999998 999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=159.30 Aligned_cols=146 Identities=21% Similarity=0.325 Sum_probs=123.7
Q ss_pred HhchhcccCcCcCceEEEEEEcC----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||+|.... ...+++|...... ......+.+|+.+++.+.|+|++++.+++.+ ...+++|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 45567889999999999998543 2457888876543 3445678899999999999999999998765 4578999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++++.+++......+.+..+..++.+++.|+.|+|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999976555577888888999999999999997 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=171.54 Aligned_cols=140 Identities=22% Similarity=0.206 Sum_probs=121.0
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
++.+...||+|+||.||+|.... +..+++|... .....+|+.+++.++|+||+++++++...+..+++||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 45666789999999999998764 6778888532 1235679999999999999999999999999999999995
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++..++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+|+..
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 688888866555678888899999999999999998 9999999999999999999999999999754
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=161.30 Aligned_cols=148 Identities=28% Similarity=0.378 Sum_probs=123.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-----------------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeee
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-----------------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRL 89 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-----------------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (183)
..+.+.+.||+|+||.||++... +...+++|.+.... ......+.+|+.+++.++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 44677789999999999987532 12357888876432 2334578899999999999999999
Q ss_pred eceEEeCCeEEEEEeccCCCCHHHHHhcCC----------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCE
Q 048219 90 LGYSLEVSKKILVYEYMSNGSLADILFNAE----------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNI 159 (183)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ni 159 (183)
++++...+..+++||++++++|.+++.... ....+.....++.|++.|+.|+|+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999886532 1244567788999999999999998 999999999999
Q ss_pred EecCCCcccccceeccccc
Q 048219 160 LMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 160 l~~~~~~~~i~dfg~a~~~ 178 (183)
+++.++.++++|||+|+..
T Consensus 162 li~~~~~~~l~dfg~~~~~ 180 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred EEcCCCCEEeccCcccccc
Confidence 9999999999999999753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=158.91 Aligned_cols=147 Identities=27% Similarity=0.373 Sum_probs=123.9
Q ss_pred HHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
...+.+.+.||+|+||.||+|.......+++|.+..... ....+..|+.+++.++|+|++++++.+ .....+++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEE-CCCCcEEEEEcC
Confidence 345778889999999999999877666789998865322 234678899999999999999998876 445678999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++.+++.... ..+++..+..++.|++.||.|+|+. +++|+||+|+||+++.++.++|+|||.++..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeec
Confidence 9999999986532 3456777788999999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-24 Score=160.06 Aligned_cols=145 Identities=25% Similarity=0.257 Sum_probs=126.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|++|.||++... .++.+++|.+.+.. ......+.+|+.+++++.|+|++++.+.+...+..+++||+
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456678999999999999865 47889999876532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+.+... ..++...+..++.|++.||.++|+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 83 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 83 VPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999988654 4567777888899999999999998 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=158.08 Aligned_cols=148 Identities=30% Similarity=0.411 Sum_probs=128.0
Q ss_pred HHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
...+.+.+.||+|+||.||++...+...+++|.+.... .....+.+|+.+++.++|+|++++++++......+++||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34566778999999999999987777788999886432 23356788999999999999999999998888999999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++.... ..+++.....++.+++.|+.|+|++ +++|+|++|+||+++.++.++++|||+++..
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence 9999999886543 4567778888999999999999998 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=159.83 Aligned_cols=144 Identities=37% Similarity=0.442 Sum_probs=124.4
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHH--HHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDERE--REFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|+||.||++.... ++.+++|.+........ .....|+.+++.++|+||+++.+++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3466789999999999999775 56899999876543332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++++.+++.. ...+....+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 99899998873 24567788888999999999999998 999999999999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=159.53 Aligned_cols=145 Identities=23% Similarity=0.300 Sum_probs=119.6
Q ss_pred hchhcccCcCcCceEEEEEEcC-Cc----EEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQ----LVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~----~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+.+.+.||+|+||.||+|.... +. .+++|.+.... ......+..|+..+..+.|+||+++++++. ....++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEE
Confidence 4455789999999999998643 32 46677765332 223356777888889999999999999875 44577899
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++++|.+++......+++.....++.|++.|+.|+|+. +++|+||||+||+++.++.+|++|||+++..
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999976556678888888999999999999998 9999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-24 Score=158.60 Aligned_cols=140 Identities=23% Similarity=0.363 Sum_probs=120.4
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.++..+.|||++++++.+...+..+++|||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 45578999999999999864 5778999987543 233445688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.... ..++.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 84 ~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 84 GSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred CChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 9886542 345667778999999999999998 9999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-24 Score=157.51 Aligned_cols=144 Identities=23% Similarity=0.374 Sum_probs=117.6
Q ss_pred hhcccCcCcCceEEEEEEcCC---cEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------CeEE
Q 048219 32 FKEKVGRGSSGTVYKGAMINR---QLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SKKI 100 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~~---~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~ 100 (183)
+.+.||+|+||.||+|..... ..+++|.++.. .......+..|+.+++.++|+|++++.+.+... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999986543 25788877543 233456788899999999999999999887532 2468
Q ss_pred EEEeccCCCCHHHHHhcC-----CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 101 LVYEYMSNGSLADILFNA-----EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
+++||++++++.+++... ...+++.....++.|++.|+.|+|++ +++|+||||+||+++.++.++|+|||+|
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999998877421 23356777788999999999999998 9999999999999999999999999999
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
+..
T Consensus 160 ~~~ 162 (272)
T cd05075 160 KKI 162 (272)
T ss_pred ccc
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-24 Score=159.84 Aligned_cols=143 Identities=23% Similarity=0.218 Sum_probs=122.3
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.||+|+||.||++... +++.+++|.+..... .....+.+|+.+++.++|++++.+.+.+...+..+++|||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 4467999999999999865 577899998865321 122346789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
++++.+.+.... ..+++.....++.|++.|+.|+|+. +|+|+|++|+||+++.++.++|+|||++..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 999988775432 3577888888999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=161.54 Aligned_cols=150 Identities=23% Similarity=0.349 Sum_probs=125.3
Q ss_pred HHHHhchhcccCcCcCceEEEEEEcC--------CcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEe
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMIN--------RQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLE 95 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (183)
....+.+.+.||+|+||.||.+.... ...+++|.+.... ......+..|+.++..+ +|+|++++.+++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34567788899999999999987532 2468888886532 23345677899999999 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEE
Q 048219 96 VSKKILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160 (183)
Q Consensus 96 ~~~~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil 160 (183)
.+..+++||++++++|.+++.... ..+.+..+..++.|++.||.|+|++ +++|+||+|+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 999999999999999999986532 2356677788999999999999998 9999999999999
Q ss_pred ecCCCcccccceeccccc
Q 048219 161 MDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 161 ~~~~~~~~i~dfg~a~~~ 178 (183)
++.++.++|+|||+|+..
T Consensus 173 l~~~~~~kL~dfg~a~~~ 190 (307)
T cd05098 173 VTEDNVMKIADFGLARDI 190 (307)
T ss_pred EcCCCcEEECCCcccccc
Confidence 999999999999999744
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-24 Score=158.00 Aligned_cols=145 Identities=27% Similarity=0.459 Sum_probs=122.4
Q ss_pred hchhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
+.+.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.++..++|+|++++.+++......+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 4566789999999999997543 2468888876432 23345688999999999999999999999988899999
Q ss_pred EeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 103 YEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
|||+++++|.+++.... ..+.+.....++.|++.|+.|||++ +++|+||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 99999999999886431 2355667778999999999999998 99999999999999999999
Q ss_pred cccceecccc
Q 048219 168 KNFRLWIGKV 177 (183)
Q Consensus 168 ~i~dfg~a~~ 177 (183)
+|+|||+++.
T Consensus 164 ~L~dfg~~~~ 173 (283)
T cd05048 164 KISDFGLSRD 173 (283)
T ss_pred EECCCcceee
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=156.42 Aligned_cols=146 Identities=20% Similarity=0.318 Sum_probs=125.9
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|++|.||+|... +++.+++|.+... .......+.+|+.++++++|++++++.+.+...+..+++|||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 566788999999999999876 6788999877532 122345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|..++... ...+++..+..++.+++.|+.|+|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999888542 24467778888999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=164.95 Aligned_cols=150 Identities=24% Similarity=0.354 Sum_probs=121.8
Q ss_pred HHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC-
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV- 96 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 96 (183)
...++.+.+.||+|+||.||+|.+. .++.+++|.+.... ......+..|+.++..+ .|+|++++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3456778889999999999999742 35679999986532 22345678899999999 589999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------------------------------------------------
Q 048219 97 SKKILVYEYMSNGSLADILFNAE--------------------------------------------------------- 119 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~--------------------------------------------------------- 119 (183)
...+++|||+++++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46789999999999998875421
Q ss_pred ---------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 120 ---------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 120 ---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
..+++.....++.|++.|+.|+|++ +++|+||||+||+++.++.++++|||+++..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 1134455567889999999999998 9999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=158.17 Aligned_cols=147 Identities=29% Similarity=0.393 Sum_probs=126.4
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.+.||+|++|.||+|... .+..+++|.+.... .....+.+|+.+++.++|++++++++++...+..+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3456678999999999999865 47788999876542 234567889999999999999999999998899999999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++|.+++.... ..+++..+..++.|++.|+.|+|++ +++|+||+|+||+++.++.++|+|||+++...
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 999999886533 3467777888999999999999998 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=158.47 Aligned_cols=140 Identities=23% Similarity=0.351 Sum_probs=115.2
Q ss_pred ccCcCcCceEEEEEEcCC---cEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMINR---QLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~---~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||++....+ ..+++|.+.... ......+.+|+.+++.++|||++++++.+......+++|||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999875432 234566554332 2345678899999999999999999999999899999999999999
Q ss_pred HHHHHhcCC---CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 111 LADILFNAE---KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 111 l~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|.+++.... ..........++.|++.||.|+|+. +++|+||||+||+++.++.++++|||++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccc
Confidence 999886532 2234455667889999999999998 999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-24 Score=159.33 Aligned_cols=149 Identities=23% Similarity=0.374 Sum_probs=124.6
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
...+.+.+.||+|+||.||++.... ...+++|.+.... ......+.+|+.++..+ +|+|++++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3445667889999999999997542 3568888876432 23345678899999999 79999999999998889
Q ss_pred EEEEEeccCCCCHHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC
Q 048219 99 KILVYEYMSNGSLADILFNA---------------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 163 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~ 163 (183)
.+++|||+++++|..++... ...+.+..+..++.|++.|+.|||++ +++|+||+|+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 99999999999999988532 23456777788999999999999998 9999999999999999
Q ss_pred CCcccccceeccccc
Q 048219 164 NRCAKNFRLWIGKVD 178 (183)
Q Consensus 164 ~~~~~i~dfg~a~~~ 178 (183)
++.++++|||+++..
T Consensus 168 ~~~~kL~Dfg~~~~~ 182 (293)
T cd05053 168 DHVMKIADFGLARDI 182 (293)
T ss_pred CCeEEeCcccccccc
Confidence 999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=155.27 Aligned_cols=146 Identities=24% Similarity=0.300 Sum_probs=125.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|++|.+|++... ++..+++|.+... .......+..|+.+++.++|+|++++++.+...+..+++|||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345678999999999999865 5778888887532 2334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++... ....++.....++.+++.|+.|+|+. +++|+|++|+||+++.++.++++|||+++..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 999999988664 34567777788899999999999998 9999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-24 Score=159.42 Aligned_cols=145 Identities=23% Similarity=0.235 Sum_probs=122.8
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
...+.||+|+||.||++... .++.+++|.+.... ......+..|+.+++.++|++++.+.+.+.+.+..+++|||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34567999999999999866 57789999876432 112245678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+.+.... ..+.+.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 9999998875432 3467777888999999999999997 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=164.28 Aligned_cols=149 Identities=25% Similarity=0.363 Sum_probs=122.3
Q ss_pred HHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEe-CC
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLE-VS 97 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 97 (183)
..++.+.+.||+|+||.||+|... +++.+++|.+.... ......+..|+.++.++ .|+|++++++++.. ..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346778889999999999999632 24679999886432 22345677899999999 79999999998865 45
Q ss_pred eEEEEEeccCCCCHHHHHhcCC----------------------------------------------------------
Q 048219 98 KKILVYEYMSNGSLADILFNAE---------------------------------------------------------- 119 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~---------------------------------------------------------- 119 (183)
..++++||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6889999999999998885321
Q ss_pred --CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 120 --KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 120 --~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
..+++..+..++.|++.||.|+|++ +|+|+||||+||+++.++.++|+|||+|+..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 1356667778899999999999998 9999999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=155.57 Aligned_cols=146 Identities=19% Similarity=0.213 Sum_probs=125.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||.|+||.+|.+... ++..+++|.+... .......+.+|+.+++.++|+|++++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 455678999999999988854 4777888886543 2333456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+.+... ...+++.....++.|++.++.|+|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 999999988664 34467778888999999999999997 9999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-24 Score=162.59 Aligned_cols=154 Identities=25% Similarity=0.364 Sum_probs=127.1
Q ss_pred HHHHHHHHhchhcccCcCcCceEEEEEEcC--------CcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeec
Q 048219 22 YAELKKITDGFKEKVGRGSSGTVYKGAMIN--------RQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLG 91 (183)
Q Consensus 22 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 91 (183)
..++...++.+.+.||+|+||.||.+.... ...+++|.+.... ......+..|+.++.++ +|+||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 445555677888999999999999997431 2357888776432 23346788899999999 7999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCC
Q 048219 92 YSLEVSKKILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKP 156 (183)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~ 156 (183)
++...+..++++||+++++|.+++.... ..+.+..+..++.|++.|+.|||++ +++|+||+|
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence 9998889999999999999999886421 2345666777899999999999998 999999999
Q ss_pred CCEEecCCCcccccceeccccc
Q 048219 157 QNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 157 ~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||+++.++.++|+|||+|+..
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~ 184 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDV 184 (334)
T ss_pred ceEEEcCCCcEEECCcccceec
Confidence 9999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-24 Score=157.12 Aligned_cols=142 Identities=26% Similarity=0.329 Sum_probs=122.5
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
..||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++|+|++++.+++...+..++++|++++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 37999999999999865 46779999887655555667889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCC--ChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccceeccccc
Q 048219 113 DILFNAEKQP--NWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVD 178 (183)
Q Consensus 113 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~ 178 (183)
+.+....... +...+..++.|++.|+.|+|+. +++|+|++|+||+++. .+.++|+|||++...
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9886543333 6677777889999999999998 9999999999999986 578999999998643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=159.51 Aligned_cols=142 Identities=22% Similarity=0.299 Sum_probs=118.6
Q ss_pred cccCcCcCceEEEEEEcC--------CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 34 EKVGRGSSGTVYKGAMIN--------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~--------~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.||+|+||.||+|.... ...+++|.+..........+.+|..+++.+.|+|++++++++......+++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997542 223666666544444445678899999999999999999999998899999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc--------ccccceecccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC--------AKNFRLWIGKV 177 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~--------~~i~dfg~a~~ 177 (183)
+++++|.+++......+++.....++.|++.|+.|+|+. +++|+||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999876555677888888999999999999998 9999999999999987765 58999998864
Q ss_pred c
Q 048219 178 D 178 (183)
Q Consensus 178 ~ 178 (183)
.
T Consensus 158 ~ 158 (258)
T cd05078 158 V 158 (258)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-24 Score=159.86 Aligned_cols=151 Identities=23% Similarity=0.362 Sum_probs=124.9
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc--------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI--------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSL 94 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (183)
+....+.+.+.||+|+||.||.+... .+..+++|.+.... ......+.+|+.++..+ +|+|++++.+.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34455667789999999999999742 23468888876432 23345688899999999 7999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCE
Q 048219 95 EVSKKILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNI 159 (183)
Q Consensus 95 ~~~~~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ni 159 (183)
.....+++|||+++++|.+++.... ..+++.....++.|++.|+.|||++ +++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999886531 2345566777899999999999998 999999999999
Q ss_pred EecCCCcccccceeccccc
Q 048219 160 LMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 160 l~~~~~~~~i~dfg~a~~~ 178 (183)
+++.++.++|+|||+|+..
T Consensus 169 li~~~~~~kl~D~g~~~~~ 187 (304)
T cd05101 169 LVTENNVMKIADFGLARDV 187 (304)
T ss_pred EEcCCCcEEECCCccceec
Confidence 9999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=171.37 Aligned_cols=148 Identities=19% Similarity=0.184 Sum_probs=123.8
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-------
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------- 97 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 97 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.++..+.|++++++.+.+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 46778889999999999999865 5788999988543 2334456788999999999999999887765322
Q ss_pred -eEEEEEeccCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 98 -KKILVYEYMSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 98 -~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
..+++|||+++++|.+.+... ...+.+.....++.|++.||.|+|+. +++||||||+||+++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 367999999999999988643 23567777788999999999999998 99999999999999999999999999
Q ss_pred ccccc
Q 048219 174 IGKVD 178 (183)
Q Consensus 174 ~a~~~ 178 (183)
+++..
T Consensus 189 ls~~~ 193 (496)
T PTZ00283 189 FSKMY 193 (496)
T ss_pred cCeec
Confidence 99865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=173.96 Aligned_cols=145 Identities=28% Similarity=0.404 Sum_probs=119.9
Q ss_pred hhcccCcCcCceEEEEEE-cCCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------eEEEEE
Q 048219 32 FKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------KKILVY 103 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~ 103 (183)
-.+.||+|+||.||+++. ..|..+|+|.+.+-. .........|+++|++++|+|||++++.=++.. ...++|
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 345799999999999994 568999999987632 223456778999999999999999998865433 457999
Q ss_pred eccCCCCHHHHHhcCC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec--CCC--cccccceecccc
Q 048219 104 EYMSNGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD--ENR--CAKNFRLWIGKV 177 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~--~~~--~~~i~dfg~a~~ 177 (183)
|||++|||...+.+.. ..+++...+.+...+..||.|||.+ +|+||||||.||++- ++| -.||+|||.||-
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999997654 4577888888999999999999988 999999999999974 333 478999999996
Q ss_pred cc
Q 048219 178 DE 179 (183)
Q Consensus 178 ~~ 179 (183)
.+
T Consensus 174 l~ 175 (732)
T KOG4250|consen 174 LD 175 (732)
T ss_pred CC
Confidence 54
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-24 Score=159.17 Aligned_cols=147 Identities=20% Similarity=0.297 Sum_probs=125.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||+|+||.||++... .+..+++|.+... .......+.+|+.++..+.|+|++++++.+...+..+++|||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456678999999999999876 5788999887543 22234568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNA--EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++.+++... ...+++.....++.+++.|+.|||+. .+++|+||+|+||+++.++.++++|||++...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99998887653 23567888888999999999999963 28999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-24 Score=160.42 Aligned_cols=151 Identities=21% Similarity=0.337 Sum_probs=126.9
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV 96 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (183)
+....+.+.+.||+|+||.||++... .+..+++|.+.... ......+.+|+.+++++ +|+|++++.+.+...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34455667789999999999998742 23468888876432 23345688999999999 799999999999989
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 97 SKKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
+..+++|||+++++|.+++.... ..+++.....++.|++.|+.|+|++ +++|+|++|+||+++.++.++++|||+|
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999886533 3367888888999999999999998 9999999999999999999999999999
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
+..
T Consensus 189 ~~~ 191 (302)
T cd05055 189 RDI 191 (302)
T ss_pred ccc
Confidence 854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-24 Score=156.62 Aligned_cols=146 Identities=26% Similarity=0.372 Sum_probs=124.0
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.+.+.||+|+||.||+|....+..+++|.+..... ....+.+|+.++++++|++++++++++. ....+++||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 34667788999999999999877777789998865322 2346788999999999999999998764 556889999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++.+++.... ..+++..+..++.+++.|+.|+|++ +++|+|++|+||+++.++.++|+|||++...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 999999886532 3467778888999999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=159.19 Aligned_cols=146 Identities=27% Similarity=0.320 Sum_probs=123.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--------hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--------DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
.+.-.+.+|+|..+.|.++..+ +++..++|++.-.. .+-.+....|+.+|+++ .||+|+++.++|++...
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 3455678999999998888755 57788888875211 12234567899999998 59999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.++|+|.++.|.|++++.. ...+.+.....|++|+..|+.|+|++ .|+||||||+||++|++.+++|.|||+|+-.
T Consensus 98 ~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999965 34567788888999999999999998 9999999999999999999999999999743
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=156.35 Aligned_cols=146 Identities=18% Similarity=0.292 Sum_probs=124.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|++|.||++... ++..+++|.+.... ......+.+|+.+++.+.|+|++++++.+...+..+++||+
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 456678999999999999854 67889998775422 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++.+++... ...+++.....++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++...
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999887531 23467778888999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=155.53 Aligned_cols=145 Identities=32% Similarity=0.479 Sum_probs=126.0
Q ss_pred hhcccCcCcCceEEEEEEcC-----CcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 32 FKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~-----~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.||.|+||.||++.... +..+++|.+...... ....+..|+..+..++|++++++++.+.+.+..+++||+
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45679999999999998654 377899998654332 456788999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhcCCCC-CChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQ-PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++.+.+...... +++.....++.|++.|+.++|+. +++|+|++|+||+++.++.++++|||+++...
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999988654433 77888888999999999999998 99999999999999999999999999997553
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-23 Score=160.02 Aligned_cols=150 Identities=23% Similarity=0.364 Sum_probs=124.4
Q ss_pred HHHHhchhcccCcCcCceEEEEEEc--------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEe
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMI--------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLE 95 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (183)
....+.+.+.||+|+||.||++... ....+++|.+.... ......+..|+.+++.+ .|+|++++.+++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3445667789999999999998742 23467888876432 23345678899999999 59999999999988
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEE
Q 048219 96 VSKKILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160 (183)
Q Consensus 96 ~~~~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil 160 (183)
.+..+++|||+++++|.+++.... ..+.+.....++.|++.||.|+|++ +++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 889999999999999999886421 2356677778899999999999998 9999999999999
Q ss_pred ecCCCcccccceeccccc
Q 048219 161 MDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 161 ~~~~~~~~i~dfg~a~~~ 178 (183)
++.++.++++|||+|+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~ 184 (314)
T cd05099 167 VTEDNVMKIADFGLARGV 184 (314)
T ss_pred EcCCCcEEEccccccccc
Confidence 999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-24 Score=159.39 Aligned_cols=145 Identities=26% Similarity=0.431 Sum_probs=120.5
Q ss_pred hchhcccCcCcCceEEEEEEcC-C--cEEEEEEccch-hhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-R--QLVAVNRLEKV-LDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~--~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+.+.||+|+||.||+|.... + ..+++|.++.. .......+.+|+.++.++ .|||++++++++...+..++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4566789999999999998653 2 24677776542 223345678899999988 69999999999998889999999
Q ss_pred ccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccc
Q 048219 105 YMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKN 169 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i 169 (183)
++++++|.+++.... ..+++.....++.|++.|+.|+|++ +++|+||||+||+++.++.++|
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 999999999885422 2356677788999999999999998 9999999999999999999999
Q ss_pred cceecccc
Q 048219 170 FRLWIGKV 177 (183)
Q Consensus 170 ~dfg~a~~ 177 (183)
+|||++..
T Consensus 161 ~dfg~~~~ 168 (297)
T cd05089 161 ADFGLSRG 168 (297)
T ss_pred CCcCCCcc
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-23 Score=156.54 Aligned_cols=145 Identities=23% Similarity=0.369 Sum_probs=119.8
Q ss_pred chhcccCcCcCceEEEEEEcC----CcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe------
Q 048219 31 GFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK------ 98 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 98 (183)
.+.+.||+|+||.||+|.... ...+++|.+.... ......+..|+..++.++|+|++++++.+.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456789999999999998542 3668999876432 2334568889999999999999999998765443
Q ss_pred EEEEEeccCCCCHHHHHhcC-----CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 99 KILVYEYMSNGSLADILFNA-----EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
.++++||++++++...+... ...+++.....++.|++.||.|+|++ +++|+|+||+||++++++.++++|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 78999999999999887432 13466777788899999999999998 99999999999999999999999999
Q ss_pred ccccc
Q 048219 174 IGKVD 178 (183)
Q Consensus 174 ~a~~~ 178 (183)
+|+..
T Consensus 159 ~~~~~ 163 (273)
T cd05035 159 LSKKI 163 (273)
T ss_pred ceeec
Confidence 99854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-24 Score=157.19 Aligned_cols=149 Identities=28% Similarity=0.404 Sum_probs=126.1
Q ss_pred HHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
....+.+.+.||+|+||.||+|...+++.+++|.+..... ....+.+|+.+++.++|+|++++.+.+ ..+..+++||+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 3455677889999999999999987888899998865332 234678899999999999999999876 45678999999
Q ss_pred cCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++.+.+.... ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999886533 3566777788899999999999997 99999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=153.98 Aligned_cols=146 Identities=18% Similarity=0.180 Sum_probs=124.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||+|+||.||.+... ++..+++|.+... .......+..|+.+++.++|+|++++.+.+.+.+..++++||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 346678999999999999865 5778888887532 23344567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++.+.+... ...++......++.|++.|+.++|++ +++|+||+|+||+++.++.++++|||.+...
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 99999887643 23456777788899999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=158.30 Aligned_cols=146 Identities=24% Similarity=0.361 Sum_probs=127.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|+|++++.+++......++++|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456678999999999999865 57889999876432 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++|.+.+......+++..+..++.|++.+|.|+|+. +++|+||+|+||+++.++.++++|||++....
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 9999998876556678888888999999999999998 99999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=166.44 Aligned_cols=144 Identities=21% Similarity=0.216 Sum_probs=121.9
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc---CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI---NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
+....+.+.+.||+|+||.||+|... .+..+++|.+... ....+|+.+++.++|+||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34456778889999999999998753 3467888877543 234579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||++. +++.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+|+..
T Consensus 164 v~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999985 688888743 34577888888999999999999998 9999999999999999999999999999754
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=173.69 Aligned_cols=141 Identities=26% Similarity=0.351 Sum_probs=124.8
Q ss_pred ccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHH
Q 048219 35 KVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD 113 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 113 (183)
.||+|++|+||-|++.. ...+++|-+..........+.+||.+.+.++|.|||++.|.+-..+.+-|+||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999775 55688888866555556789999999999999999999999888888899999999999999
Q ss_pred HHhcCCCCC--ChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccceeccccc
Q 048219 114 ILFNAEKQP--NWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVD 178 (183)
Q Consensus 114 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~ 178 (183)
++......+ ++.+.-.+.+||++||.|||++ .|||||||-+|++++. +|.+||+|||-++-.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh
Confidence 998766555 6788888999999999999998 9999999999999985 599999999988743
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=167.56 Aligned_cols=148 Identities=22% Similarity=0.252 Sum_probs=131.9
Q ss_pred HhchhcccCcCcCceEEEEEE-cCCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.|.+.+.||+|-|.+|-+|+. .+|..||+|.+.+-. ......+..|+++|+.++|||||+++++..++..+|+++|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 477888999999999999884 578899999997642 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec-CCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~-~~~~~~i~dfg~a~~~~ 179 (183)
-.+|+|++++......+++.....++.||+.|+.|+|.- .+|||||||+|+++- ..|-+|+.|||++.-+.
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999998888888888889999999999999987 999999999999976 45999999999998654
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=157.93 Aligned_cols=146 Identities=25% Similarity=0.375 Sum_probs=122.1
Q ss_pred hchhcccCcCcCceEEEEEEcC------CcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
+.+.+.||+|+||.||+|.... +..+++|.+..... .....+..|+.++..++|+||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 4566789999999999997532 46789999874432 2335678899999999999999999999998999999
Q ss_pred EeccCCCCHHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 103 YEYMSNGSLADILFNA---------------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
+|+++++++.+++... ...+.+..+..++.|++.||.|+|++ +++|+||||+||+++.++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 9999999999988532 12355666777899999999999998 99999999999999999999
Q ss_pred cccceeccccc
Q 048219 168 KNFRLWIGKVD 178 (183)
Q Consensus 168 ~i~dfg~a~~~ 178 (183)
|++|||+++..
T Consensus 164 kl~Dfg~~~~~ 174 (283)
T cd05091 164 KISDLGLFREV 174 (283)
T ss_pred Eeccccccccc
Confidence 99999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=153.36 Aligned_cols=144 Identities=30% Similarity=0.378 Sum_probs=127.8
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+.+.||+|++|.+|++.... +..+++|.+..... ...+.+|+.+++.++|+|++++.+.+......++++|++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 4566789999999999998765 67889998765422 56788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.+.+......+++.....++.|++.|+.|+|+. +++|+|++|+||+++.++.++++|||++...
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 999999876556678888888999999999999998 9999999999999999999999999998864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=163.42 Aligned_cols=139 Identities=22% Similarity=0.116 Sum_probs=108.3
Q ss_pred HhchhcccCcCcCceEEEEEEc--CCcEEEEEEccch-----hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI--NRQLVAVNRLEKV-----LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~--~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.++..++|++++..+.. .+..++
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~L 95 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGL 95 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEE
Confidence 4667788999999999999865 4666788875432 12234568899999999999998853322 256899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCC-CCCCEEecCCCcccccceeccccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDI-KPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
+|||++|++|.. .. .... ..++.+++.+|.|+|++ +|+|||| ||+||+++.++.++|+|||+|+....
T Consensus 96 VmE~~~G~~L~~-~~----~~~~---~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 96 VRGWTEGVPLHL-AR----PHGD---PAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEccCCCCHHH-hC----ccch---HHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 999999999963 21 1111 34678999999999998 9999999 99999999889999999999997654
Q ss_pred c
Q 048219 181 R 181 (183)
Q Consensus 181 ~ 181 (183)
+
T Consensus 165 ~ 165 (365)
T PRK09188 165 R 165 (365)
T ss_pred C
Confidence 3
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=155.38 Aligned_cols=145 Identities=26% Similarity=0.364 Sum_probs=124.1
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchh------hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL------DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+...+.||+|+||.||+|...++..+++|.+.... ......+.+|+.+++.++|+|++++.+++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 34556899999999999987778889999875321 122346888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++++|.+++... ..+.+..+..++.|++.++.|+|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 82 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 82 EFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999988653 3456777777899999999999998 9999999999999999999999999998753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=158.28 Aligned_cols=144 Identities=20% Similarity=0.221 Sum_probs=123.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||++... .++.+++|.+.... ......+.+|+.+++.++|+|++++++.+...+..+++||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345678999999999999866 46789999876542 22334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++++|.+++... ..+.+.....++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||+++.
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 83 VEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 9999999998654 3466777777889999999999998 999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=156.30 Aligned_cols=148 Identities=24% Similarity=0.355 Sum_probs=124.3
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
...+.+.+.||+|+||.||++.... +..+++|.+.... ......+.+|+.++..++|+|++++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3455667889999999999987542 3578899876442 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC---------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccc
Q 048219 100 ILVYEYMSNGSLADILFNAE---------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~ 170 (183)
+++||++++++|.+++.... ..+.+..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999886421 1245667778899999999999998 99999999999999999999999
Q ss_pred ceecccc
Q 048219 171 RLWIGKV 177 (183)
Q Consensus 171 dfg~a~~ 177 (183)
|||+++.
T Consensus 162 dfg~~~~ 168 (277)
T cd05032 162 DFGMTRD 168 (277)
T ss_pred Ccccchh
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=155.40 Aligned_cols=146 Identities=25% Similarity=0.359 Sum_probs=122.7
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.+.+.||+|++|.||++....+..+++|.+.... .....+.+|+.+++.++|++++++.+++. .+..+++||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3466778899999999999987766678888875432 22346778999999999999999988764 566889999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++.... ..+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 999999886533 3466777888999999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=158.06 Aligned_cols=148 Identities=28% Similarity=0.366 Sum_probs=125.0
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-----------------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeee
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-----------------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRL 89 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-----------------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (183)
..+.+.+.||+|+||.||++.... ...+++|.+.... ......+..|+.++..++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 346677899999999999987542 2347888876543 2344568889999999999999999
Q ss_pred eceEEeCCeEEEEEeccCCCCHHHHHhcCC----------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCE
Q 048219 90 LGYSLEVSKKILVYEYMSNGSLADILFNAE----------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNI 159 (183)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ni 159 (183)
.+++...+..++++|++++++|.+++.... ..+++..+..++.|++.|+.|||++ +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999998899999999999999999886533 2467778888999999999999998 999999999999
Q ss_pred EecCCCcccccceeccccc
Q 048219 160 LMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 160 l~~~~~~~~i~dfg~a~~~ 178 (183)
+++.++.++++|||+++..
T Consensus 162 li~~~~~~~l~dfg~~~~~ 180 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred eecCCCceEEccccceeec
Confidence 9999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=157.49 Aligned_cols=143 Identities=27% Similarity=0.381 Sum_probs=120.8
Q ss_pred chhcccCcCcCceEEEEEE-----cCCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAM-----INRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKILV 102 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~-----~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 102 (183)
.+.+.||+|+||.||.+.. ..+..+++|.+.... ......+.+|+.+++.++|+|++++.+++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5667899999999987653 245678999886542 23345678899999999999999999987653 457899
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+++++++.+++.. ..+++..+..++.|++.|+.|+|++ +++|+||||+||+++.++.++++|||+++..
T Consensus 87 ~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 87 MEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999998855 3477888888999999999999998 9999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=156.77 Aligned_cols=146 Identities=27% Similarity=0.400 Sum_probs=123.7
Q ss_pred HhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
.+.+.+.||+|+||.||+|... ..+.+++|.+...... ....+.+|+.++++++|+|++++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 3455678999999999999854 2356888887654333 34568889999999999999999999988888999
Q ss_pred EEeccCCCCHHHHHhcCC--------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 102 VYEYMSNGSLADILFNAE--------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
+||++++++|.+++.... ..+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++++|||
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999886533 1467788888999999999999998 99999999999999999999999999
Q ss_pred cccc
Q 048219 174 IGKV 177 (183)
Q Consensus 174 ~a~~ 177 (183)
+++.
T Consensus 163 ~~~~ 166 (275)
T cd05046 163 LSKD 166 (275)
T ss_pred cccc
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=158.70 Aligned_cols=144 Identities=25% Similarity=0.333 Sum_probs=122.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||+|++|.||+|... ++..+++|.+..... .....+.+|+.+++.++|+|++++.+++.+.+..+++|||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 455678999999999999876 577899998764321 112346689999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+ ++.+++......+.+.....++.|++.||.|+|++ +++|+||+|+||+++.++.++++|||+++.
T Consensus 87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccc
Confidence 5 89888866555567777888899999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=154.21 Aligned_cols=140 Identities=26% Similarity=0.472 Sum_probs=116.7
Q ss_pred ccCcCcCceEEEEEEcC----CcEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeEEEEEeccCC
Q 048219 35 KVGRGSSGTVYKGAMIN----RQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSN 108 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~ 108 (183)
.||+|+||.||+|.... ...+++|.+... .......+..|+.+++.++|||++++++++.. .+..++++|++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 58999999999997532 356888887542 23344567889999999999999999997764 5567899999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++.+++........+.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||+++.
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARD 147 (262)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccc
Confidence 999999865444456666777889999999999998 999999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=156.86 Aligned_cols=145 Identities=23% Similarity=0.381 Sum_probs=120.7
Q ss_pred chhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.+.||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 355689999999999997532 2457777765432 233457888999999999999999999999889999999
Q ss_pred eccCCCCHHHHHhcCC-----------------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEE
Q 048219 104 EYMSNGSLADILFNAE-----------------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil 160 (183)
||++++++.+++.... ..+++.....++.|++.|+.|||++ +++|+||+|+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 9999999999875421 2345667788899999999999998 9999999999999
Q ss_pred ecCCCcccccceeccccc
Q 048219 161 MDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 161 ~~~~~~~~i~dfg~a~~~ 178 (183)
++.++.++|+|||+++..
T Consensus 160 l~~~~~~kl~dfg~~~~~ 177 (290)
T cd05045 160 VAEGRKMKISDFGLSRDV 177 (290)
T ss_pred EcCCCcEEeccccccccc
Confidence 999999999999999753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=159.52 Aligned_cols=141 Identities=20% Similarity=0.220 Sum_probs=120.2
Q ss_pred hhcccCcC--cCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 32 FKEKVGRG--SSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 32 ~~~~lg~g--~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.||+| +|+.||++... ++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 67889999865 57889999986532 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 107 SNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 107 ~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
+++++.+++... ...+++..+..++.|++.||.|+|++ +++|+||||+||+++.++.+++.||+.+
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchh
Confidence 999999988653 23467788888999999999999998 9999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=163.74 Aligned_cols=144 Identities=22% Similarity=0.297 Sum_probs=118.8
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------e
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------K 98 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~ 98 (183)
..|.+.+.||+|+||.||++... .+..+++|.+.... ......+.+|+.++..++|+||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45667789999999999999865 47889999986432 233456778999999999999999999886443 4
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++|||+.+ ++.+.+.. .++...+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||+|+..
T Consensus 101 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 7899999965 56665532 356667777899999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=155.58 Aligned_cols=147 Identities=23% Similarity=0.350 Sum_probs=124.4
Q ss_pred HHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..++.+.+.||+|+||.||++....+..+++|.+.... .....+.+|+.+++.++|++++++.+.+.. ...+++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 34566778999999999999987777778898876532 234567889999999999999999988876 7789999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++.+++.... ...++..+..++.|++.|+.|+|+. +++|+||+|+||+++..+.++++|||.+...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeec
Confidence 9999999886532 3456667777899999999999997 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=154.48 Aligned_cols=139 Identities=30% Similarity=0.468 Sum_probs=117.3
Q ss_pred ccCcCcCceEEEEEEcC-C--cEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMIN-R--QLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~-~--~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||++.... + ..+++|.+.... ......+.+|+.++.++ .|||++++++++...+..+++||+++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998654 3 246777776432 33345688899999999 7999999999999888999999999999
Q ss_pred CHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceec
Q 048219 110 SLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWI 174 (183)
Q Consensus 110 ~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~ 174 (183)
+|.+++.... ..+.+..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 9999886422 1356677788999999999999997 999999999999999999999999999
Q ss_pred cc
Q 048219 175 GK 176 (183)
Q Consensus 175 a~ 176 (183)
++
T Consensus 159 ~~ 160 (270)
T cd05047 159 SR 160 (270)
T ss_pred cc
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=159.12 Aligned_cols=146 Identities=23% Similarity=0.225 Sum_probs=126.0
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|++|.||+|.... +..+++|.+..... .....+..|+.++..++|++++++++.+......+++||+
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 4455789999999999998764 78899998865322 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+.+++|.+++.... ..+++.....++.|++.||.|+|+. +++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 99999999886532 4567777888899999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=160.65 Aligned_cols=140 Identities=27% Similarity=0.319 Sum_probs=113.4
Q ss_pred cccCcCcCceEEEEEEc---CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMI---NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 108 (183)
..||+|+||.||+|... .+..+++|.+.... ....+.+|+.+++.++||||+++.+.+.. ....++++|++.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 47999999999999854 45778999886432 12346789999999999999999998864 456889999985
Q ss_pred CCHHHHHhcC--------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe----cCCCcccccceeccc
Q 048219 109 GSLADILFNA--------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM----DENRCAKNFRLWIGK 176 (183)
Q Consensus 109 ~~l~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~----~~~~~~~i~dfg~a~ 176 (183)
+++.+++... ...++...+..++.|++.||.|||++ +++|+||||+||++ +..+.+||+|||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 5888776432 12356677788999999999999998 99999999999999 455789999999998
Q ss_pred ccc
Q 048219 177 VDE 179 (183)
Q Consensus 177 ~~~ 179 (183)
...
T Consensus 161 ~~~ 163 (317)
T cd07868 161 LFN 163 (317)
T ss_pred ccC
Confidence 653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=154.17 Aligned_cols=145 Identities=25% Similarity=0.277 Sum_probs=123.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-----hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-----DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+.+.+.||+|++|.||.+... .+..+++|.+.... ......+.+|+.++++++|+|++++++++......++++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 455678999999999999865 57788988875321 112346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++++.+.+... ..+++.....++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 84 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 84 EYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999888653 3456677778899999999999998 9999999999999999999999999998743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=161.91 Aligned_cols=144 Identities=24% Similarity=0.331 Sum_probs=120.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeC------CeE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SKK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 99 (183)
+|.+.+.||+|+||.||+|... .+..+++|.+..... .....+.+|+.+++.++|+||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 4666788999999999999865 577899999865422 2234577899999999999999999887533 346
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++++ ++++...+.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 96 ~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 96 YLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 8899987 7789887743 3577788888999999999999998 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=153.93 Aligned_cols=145 Identities=30% Similarity=0.377 Sum_probs=124.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-----hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-----DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+...+.||+|++|.||+|... ++..+++|.+.... .+....+.+|+.+++.++|++++++.+++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 344568999999999999876 67889999875432 234467889999999999999999999999889999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+++++|.+++... ..+++.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 82 ELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999988653 3466777778899999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=158.57 Aligned_cols=144 Identities=26% Similarity=0.368 Sum_probs=126.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+.+.||.|++|.||++... .++.+++|.+..........+.+|+.+++.++|+|++++.+.+...+..++++||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 555678999999999999864 5788999988654444456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++..++.. ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 101 ~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 101 GSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 999998854 3467788888999999999999998 9999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=156.62 Aligned_cols=145 Identities=26% Similarity=0.370 Sum_probs=122.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|++|.||+|... ++..+++|.+.... ......+.+|+.++..+.|+|++++.+++..++..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345678999999999999875 57789999875422 112345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ +++.+++.... ..+++..+..++.|++.||.|+|+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 7 58887775432 4567778888999999999999998 9999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=154.07 Aligned_cols=144 Identities=27% Similarity=0.434 Sum_probs=124.2
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
+.+.+.||+|+||.||++....+..+++|.+..... ....+..|+.+++.++|++++++++++......++++|+++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 456678999999999999877677889998764321 2345778999999999999999999998888999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|.+.+......+.+.....++.+++.++.++|+. +++|+|++|+||+++.++.++|+|||+++.
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceee
Confidence 99998865444567777788899999999999998 999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-25 Score=161.78 Aligned_cols=149 Identities=26% Similarity=0.310 Sum_probs=121.6
Q ss_pred HhchhcccCcCcCceEEEEEEcC-----CcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 100 (183)
.|+....||+|++|.||+|...+ .+.+|+|.++.. .........+|+.+++.++|+|++.+..++.. ...++
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 35555689999999999996332 346788888643 12223567789999999999999999999877 77899
Q ss_pred EEEeccCCCCHHHHHhcCC----CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC----Ccccccce
Q 048219 101 LVYEYMSNGSLADILFNAE----KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN----RCAKNFRL 172 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~----~~~~i~df 172 (183)
+++||++. +|.+.+.... +.++......|+-|++.|+.|||++ =|+||||||+||++-.+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999975 9999886432 4566677778899999999999998 89999999999999766 89999999
Q ss_pred ecccccccc
Q 048219 173 WIGKVDEAR 181 (183)
Q Consensus 173 g~a~~~~~~ 181 (183)
|+|++++.+
T Consensus 181 GlaR~~~~p 189 (438)
T KOG0666|consen 181 GLARLFNNP 189 (438)
T ss_pred cHHHHhhcc
Confidence 999988653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=167.24 Aligned_cols=142 Identities=22% Similarity=0.302 Sum_probs=114.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--------CeE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--------SKK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~ 99 (183)
.|.+.+.||+|+||.||+|... .+..+|+|.+.... ....+|+.+++.++|+|++++.+++... ..+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4666788999999999999875 57789999875432 2234689999999999999998877532 246
Q ss_pred EEEEeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceecc
Q 048219 100 ILVYEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIG 175 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a 175 (183)
+++|||+++ ++.+.+.. ....++......++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||+|
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 789999975 77666542 234567778888899999999999998 999999999999999664 7999999999
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
+..
T Consensus 219 ~~~ 221 (440)
T PTZ00036 219 KNL 221 (440)
T ss_pred hhc
Confidence 854
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=155.37 Aligned_cols=139 Identities=26% Similarity=0.341 Sum_probs=122.5
Q ss_pred cCcCcCceEEEEEEcC-CcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 36 VGRGSSGTVYKGAMIN-RQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 36 lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
||.|+||.||++.... ++.+++|.+..... .....+.+|+.++..++|+|++++.+.+......++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999764 88899998865432 3345688899999999999999999999989999999999999999
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++.... .+++..+..++.|++.||.|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~ 143 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence 99886543 567788888999999999999998 9999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-25 Score=181.29 Aligned_cols=144 Identities=22% Similarity=0.179 Sum_probs=126.4
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||-|..++.+ +++.+|.|++.++. .....-|..|-.+|..-..+=|+.++.+|++..++|+|||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 4566789999999999999976 47889999998853 2234567888889987777789999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
|++||+|-.++.... .+++.+...|..++..||.-+|+. |+||||+||+|+|+|..|++|++|||-+-
T Consensus 156 Y~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999998776 577788888999999999999998 99999999999999999999999999764
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=158.41 Aligned_cols=139 Identities=25% Similarity=0.376 Sum_probs=122.6
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
..||+|+||.||++... ++..+++|.+..........+.+|+.+++.++|+|++++.+.+...+..+++||+++++++.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 57999999999999865 57789999886554445567889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++.. ..+++.....++.|++.|+.|+|++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 108 ~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 108 DIVTH--TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 88743 3467778888999999999999998 999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-23 Score=153.35 Aligned_cols=144 Identities=27% Similarity=0.363 Sum_probs=121.3
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEE-eCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSL-EVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 107 (183)
.+.+.+.||+|+||.||++... +..+++|...... ....+.+|+.+++.++|++++++.+++. ..+..++++|+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4566788999999999998654 5568888876432 2346788999999999999999998765 4567899999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++.... ...++.....++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||+++..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceec
Confidence 999999886543 2366777788999999999999998 9999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-23 Score=155.68 Aligned_cols=149 Identities=21% Similarity=0.295 Sum_probs=125.6
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC-----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKK 99 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 99 (183)
..++.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++|+|++++.+++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4556777899999999999998665 6778888876432 3345668889999999999999999998765 4678
Q ss_pred EEEEeccCCCCHHHHHhcCC-------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccce
Q 048219 100 ILVYEYMSNGSLADILFNAE-------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRL 172 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~df 172 (183)
++++++++++++.+++.... ..+++.....++.|++.||.|||++ +++|+||+|+||+++.++.++++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 89999999999999886532 3467777888999999999999998 9999999999999999999999999
Q ss_pred eccccc
Q 048219 173 WIGKVD 178 (183)
Q Consensus 173 g~a~~~ 178 (183)
|+++..
T Consensus 162 g~~~~~ 167 (280)
T cd05043 162 ALSRDL 167 (280)
T ss_pred CCcccc
Confidence 999843
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=158.04 Aligned_cols=145 Identities=23% Similarity=0.338 Sum_probs=115.4
Q ss_pred hchhcccCcCcCceEEEEEEc--CCcEEEEEEccchhh--HHHHHHHHHHHHHhhc---CCCceeeeeceEE-----eCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI--NRQLVAVNRLEKVLD--EREREFQTEIKVIGRT---HHRNLVRLLGYSL-----EVS 97 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~--~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~ 97 (183)
|.+.+.||+|+||.||+|... .+..+++|.+..... .......+|+.+++.+ .||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 556678999999999999864 357788988754321 1123445566666654 6999999999875 245
Q ss_pred eEEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 98 KKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
..+++||+++ +++.+++.... ..+++..+..++.|++.||.|+|+. +++|+||||+||+++.++.++|+|||+|+
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999996 58888886532 3467778888999999999999998 99999999999999999999999999997
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 159 ~~ 160 (290)
T cd07862 159 IY 160 (290)
T ss_pred ec
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=155.49 Aligned_cols=146 Identities=32% Similarity=0.386 Sum_probs=123.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---------HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---------EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
+.+...||+|++|.||+|... .+..+++|.+..... .....+..|+.++..++|+|++++.+++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345568999999999999865 467888887754211 1124578899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++|++++++|.+++... ..+++.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999988653 3456777778999999999999998 99999999999999999999999999987554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-23 Score=154.32 Aligned_cols=147 Identities=28% Similarity=0.422 Sum_probs=122.7
Q ss_pred HhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
.+.+.+.||+|++|.||+|.... +..+++|.+.... ......+..|+.+++.++|+|++++++++.+....++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 45566789999999999998653 4567888875432 2234568889999999999999999999988888999
Q ss_pred EEeccCCCCHHHHHhcCC------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC---cccccce
Q 048219 102 VYEYMSNGSLADILFNAE------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR---CAKNFRL 172 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~---~~~i~df 172 (183)
+||++++++|.+++.... ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++ .++++||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999886532 2467778888999999999999998 999999999999998754 5899999
Q ss_pred eccccc
Q 048219 173 WIGKVD 178 (183)
Q Consensus 173 g~a~~~ 178 (183)
|+|+..
T Consensus 164 g~~~~~ 169 (277)
T cd05036 164 GMARDI 169 (277)
T ss_pred cccccc
Confidence 999753
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-26 Score=160.34 Aligned_cols=145 Identities=20% Similarity=0.290 Sum_probs=119.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccc--hhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK--VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|+|+.|+++... +++.+++|++.. ......+.+.+|+++.+.++||||+++...+......|+|+|++
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 456678999999999998754 466677666543 23345677889999999999999999999998999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~ 178 (183)
.|++|+.-+..+ ..+.+.....++.|++.+|.|+|.+ +|+|||+||+|+++.. ..-+|++|||+|.-.
T Consensus 93 ~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 93 TGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999998766543 2344556667899999999999999 9999999999999853 356999999999754
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-23 Score=152.24 Aligned_cols=139 Identities=25% Similarity=0.351 Sum_probs=117.9
Q ss_pred ccCcCcCceEEEEEEc---CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI---NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|... .+..+++|.+.... ......+..|+.+++.+.|+|++++++++. ....+++||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999643 46778999876432 233456888999999999999999998875 45678999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++.+++... ..+++.....++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||+|+..
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 999988653 3567778888999999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=171.81 Aligned_cols=154 Identities=27% Similarity=0.379 Sum_probs=132.5
Q ss_pred CHHHHHHHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 21 SYAELKKITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 21 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
..+++++-......+||-|.||.||.|.++. ...|++|.++.. ......|+.|+.+|+.++|||+|+++|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555555555556789999999999999876 567899998754 34457899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCC-CChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQ-PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||++|||.+|.|.+++...++. .+....++++.||..|+.||... .++||||.++|+|+.++..+|++|||++++-
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999876644 34445566789999999999988 9999999999999999999999999999974
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=155.69 Aligned_cols=145 Identities=24% Similarity=0.364 Sum_probs=123.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh----------hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL----------DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (183)
|...+.||+|+||.||+|... ++..+++|.++... ....+.+..|+.+++.++|+|++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 445678999999999999865 57789999875321 1112457789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++||++++++|.+.+... ..+++..+..++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||+++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999988654 3567777788899999999999998 9999999999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-23 Score=154.62 Aligned_cols=145 Identities=29% Similarity=0.398 Sum_probs=124.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+...+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.+.|+|++++.+.+...+..++++||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3445567999999999999865 46778898876432 333456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++.+.+.. ..+.+..+..++.+++.|+.|+|++ +++|+||+|+||+++.++.++++|||+++..
T Consensus 85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccc
Confidence 99999988743 3466777778899999999999998 9999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=157.15 Aligned_cols=144 Identities=27% Similarity=0.316 Sum_probs=120.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
|.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|+|++++.+++...+..++++|++.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 456678999999999999865 577899998754321 112356789999999999999999999998899999999996
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++.+.+......+.+.....++.|++.||.|+|+. +++|+||+|+||+++.++.++|+|||+|+.
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 677776654444456667777899999999999998 999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-23 Score=155.48 Aligned_cols=145 Identities=24% Similarity=0.292 Sum_probs=123.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|++|.||++... +++.+++|.+.... ......+.+|+.+++.++|+|++++.+++......+++|||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 455678999999999999876 47889999875432 122345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.+...... ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 83 DHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred CccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceec
Confidence 98777766543 34577888888999999999999997 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=154.92 Aligned_cols=145 Identities=23% Similarity=0.246 Sum_probs=126.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||.|+||.||++... .+..+++|.+.+.. ......+.+|+.++++++|||++++.+.+...+..++++|+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456678999999999999876 47889999886532 12346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+.+++|...+... ..+.+..+..++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||++...
T Consensus 82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 9999999988654 3567778888999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=162.46 Aligned_cols=144 Identities=21% Similarity=0.298 Sum_probs=118.8
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------Ce
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SK 98 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 98 (183)
.+|.+.+.||+|+||.||++... .++.+++|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 35667789999999999999865 47789999886532 23345677899999999999999999988643 24
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++||++++ ++.+.+.. .++...+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 97 ~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 6899999965 66665532 356677777899999999999998 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-23 Score=155.79 Aligned_cols=145 Identities=28% Similarity=0.372 Sum_probs=124.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||++... +++.+++|.+... .......+.+|+.+++.++|+|++++.+++...+..++++||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 566678999999999999865 5788999887532 233445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++ +++.+.+......+.+..+..++.|++.||.|+|+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 97 ~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 97 CL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred hC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence 97 577776655445677888888999999999999998 9999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-23 Score=154.08 Aligned_cols=144 Identities=26% Similarity=0.381 Sum_probs=122.4
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh------hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL------DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
...+.||+|++|.||.+... ++..+++|.+.... ......+..|+.+++.++|+|++++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 44567999999999999864 57788998875422 123456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~ 178 (183)
|++++++|.+++... ..+++.....++.|++.|+.|||+. +++|+||+|+||+++.++ .++|+|||++...
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 83 EWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred eccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999988653 3466778888999999999999998 999999999999998775 6999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=157.69 Aligned_cols=145 Identities=26% Similarity=0.395 Sum_probs=119.7
Q ss_pred hchhcccCcCcCceEEEEEEcC-Cc----EEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQ----LVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~----~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+...+.||+|+||.||++.... +. .+++|.+.... ......+.+|+.+++.++|+|++++++.+... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 3455689999999999998643 32 46788776432 22234678899999999999999999988654 467899
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++++.+.+......+++.....++.|++.||.|+|++ +++|+||||+||+++.++.+|++|||+++..
T Consensus 88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999998876555567778888999999999999998 9999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-23 Score=151.73 Aligned_cols=140 Identities=26% Similarity=0.374 Sum_probs=118.6
Q ss_pred cccCcCcCceEEEEEEcC----CcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.||+|+||.||+|.+.. ...+++|.+..... .....+.+|+.+++.+.|+|++++++++. .+..+++||++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 368999999999997542 25788998765432 34456888999999999999999998765 4567999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.+++.... .+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 99999986543 567888888999999999999998 9999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-23 Score=156.11 Aligned_cols=146 Identities=27% Similarity=0.365 Sum_probs=126.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..+.+.+.||+|+||.||++... ++..+++|.+..........+.+|+.+++.++|||++++.+.+...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 45667788999999999999864 56789999876443344466888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++.+++.. ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 99999998854 3456777788999999999999998 9999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=157.64 Aligned_cols=145 Identities=25% Similarity=0.338 Sum_probs=123.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|+||.||+|... .+..+++|.+..... .....+..|+.+++.++|+|++++.+++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 455678999999999999976 577889998754321 12245677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ +++.+.+......+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 6 478777765445577888888999999999999998 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-23 Score=153.31 Aligned_cols=145 Identities=28% Similarity=0.359 Sum_probs=125.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||.|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|+|++++.+.+.+....++++|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 455678999999999999866 57788999876432 2334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++.+.+... .+++.....++.|++.++.++|+. +++|+|++|+||+++.++.++++|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 99999988653 567788888999999999999998 99999999999999999999999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-23 Score=155.57 Aligned_cols=146 Identities=20% Similarity=0.281 Sum_probs=123.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 103 (183)
.+.+.+.||+|++|.||+|... .+..+++|.+..... .....+.+|+.++..++|+|++++.+++... +..++++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3455678999999999999976 467888888864321 1223467899999999999999999998877 8899999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++ ++.+++......+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99974 89888866555678888889999999999999998 9999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=157.63 Aligned_cols=139 Identities=23% Similarity=0.337 Sum_probs=121.6
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
..||+|+||.||++... .+..+++|.+..........+.+|+.++..+.|||++++.+.+...+..++++|+++++++.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 36999999999999865 57889999876433334456788999999999999999999999999999999999999998
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
..+.. ..+++..+..++.|++.|+.++|++ +++|+||+|+||+++.++.++|+|||+++.
T Consensus 107 ~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 107 DIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred HHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 87744 3467778888999999999999998 999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=152.09 Aligned_cols=144 Identities=27% Similarity=0.397 Sum_probs=123.9
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+...+.||.|+||.||.|... .+..+++|.+.... ......+.+|+.+++.+.|++++++.+.+.+.+..+++||+++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 445567999999999999865 57788998876432 3344678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++.+.+.. ..+++.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 86 ~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 86 GGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 9999998854 3466777777899999999999998 9999999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=151.76 Aligned_cols=143 Identities=31% Similarity=0.477 Sum_probs=120.4
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.+.||+|+||.||++.. .+..+++|.+.... ....+.+|+.+++.++|+|++++.+++.. +..+++||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCC
Confidence 356677899999999999864 56678888875432 23567889999999999999999998865 457899999999
Q ss_pred CCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.+++.... ...+......++.|++.|+.|+|++ +++|+|++|+||+++.++.++|+|||+++..
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceec
Confidence 99999986543 3466777788999999999999998 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=152.38 Aligned_cols=145 Identities=24% Similarity=0.256 Sum_probs=121.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch-----hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-----LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKIL 101 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 101 (183)
+.+.+.||+|+||.||.+... ++..+++|.+... .......+.+|+.++..+.|+|++++.+++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 455678999999999999865 4778999887421 122345678899999999999999999988753 46789
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||++++++|.+++... ..+++.....++.|++.+|.|+|+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 99999999999988654 3356677788999999999999998 9999999999999999999999999998743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=153.16 Aligned_cols=145 Identities=24% Similarity=0.364 Sum_probs=126.6
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.||+|++|.||++... +++.+++|.+.... ......+.+|+.+++.+.|+|++++++.+...+..++++|++++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 44568999999999999876 57888999876542 33446788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.+++......+++.....++.|++.++.|+|+ . +++|+||+|+||+++.++.++++|||.+...
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 84 GSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred CcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 99999987654567778888899999999999999 7 9999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=160.65 Aligned_cols=145 Identities=20% Similarity=0.291 Sum_probs=119.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------Ce
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SK 98 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 98 (183)
..|.+.+.||+|+||.||++... .+..+++|.+.... ......+.+|+.+++.++|+|++++.+++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 34667789999999999999865 47789999886532 23345678899999999999999999887543 35
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++|||+++ ++.+.+.. .++...+..++.|++.||.|+|++ +|+|+||||+||+++.++.++|+|||+|+..
T Consensus 104 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 7999999965 67666632 356677778899999999999998 9999999999999999999999999999864
Q ss_pred c
Q 048219 179 E 179 (183)
Q Consensus 179 ~ 179 (183)
.
T Consensus 177 ~ 177 (364)
T cd07875 177 G 177 (364)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=154.47 Aligned_cols=149 Identities=21% Similarity=0.254 Sum_probs=125.7
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
...+.+.+.||+|+||.||++... .+..+++|.+.... ......+.+|+.++..++|+|++++.+.+...+..+++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 345667788999999999999865 47778888765432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++++.+.+... ..+++.....++.+++.++.|||+. .+++|+|++|+||+++.++.++++|||++...
T Consensus 84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 84 FMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred cCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 99999998887553 3467777888999999999999963 28999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=165.62 Aligned_cols=145 Identities=26% Similarity=0.429 Sum_probs=120.7
Q ss_pred ceeCHHHHHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC
Q 048219 18 FSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS 97 (183)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (183)
+.++|+++-.. +=||.|+.|.||.|+..+ ..||+|++..... .+|.=|++++|+||+.+.|+|....
T Consensus 119 WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~n-etVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 119 WEIPFEEISEL-----EWLGSGAQGAVFLGRLHN-ETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred ccCCHHHhhhh-----hhhccCcccceeeeeccC-ceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCc
Confidence 34455544444 349999999999997654 4688888753211 2466789999999999999998888
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
-++|+||||+.|-|+..+... +..+......+..+|+.|+.|||.+ .|+|||||.-|||+..+..+||+|||-++.
T Consensus 186 cyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred eeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 899999999999999999764 4566777888999999999999998 999999999999999999999999999886
Q ss_pred cc
Q 048219 178 DE 179 (183)
Q Consensus 178 ~~ 179 (183)
..
T Consensus 262 ~~ 263 (904)
T KOG4721|consen 262 LS 263 (904)
T ss_pred hh
Confidence 64
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=155.16 Aligned_cols=146 Identities=26% Similarity=0.436 Sum_probs=122.8
Q ss_pred HhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
.+.+...||+|+||.||++... .+..+++|.+..... .....+.+|+.++..+.|+|++++++++......++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 3556678999999999999753 356788998765432 234568889999999999999999999998889999
Q ss_pred EEeccCCCCHHHHHhcCC---------------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEE
Q 048219 102 VYEYMSNGSLADILFNAE---------------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil 160 (183)
++|++++++|.+++.... ..+.+..+..++.|++.||.|+|++ +++|+||+|+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 999999999999886321 1245666778999999999999998 9999999999999
Q ss_pred ecCCCcccccceecccc
Q 048219 161 MDENRCAKNFRLWIGKV 177 (183)
Q Consensus 161 ~~~~~~~~i~dfg~a~~ 177 (183)
++.++.++++|||+++.
T Consensus 163 ~~~~~~~~l~dfg~~~~ 179 (288)
T cd05050 163 VGENMVVKIADFGLSRN 179 (288)
T ss_pred ecCCCceEECcccccee
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-23 Score=151.17 Aligned_cols=146 Identities=21% Similarity=0.201 Sum_probs=125.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|+||.+|.+... +++.+++|.+... .......+.+|+.+++.++|+|++++.+.+...+..++++|++
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 455678999999999999865 5778999987642 1233456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++.+.+.... ...++.....++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||++...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 9999999886533 3456777788999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=150.95 Aligned_cols=145 Identities=24% Similarity=0.277 Sum_probs=121.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-----hHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-----DEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKIL 101 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (183)
+...+.+|+|+||.||++... .+..+++|.+.... ......+.+|+.+++.++|+|++++.+.+.. ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 455678999999999999865 47788988875321 1223467889999999999999999998875 356789
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|++++++|.+.+.... .+++.....++.|++.|+.|+|+. +++|+|++|+||+++.++.++|+|||+++..
T Consensus 84 ~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 999999999999886533 456777778899999999999987 9999999999999999999999999998743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=151.84 Aligned_cols=146 Identities=27% Similarity=0.379 Sum_probs=126.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|+||.+|++... ++..+++|.+..... .....+.+|+.+++.++|++++++.+.+...+..++++||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 456678999999999999865 577889888765432 35567889999999999999999999998899999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++|.+.+... ..+.+.....++.+++.|+.|+|+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 82 SGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred CCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 999999988653 3356677777899999999999998 99999999999999999999999999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=155.78 Aligned_cols=145 Identities=27% Similarity=0.323 Sum_probs=123.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|+||.||+|... .++.+++|.+..... .....+.+|+++++.++|+|++++.+++.+.+..++++||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 445678999999999999976 478899998764321 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++..+... ...+++..+..++.|++.++.|||+. +++|+|++|+||+++.++.++++|||++...
T Consensus 83 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 83 DHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred CccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 98888776643 23467888888999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=151.70 Aligned_cols=144 Identities=28% Similarity=0.403 Sum_probs=123.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||.|+||.||++... ++..+++|...... ......+.+|+.++..++|+|++++++.+...+..+++|||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 445568999999999999864 57788998875432 2334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++.+++.. ..+++.....++.+++.++.++|+. +++|+|++|+||+++.++.++++|||+++..
T Consensus 86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 86 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 9999988854 3467777888999999999999998 9999999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-22 Score=153.11 Aligned_cols=146 Identities=27% Similarity=0.375 Sum_probs=123.9
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+...+.||+|+||.||++... ++..+++|.+... .......+..|+.+++.++|+|++++.+++......+++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 455678999999999999865 5778889887532 223345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++ ++.+.+......+++..+..++.+++.|+.|+|++ +++|+||+|+||+++.++.++++|||++....
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 975 77777755555677888888999999999999998 99999999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=149.91 Aligned_cols=146 Identities=22% Similarity=0.228 Sum_probs=123.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 105 (183)
|.+.+.||.|++|.||.+... +++.+++|.+.... ......+.+|+.+++.++|++++++.+.+.. .+..++++|+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567788999999999999865 46778988875432 2334567889999999999999999888764 4468899999
Q ss_pred cCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++.+.+... ...+++..+..++.+++.++.++|++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 9999999988653 24467888888999999999999998 9999999999999999999999999999755
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-23 Score=152.22 Aligned_cols=145 Identities=32% Similarity=0.457 Sum_probs=121.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC------CeEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV------SKKIL 101 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~l 101 (183)
+.+.+.||+|+||.||+|... .+..+++|.+.... .....+..|+.++..+ .|+|++++.+.+... ...++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 455678999999999999865 46778888875432 2334677889999888 699999999998753 45789
Q ss_pred EEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|||++++++.+++.... ..+.+..+..++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999887533 4567788888999999999999998 9999999999999999999999999999743
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=154.84 Aligned_cols=145 Identities=26% Similarity=0.344 Sum_probs=115.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--HHHHHHHHHHHHhhc---CCCceeeeeceEEe-----CCe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--REREFQTEIKVIGRT---HHRNLVRLLGYSLE-----VSK 98 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~ 98 (183)
|.+.+.||+|+||.||+|... +++.+++|.+...... ......+|+.++..+ +|+|++++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456678999999999999876 5778999987642211 122345566666554 79999999998764 345
Q ss_pred EEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 99 KILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
.++++|++++ ++.+++.... ..+++..+..++.|++.||.|+|+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 7899999974 8888775533 3467788888999999999999998 999999999999999999999999999986
Q ss_pred c
Q 048219 178 D 178 (183)
Q Consensus 178 ~ 178 (183)
.
T Consensus 158 ~ 158 (288)
T cd07863 158 Y 158 (288)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=156.10 Aligned_cols=140 Identities=27% Similarity=0.330 Sum_probs=112.9
Q ss_pred cccCcCcCceEEEEEEc---CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMI---NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 108 (183)
..||+|+||.||+|... .+..+++|.+.... ....+.+|+.+++.++|+|++++.+++.. ....++++||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 47999999999999865 34678888876532 12356789999999999999999998854 557889999986
Q ss_pred CCHHHHHhcC--------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe----cCCCcccccceeccc
Q 048219 109 GSLADILFNA--------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM----DENRCAKNFRLWIGK 176 (183)
Q Consensus 109 ~~l~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~----~~~~~~~i~dfg~a~ 176 (183)
+++.+.+... ...+++..+..++.|++.||.|+|+. +++|+||||+||++ +..+.++|+|||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 4777766421 12356677778999999999999998 99999999999999 456789999999998
Q ss_pred ccc
Q 048219 177 VDE 179 (183)
Q Consensus 177 ~~~ 179 (183)
...
T Consensus 161 ~~~ 163 (317)
T cd07867 161 LFN 163 (317)
T ss_pred ccC
Confidence 653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=151.34 Aligned_cols=144 Identities=23% Similarity=0.353 Sum_probs=123.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch-hhHHHHHHHHHHHHHhhcC---CCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-LDEREREFQTEIKVIGRTH---HRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e 104 (183)
|.+.+.||+|+||.||+|... .+..+++|.+... .......+.+|+.+++.+. |+|++++.+++......+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 345568999999999999964 5788999987543 2233456778999998886 9999999999998899999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++.. ..+++.....++.|++.++.|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 83 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 83 YAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred cCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 9999999998854 3567778888999999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=152.01 Aligned_cols=140 Identities=23% Similarity=0.254 Sum_probs=119.8
Q ss_pred cCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 36 lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
||+|+||.||++... ++..+++|.+..... .....+..|+.+++.++||+++++.+.+...+..+++|||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 577889988764321 1234567899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 112 ADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 112 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+.+.... ..+.+.....++.|++.++.|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 98886543 3467777788899999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=173.18 Aligned_cols=152 Identities=20% Similarity=0.289 Sum_probs=122.4
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKIL 101 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (183)
...|.+.+.||+|+||.||+|.... +..+++|.+... .......+..|+.++..++||||++++++|.. ...+++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 3457778899999999999999764 567788876532 22334568889999999999999999998865 356899
Q ss_pred EEeccCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCC----CCceecCCCCCCEEecCC----------
Q 048219 102 VYEYMSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECE----TQIIHCDIKPQNILMDEN---------- 164 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~----~~i~H~dl~~~nil~~~~---------- 164 (183)
+|||+++++|.+++... ...+++..+..|+.||+.||.|||.... .+|+|+||||+||+++..
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999988642 2357788888999999999999998410 259999999999999642
Q ss_pred -------Ccccccceeccccc
Q 048219 165 -------RCAKNFRLWIGKVD 178 (183)
Q Consensus 165 -------~~~~i~dfg~a~~~ 178 (183)
..+||+|||+|+..
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l 192 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNI 192 (1021)
T ss_pred ccccCCCCceEEccCCccccc
Confidence 34899999999854
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=149.87 Aligned_cols=146 Identities=32% Similarity=0.397 Sum_probs=127.8
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||.|++|.+|++.... ++.+++|.+..... .....+..|+..+..++|+|++++.+.+...+..++++|+++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 3455789999999999998764 88899998765433 345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++|.+++... ..+++.....++.|++.++.|+|+ . +++|+|++|+||+++.++.++++|||++....
T Consensus 83 ~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 83 GGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999998654 456778888899999999999999 8 99999999999999999999999999988653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=150.63 Aligned_cols=145 Identities=26% Similarity=0.297 Sum_probs=121.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch-----hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-----LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKIL 101 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 101 (183)
+.+.+.||+|+||.||++... ++..+++|.+... .......+.+|+.+++.++|++++++.+.+.+. +..++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456678999999999999865 5788999876421 123345688899999999999999999988753 46889
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|++++++|.+.+.... .+.+.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 999999999998886533 356777788999999999999998 9999999999999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-24 Score=150.13 Aligned_cols=150 Identities=23% Similarity=0.216 Sum_probs=129.7
Q ss_pred HHHhchhcccCcCcCceEEEEEE-cCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----CeEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-----SKKI 100 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 100 (183)
..+|.+.+.+|+|+|+.|+.+.. .++..+|+|++.....++.+..++|++..++++|||++++.+....+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 45788889999999999999984 46789999999877777778899999999999999999998876532 2489
Q ss_pred EEEeccCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 101 LVYEYMSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++.|...|++.+.+... +...++..++.|+.+++.||.++|+. ..++.|+|+||.||++.+++.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999988653 34678889999999999999999997 23599999999999999999999999999874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-22 Score=150.84 Aligned_cols=145 Identities=28% Similarity=0.380 Sum_probs=127.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+.+.+|+|++|.||++... .+..+++|.+..... ....+..|+..++.++|+|++++.+.+...+..++++|++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 445568999999999999876 577889998865433 445678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.+++......+++.....++.+++.|+.++|+. +++|+|++|+||+++.++.++|+|||++...
T Consensus 100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999976544677888888999999999999997 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=147.76 Aligned_cols=139 Identities=12% Similarity=0.133 Sum_probs=104.4
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhH--H------------------------HHHHHHHHHHHhhcCCCcee
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE--R------------------------EREFQTEIKVIGRTHHRNLV 87 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i~ 87 (183)
..||+|++|.||+|...++..+++|.+...... . ......|+..+..+.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999778889999998653211 0 11234588999998877664
Q ss_pred eeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHh-hhCCCCCceecCCCCCCEEecCCCc
Q 048219 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYL-HDECETQIIHCDIKPQNILMDENRC 166 (183)
Q Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dl~~~nil~~~~~~ 166 (183)
...... . ...+++|||++++++...... ...++......++.|++.+|.++ |+. +++|+|+||+||+++ ++.
T Consensus 83 ~p~~~~-~-~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPIL-L-KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEE-e-cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence 433222 2 233899999988766543322 23466777788999999999999 687 999999999999998 478
Q ss_pred ccccceecccccc
Q 048219 167 AKNFRLWIGKVDE 179 (183)
Q Consensus 167 ~~i~dfg~a~~~~ 179 (183)
++++|||+|...+
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-23 Score=155.48 Aligned_cols=145 Identities=24% Similarity=0.312 Sum_probs=120.3
Q ss_pred hchhcccCcCcCceEEEEEEcC---CcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN---RQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKIL 101 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~---~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 101 (183)
+.+.+.||+|++|.||+|.... +..+++|.+.... ......+.+|+.++..++|||++++.+++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4566789999999999999654 6789999887532 22235677899999999999999999999887 78999
Q ss_pred EEeccCCCCHHHHHhcCC----CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC----CCccccccee
Q 048219 102 VYEYMSNGSLADILFNAE----KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE----NRCAKNFRLW 173 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~----~~~~~i~dfg 173 (183)
+||++++ ++.+.+.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++. .+.+|++|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999965 6766654321 2456777788999999999999998 9999999999999999 8999999999
Q ss_pred ccccc
Q 048219 174 IGKVD 178 (183)
Q Consensus 174 ~a~~~ 178 (183)
+++..
T Consensus 158 ~~~~~ 162 (316)
T cd07842 158 LARLF 162 (316)
T ss_pred ccccc
Confidence 98864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=152.84 Aligned_cols=145 Identities=24% Similarity=0.208 Sum_probs=122.1
Q ss_pred hchhcccCcCcCceEEEEEEc----CCcEEEEEEccchhh----HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLD----EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (183)
+.+.+.||+|+||.||.+... ++..+++|.+..... .....+.+|+.++..+ +|++|+++.+.+......+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 345678999999999998853 577899998864321 2235677899999999 5899999999998888999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|+++++++.+.+... ..+.+.....++.|++.||.|+|+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 999999999999988653 3456677777888999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-22 Score=152.44 Aligned_cols=140 Identities=24% Similarity=0.352 Sum_probs=122.4
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
..||+|+||.||++... ++..+++|.+..........+.+|+.+++.++|+|++++.+.+...+..+++|||++++++.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999865 57889999876544445567889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+.+.. ..+++.....++.|++.++.|+|++ +++|+|++|+||+++.++.++++|||++...
T Consensus 106 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 106 DIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 87743 3467777888999999999999998 9999999999999999999999999988643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=152.32 Aligned_cols=140 Identities=25% Similarity=0.365 Sum_probs=124.5
Q ss_pred cccCcCcCceEEEEE-EcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
+.||+|+++.|-.+. ..++..+|+|++++.......+..+|++.+...+ |+||++++++|++..+.|+|||-+.||++
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 469999999999887 5678999999999988888889999999998885 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---Ccccccceecccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAKNFRLWIGKV 177 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---~~~~i~dfg~a~~ 177 (183)
.+.+.+. ..+++.....+.++|+.||.|||.. +|.||||||+|||-... .-+||+||.++.-
T Consensus 164 LshI~~~-~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 164 LSHIQKR-KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred HHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccc
Confidence 9888654 5677888888999999999999998 99999999999996443 4589999998764
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-22 Score=150.94 Aligned_cols=139 Identities=23% Similarity=0.348 Sum_probs=121.8
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
+.||+|++|.||++... .+..+++|.+..........+.+|+.+++.+.|+|++++++++...+..++++|++++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 57999999999999864 57788998876443344556788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+.+.. ..++...+..++.|++.++.++|++ +++|+||+|+||+++.++.++++|||++..
T Consensus 105 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 105 DIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred HHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 98865 3466777788999999999999998 999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-22 Score=147.69 Aligned_cols=146 Identities=25% Similarity=0.369 Sum_probs=126.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|++|.+|++... .++.+++|.+..... .....+.+|++++..+.|++++++.+++.+.+..++++|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 455678999999999999865 467889988865432 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++|.+.+... ..+++.....++.|++.++.++|+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 999999988654 4567788888999999999999998 99999999999999999999999999998653
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-22 Score=146.67 Aligned_cols=146 Identities=27% Similarity=0.437 Sum_probs=128.4
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
...+.||+|++|.+|++... ++..+++|.+..........+.+|+..++.+.|++++++.+.+......++++|+++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 34567999999999999976 57789999887654445567889999999999999999999999899999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|.+++......+++..+..++.|++.++.++|.+ +++|+|++|+||+++.++.++|+|||.+....
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 99998866545677888888999999999999997 99999999999999999999999999998654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=152.93 Aligned_cols=147 Identities=24% Similarity=0.317 Sum_probs=122.7
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-------
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------- 97 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 97 (183)
..+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|||++++.+++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 44667788999999999999976 47788898886432 122345678999999999999999999887644
Q ss_pred ---eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceec
Q 048219 98 ---KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWI 174 (183)
Q Consensus 98 ---~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~ 174 (183)
..++++|++++ ++...+......+++.....++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999976 77777755444577888888999999999999998 999999999999999999999999999
Q ss_pred cccc
Q 048219 175 GKVD 178 (183)
Q Consensus 175 a~~~ 178 (183)
+...
T Consensus 163 ~~~~ 166 (302)
T cd07864 163 ARLY 166 (302)
T ss_pred cccc
Confidence 9865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-22 Score=148.56 Aligned_cols=147 Identities=25% Similarity=0.379 Sum_probs=125.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||.|++|.||++... ++..+++|.+.... ......+.+|+..++.++|+|++++.+.+...+..++++|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 456678999999999999865 56778888875432 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNA--EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++.+.+... ...+++.....++.|++.|+.+||+. +++|+||+|+||++++++.++++|||++....
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 99999988653 23567777888999999999999998 99999999999999999999999999987553
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-22 Score=148.90 Aligned_cols=147 Identities=22% Similarity=0.318 Sum_probs=122.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 104 (183)
|.+.+.||.|+||.||++... .+..+++|.+... .......+..|+.+++.++|+|++++++.+.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 345678999999999999865 5677888887532 23344568889999999999999999988764 456789999
Q ss_pred ccCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhh-----hCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 105 YMSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLH-----DECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 105 ~~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh-----~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
|+++++|.+++... ...+++.....++.|++.|+.++| +. +++|+|++|+||+++.++.++++|||+++
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999988653 345677788889999999999999 66 99999999999999999999999999998
Q ss_pred ccc
Q 048219 177 VDE 179 (183)
Q Consensus 177 ~~~ 179 (183)
...
T Consensus 159 ~~~ 161 (265)
T cd08217 159 ILG 161 (265)
T ss_pred ccc
Confidence 653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-22 Score=148.79 Aligned_cols=140 Identities=21% Similarity=0.242 Sum_probs=121.5
Q ss_pred cCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 36 lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
||.|++|.||++... .+..+++|.+.+.. ......+.+|+.+++.++|+|++++.+.+.+.+..++++|++++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 47789999876432 22345688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
.+++... ..++...+..++.|++.|+.|+|++ +++|+|++|+||+++.++.++|+|||+++...
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~ 144 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK 144 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccC
Confidence 9988653 3466777778899999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=151.35 Aligned_cols=145 Identities=25% Similarity=0.361 Sum_probs=122.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||.|++|.||+|... ++..+++|.+..... .....+.+|+.+++.++|+|++++.+++.+.+..+++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 345678999999999999976 577889998764322 223456789999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ ++.+++.... ..+.+..+..++.|++.|+.|+|+. +++|+|++|+||+++.++.++++|||+++..
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 5 8888775533 3467788888999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=151.28 Aligned_cols=145 Identities=26% Similarity=0.364 Sum_probs=124.1
Q ss_pred chhcccCcCcCceEEEEEEcC-CcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEEEEec
Q 048219 31 GFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKILVYEY 105 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 105 (183)
.+.+.||+|++|.||+|.... +..+++|.+.... ......+..|+.+++.+.|+|++++.+++... +..++++||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 355789999999999998764 7788999987542 22335677899999999999999999999877 789999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++ ++.+.+......+.+.....++.|++.|+.+||+. +++|+|++|+||+++.++.++++|||++....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 975 88888865545677788888999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=151.18 Aligned_cols=140 Identities=30% Similarity=0.445 Sum_probs=117.2
Q ss_pred ccCcCcCceEEEEEEcC-------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 35 KVGRGSSGTVYKGAMIN-------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~-------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.||+|+||.||++.... +..+++|.+.+.. ......+.+|+.+++.++|+||+++.+++......+++||++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999997542 2467788765432 234456888999999999999999999999888999999999
Q ss_pred CCCCHHHHHhcCC------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-----cccccceecc
Q 048219 107 SNGSLADILFNAE------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-----CAKNFRLWIG 175 (183)
Q Consensus 107 ~~~~l~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-----~~~i~dfg~a 175 (183)
++++|.+++.... ..+.+..+..++.|++.|+.|+|+. +++|+||+|+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999886421 2355677778899999999999987 999999999999999877 8999999998
Q ss_pred cc
Q 048219 176 KV 177 (183)
Q Consensus 176 ~~ 177 (183)
+.
T Consensus 159 ~~ 160 (269)
T cd05044 159 RD 160 (269)
T ss_pred cc
Confidence 74
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=152.07 Aligned_cols=146 Identities=24% Similarity=0.299 Sum_probs=123.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|++|.||+|... +++.+++|.+.... ......+.+|+.+++.++|+|++++.+.+...+..++++||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456678999999999999876 46789999876432 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++.+..+... ...+++..+..++.|++.|+.|||.+ +++|+|++|+||+++.++.++|+|||++....
T Consensus 83 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 83 ERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 88666554433 34467778888999999999999998 99999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=147.85 Aligned_cols=146 Identities=25% Similarity=0.342 Sum_probs=127.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||.|++|.||++... ++..+++|.+.... ......+..|+++++.++|+|++++.+.+...+..++++|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 445678999999999999865 57788898886542 244566888999999999999999999999889999999999
Q ss_pred CCCCHHHHHhcCC---CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE---KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+.+.... ..+++.....++.+++.|+.++|+. +++|+|++|+||+++.++.++++|||++...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeec
Confidence 9999999887642 5577888888999999999999998 9999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=163.74 Aligned_cols=141 Identities=21% Similarity=0.235 Sum_probs=120.0
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
+.||-|+||.|.+++.. +..++|.|.+.+...- .......|-++|..-.++=+|+++..|.+.+++|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 47999999999998854 4667888888765322 2345667888888888899999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++.+++.+-+ .+.+.....++.++..|+++.|.. |++||||||+|||+|.+|.+||.||||+.-+
T Consensus 715 DmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 715 DMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred cHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence 9999997654 355666667889999999999998 9999999999999999999999999999754
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=148.24 Aligned_cols=146 Identities=24% Similarity=0.255 Sum_probs=123.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|++|.+|++... ++..+++|.+... .......+.+|+.+++.++|+|++++.+.+...+..+++||++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 455678999999999999865 5778888887543 2233467889999999999999999999998889999999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~~~ 178 (183)
++++|.+++.... ..+++..+..++.+++.++.|+|++ +++|+|++|+||+++.+ +.++++|||+++..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 9999999986643 3467778888999999999999998 99999999999999865 46799999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=151.22 Aligned_cols=146 Identities=24% Similarity=0.304 Sum_probs=119.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEE-----eCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSL-----EVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~l 101 (183)
.+.+.+.||+|+||.||++... .+..+++|.+.... .....+.+|+.++..+ +|+|++++++++. ..+..++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 4556678999999999999865 46778888875422 2234577889999998 6999999999874 3456899
Q ss_pred EEeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|||+++++|.+++.. ....+.+..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999987753 223456777778899999999999998 9999999999999999999999999998743
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=165.91 Aligned_cols=147 Identities=16% Similarity=0.244 Sum_probs=111.6
Q ss_pred HHhchhcccCcCcCceEEEEEEcC--CcEEEEE--------------Eccc---hhhHHHHHHHHHHHHHhhcCCCceee
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN--RQLVAVN--------------RLEK---VLDEREREFQTEIKVIGRTHHRNLVR 88 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~ik--------------~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~ 88 (183)
..|.+.+.||+|+||.||+|..+. +...+.+ .+.+ ........+.+|+.+++.++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 457777899999999999986432 1111111 0111 01112345778999999999999999
Q ss_pred eeceEEeCCeEEEEEeccCCCCHHHHHhcCC----CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC
Q 048219 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAE----KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164 (183)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~ 164 (183)
+++++...+..+++++++. +++.+++.... ..........++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 9999999999999999985 57777664321 1122344566899999999999998 99999999999999999
Q ss_pred Ccccccceeccccc
Q 048219 165 RCAKNFRLWIGKVD 178 (183)
Q Consensus 165 ~~~~i~dfg~a~~~ 178 (183)
+.+||+|||+|+..
T Consensus 304 ~~vkL~DFGla~~~ 317 (501)
T PHA03210 304 GKIVLGDFGTAMPF 317 (501)
T ss_pred CCEEEEeCCCceec
Confidence 99999999999754
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=153.74 Aligned_cols=146 Identities=24% Similarity=0.334 Sum_probs=121.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 104 (183)
+.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|+|++++.+++... +..+++||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 456678999999999999975 478899998753321 1123456799999999999999999998754 56899999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++. +++.+++......+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||+++...
T Consensus 89 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 89 YCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred cCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 996 488888765555677888888999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=149.58 Aligned_cols=139 Identities=22% Similarity=0.197 Sum_probs=113.1
Q ss_pred cCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHH---hhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVI---GRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 36 lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
||+|+||.||++... ++..+++|.+.+... .......+|...+ ....|++++.+.+.+...+..+++|||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 799999999999875 477899998754321 1122233444333 334789999999999988999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.+.+... ..+++.....++.|++.|+.|+|+. +++|+||||+||+++.++.++++|||++...
T Consensus 82 ~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 82 GDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 9999888643 3477888888999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=152.86 Aligned_cols=146 Identities=24% Similarity=0.344 Sum_probs=120.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC--------
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS-------- 97 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 97 (183)
.+.+.+.||+|+||.||+|... +++.+++|.+.... ......+.+|+.+++.++||+++++.+++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 3666788999999999999865 57889999875322 112234567999999999999999999886543
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
..+++||++. +++.+.+......+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 3599999996 488887765544677888888999999999999998 999999999999999999999999999975
Q ss_pred c
Q 048219 178 D 178 (183)
Q Consensus 178 ~ 178 (183)
.
T Consensus 169 ~ 169 (310)
T cd07865 169 F 169 (310)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=150.26 Aligned_cols=146 Identities=22% Similarity=0.292 Sum_probs=118.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHH-HhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKV-IGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|+||.||++... ++..+++|.+.... ......+..|... ++...|+|++++++++...+..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 345678999999999999876 58889999886532 2223345556554 56678999999999999999999999999
Q ss_pred CCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ +++.+++.. ....+++..+..++.|++.|+.|+|++ .+++|+||+|+||+++.++.+||+|||+|+..
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 6 578777643 224567888888999999999999974 38999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-24 Score=162.71 Aligned_cols=144 Identities=31% Similarity=0.411 Sum_probs=124.0
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.-.+.||+|+||.||+|.+. .++.||+|.+.-.... ....+++|+.+|..++++||.++++.|.....++++|||+.|
T Consensus 16 ~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g 95 (467)
T KOG0201|consen 16 TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG 95 (467)
T ss_pred ccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence 33467999999999999965 5788999998654322 346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++.+.+.... .+.+..+.-++++++.|+.|+|.+ +.+|||+|+.||++..++.+|++|||.|-..
T Consensus 96 Gsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 96 GSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred cchhhhhccCC-CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeee
Confidence 99999886543 335666666889999999999998 9999999999999999999999999998754
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-22 Score=149.78 Aligned_cols=145 Identities=26% Similarity=0.344 Sum_probs=118.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|.+|.||++... +++.+++|.+..... .....+.+|+.+++.++|+|++++.+++...+..+++|||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 456678999999999999875 577899998754321 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~ 178 (183)
+ +++.+.+.... ..........++.|++.||.|||++ +++|+||+|+||+++. ++.+|++|||+++..
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 6 47777765432 2245666677889999999999998 9999999999999985 467899999999753
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=149.41 Aligned_cols=143 Identities=21% Similarity=0.281 Sum_probs=118.9
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcC-CCceeeeeceEEeC--CeEEEEEec
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTH-HRNLVRLLGYSLEV--SKKILVYEY 105 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~ 105 (183)
.+.+.+|+|+||.||++... ++..+++|.+.... .........|+..+.++. |+|++++.+++.+. +..++++||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45568999999999999865 57788999876532 112233456888888885 99999999999877 889999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++ +++.+.+......+++..+..++.|++.||.|+|+. +++|+||+|+||+++. +.++|+|||+++..
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 97 488887765445678888888999999999999998 9999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-22 Score=149.11 Aligned_cols=145 Identities=23% Similarity=0.320 Sum_probs=121.0
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEEEecc
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYM 106 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 106 (183)
...+.||.|++|.||++... .+..+++|.+..... .....+.+|+++++.++|+||+++++++.. .+..+++|||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 44568999999999999975 467888888764322 334568889999999999999999998864 44689999999
Q ss_pred CCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++.. ....++......++.|++.+|.|+|+. +++|+|++|+||+++.++.++++|||++...
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 99999887643 223456777788999999999999998 9999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=149.98 Aligned_cols=146 Identities=26% Similarity=0.311 Sum_probs=126.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 104 (183)
|.+.+.||+|++|.||++... ++..+++|.+.+.. ......+..|..++..+. |+|++++++.+...+..+++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456678999999999999865 57889999876522 222356778899999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++|.+.+... ..+++.....++.|++.|+.+||+. +++|+|++|+||+++.++.++++|||++....
T Consensus 83 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 83 YAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999988654 3577888888999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-22 Score=147.15 Aligned_cols=147 Identities=23% Similarity=0.346 Sum_probs=119.9
Q ss_pred hchhcccCcCcCceEEEEEEcC--CcEEEEEEccch----------hhHHHHHHHHHHHHHhh-cCCCceeeeeceEEeC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN--RQLVAVNRLEKV----------LDEREREFQTEIKVIGR-THHRNLVRLLGYSLEV 96 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~--~~~~~ik~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~ 96 (183)
+.+.+.||+|+||.||++.... +..+++|.+... .......+..|+.++.+ ++|+|++++++.+...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456789999999999998654 677888876421 12233456778887764 7899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 97 SKKILVYEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
+..+++|||++++++.+.+.. ....+++.....++.|++.++.++|+. .+++|+|++|+||+++.++.++++|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999887743 234567777788999999999999963 289999999999999999999999999
Q ss_pred ccccc
Q 048219 174 IGKVD 178 (183)
Q Consensus 174 ~a~~~ 178 (183)
++...
T Consensus 160 ~~~~~ 164 (269)
T cd08528 160 LAKQK 164 (269)
T ss_pred ceeec
Confidence 99754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-22 Score=145.79 Aligned_cols=145 Identities=30% Similarity=0.388 Sum_probs=126.3
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEEEEec
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKILVYEY 105 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 105 (183)
...+.||+|++|.+|+|... ++..+++|.+.... ......+.+|+.++++++|+|++++.+.+... ...++++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 44568999999999999976 57788888876543 23456788999999999999999999999887 889999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++.+++.... .+++..+..++.+++.++.|+|+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 83 VSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999886644 667888888999999999999997 99999999999999999999999999988654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-22 Score=146.58 Aligned_cols=145 Identities=24% Similarity=0.352 Sum_probs=117.4
Q ss_pred chhcccCcCcCceEEEEEEc----CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------e
Q 048219 31 GFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------K 98 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~ 98 (183)
.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++|||++++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35568999999999999743 35789999876432 233456788999999999999999999876432 2
Q ss_pred EEEEEeccCCCCHHHHHhcC-----CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 99 KILVYEYMSNGSLADILFNA-----EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
.++++++++++++..++... ...++......++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 36788999999998776432 12356677788999999999999998 99999999999999999999999999
Q ss_pred ccccc
Q 048219 174 IGKVD 178 (183)
Q Consensus 174 ~a~~~ 178 (183)
.++..
T Consensus 159 ~~~~~ 163 (273)
T cd05074 159 LSKKI 163 (273)
T ss_pred ccccc
Confidence 98854
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-22 Score=147.12 Aligned_cols=140 Identities=22% Similarity=0.195 Sum_probs=114.0
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHH---HHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEI---KVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.||+|+||.||++... .++.+++|.+.+... ........|. ..++...|++++++.+.+...+..+++|||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999865 578899998764321 1111223333 34445679999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+.+... ..+++..+..++.|++.|+.|+|+. +++|+|++|+||+++.++.++|+|||+++..
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 99998888543 4577888888999999999999998 9999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-22 Score=145.78 Aligned_cols=141 Identities=21% Similarity=0.250 Sum_probs=115.6
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHH-HhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKV-IGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.||+|++|.||+|... .++.+++|.+.+... ........|... .....|+|++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999865 478899998864321 112233444443 3455899999999999998999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.+++... ..+++..+..++.|++.||.|+|+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999988653 3466777888999999999999998 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=150.47 Aligned_cols=144 Identities=22% Similarity=0.338 Sum_probs=121.9
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
...+.||.|++|.||+|... ++..+++|.+.... ......+.+|+++++.++|+|++++.+++.+.+..+++|||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 45568999999999999865 57789999875432 1223467889999999999999999999999999999999996
Q ss_pred CCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++..++... ...+++.....++.|++.|+.|+|+. +++|+|++|+||+++.++.++++|||+++..
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 5888877543 24567788888999999999999998 9999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-22 Score=149.88 Aligned_cols=145 Identities=26% Similarity=0.347 Sum_probs=119.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--HHHHHHHHHHHHhhcC-CCceeeeeceEEeCCe-----EE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--REREFQTEIKVIGRTH-HRNLVRLLGYSLEVSK-----KI 100 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~~ 100 (183)
+.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.++..+. |+|++++.+++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 455678999999999999976 5788999987543211 2346778999999995 6999999998876555 79
Q ss_pred EEEeccCCCCHHHHHhcCC----CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccceecc
Q 048219 101 LVYEYMSNGSLADILFNAE----KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRLWIG 175 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg~a 175 (183)
++|||+++ ++.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++. ++.++++|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 7888775422 3467788888999999999999998 9999999999999998 789999999998
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
+..
T Consensus 159 ~~~ 161 (295)
T cd07837 159 RAF 161 (295)
T ss_pred eec
Confidence 754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=148.61 Aligned_cols=145 Identities=26% Similarity=0.384 Sum_probs=122.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+...+.||+|++|.||++... ++..+++|.+... .......+.+|+.+++.++|+|++++.+++......++++||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 444567999999999999965 4677888887531 223345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+. +++.+.+......+++..+..++.|++.++.|+|+. +++|+||+|+||+++.++.++++|||++...
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 96 578777755555577788888899999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=146.05 Aligned_cols=143 Identities=21% Similarity=0.386 Sum_probs=120.0
Q ss_pred HhchhcccCcCcCceEEEEEE-cCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCC--eEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVS--KKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e 104 (183)
.+.+..++|+|.++.|+.|.. .+...+.+|.+++. ..+.+.+|+.+|+.+. ||||+++++...++. -..+++|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 355667899999999999984 45677889998754 4567889999999997 999999999987754 3568999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceecccccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~~~~~~ 181 (183)
++.+.+...+. ..++...+..++.+++.||.|+|++ ||.|||+||.|+++|.. ..++++|||+|.|+...
T Consensus 116 ~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 116 YVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99887776655 2466778888999999999999998 99999999999999955 78999999999998653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-23 Score=167.88 Aligned_cols=143 Identities=27% Similarity=0.370 Sum_probs=125.6
Q ss_pred cccCcCcCceEEEEEEc-CC----cEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 34 EKVGRGSSGTVYKGAMI-NR----QLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~----~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
++||+|+||+||+|.+. ++ .+|++|.+... .+.....+++|+-+|..+.|||++++++++.... +-||++|+|
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP 780 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMP 780 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcc
Confidence 58999999999999864 33 45778776543 3445678999999999999999999999997655 778999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
.|.|.+++...+..++....+.|+.||++|+.|||.+ +++||||.++|+|+.+-..+||.|||+|++...
T Consensus 781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999998888888889999999999999999998 999999999999999999999999999997643
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-21 Score=147.61 Aligned_cols=142 Identities=29% Similarity=0.404 Sum_probs=120.9
Q ss_pred hcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 33 KEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.||+|+||.||+|... .+..+++|.+... .......+..|+.+++.++|+|++++.+++.+....+++|||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 357999999999999865 5778888887532 22233567889999999999999999999999999999999996
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.+.+......+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++++|||++...
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 577777765555677888888999999999999998 9999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=146.84 Aligned_cols=147 Identities=29% Similarity=0.402 Sum_probs=123.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCC------eE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVS------KK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~ 99 (183)
.++.+.+.||+|++|.+|+|... .+..+++|.+..... ....+.+|+.+++++ .|+|++++.+++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 35667789999999999999975 467788888765432 335688899999998 6999999999997644 48
Q ss_pred EEEEeccCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 100 ILVYEYMSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
+++||++++++|.+++... ...+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 9999999999999887542 24567777888999999999999998 99999999999999999999999999986
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 162 ~~ 163 (275)
T cd06608 162 QL 163 (275)
T ss_pred ec
Confidence 53
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=152.81 Aligned_cols=144 Identities=22% Similarity=0.283 Sum_probs=119.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------Ce
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SK 98 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 98 (183)
..+...+.||+|+||.||+|... .+..+++|.+.+. .......+.+|+.+++.++|+|++++.+++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 34666788999999999999865 5788999988643 223345677899999999999999999987643 34
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++||++. +++.+.+... ++......++.|++.||.|||++ +++|+||||+||+++.++.++++|||+|+..
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 799999996 4787776432 66677777899999999999998 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=140.39 Aligned_cols=139 Identities=14% Similarity=0.108 Sum_probs=105.9
Q ss_pred hcccCcCcCceEEEEEEcCCcEEEEEEccchhhH--------------------------HHHHHHHHHHHHhhcCCCce
Q 048219 33 KEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE--------------------------REREFQTEIKVIGRTHHRNL 86 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~i 86 (183)
...||+|++|.||+|...++..+++|.+...... ....+..|...+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999998778889999987653210 01223578889999988887
Q ss_pred eeeeceEEeCCeEEEEEeccCCCCHHHH-HhcCCCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecCC
Q 048219 87 VRLLGYSLEVSKKILVYEYMSNGSLADI-LFNAEKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDEN 164 (183)
Q Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~~ 164 (183)
.....+... ..+++|||++++++... +.. ...+......++.|++.++.++|. . +++|+|+||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 554443332 24899999988754332 322 234556677889999999999999 7 999999999999999 7
Q ss_pred Ccccccceecccccc
Q 048219 165 RCAKNFRLWIGKVDE 179 (183)
Q Consensus 165 ~~~~i~dfg~a~~~~ 179 (183)
+.++++|||+|+..+
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=150.78 Aligned_cols=139 Identities=22% Similarity=0.207 Sum_probs=117.7
Q ss_pred cccCcC--cCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 34 EKVGRG--SSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g--~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
..||+| +||.||.+.+. .++.+++|.+... .......+.+|+.+++.++|+||+++++++...+..++++|++++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 89999999875 5789999987642 223346788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 109 GSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 109 ~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
+++.+++.... ..+++..+..++.|++.||.|+|+. +++|+||||+||+++.++.+++.||+.+
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHH
Confidence 99999886532 3466777778999999999999997 9999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=145.99 Aligned_cols=146 Identities=22% Similarity=0.303 Sum_probs=123.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|+||.||++... .+..+++|.+.... ......+.+|+.+++.++|+|++++.+.+...+..++++|++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456678999999999999875 46788888875431 123346778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~ 178 (183)
+++++.+++.... ..+++.....++.|++.|+.|+|+. +++|+|++|+||++++++ .++++|||.+...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 9999999886533 3457778888999999999999998 999999999999999875 5699999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-22 Score=149.78 Aligned_cols=135 Identities=21% Similarity=0.184 Sum_probs=113.1
Q ss_pred CceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHHHHhc
Q 048219 41 SGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN 117 (183)
Q Consensus 41 ~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~ 117 (183)
++.+|.+... ++..+++|.+... .......+..|+.+++.++|+||+++.+++...+..+++|||++++++.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~ 92 (314)
T cd08216 13 LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKT 92 (314)
T ss_pred CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHH
Confidence 3445555433 5788999987643 234456788999999999999999999999999999999999999999998865
Q ss_pred C-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 118 A-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 118 ~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
. ...+.+.....++.|++.||.|||++ +|+|+||+|+||+++.++.+++.|||.+...
T Consensus 93 ~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 93 HFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceee
Confidence 3 23466777778899999999999998 9999999999999999999999999988643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=153.50 Aligned_cols=145 Identities=24% Similarity=0.329 Sum_probs=123.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-----eEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS-----KKIL 101 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 101 (183)
+.+.+.||+|++|.||+|... .+..+++|.+.... ......+..|+.+++.++|+|++++.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456678999999999999975 47889999887543 334467888999999999999999999987764 7899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+||+++ +++.+.+.... .+++.....++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||++....
T Consensus 82 v~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999997 48888875533 567788888999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=148.68 Aligned_cols=144 Identities=22% Similarity=0.363 Sum_probs=123.5
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+.||+|++|.||++... ++..+++|.+..... .....+..|+.+++.++|++++++.+.+...+..++++|++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4567999999999999865 577889998765432 2345677899999999999999999999999999999999975
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++.+.+......+++..+..++.|++.++.|+|+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~ 149 (283)
T cd05118 83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFG 149 (283)
T ss_pred -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence 88887766545677888888999999999999998 99999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=151.22 Aligned_cols=145 Identities=23% Similarity=0.353 Sum_probs=119.7
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC--CeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV--SKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 101 (183)
..+.+.+.||+|+||.||+|... .+..+++|.+... .......+..|+.++.++ +|+|++++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 34566788999999999999876 4778889987542 122334566799999999 999999999988643 46899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||+++ +++...+... .+.+.....++.|++.||.|||+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 999997 5888877543 566777777899999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=153.79 Aligned_cols=142 Identities=30% Similarity=0.453 Sum_probs=119.9
Q ss_pred hhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhh--cCCCceeeeeceEEeCC----eEEEEEec
Q 048219 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGR--THHRNLVRLLGYSLEVS----KKILVYEY 105 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~ 105 (183)
+.+.+|+|.||.||+|...+ +.||+|++.. ...+.+.+|-++... ++|+||++++++-.... .+++|++|
T Consensus 214 l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 45689999999999997655 7899999853 334567777777654 58999999998876544 68999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhC------CCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE------CETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~------~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
.+.|+|.+++.. ...+|.....++..++.||.|||.. .+.+|+|||+|.+|||+..+.+..|+|||+|-.+.
T Consensus 290 h~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 290 HPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred ccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 999999999976 4567888889999999999999964 35689999999999999999999999999998653
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=147.56 Aligned_cols=144 Identities=25% Similarity=0.362 Sum_probs=122.3
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.||.|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|++++++.+++.+.+..++++|+++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 35578999999999999865 57889999875432 1122457789999999999999999999999999999999995
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.+++.... ..+++.....++.|++.||.|+|++ +++|+|++|+||+++.++.++++|||+++..
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 58888875543 3567888888999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=153.31 Aligned_cols=145 Identities=19% Similarity=0.288 Sum_probs=120.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEe----CCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLE----VSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 101 (183)
.+.+.+.||+|++|.||++... ++..+++|.+.... ......+..|+.+++.++|+|++++.+++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 4556678999999999999865 57889999886532 2234567789999999999999999988753 346899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++||+. +++.+.+... ..+++.....++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 86 v~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 86 VMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 999995 5888877543 3477888888999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=151.06 Aligned_cols=142 Identities=20% Similarity=0.260 Sum_probs=119.7
Q ss_pred hcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH--------------HHHHHHHHHHHhhcCCCceeeeeceEEeCC
Q 048219 33 KEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER--------------EREFQTEIKVIGRTHHRNLVRLLGYSLEVS 97 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (183)
.+.||.|+||.||+|... .+..+++|.+....... ...+.+|+.++..++|+|++++.+++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 356999999999999865 57889999875432111 114678999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
..+++||++. +++.+.+... ..++......++.|++.||.|||+. +++|+||+|+||+++.++.++++|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999996 5888888543 3466777888999999999999998 999999999999999999999999999975
Q ss_pred cc
Q 048219 178 DE 179 (183)
Q Consensus 178 ~~ 179 (183)
..
T Consensus 169 ~~ 170 (335)
T PTZ00024 169 YG 170 (335)
T ss_pred cc
Confidence 44
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=147.36 Aligned_cols=145 Identities=24% Similarity=0.352 Sum_probs=122.2
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccC
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.||+|++|.||+|... .+..+++|.+..... .......+|+..+..+. |+|++++++.+...+..+++||++
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45678999999999999976 467889998765422 12223456889999998 999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++.+.+.... ..+++.....++.|++.++.|||++ +++|+||+|+||+++.++.++++|||+++...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 778988876543 3567888888999999999999998 99999999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=147.59 Aligned_cols=145 Identities=23% Similarity=0.203 Sum_probs=121.4
Q ss_pred hchhcccCcCcCceEEEEEEc----CCcEEEEEEccchhh----HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLD----EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (183)
+.+.+.||+|++|.||++... .+..+++|.+.+... .....+.+|+.++.++ .|++++++.+.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 345678999999999998743 456789998764321 2234577899999999 5999999999998888999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|||++++++.+.+... ..+.+.....++.|++.+|.|+|+. +++|+|++|+||+++.++.++++|||+++..
T Consensus 82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 999999999999888543 3466777788899999999999997 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=156.53 Aligned_cols=142 Identities=22% Similarity=0.237 Sum_probs=123.5
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH---HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
..||+|+||.|+-+..+ +|+-+|.|.+.+..... ....++|-.+|.+++.++||.+-.+|++.+.+++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 47999999999998865 57888888887654322 235788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 110 SLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 110 ~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|.-.+.+.+ ..+++.....++.+|+.||.+||.. +||.|||||+|||+|++|+++|+|+|+|.-.
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9977776544 4567888888999999999999998 9999999999999999999999999999754
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=155.13 Aligned_cols=149 Identities=19% Similarity=0.253 Sum_probs=125.2
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccch--hhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKV--LDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 101 (183)
+....|.+.++||.|+.+.||++...+...+++|++.-. .......+.+|+.+|.+++ |.+|++++++-...+.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 445567788899999999999998877777887776432 2333467899999999996 8999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|||+= ..+|-+.+.+.........+..+..|+++++.++|.+ +|||.||||.|+++- .|.+||+|||+|+..
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99966 5699999987765555456777899999999999998 999999999999985 477899999999865
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=146.61 Aligned_cols=145 Identities=24% Similarity=0.350 Sum_probs=120.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC-----CeEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV-----SKKILV 102 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv 102 (183)
+.+.+.||+|+||.||++... +++.+++|.+.... .....+..|+.+++++ +|+|++++.+++... +..+++
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 556678999999999999875 57788888876432 2234566788888888 799999999998753 357999
Q ss_pred EeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|||+++++|.+++.. ....+.+.....++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 999999999988753 234567778888999999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=144.59 Aligned_cols=146 Identities=28% Similarity=0.355 Sum_probs=124.3
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.+|+|++|.+|++... ++..+++|.+.... ......+..|+.+++.++|+|++++.+.+......++++|++
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 455678999999999999865 56788888876432 233456778999999999999999999999889999999999
Q ss_pred CCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++.+++... ...+.+..+..++.+++.|+.++|+. +++|+|++|+||+++.++.++++|||+++..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 999999888552 24466777788999999999999998 9999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-21 Score=145.72 Aligned_cols=147 Identities=31% Similarity=0.432 Sum_probs=121.0
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEe------CCeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLE------VSKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~ 99 (183)
..+.+.+.+|+|+||.||+|... .+..+++|...... .....+..|+.++.++ .|+|++++++++.. .+..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 34566678999999999999875 46788888875432 2334577788888888 69999999999853 3568
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|||++++++.+++.... ..+.+..+..++.|++.|+.|+|+. +++|+|++|+||+++.++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 99999999999999886532 3456677777889999999999998 9999999999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=168.43 Aligned_cols=140 Identities=27% Similarity=0.405 Sum_probs=103.9
Q ss_pred cccCcCcCceEEEEEE-cCCcEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE------------
Q 048219 34 EKVGRGSSGTVYKGAM-INRQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK------------ 99 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------------ 99 (183)
+.||+|+||.||+++- .+|..+|+|++.-. .......+.+|+.++.+++|||+++++.+|.....-
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 4799999999999985 48999999998543 233346789999999999999999998876432110
Q ss_pred --------------------------------------------------------------------------------
Q 048219 100 -------------------------------------------------------------------------------- 99 (183)
Q Consensus 100 -------------------------------------------------------------------------------- 99 (183)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------------------EEEEeccCCCCHHHHHhcCCCCC-ChHHHHHHHHHHHHHHHHhhhCCCCCcee
Q 048219 100 ---------------------------ILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQIIH 151 (183)
Q Consensus 100 ---------------------------~lv~e~~~~~~l~~~l~~~~~~~-~~~~~~~i~~~i~~~l~~lh~~~~~~i~H 151 (183)
||=||||+..++..++.. +... .....+.++.+|+.||.|+|++ +++|
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~~---giIH 720 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHDQ---GIIH 720 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHhC---ceee
Confidence 223344433333333322 1111 1223345789999999999998 9999
Q ss_pred cCCCCCCEEecCCCcccccceecccc
Q 048219 152 CDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 152 ~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|||||.||++++++.+||+|||+|+.
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchh
Confidence 99999999999999999999999987
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=151.00 Aligned_cols=144 Identities=21% Similarity=0.292 Sum_probs=119.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------eE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------KK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 99 (183)
+|.+.+.||+|+||.||++... ++..+++|.+.+.. ......+.+|+.+++.++|+||+++.+++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 3556678999999999999855 57889999875432 222346788999999999999999999887543 35
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|++ ++++...+.. ..+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||+++..
T Consensus 96 ~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred EEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 8999998 6788887753 3567788888999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=156.48 Aligned_cols=146 Identities=19% Similarity=0.233 Sum_probs=112.1
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCC------CceeeeeceEEeC-CeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH------RNLVRLLGYSLEV-SKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~ 99 (183)
..|.+.+.||+|+||.||+|... .+..+|+|.+.... ........|+.++..+.| .+++.+.+++... .+.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 34667788999999999999865 46789999986432 222334556666665544 4588888887654 578
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC--------------
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-------------- 165 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-------------- 165 (183)
+++|+++ ++++.+++... ..+++..+..++.|++.||.|||++ .+|+||||||+||+++..+
T Consensus 208 ~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 8999988 67888877553 3567778888999999999999972 2899999999999998765
Q ss_pred --cccccceeccccc
Q 048219 166 --CAKNFRLWIGKVD 178 (183)
Q Consensus 166 --~~~i~dfg~a~~~ 178 (183)
.+||+|||.+...
T Consensus 284 ~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 284 PCRVRICDLGGCCDE 298 (467)
T ss_pred CceEEECCCCccccC
Confidence 4899999987643
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-22 Score=150.89 Aligned_cols=144 Identities=21% Similarity=0.298 Sum_probs=119.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----CeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-----SKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 101 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+.... ......+..|+.+++.++|+|++++.+++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4566788999999999999865 57889999886421 22334577899999999999999999887543 35789
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|++. +++...+.. ..+.+..+..++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 86 v~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 86 VQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred Eehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999996 488777643 3567778888999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=147.48 Aligned_cols=143 Identities=27% Similarity=0.357 Sum_probs=123.5
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+.||+|.+|.||+|... ++..+++|.+.... ......+..|+.+++.++|++++++.+++...+..++++|+++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4467999999999999876 47889999876542 2233567789999999999999999999998899999999997
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++.+++......+++.....++.+++.|+.+||++ +++|+|++|+||+++.++.++|+|||+++..
T Consensus 82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 589998876544577888888999999999999998 9999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=158.15 Aligned_cols=145 Identities=22% Similarity=0.240 Sum_probs=120.6
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhh--HH------HHHHHHHHHHHhhcC---CCceeeeeceEEeCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLD--ER------EREFQTEIKVIGRTH---HRNLVRLLGYSLEVS 97 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~--~~------~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~ 97 (183)
|...+.+|.|+||.|+.|.++. ...|.+|.+.+..- .. ...+..||.+|..++ |+||++++++|++.+
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 3344689999999999999775 67788888765321 11 123567999999986 999999999999999
Q ss_pred eEEEEEecc-CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 98 KKILVYEYM-SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 98 ~~~lv~e~~-~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
++|++||-- ++-+|++++... ..+.+.....|.+|+..|+.+||+. +|+|||+|-+|++++.+|-+|++|||.|.
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred eeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchh
Confidence 999999854 466899988654 3467888888999999999999998 99999999999999999999999999986
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 719 ~~ 720 (772)
T KOG1152|consen 719 YT 720 (772)
T ss_pred hh
Confidence 43
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=147.96 Aligned_cols=139 Identities=22% Similarity=0.278 Sum_probs=115.4
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEe----CCeEEEEEeccC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLE----VSKKILVYEYMS 107 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~ 107 (183)
+.||-|-.|.|..|..+ +++.+|+|.+.. .....+|+++.=.. .|+|||.+.++|.. ...+.+|||+++
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 57999999999999865 467788777642 23556788876554 59999999999864 335678999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceeccccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~~~ 180 (183)
||.|++.+.+.+ ..+++....+|++||+.|+.|||+. .|.||||||+|+|... +..+|++|||+|+....
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999997765 4588999999999999999999998 9999999999999864 46799999999997653
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=150.26 Aligned_cols=145 Identities=21% Similarity=0.326 Sum_probs=120.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----CeEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-----SKKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 100 (183)
.+.+.+.||+|+||.||++... ++..+++|.+.... ......+..|+.+++.++|+|++++.+++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3556678999999999999865 57889999876431 22334567899999999999999999987644 3479
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++||+. +++.+.+... ..+++.....++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+|+..
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 86 IVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999995 6888877543 4577788888999999999999998 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-21 Score=143.16 Aligned_cols=139 Identities=22% Similarity=0.234 Sum_probs=112.3
Q ss_pred chhcc--cCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhh-cCCCceeeeeceEEeCCeEEEEEecc
Q 048219 31 GFKEK--VGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 31 ~~~~~--lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+. +|+|+||.||++... .+..+++|.+........ |+..... ..|+|++++++.+...+..+++|||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 599999999999865 467788888754321111 2222221 26999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~ 178 (183)
++++|.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++ .++++|||+++..
T Consensus 92 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 92 KDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999986543 678888889999999999999998 999999999999999988 9999999998754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-22 Score=160.97 Aligned_cols=144 Identities=26% Similarity=0.330 Sum_probs=120.5
Q ss_pred chhcccCcCcCceEEEEEEcC--C--cEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 31 GFKEKVGRGSSGTVYKGAMIN--R--QLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~--~--~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.+.+.||+|+||.||+|.+.. + ..||+|.+...... ....|++|+..|.+++|+|+++++|+..+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 355789999999999998653 3 35788888654322 45679999999999999999999999887 677899999
Q ss_pred cCCCCHHHHHhc-CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFN-AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++.|+|.+.+.. ....+--.....++.||+.|+.||.++ ++|||||.++|+++-....+||+|||+.+-.
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 999999999976 223333455567899999999999998 9999999999999999999999999998843
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=146.26 Aligned_cols=146 Identities=23% Similarity=0.325 Sum_probs=119.3
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|++|.||++.... +..+++|.+.+.. ......+..|+..+... .|+|++++++++.+....+++||++
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 4566789999999999999764 7889999986532 22344566677766666 4999999999999999999999998
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ +++..+.......+++..+..++.|++.|+.|+|+. .+++|+||+|+||+++.++.++|+|||++...
T Consensus 97 ~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 97 S-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred C-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 5 477776655445677777788999999999999973 28999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-21 Score=141.64 Aligned_cols=139 Identities=28% Similarity=0.267 Sum_probs=120.5
Q ss_pred cCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 36 lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
||+|++|.+|.+... .+..+++|.+.+... .....+..|+.+++.++|++++++.+.+...+..+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999865 477889988765322 1334678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+.+... ..+++.....++.|++.++.++|+. +++|+|++|+||+++.++.++++|||++...
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 9988654 3467778888999999999999997 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=148.22 Aligned_cols=147 Identities=27% Similarity=0.366 Sum_probs=120.4
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--HHHHHHHHHHHHhhcCCCceeeeeceEEeCC-------
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--REREFQTEIKVIGRTHHRNLVRLLGYSLEVS------- 97 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 97 (183)
..+.+.+.||+|++|.||+|... ++..+++|.+...... ......+|+.+++.++|+|++++.+.+....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34667788999999999999865 4778899887543211 1234678999999999999999998875433
Q ss_pred -eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 98 -KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 98 -~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
..++++||+.+ ++...+......+++..+..++.|++.||.|+|+. +++|+||+|+||+++.++.++++|||+++
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 36899999864 77776655445678888888999999999999998 99999999999999999999999999998
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 164 ~~ 165 (311)
T cd07866 164 PY 165 (311)
T ss_pred hc
Confidence 54
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-21 Score=143.84 Aligned_cols=144 Identities=28% Similarity=0.393 Sum_probs=117.9
Q ss_pred chhcccCcCcCceEEEEEEcC-CcEEEEEEccchhh--HHHHHHHHHHHHHhhc---CCCceeeeeceEEeCCe-----E
Q 048219 31 GFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLD--EREREFQTEIKVIGRT---HHRNLVRLLGYSLEVSK-----K 99 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~ 99 (183)
.+.+.||+|+||.||++.... +..+++|.+..... .....+.+|+.++..+ .|+|++++.+.+..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 355689999999999999764 78899998864321 1223455677766655 69999999999987766 8
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++||++++ ++.+++.... ..+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++++|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999974 7888776533 3567888888999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-21 Score=148.55 Aligned_cols=144 Identities=23% Similarity=0.300 Sum_probs=118.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------CeE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SKK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 99 (183)
++.+.+.||+|+||.||++... ++..+++|.+.+.. ......+.+|+.++..++|+||+++.+++... +..
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 3455678999999999999864 57889999886532 22245677899999999999999999887543 346
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++++ ++++.+.+.. ..+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 98 ~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 98 YLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred EEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 7888876 7789887743 3467778888999999999999998 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=144.50 Aligned_cols=145 Identities=19% Similarity=0.249 Sum_probs=116.5
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccch-----hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV-----LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
|.+.+.||+|+||.||++.... +...+++.++.. .......+..|+.+++.++|||++++++.+.+....++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5667889999999999998654 333334443321 1222345667889999999999999999999888999999
Q ss_pred eccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||++++++...+.. ....+++.....++.|++.|+.|+|+. +++|+|++|+||+++. +.++++|||+++..
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999987753 224567778888999999999999998 9999999999999975 56999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=149.83 Aligned_cols=144 Identities=23% Similarity=0.308 Sum_probs=119.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----------
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV----------- 96 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----------- 96 (183)
++.+.+.||.|+||.||+|... ++..+++|.+..........+.+|+.+++.++|+|++++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4566678999999999999865 5788999987654444556788899999999999999998776543
Q ss_pred ---CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccce
Q 048219 97 ---SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRL 172 (183)
Q Consensus 97 ---~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~df 172 (183)
...++++||++ +++.+.+.. ..+++.....++.|++.|+.|||+. +++|+||+|+||+++. ++.++++||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 588887753 3466778888999999999999998 9999999999999985 467899999
Q ss_pred eccccc
Q 048219 173 WIGKVD 178 (183)
Q Consensus 173 g~a~~~ 178 (183)
|+++..
T Consensus 160 g~~~~~ 165 (342)
T cd07854 160 GLARIV 165 (342)
T ss_pred ccceec
Confidence 999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=138.27 Aligned_cols=135 Identities=16% Similarity=0.198 Sum_probs=101.1
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhc-----CCCceeeeeceEEeCC---eEE-EEEe
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRT-----HHRNLVRLLGYSLEVS---KKI-LVYE 104 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e 104 (183)
+.||+|++|.||. .......++|.+..........+.+|+.+++.+ .||||+++++++++.. ..+ +++|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4799999999995 433222357776543233445689999999999 5799999999998763 334 7899
Q ss_pred c--cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHH-HHhhhCCCCCceecCCCCCCEEecCC----Ccccccc-eeccc
Q 048219 105 Y--MSNGSLADILFNAEKQPNWIERTGIARDIARGI-LYLHDECETQIIHCDIKPQNILMDEN----RCAKNFR-LWIGK 176 (183)
Q Consensus 105 ~--~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~~~~i~H~dl~~~nil~~~~----~~~~i~d-fg~a~ 176 (183)
+ +++++|.+++.+. .+.+. ..++.+++.++ .|||++ +|+||||||+||+++.. ..++|+| ||.+.
T Consensus 86 ~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 86 FDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred CCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 9 5578999999653 23333 34567878777 899998 99999999999999743 3799999 66555
Q ss_pred c
Q 048219 177 V 177 (183)
Q Consensus 177 ~ 177 (183)
+
T Consensus 159 ~ 159 (210)
T PRK10345 159 F 159 (210)
T ss_pred e
Confidence 4
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-23 Score=149.46 Aligned_cols=144 Identities=23% Similarity=0.373 Sum_probs=117.2
Q ss_pred cccCcCcCceEEEEEEcC-CcEEEEEEcc--chhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--------CCeEEEE
Q 048219 34 EKVGRGSSGTVYKGAMIN-RQLVAVNRLE--KVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--------VSKKILV 102 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~-~~~~~ik~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv 102 (183)
.++|+|.||.|++|+.++ ++.|++|++- ..........++|+.+|..++|+|++.+.+.|.. ...+|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 479999999999998654 5666765531 1101112346789999999999999988887753 1237999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
+.+|+. +|.-++.+....+....+..++.++..||.|+|.+ .|+|||+|++|++++.++.++|+|||+|+.+.++
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 999964 99999987766788889999999999999999998 9999999999999999999999999999887654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=145.77 Aligned_cols=144 Identities=23% Similarity=0.303 Sum_probs=119.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 104 (183)
.|.+.+.||.|+||.||++... .+..+++|.+.+.. ......+..|+.++..++|||++++.+++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 3556678999999999999865 67889999875422 2234567789999999999999999998875 457889999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++ ++++...+.. ..+.......++.|++.||.|+|+. +++|+|++|+||+++.++.++++|||++...
T Consensus 91 ~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 91 LL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred hh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 98 5688887753 2355666677899999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=141.99 Aligned_cols=143 Identities=25% Similarity=0.326 Sum_probs=116.2
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccCC
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
..+.||+|+||.||++... ++..+++|.+.... ......+..|+.++.++. |+|++++++++...+..+++||++..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 3457999999999999865 47889999876432 233456788999998886 99999999999988899999999854
Q ss_pred CCHHHHHh---c-CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 109 GSLADILF---N-AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 109 ~~l~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
++.++.. . ....+++.....++.+++.|+.|+|+. .+++|+||+|+||+++.++.++|+|||+|+.
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 5544332 1 224577788888999999999999963 2899999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=170.74 Aligned_cols=141 Identities=29% Similarity=0.413 Sum_probs=118.3
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
..||.|.||.||.|... +|...|+|-++-.. ......+.+|..++..++|||+++++|+-......+|+||||.+|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 47999999999999854 56777777664322 2223457899999999999999999999888899999999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|.+.+.. ++..++....-+..|++.|+.|||.+ +|||||+||+||+++.+|.+|..|||.|.-.
T Consensus 1321 La~ll~~-gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1321 LASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 9998854 33445555555789999999999998 9999999999999999999999999999854
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=145.95 Aligned_cols=144 Identities=19% Similarity=0.306 Sum_probs=116.3
Q ss_pred hchhcccCcCcCceEEEEEEc-C--CcEEEEEEccchh--hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC----CeE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-N--RQLVAVNRLEKVL--DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV----SKK 99 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~--~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~ 99 (183)
+.+.+.||+|+||.||++... . +..+++|.+.... ......+..|+.++..+ .|+|++++.+.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456678999999999999865 3 6778999876421 22345677899999988 599999998875432 356
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++++. ++|.+.+.. ...+++.....++.|++.||.|+|+. +++|+||+|+||+++.++.++|+|||+|+..
T Consensus 82 ~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 78889885 688887754 34567788888999999999999998 9999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-23 Score=147.46 Aligned_cols=142 Identities=24% Similarity=0.354 Sum_probs=113.3
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-----eEEEEEec
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVS-----KKILVYEY 105 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~ 105 (183)
.-||-|+||.||...+. +++.+++|++-+..+ ...+++.+|+..|..++|.|++...+....+. .+|.++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 36999999999988865 588899888765432 23467888999999999999999888765433 24667787
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
+. .+|...+... ..++..-+.-+..||+.||.|||+. +|.|||+||.|.+++.++.+||+|||+|++++.
T Consensus 139 mQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 MQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 75 4777766543 3444445555789999999999998 999999999999999999999999999998864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=139.54 Aligned_cols=142 Identities=22% Similarity=0.355 Sum_probs=114.2
Q ss_pred cccCcCcCceEEEEEEcC-CcEEEEEEccch-hhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 34 EKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV-LDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.-||.|+-|.||+++.+. +...|+|++.+. ..+..++++..++++..- ..|.||+.+|+|......++-||.+. ..
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HH
Confidence 358999999999999764 788999998764 345567777777766554 48999999999999999999999884 35
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+..++..-....++.-.-.+..-+..||.||... ++|+|||+||+|||+|+.|++|+||||++...
T Consensus 177 ~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 177 AEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeeccccccee
Confidence 6666655445555554445667788999999875 49999999999999999999999999999754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=147.73 Aligned_cols=154 Identities=26% Similarity=0.297 Sum_probs=124.6
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEc--cc-hhhHH----HHHHHHHHHHHhhcCCCceeeeeceEE-eCC
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRL--EK-VLDER----EREFQTEIKVIGRTHHRNLVRLLGYSL-EVS 97 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~--~~-~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 97 (183)
..+|-+...||+|+|+.||+|.+.. ..-+|+|+- .+ +..+. .+...+|.++.+.+.||.||+++++|- +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3456666789999999999999765 556677762 22 22211 245788999999999999999999984 677
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceec
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWI 174 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~ 174 (183)
..|-|+|||+|.+|..++... +...+.....|+-||+.||.||... ..+|+|-||||.|||+-. -|.+||.|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 889999999999999999764 4567788888999999999999985 469999999999999854 37899999999
Q ss_pred cccccccc
Q 048219 175 GKVDEARS 182 (183)
Q Consensus 175 a~~~~~~~ 182 (183)
+++-+.-|
T Consensus 620 SKIMdddS 627 (775)
T KOG1151|consen 620 SKIMDDDS 627 (775)
T ss_pred hhhccCCc
Confidence 99876543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-22 Score=152.54 Aligned_cols=150 Identities=25% Similarity=0.276 Sum_probs=123.3
Q ss_pred HHHHHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh---hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 24 ELKKITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL---DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 24 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
-++.-..++...||.|+||.|.+|..+. ..++|+|++++.- ..+..-...|-++|... +.|.++++..+|++.++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3455557788899999999999998664 5778999987642 12233456677777766 46789999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+|+||||+.||+|.-.+.+.++ +-++....++.+|+.||-+||+. +|+.||||.+|+++|.+|.+||.|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999999766655543 44556677899999999999998 999999999999999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=132.31 Aligned_cols=143 Identities=23% Similarity=0.305 Sum_probs=115.7
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhh-cCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
..||+|++|.|-+-+.. ++...|+|.+.-.. ....++++.|+.+..+ ...|.++.++|.+......++.||.+. .|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hh
Confidence 46999999998877754 68888999886432 2334567778886654 469999999999999999999999995 57
Q ss_pred HHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 111 LADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 111 l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+..+... .+...++.-+-.|+..+..||.|||++ ..++|||+||+|||++.+|.+|+||||++....
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 7765543 344566776677888999999999986 699999999999999999999999999987553
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-21 Score=146.31 Aligned_cols=144 Identities=24% Similarity=0.315 Sum_probs=120.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe------E
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK------K 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~ 99 (183)
+|.+...||+|++|.||+|... ++..+++|.+.... ......+..|+.+++.+.|+|++++.+++..... .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 3556678999999999999876 46789999876432 2233557789999999999999999888765544 8
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|++ +++|.+++.. ..+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 96 ~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 9999998 6699888854 3467788888999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=136.98 Aligned_cols=130 Identities=20% Similarity=0.134 Sum_probs=109.1
Q ss_pred CcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHHHHhc
Q 048219 39 GSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN 117 (183)
Q Consensus 39 g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~ 117 (183)
|.+|.||++.+. +++.+++|.+..... ...|...+....|||++++++.+...+..+++||++++++|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 789999999975 578899999865321 22334444455699999999999999999999999999999998865
Q ss_pred CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 118 AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 118 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
.. .+++.....++.|++.|+.|+|+. +++|+|+||+||+++.++.++++|||.+..
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~ 134 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSE 134 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhc
Confidence 33 467788888999999999999998 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-20 Score=132.68 Aligned_cols=146 Identities=31% Similarity=0.417 Sum_probs=126.5
Q ss_pred chhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 31 GFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.||+|++|.+|++.... ++.+++|.+...... ....+..|+..+..++|++++++++.+......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 345679999999999999765 788999998765443 456788899999999999999999999888899999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|.+++.......++.....++.+++.++.++|+. +++|+|++++|++++.++.++++|||.+....
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 999998865433266777788899999999999998 99999999999999999999999999998664
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=144.37 Aligned_cols=143 Identities=22% Similarity=0.300 Sum_probs=116.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------eE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------KK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 99 (183)
.+.+.+.||+|+||.||+|... .+..+++|.+.+... .....+..|+.+++.+.|+|++++.+++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 3455578999999999999865 578899998865321 12345778999999999999999999886542 46
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|++. .++..... ..+++..+..++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||+++..
T Consensus 96 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 89999985 46666542 3466777788899999999999998 9999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=152.24 Aligned_cols=144 Identities=31% Similarity=0.444 Sum_probs=120.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEe-----CCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLE-----VSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~~~~~l 101 (183)
.+.|.+.+|.|++|.||++... .++..++|+....... ...+-.|.++++..+ |||++.++++|.- .+.+++
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3557789999999999999855 5677778877654322 345666788888774 9999999999862 557999
Q ss_pred EEeccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 102 VYEYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
|||+|.+|++.++++.- +..+.+..+..|+.+++.|+.+||.+ .++|||+|-.||++..++.+|++|||++.
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeee
Confidence 99999999999999753 34567888888999999999999998 99999999999999999999999999986
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-21 Score=144.22 Aligned_cols=144 Identities=26% Similarity=0.347 Sum_probs=117.9
Q ss_pred chhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhh--cCCCceeeeeceEEeCC----eEEEEEe
Q 048219 31 GFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGR--THHRNLVRLLGYSLEVS----KKILVYE 104 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e 104 (183)
.+.+.||+|.||.||+|.++. ..||+|++.. .+.....+|.++.+. ++|+||+.+.++-...+ .+++|++
T Consensus 214 ~L~e~IGkGRyGEVwrG~wrG-e~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWRG-EDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeeccccC-CceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 345789999999999998765 4689999864 234567778887764 59999999988865332 5799999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhC-----CCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE-----CETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|-+.|||++++.. ..++....+.++..++.||.+||.. .+..|.|||||..||++..+++..|+|+|+|--++
T Consensus 290 YHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred cccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 9999999999965 4566667777889999999999953 35679999999999999999999999999997664
Q ss_pred c
Q 048219 180 A 180 (183)
Q Consensus 180 ~ 180 (183)
.
T Consensus 368 ~ 368 (513)
T KOG2052|consen 368 S 368 (513)
T ss_pred c
Confidence 4
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=140.89 Aligned_cols=147 Identities=20% Similarity=0.187 Sum_probs=103.6
Q ss_pred HHHhchhcccCcCcCceEEEEEEcCC----cEEEEEEcc--chhhHHH---------HHHHHHHHHHhhcCCCceeeeec
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMINR----QLVAVNRLE--KVLDERE---------REFQTEIKVIGRTHHRNLVRLLG 91 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~ik~~~--~~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~ 91 (183)
...|.+.+.||+|+||.||+|..... ..+++|... ....... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 34577788999999999999986543 334444322 1100000 11122334455678999999988
Q ss_pred eEEeCC----eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 92 YSLEVS----KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 92 ~~~~~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
.+.... ..+++++.+. .++.+.+... ...++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 765433 3467777764 4666655432 2345667778999999999999998 99999999999999999999
Q ss_pred cccceeccccc
Q 048219 168 KNFRLWIGKVD 178 (183)
Q Consensus 168 ~i~dfg~a~~~ 178 (183)
+|+|||+|+..
T Consensus 166 ~l~DFGla~~~ 176 (294)
T PHA02882 166 YIIDYGIASHF 176 (294)
T ss_pred EEEEcCCceee
Confidence 99999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=148.64 Aligned_cols=147 Identities=21% Similarity=0.315 Sum_probs=107.1
Q ss_pred HhchhcccCcCcCceEEEEEE-----------------cCCcEEEEEEccchhhHHHHH--------------HHHHHHH
Q 048219 29 TDGFKEKVGRGSSGTVYKGAM-----------------INRQLVAVNRLEKVLDERERE--------------FQTEIKV 77 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~-----------------~~~~~~~ik~~~~~~~~~~~~--------------~~~e~~~ 77 (183)
.+.+.++||+|+||.||+|.. ..+..|++|.+.......... ...|+..
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 355667899999999999863 124568999876432221111 2335666
Q ss_pred HhhcCCCce-----eeeeceEEe--------CCeEEEEEeccCCCCHHHHHhcCCC-----------------------C
Q 048219 78 IGRTHHRNL-----VRLLGYSLE--------VSKKILVYEYMSNGSLADILFNAEK-----------------------Q 121 (183)
Q Consensus 78 l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~l~~~l~~~~~-----------------------~ 121 (183)
+.+++|.++ +++.++|.. .+..++|+||+++++|.+++..... .
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 666665543 555666542 3567999999999999988853211 1
Q ss_pred CChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 122 PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 122 ~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
..+..+..++.|++.++.|+|+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~ 359 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence 23445667889999999999998 9999999999999999999999999999643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=153.54 Aligned_cols=144 Identities=24% Similarity=0.370 Sum_probs=124.0
Q ss_pred chhcccCcCcCceEEEEEEc----C----CcEEEEEEccchhh-HHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMI----N----RQLVAVNRLEKVLD-EREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~----~----~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 100 (183)
.+.+.+|+|+||.|++|... . ...||+|.++.... .....+..|+.+|..+. |+|++.+.+++...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45568999999999999733 1 34688998875432 34567899999999985 999999999998889999
Q ss_pred EEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 101 LVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
+++||+..|+|..++...+ ..++....+.++.||+.|+.||.+. +++||||.++||++..+.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999997655 2366778888999999999999998 999999999999999999
Q ss_pred cccccceecccc
Q 048219 166 CAKNFRLWIGKV 177 (183)
Q Consensus 166 ~~~i~dfg~a~~ 177 (183)
.+||+|||+|+-
T Consensus 456 ~~kIaDFGlar~ 467 (609)
T KOG0200|consen 456 VIKIADFGLARD 467 (609)
T ss_pred EEEEccccceec
Confidence 999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-19 Score=127.22 Aligned_cols=142 Identities=33% Similarity=0.437 Sum_probs=122.7
Q ss_pred cCcCcCceEEEEEEcC-CcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHH
Q 048219 36 VGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD 113 (183)
Q Consensus 36 lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 113 (183)
||+|++|.+|++.... +..+++|........ ....+.+|+..++.++|++++++.+++......++++|+++++++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998764 788899988754332 34568889999999999999999999998889999999999899999
Q ss_pred HHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccceeccccccc
Q 048219 114 ILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 114 ~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~~~ 180 (183)
++.......+......++.+++.++.++|+. +++|+|++|.||+++. .+.++++|||.+.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 9865433566777888999999999999998 9999999999999999 89999999999986543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-20 Score=132.42 Aligned_cols=136 Identities=18% Similarity=0.289 Sum_probs=109.4
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchh---h-----HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL---D-----EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.||+|++|.||+|.. .+..+++|...... . .....+.+|+.++..+.|++++.+..++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 44567777643211 1 1123577899999999999888777777777888999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|+++.+.+.... . ....++.+++.++.++|+. +++|+|++|+||+++ ++.++++|||.|+...
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 99999999885421 2 5567889999999999998 999999999999999 7889999999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=156.34 Aligned_cols=136 Identities=27% Similarity=0.478 Sum_probs=112.5
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
..+.||+|+||.||+|... .+..+++|.+...... ...|+..+++++||||+++++++.+.+..++||||+++++
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 3457999999999999874 6788999988643221 1245788999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
|.+++.. +++..+..++.|++.|+.|+|..+..+++|||+||+||+++.++..++. ||.+.
T Consensus 770 L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 770 LSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred HHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 9999843 6778888899999999999995444599999999999999988776654 55543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=132.62 Aligned_cols=148 Identities=22% Similarity=0.254 Sum_probs=120.0
Q ss_pred HHHHHhchhcccCcCcCceEEEEEE-cCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCC-CceeeeeceEEeCCeEEEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH-RNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 102 (183)
+..-.+.+..+||.|+||.+|.|.. ..+..||+|.=... ..-..+.-|..+.+.+++ ..|+.+..+........+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 3444577788999999999999985 46889999874321 112346678888888875 4566666666677888999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---Ccccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---~~~~i~dfg~a~~~ 178 (183)
|+.+ |++|.+++..+.+.++-.+.+.++.|++.-++|+|.+ +++||||||+|+++.-+ +.+-++|||+|+-+
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9988 8999999988777888888899999999999999998 99999999999998744 46889999999966
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=147.04 Aligned_cols=136 Identities=20% Similarity=0.363 Sum_probs=107.2
Q ss_pred hhcccCcCcCceEEEEEEcCCcEEEEEEccchh-------hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-------DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
..+.||+|+||.||++.......+..+...+.. .....++.+|+.++..++|++++.+..++.+....+++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 356899999999999886554333222222110 1123457889999999999999887777777778899999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
|+++++|.+.+. ....++.+++.++.++|+. +++|+|+||+||++ .++.++++|||+|+....
T Consensus 417 ~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~~~ 479 (535)
T PRK09605 417 YIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSDL 479 (535)
T ss_pred ecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccCCc
Confidence 999999988774 2345788999999999998 99999999999999 577899999999997643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-20 Score=133.60 Aligned_cols=145 Identities=13% Similarity=0.203 Sum_probs=117.4
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeec-eEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLG-YSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~-~~~~~~~~~lv~e~ 105 (183)
.+.+.+.+|+|-||.+.+++++. +..+++|.+.+.. ...+.+.+|...--.++ |.||+.-++ +|++.+.+++++|+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 36677899999999999999775 5667888876543 34567888888777775 788887654 46677888899999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec-CC-Ccccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-EN-RCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~-~~-~~~~i~dfg~a~~~~ 179 (183)
+|.|+|.+-+.. ...++.....++.|++.|+.|+|+. .+||||||.+|||+- .+ -.+|++|||++....
T Consensus 104 aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 104 APRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred CccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999887743 4566777778999999999999998 999999999999974 33 479999999987543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=128.99 Aligned_cols=131 Identities=19% Similarity=0.342 Sum_probs=103.5
Q ss_pred cCcCcCceEEEEEEcCCcEEEEEEccchh--------hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 36 VGRGSSGTVYKGAMINRQLVAVNRLEKVL--------DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 36 lg~g~~g~v~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
||+|++|.||++.. .+..+++|...... .....++.+|+.++..+.++++..+..++...+..+++||+++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 79999999999984 44567777643211 1112457789999999988776665555666777899999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+++.+.+.... . .++.+++.++.++|+. +++|+|++|+||+++ ++.++++|||+|+...
T Consensus 81 g~~l~~~~~~~~-----~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 81 GKPLKDVIEEGN-----D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CccHHHHHhhcH-----H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999988774321 1 5788999999999998 999999999999999 7899999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=136.37 Aligned_cols=150 Identities=20% Similarity=0.272 Sum_probs=122.9
Q ss_pred HHHHHhchhcccCcCcCceEEEEE-EcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 102 (183)
+....+.+.++||+|+||.++.|. ..++..||||.= ........+..|.+..+.+. .+.|+.++.+-...-+..+|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE--PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE--PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEec--cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 344567788999999999999997 568889999872 22233456777888777775 57888877655556677899
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-----Ccccccceecccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-----RCAKNFRLWIGKV 177 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-----~~~~i~dfg~a~~ 177 (183)
+|.+ |.+|.+++.-+++.++..+..+++.|++.-+.++|++ .+|.||+||+|+|+... +.+.++|||+|+.
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9988 8999999988888899999999999999999999998 99999999999999754 3578999999998
Q ss_pred ccc
Q 048219 178 DEA 180 (183)
Q Consensus 178 ~~~ 180 (183)
+..
T Consensus 179 YrD 181 (449)
T KOG1165|consen 179 YRD 181 (449)
T ss_pred hcC
Confidence 754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-19 Score=126.56 Aligned_cols=133 Identities=15% Similarity=0.110 Sum_probs=101.5
Q ss_pred hcccCcCcCceEEEEEEcCCcEEEEEEccchhh----HHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccC
Q 048219 33 KEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLD----EREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
...|++|.||.|+.+.. .+..+..+.+..... .....+.+|+++|+++. ++++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35689999999997765 455566555543321 11224788999999996 4778888775 45789999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCC-CCCCEEecCCCcccccceecccccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDI-KPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
|.+|.+.... . ...+..|++.++.++|++ +|+|+|| ||+||+++.++.++|+|||+|.....+
T Consensus 82 G~~L~~~~~~-----~---~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 82 GAAMYQRPPR-----G---DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred CccHHhhhhh-----h---hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9888754311 1 124668899999999998 9999999 799999999999999999999976543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-21 Score=149.85 Aligned_cols=142 Identities=20% Similarity=0.199 Sum_probs=121.2
Q ss_pred cccCcCcCceEEEEEEcCCc-EEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 34 EKVGRGSSGTVYKGAMINRQ-LVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~-~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
..||-|+||.|=++...... .+|+|.+++.. ......+..|-.+|.....+.|++++..|.+...+|+.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 47999999999887755433 47778777643 334567888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
.++..+...+ .++..+...++.-++.|+.|||++ +|+.|||||+|+++|..|.+||.|||+|+...
T Consensus 506 ElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 506 ELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999997654 455666666888899999999998 99999999999999999999999999999654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=130.83 Aligned_cols=141 Identities=16% Similarity=0.174 Sum_probs=104.8
Q ss_pred hchhcccCcCcCceEEEEE--EcCCcEEEEEEccchhhH------------------------HHHHHHHHHHHHhhcCC
Q 048219 30 DGFKEKVGRGSSGTVYKGA--MINRQLVAVNRLEKVLDE------------------------REREFQTEIKVIGRTHH 83 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~--~~~~~~~~ik~~~~~~~~------------------------~~~~~~~e~~~l~~l~h 83 (183)
+.+.+.||+|++|.||+|. ..++..+++|.+...... ....+..|+.++..+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5677899999999999998 457889999987642110 11235679999988865
Q ss_pred Cc--eeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCC-ceecCCCCCCEE
Q 048219 84 RN--LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ-IIHCDIKPQNIL 160 (183)
Q Consensus 84 ~~--i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-i~H~dl~~~nil 160 (183)
.. ++++++. ...+++||++++.++....... ..........++.|++.++.++|++ + ++|+|+||+||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 32 3333332 2358999999987776544221 2233444567889999999999998 8 999999999999
Q ss_pred ecCCCcccccceecccccc
Q 048219 161 MDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 161 ~~~~~~~~i~dfg~a~~~~ 179 (183)
++ .+.++++|||.|....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 7889999999998553
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=135.37 Aligned_cols=159 Identities=18% Similarity=0.229 Sum_probs=126.6
Q ss_pred CCceeCHHHHHHHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCC--C----ceee
Q 048219 16 TPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHH--R----NLVR 88 (183)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h--~----~i~~ 88 (183)
-+..+..++....++.+.+.+|+|+||.|-++.+.. +..+|+|+++.... ..+....|+++|+++.+ | -++.
T Consensus 77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 334455556667778888999999999999999765 56788888876543 33456779999999842 1 3677
Q ss_pred eeceEEeCCeEEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---
Q 048219 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN--- 164 (183)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~--- 164 (183)
+.++|...++.+||+|.+ |.|+++++.... ..++...+..++.|++.++.+||+. +++|.||||+||++-.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 888899999999999988 779999997644 4466677888999999999999998 99999999999998432
Q ss_pred -----------------Ccccccceecccccc
Q 048219 165 -----------------RCAKNFRLWIGKVDE 179 (183)
Q Consensus 165 -----------------~~~~i~dfg~a~~~~ 179 (183)
..++++|||.|.+..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~ 263 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH 263 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceec
Confidence 247899999998753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=129.17 Aligned_cols=140 Identities=14% Similarity=0.123 Sum_probs=109.2
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHH---HH------HHHHHHHHhhcCCCceeeeeceEEe
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERE---RE------FQTEIKVIGRTHHRNLVRLLGYSLE 95 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~---~~------~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (183)
+-..++...+.+|.|.||.||.+.. ++..+++|.+.+...... .. +.+|+..+.++.|+++..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3344566668899999999999765 566799999864332221 22 4678889999999999999887664
Q ss_pred C--------CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 96 V--------SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 96 ~--------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
. +..+++|||++|.+|.+... .+. ....+++.++..+|.. +++|+|++|+|++++.++ +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 3 35789999999999977631 112 2456899999999998 999999999999999888 9
Q ss_pred cccceeccccc
Q 048219 168 KNFRLWIGKVD 178 (183)
Q Consensus 168 ~i~dfg~a~~~ 178 (183)
+++|||.++..
T Consensus 174 ~liDfg~~~~~ 184 (232)
T PRK10359 174 RIIDLSGKRCT 184 (232)
T ss_pred EEEECCCcccc
Confidence 99999988755
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=137.41 Aligned_cols=133 Identities=23% Similarity=0.340 Sum_probs=109.2
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcC-----C---CceeeeeceEEe---
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTH-----H---RNLVRLLGYSLE--- 95 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~--- 95 (183)
.+|.+..+||+|-|++||+|.+.. ..-||+|+.+.. +..++....||.+|+++. + ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 567777899999999999999765 556788877544 455667788999999873 2 369999999963
Q ss_pred -CCeEEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC
Q 048219 96 -VSKKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164 (183)
Q Consensus 96 -~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~ 164 (183)
..++++|+|++ |..|..++.... +.++...+..|+.||+.||.|||.. ++|+|.||||+|||+...
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeecc
Confidence 34789999998 778888887654 5567788889999999999999987 599999999999999754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=135.53 Aligned_cols=140 Identities=24% Similarity=0.288 Sum_probs=106.2
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHH-hhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVI-GRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
..||.|+||.|++-..+ .++..|+|++..... ....+++.|.+.. +.-+.|+||+++|+...++..++-||.+. .|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 36999999999998865 588999999864322 3345677777755 44468999999999999999999999995 46
Q ss_pred HHHHHhc----CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 111 LADILFN----AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 111 l~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
+..+... .....++.-.-.|..-...||.||... +.|+|||+||+|||++..|.+|+||||++.
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchH
Confidence 6654421 112233332223334456799999875 599999999999999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.3e-19 Score=127.66 Aligned_cols=137 Identities=31% Similarity=0.411 Sum_probs=118.3
Q ss_pred cCceEEEEEEcC-CcEEEEEEccchhhHH-HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHHHHhc
Q 048219 40 SSGTVYKGAMIN-RQLVAVNRLEKVLDER-EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN 117 (183)
Q Consensus 40 ~~g~v~~~~~~~-~~~~~ik~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~ 117 (183)
+||.+|++.... +..+++|.+....... ...+..|+..++.++|++++++.+.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 478999999764 7889999987543322 56788999999999999999999999988999999999999899998865
Q ss_pred CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 118 AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 118 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
... .+......++.+++.++.++|+. +++|+|++|+||+++.++.++++|||.+.....
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 332 56777888999999999999998 999999999999999999999999999986543
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=145.90 Aligned_cols=142 Identities=24% Similarity=0.273 Sum_probs=96.4
Q ss_pred HhchhcccCcCcCceEEEEEEcC-----CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeece------EEeCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY------SLEVS 97 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~~ 97 (183)
.+.+.+.||+|+||.||+|.... +..+++|.+...... ....++ .+....+.++..+... .....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 35566789999999999998654 578999987542211 111111 1111111112111111 23456
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCC-------------------ChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCC
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQP-------------------NWIERTGIARDIARGILYLHDECETQIIHCDIKPQN 158 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~n 158 (183)
..++++||+++++|.+++....... ....+..++.|++.||.|+|++ +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 7899999999999999886432110 0122345789999999999998 99999999999
Q ss_pred EEecC-CCcccccceecccc
Q 048219 159 ILMDE-NRCAKNFRLWIGKV 177 (183)
Q Consensus 159 il~~~-~~~~~i~dfg~a~~ 177 (183)
||++. .+.+||+|||+|+.
T Consensus 286 ILl~~~~~~~KL~DFGlA~~ 305 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAAD 305 (566)
T ss_pred EEEeCCCCcEEEEeCCCccc
Confidence 99996 57899999999974
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.6e-21 Score=150.92 Aligned_cols=148 Identities=27% Similarity=0.351 Sum_probs=127.5
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
-.+++...+|.|++|-||++++. .+++.++|.++-....+..-++.|+-.++..+|+||+.+++.|...+.+++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 34566778999999999999966 57788888887655556677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
.+|++++.-. ....+.+.++...+++.++|+.|+|+. +-+|||+|-.||++.+.+.+|+.|||.+--+.
T Consensus 95 gggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 95 GGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred CCCcccceee-ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 9999988553 334566777778899999999999998 88999999999999999999999999986443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=134.98 Aligned_cols=143 Identities=24% Similarity=0.236 Sum_probs=118.9
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEecc
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+...||+|++..|.+++.. +.+.+|+|.+++.... +....+.|-.+..+. +||.++.+..+|+++..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4468999999999999855 5678999998775432 223456677777655 5999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||+|.....+. +.+++.-...+..+|+.||+|||++ +|+.||||.+|+++|..|.+|+.|+|+++.+
T Consensus 334 ~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 334 NGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred cCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999997655443 4456666666899999999999998 9999999999999999999999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=142.21 Aligned_cols=144 Identities=24% Similarity=0.255 Sum_probs=116.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+...+|.|+|+.|..+... +.+..++|++.+. .....+|+.++... +|+|++++.+.+.+..+.|+|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 4566678999999999988865 4667788888764 22344567655544 6999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe-cCCCcccccceecccccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM-DENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~-~~~~~~~i~dfg~a~~~~~~ 181 (183)
.++.+...+..... .. ..+..|+.+++.++.|||++ +++||||||+|||+ +..++++|+|||.++..+++
T Consensus 399 ~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred cccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99888777654322 22 56667999999999999998 99999999999999 58899999999999876543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=122.81 Aligned_cols=136 Identities=16% Similarity=0.168 Sum_probs=102.2
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhh----------------------HHHHHHHHHHHHHhhcCCCc--
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLD----------------------EREREFQTEIKVIGRTHHRN-- 85 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~~-- 85 (183)
+.+.+.||+|+||.||++...++..+++|.+..... ........|..++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 556678999999999999887888999997542110 01123566888888887663
Q ss_pred eeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
++.+. ..+..+++|||++++++...... .....++.+++.++.++|.. +++|+|++|+||++++++
T Consensus 97 v~~~~----~~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPI----DWNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCcee----ecCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCC
Confidence 33332 23456899999999888664321 12345778999999999997 999999999999999999
Q ss_pred cccccceecccccc
Q 048219 166 CAKNFRLWIGKVDE 179 (183)
Q Consensus 166 ~~~i~dfg~a~~~~ 179 (183)
.++++|||+|.-..
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=135.12 Aligned_cols=138 Identities=22% Similarity=0.356 Sum_probs=116.9
Q ss_pred hchhcccCcCcCceEEEEEEcC----CcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+...+++|+|+|+.||++.... ...+++|.+.... ...++.+|++.|..+. +.|++++.+++...+...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 3445789999999999998543 5678888876532 2346889999998885 8899999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceeccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGK 176 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~ 176 (183)
|++..+..++... ++...+..++..++.||.++|.+ +|+|||+||+|++++.. +.-.|+|||+|.
T Consensus 116 ~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence 9999888887743 45667777899999999999998 99999999999999865 788899999997
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=132.72 Aligned_cols=144 Identities=21% Similarity=0.257 Sum_probs=113.4
Q ss_pred HhchhcccCcCcCceEEEEEEcCC--cEEEEEEccchhhHHHHHHHHHHHHHhhcCC----CceeeeeceE-EeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINR--QLVAVNRLEKVLDEREREFQTEIKVIGRTHH----RNLVRLLGYS-LEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~-~~~~~~~l 101 (183)
.+.+...||+|+||.||.+..... ..+++|.-..........+..|..++..+.. +++..+.... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 677888999999999999997654 3566665433211111146667888877752 4777777777 46678899
Q ss_pred EEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-----Ccccccceecc
Q 048219 102 VYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-----RCAKNFRLWIG 175 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-----~~~~i~dfg~a 175 (183)
||+.+ |.+|.++..... +.++..+...++.|++.+|.++|+. +++|||+||+|++++.. ..+.++|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 889999886554 6778888999999999999999998 99999999999999865 46899999999
Q ss_pred c
Q 048219 176 K 176 (183)
Q Consensus 176 ~ 176 (183)
+
T Consensus 175 r 175 (322)
T KOG1164|consen 175 R 175 (322)
T ss_pred c
Confidence 8
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=138.93 Aligned_cols=139 Identities=29% Similarity=0.369 Sum_probs=108.9
Q ss_pred hcccCcCcCc-eEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 33 KEKVGRGSSG-TVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 33 ~~~lg~g~~g-~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.+.+|.|+.| .||+|... ++.||+|++-.. ...-+.+|+.+|+.- .||||+++++.-.++...||..|.| .++
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 3578999988 47888654 458998887543 334567899999876 5999999998888889999999999 579
Q ss_pred HHHHHhcC--CCCCCh-HHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---C--Ccccccceecccccc
Q 048219 111 LADILFNA--EKQPNW-IERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---N--RCAKNFRLWIGKVDE 179 (183)
Q Consensus 111 l~~~l~~~--~~~~~~-~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~--~~~~i~dfg~a~~~~ 179 (183)
|.+++... ...... .....+..|++.|+.+||+- +|+||||||.|||++. + ..++|+|||+++-.+
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999763 111111 23355778999999999996 9999999999999976 2 468999999999653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-18 Score=132.04 Aligned_cols=161 Identities=18% Similarity=0.195 Sum_probs=131.3
Q ss_pred CCCCCceeCHHHHHHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCC------Cc
Q 048219 13 TLTTPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH------RN 85 (183)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h------~~ 85 (183)
+.+-.+.+.++++--.+|.+....|+|-|+.|..|.+. .+..||||++.+..... +.=+.|+++|++|.. -+
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhH
Confidence 45556667788887788888888999999999999976 47799999997653322 233568999998853 27
Q ss_pred eeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCC--CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC
Q 048219 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEK--QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 163 (183)
Q Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~ 163 (183)
.++++..|...+++|+|+|-+ ...|-+.+...+. .+....+..++.|+..||..|.. ++|+|.||||.|||+++
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEecc
Confidence 888999999999999999988 4589999987653 35566777899999999999986 49999999999999998
Q ss_pred C-Ccccccceeccccc
Q 048219 164 N-RCAKNFRLWIGKVD 178 (183)
Q Consensus 164 ~-~~~~i~dfg~a~~~ 178 (183)
. ..+||||||.|.+.
T Consensus 572 ~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFA 587 (752)
T ss_pred CcceeeeccCcccccc
Confidence 7 57999999999765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=112.00 Aligned_cols=137 Identities=15% Similarity=0.164 Sum_probs=108.8
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCC--CceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH--RNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
+.+++|.++.||++...+ ..+++|....... ...+..|+..+..+++ ..++++..+....+..++++|++++.++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 468999999999998755 5678888765432 3467788898988876 4788888877777789999999988766
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
... +......+..+++.++..+|.....+++|+|++|+|++++..+.++++|||.|......
T Consensus 81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~~ 142 (155)
T cd05120 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142 (155)
T ss_pred ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCChH
Confidence 543 23445567789999999999853347999999999999999899999999999876543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.8e-17 Score=114.22 Aligned_cols=136 Identities=15% Similarity=0.184 Sum_probs=92.7
Q ss_pred hcccCcCcCceEEEEEEcCCcEEEEEEccchhhH--HHH----------------------HHHHHHHHHhhcCCCc--e
Q 048219 33 KEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE--RER----------------------EFQTEIKVIGRTHHRN--L 86 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~--~~~----------------------~~~~e~~~l~~l~h~~--i 86 (183)
.+.||+|+||.||+|...++..+++|.+...... ... ....|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3569999999999998777889999987542211 000 1134555555553332 3
Q ss_pred eeeeceEEeCCeEEEEEeccCCCCHHH-HHhcCCCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecCC
Q 048219 87 VRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDEN 164 (183)
Q Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~l~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~~ 164 (183)
.++++. ...+++|||++++++.. .+.... . ......++.+++.++.++|. . +++|+|++|+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 333322 34589999999843321 111110 0 03445678899999999998 6 999999999999999 8
Q ss_pred Ccccccceecccccc
Q 048219 165 RCAKNFRLWIGKVDE 179 (183)
Q Consensus 165 ~~~~i~dfg~a~~~~ 179 (183)
+.++++|||.|....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-17 Score=121.89 Aligned_cols=137 Identities=23% Similarity=0.362 Sum_probs=105.1
Q ss_pred ccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------eEEEEEec
Q 048219 35 KVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------KKILVYEY 105 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~ 105 (183)
-+|.|+- .|-.+.+. .++.+++|.+.... ....++..+|..++..++|+|+++++.+|.... ..|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 3455555 44444433 46778888765432 122456788999999999999999999985332 46899999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+. .++...+.. .++-.++..+..|++.|+.++|+. +|+||||||+||++..++.+||.|||+|+-.+
T Consensus 103 m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 103 MD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred hh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence 95 477776643 234456667889999999999998 99999999999999999999999999998654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=8e-16 Score=112.82 Aligned_cols=135 Identities=16% Similarity=0.150 Sum_probs=99.1
Q ss_pred ccC-cCcCceEEEEEEcCCcEEEEEEccchh------h-------HHHHHHHHHHHHHhhcCCCce--eeeeceEEeC-C
Q 048219 35 KVG-RGSSGTVYKGAMINRQLVAVNRLEKVL------D-------EREREFQTEIKVIGRTHHRNL--VRLLGYSLEV-S 97 (183)
Q Consensus 35 ~lg-~g~~g~v~~~~~~~~~~~~ik~~~~~~------~-------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~-~ 97 (183)
.+| .|+.|.+|.+... +..+++|...+.. . ....++.+|+.++..+.|+++ +.+.++.... .
T Consensus 38 ~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred eeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 566 6788888887654 4567777664311 0 122457889999999988775 5566654332 2
Q ss_pred ---eEEEEEeccCC-CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 98 ---KKILVYEYMSN-GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 98 ---~~~lv~e~~~~-~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
..+++||++++ .++.+++... .++.. ...+++.++.++|++ +|+|+|+||+||+++.++.++++|||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECC
Confidence 23599999997 6888887542 22222 357899999999998 99999999999999988899999999
Q ss_pred cccccc
Q 048219 174 IGKVDE 179 (183)
Q Consensus 174 ~a~~~~ 179 (183)
.+++..
T Consensus 188 ~~~~~~ 193 (239)
T PRK01723 188 RGELRT 193 (239)
T ss_pred CcccCC
Confidence 999865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-15 Score=113.68 Aligned_cols=143 Identities=34% Similarity=0.473 Sum_probs=119.1
Q ss_pred chhcccCcCcCceEEEEEEcCCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCC-ceeeeeceEEeCCeEEEEEecc
Q 048219 31 GFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHR-NLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+.+|.|+|+.||.+... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 44567899999999999876 66778877654322 356788899999999988 7999999997777789999999
Q ss_pred CCCCHHHHHhcCC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceeccccc
Q 048219 107 SNGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~ 178 (183)
.++++.+.+.... ..........+..|++.++.++|.. +++|||+||+||+++..+ .++++|||+++..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999997665443 1567778888999999999999998 899999999999999988 7999999999743
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-16 Score=133.05 Aligned_cols=146 Identities=23% Similarity=0.231 Sum_probs=111.6
Q ss_pred HHHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC---CCceeeeeceEEeCCeEE
Q 048219 24 ELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH---HRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 24 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 100 (183)
++....+.+.+.+|+|++|.||+|...+++++|+|.=++..+=... .-..++.+|+ -+.++.+..++..++..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 4445567788899999999999999888999999986543211000 0011222222 245666777777888889
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-------CCccccccee
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-------NRCAKNFRLW 173 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-------~~~~~i~dfg 173 (183)
+++||.+.|+|.+++. ..+.+++.....++.|++..+..||+. +|||+||||+|+++.. +..++|+|||
T Consensus 771 lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999886 456678888888999999999999998 9999999999999843 3468999999
Q ss_pred ccc
Q 048219 174 IGK 176 (183)
Q Consensus 174 ~a~ 176 (183)
-|-
T Consensus 847 ~si 849 (974)
T KOG1166|consen 847 RSI 849 (974)
T ss_pred cce
Confidence 763
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4e-14 Score=97.75 Aligned_cols=134 Identities=20% Similarity=0.381 Sum_probs=99.6
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchh-------hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVL-------DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+|+-+.++.+.+.....+...++.+.. .-...+..+|+.++..+.-..+..+.-+..+++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 467888888888765543333333343322 1123567889999988865566666666678888899999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
|..+.+.+... ...++..+-.-+.-||.+ +|+|+||+++|+++...+ +.++|||++.+-+.
T Consensus 83 G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 83 GELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred ChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 98888888653 134667777788899998 999999999999998766 88999999997654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.5e-15 Score=112.46 Aligned_cols=145 Identities=21% Similarity=0.288 Sum_probs=114.0
Q ss_pred HhchhcccCcCcCceEEEEEEcCC------cEEEEEEccc-hhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINR------QLVAVNRLEK-VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~------~~~~ik~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 100 (183)
+..+...+.+|+||.||.|.+++. +.+.+|.++. ..+.+...++.|...+..+.|||+.++.+++.. ....+
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 344445788999999999976643 3345555543 234455678899999999999999999998864 45667
Q ss_pred EEEeccCCCCHHHHHhcCC-------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 101 LVYEYMSNGSLADILFNAE-------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
..+.+..-|.|..++...+ +..+..+...++.|++.|+.|+|.+ +++|.||.++|+++|+.-.+|++|--
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccch
Confidence 7778787789999987321 3344556667889999999999998 99999999999999999999999988
Q ss_pred ccc
Q 048219 174 IGK 176 (183)
Q Consensus 174 ~a~ 176 (183)
+++
T Consensus 442 LSR 444 (563)
T KOG1024|consen 442 LSR 444 (563)
T ss_pred hcc
Confidence 887
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=113.24 Aligned_cols=140 Identities=18% Similarity=0.212 Sum_probs=93.9
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHH----------------------------------------HHHHH
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERE----------------------------------------REFQT 73 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~----------------------------------------~~~~~ 73 (183)
+.+|.|++|.||+|...+|+.|++|...+...... -.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 35999999999999998999999998754211100 01233
Q ss_pred HHHHHhhc----CCCceeeeeceEE-eCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHH-HHHHhhhCCCC
Q 048219 74 EIKVIGRT----HHRNLVRLLGYSL-EVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR-GILYLHDECET 147 (183)
Q Consensus 74 e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~lh~~~~~ 147 (183)
|...+..+ ++.+-+.+...+. ..+..+++|||++|.++.+.......... ...++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~--- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD--- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC---
Confidence 55544443 3333333333332 24456899999999998876643211122 2234444444 35667876
Q ss_pred CceecCCCCCCEEecCCCcccccceecccccc
Q 048219 148 QIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 148 ~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++|+|++|.||+++.++.++++|||++....
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-13 Score=95.57 Aligned_cols=145 Identities=17% Similarity=0.253 Sum_probs=103.2
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchh-------hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-------DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..+-+|+-+.|+.+.+.....+...++.+.. .-..++..+|++.|.++.--.|.-+.-++.+.....+.|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 4567888888888876655444333343321 122467889999998876555555555677888889999999
Q ss_pred CC-CCHHHHHhcCCCC-CChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC---cccccceecccccccc
Q 048219 107 SN-GSLADILFNAEKQ-PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR---CAKNFRLWIGKVDEAR 181 (183)
Q Consensus 107 ~~-~~l~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~---~~~i~dfg~a~~~~~~ 181 (183)
+| .++.+++...... ........++.++-..+.-||.+ .++|+||+++||++..++ .+.++|||++.+-...
T Consensus 93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~~~ 169 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSRLP 169 (229)
T ss_pred cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcccCc
Confidence 87 4666776553322 22233356888999999999998 999999999999997664 3479999999875443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.4e-13 Score=94.44 Aligned_cols=133 Identities=14% Similarity=0.135 Sum_probs=91.7
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCce-eeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNL-VRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
+.++.|.++.+|++... +..+++|....... .......|..++..+.+.++ ++++.. .....+++||+++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 35788999999998755 56788888654321 12234668888887754443 344433 333457999999988765
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCC--CCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDEC--ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
.. ... ......+++.++..+|+.. ...++|+|++|.||+++ .+.++++||+.|...+.
T Consensus 80 ~~------~~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~~ 139 (170)
T cd05151 80 TE------DFS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMNDP 139 (170)
T ss_pred cc------ccc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCCh
Confidence 42 011 1224578899999999862 12259999999999999 66789999999987653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.4e-14 Score=119.21 Aligned_cols=89 Identities=19% Similarity=0.228 Sum_probs=68.0
Q ss_pred ceeeeeceE-------EeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCC
Q 048219 85 NLVRLLGYS-------LEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQ 157 (183)
Q Consensus 85 ~i~~~~~~~-------~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ 157 (183)
||..+.+++ .....+++++|++ +++|.+++......+++..+..++.|++.||.|||++ +|+||||||+
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~ 109 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPS 109 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCch
Confidence 455555554 1223466778887 5699999976555678888889999999999999998 9999999999
Q ss_pred CEEecC-------------------CCcccccceecccc
Q 048219 158 NILMDE-------------------NRCAKNFRLWIGKV 177 (183)
Q Consensus 158 nil~~~-------------------~~~~~i~dfg~a~~ 177 (183)
|||++. ++.+|++|||+|+.
T Consensus 110 NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 110 CFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR 148 (793)
T ss_pred hEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence 999954 44566777777653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.5e-13 Score=106.60 Aligned_cols=136 Identities=14% Similarity=0.112 Sum_probs=87.0
Q ss_pred cccCcCcCceEEEEEEcC-CcEEEEEEccchhhH----------------------------------HHHH------HH
Q 048219 34 EKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDE----------------------------------RERE------FQ 72 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~----------------------------------~~~~------~~ 72 (183)
+-+|.|++|.||+|...+ |+.|++|...+.... .... +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999877 899999998643110 0111 23
Q ss_pred HHHHHHhhc----CCCceeeeeceEEe-CCeEEEEEeccCCCCHHHHHh--cCCCC---CChHHHHHHHHHHHHHHHHhh
Q 048219 73 TEIKVIGRT----HHRNLVRLLGYSLE-VSKKILVYEYMSNGSLADILF--NAEKQ---PNWIERTGIARDIARGILYLH 142 (183)
Q Consensus 73 ~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~l~--~~~~~---~~~~~~~~i~~~i~~~l~~lh 142 (183)
.|+..+.++ .+.+.+.+...+.+ .+..+++|||+.|+++.+.-. ..+.. +.......++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 344433333 23344444444432 456789999999999976422 11111 11111222333332
Q ss_pred hCCCCCceecCCCCCCEEecCCC----cccccceecccccc
Q 048219 143 DECETQIIHCDIKPQNILMDENR----CAKNFRLWIGKVDE 179 (183)
Q Consensus 143 ~~~~~~i~H~dl~~~nil~~~~~----~~~i~dfg~a~~~~ 179 (183)
.. +++|+|++|.||+++.++ .++++|||++...+
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 33 999999999999999887 89999999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-13 Score=113.18 Aligned_cols=142 Identities=19% Similarity=0.257 Sum_probs=103.1
Q ss_pred cccCcCcCceEEEEEEcC-CcEEEEEEcc----chh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 34 EKVGRGSSGTVYKGAMIN-RQLVAVNRLE----KVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~-~~~~~ik~~~----~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..+|.|++|.++.+.... ......+... ... ......+..|..+-..+.|+|++.....+.......-.||||
T Consensus 324 ~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~ 403 (601)
T KOG0590|consen 324 RVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYC 403 (601)
T ss_pred ceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcc
Confidence 468899999666554332 1111111111 111 111223667777778899999887766666555555559999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
++ +|+.++... ..++...+..+++|++.|+.|+|+. ++.|||+|++|+++..++.+||+|||.+.++..
T Consensus 404 ~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 404 PY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99 999988653 2455666777899999999999998 999999999999999999999999999998753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.2e-11 Score=84.86 Aligned_cols=137 Identities=13% Similarity=0.114 Sum_probs=90.9
Q ss_pred cccCcCcCceEEEEEEcC-------CcEEEEEEccchh------------h--------------HHHHHHHHHHHHHhh
Q 048219 34 EKVGRGSSGTVYKGAMIN-------RQLVAVNRLEKVL------------D--------------EREREFQTEIKVIGR 80 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~-------~~~~~ik~~~~~~------------~--------------~~~~~~~~e~~~l~~ 80 (183)
..||.|.-+.||.|.... +..+|+|...... . ........|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 357889999999997542 3567777643100 0 001123478888988
Q ss_pred cCC--CceeeeeceEEeCCeEEEEEeccCCCCHH-HHHhcCCCCCChHHHHHHHHHHHHHHHHh-hhCCCCCceecCCCC
Q 048219 81 THH--RNLVRLLGYSLEVSKKILVYEYMSNGSLA-DILFNAEKQPNWIERTGIARDIARGILYL-HDECETQIIHCDIKP 156 (183)
Q Consensus 81 l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~l~-~~l~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dl~~ 156 (183)
+.. -+++.++.+ ...+++||++.+..+. ..+.. ..........+..+++.++..+ |.. +++|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 853 345555543 5678999999754332 22222 1222333445678899999888 776 999999999
Q ss_pred CCEEecCCCcccccceeccccccc
Q 048219 157 QNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 157 ~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
.||+++ ++.+.++|||.|...+.
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCCC
Confidence 999997 46789999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.3e-13 Score=105.49 Aligned_cols=139 Identities=21% Similarity=0.168 Sum_probs=109.4
Q ss_pred cCcCcCceEEEEEEc----CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccCC
Q 048219 36 VGRGSSGTVYKGAMI----NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 36 lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+|+|++|.|++++.. .+..++.|.+.+... ........|-.++...+ ||.++++...++..+..++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 689999999876532 355666666554321 11113445666777776 99999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++..+.... .+++.....+..+++.++.++|+. +++++|+|++||+++.+|.+++.|||++++.
T Consensus 82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred chhhhccccCC-chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHh
Confidence 99988886543 344555556778899999999998 9999999999999999999999999999865
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.9e-11 Score=86.18 Aligned_cols=145 Identities=17% Similarity=0.210 Sum_probs=96.5
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCC--ceeeeeceEEeC---CeEEEEEeccC
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHR--NLVRLLGYSLEV---SKKILVYEYMS 107 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~lv~e~~~ 107 (183)
+.++.|..+.+|++...++..+++|....... .....+..|..++..+.+. .+++++.+.... +..+++||+++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 35789999999998876656788888654321 1234578899999888653 355666555443 25689999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhC-------------------------------------------
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE------------------------------------------- 144 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~------------------------------------------- 144 (183)
|.++...+.. ...+......++.+++..+..+|+.
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 8766553311 1223333334445555555555421
Q ss_pred ----------CCCCceecCCCCCCEEecC--CCcccccceeccccccc
Q 048219 145 ----------CETQIIHCDIKPQNILMDE--NRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 145 ----------~~~~i~H~dl~~~nil~~~--~~~~~i~dfg~a~~~~~ 180 (183)
....++|+|+.+.||+++. .+.+.++||+.|..+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~~ 209 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGDP 209 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCCh
Confidence 1246799999999999998 56678999999987653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.4e-11 Score=95.33 Aligned_cols=99 Identities=31% Similarity=0.508 Sum_probs=90.6
Q ss_pred HhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCc-eecCCCC
Q 048219 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI-IHCDIKP 156 (183)
Q Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i-~H~dl~~ 156 (183)
|+.+.|.|+.++.|.+.++...+.+.++|+.|+|.+.+......+++.....++++++.||.|+|.. +| .|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 3567899999999999999999999999999999999988778888888888999999999999986 44 8999999
Q ss_pred CCEEecCCCcccccceecccccc
Q 048219 157 QNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 157 ~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|+++|....+|+.|||+..+..
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred ccceeeeeEEEEechhhhccccc
Confidence 99999999999999999998763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.5e-11 Score=87.86 Aligned_cols=137 Identities=24% Similarity=0.399 Sum_probs=106.2
Q ss_pred hhcccCcCcCceEEEEEEcCCcEEEEEEc--cchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~~~~~~ik~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
+..+|.+...|..|+|++.....|+ |++ ........+.+..|...|+-++||||..+.++|..+.++.+++.|+|.+
T Consensus 194 l~tkl~e~hsgelwrgrwqgndiva-kil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGNDIVA-KILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCcchhh-hhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 4457888899999999987765443 333 2222333456888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCC-CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccc
Q 048219 110 SLADILFNAEK-QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 110 ~l~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~ 170 (183)
+|+..+..... ..+..+...++..++.|+.|||+-- .-|..-.|....+++|++-+++|.
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence 99999976432 2345566778999999999999852 123345688999999999887764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-10 Score=88.61 Aligned_cols=88 Identities=20% Similarity=0.292 Sum_probs=68.9
Q ss_pred CCCceeeeeceEEeCC---------------------------eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHH
Q 048219 82 HHRNLVRLLGYSLEVS---------------------------KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDI 134 (183)
Q Consensus 82 ~h~~i~~~~~~~~~~~---------------------------~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i 134 (183)
+||||+++.++|.+.- ..|+||...+ .+|-++++.. ..+......+..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC--CCchHHHHHHHHHH
Confidence 6999999988875421 1378887774 4888888653 44556666688999
Q ss_pred HHHHHHhhhCCCCCceecCCCCCCEEe--cCCC--cccccceecc
Q 048219 135 ARGILYLHDECETQIIHCDIKPQNILM--DENR--CAKNFRLWIG 175 (183)
Q Consensus 135 ~~~l~~lh~~~~~~i~H~dl~~~nil~--~~~~--~~~i~dfg~a 175 (183)
+.|+.|||.+ ++.|||+|.+||++ |+++ .+.++|||.+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEccccee
Confidence 9999999998 99999999999997 3333 5778999976
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.4e-09 Score=76.77 Aligned_cols=125 Identities=19% Similarity=0.191 Sum_probs=76.0
Q ss_pred EEEEEEcCCcEEEEEEccch--------------------------hhHHHHHHHHHHHHHhhcCCC--ceeeeeceEEe
Q 048219 44 VYKGAMINRQLVAVNRLEKV--------------------------LDEREREFQTEIKVIGRTHHR--NLVRLLGYSLE 95 (183)
Q Consensus 44 v~~~~~~~~~~~~ik~~~~~--------------------------~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~ 95 (183)
||.|...++..+++|.-... .......+..|.+.|..+... ++++++.+
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--- 78 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--- 78 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE---
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE---
Confidence 67777777777777764320 001123467899999998755 45555533
Q ss_pred CCeEEEEEeccC--CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHH-hhhCCCCCceecCCCCCCEEecCCCcccccce
Q 048219 96 VSKKILVYEYMS--NGSLADILFNAEKQPNWIERTGIARDIARGILY-LHDECETQIIHCDIKPQNILMDENRCAKNFRL 172 (183)
Q Consensus 96 ~~~~~lv~e~~~--~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~~~~i~H~dl~~~nil~~~~~~~~i~df 172 (183)
....++|||++ |..+..+...... ......+..+++..+.. +|.. +++|+||++.||+++++ .+.++||
T Consensus 79 -~~~~ivME~I~~~G~~~~~l~~~~~~---~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 -NRNVIVMEYIGEDGVPLPRLKDVDLS---PEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp -ETTEEEEE--EETTEEGGCHHHCGGG---GSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred -eCCEEEEEecCCCccchhhHHhcccc---chhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 24569999998 6555544322101 12233455666664444 5676 99999999999999987 8999999
Q ss_pred ecccccc
Q 048219 173 WIGKVDE 179 (183)
Q Consensus 173 g~a~~~~ 179 (183)
|.|.-..
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.1e-08 Score=74.68 Aligned_cols=132 Identities=13% Similarity=0.061 Sum_probs=88.5
Q ss_pred eEEEEEEcCCcEEEEEEccchhh-HHH----------HHHHHHHHHHhhcCCCcee--eeeceEEe-----CCeEEEEEe
Q 048219 43 TVYKGAMINRQLVAVNRLEKVLD-ERE----------REFQTEIKVIGRTHHRNLV--RLLGYSLE-----VSKKILVYE 104 (183)
Q Consensus 43 ~v~~~~~~~~~~~~ik~~~~~~~-~~~----------~~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~~~~~lv~e 104 (183)
.|.+.. .+++.+.+|......- +.. ..+.+|...+.++...+|. .+..+.+. ....+++||
T Consensus 37 rvvr~~-~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFE-LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEE-ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 344443 3566788886533210 001 1366788888777443333 33444432 234789999
Q ss_pred ccCCC-CHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-------CCcccccceecc
Q 048219 105 YMSNG-SLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-------NRCAKNFRLWIG 175 (183)
Q Consensus 105 ~~~~~-~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-------~~~~~i~dfg~a 175 (183)
++++. ++.+++... ...........++.+++..+.-||++ +++|+|++++||+++. ...+.++||+.+
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99876 788877431 12233445557889999999999998 9999999999999985 357899999998
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
++.
T Consensus 193 ~~~ 195 (268)
T PRK15123 193 QIR 195 (268)
T ss_pred ccc
Confidence 653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.7e-09 Score=79.68 Aligned_cols=143 Identities=17% Similarity=0.179 Sum_probs=83.3
Q ss_pred hcccCcCcCceEEEEEEcC-CcEEEEEEccch---hhHHHHHHHHHHHHHhhcCC----------CceeeeeceE-----
Q 048219 33 KEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV---LDEREREFQTEIKVIGRTHH----------RNLVRLLGYS----- 93 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~----- 93 (183)
...||.|.++.||.+.+.+ ++.+++|...-. .....+.+.+|.-....+.+ -.++-.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 3579999999999999875 778888875421 11123344444433322211 1122112211
Q ss_pred ----EeCC--------eEEEEEeccCCCCHHHHHhc---CCCC---CChHHHHHHHHHHHHHHHHhhhCCCCCceecCCC
Q 048219 94 ----LEVS--------KKILVYEYMSNGSLADILFN---AEKQ---PNWIERTGIARDIARGILYLHDECETQIIHCDIK 155 (183)
Q Consensus 94 ----~~~~--------~~~lv~e~~~~~~l~~~l~~---~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~ 155 (183)
.... +.+++|+-+ .++|.+++.. .... ........+..|+.+.+.++|.. +++|+|++
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 1111 235667766 4588877642 1111 12233344568899999999998 99999999
Q ss_pred CCCEEecCCCcccccceecccccc
Q 048219 156 PQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 156 ~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+|++++.+|.+.+.||+...-..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g 196 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAG 196 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETT
T ss_pred eeeEEEcCCCCEEEcChHHHeecC
Confidence 999999999999999998766443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-10 Score=98.00 Aligned_cols=139 Identities=20% Similarity=0.109 Sum_probs=100.9
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchh-hHHH---HHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-DERE---REFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~-~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
..+.+.||++.|=.+.+|.+.+|. +.+|.+.+.. .... .+.+.|+. ....++||.+.+.-+.......|+|=+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 445678999999999999988886 7777765433 2222 23344444 4455799998876665555556666677
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
. ..+|++.+..++ .+......-|+.|++.|+.-+|.. +|+|+|||.+|||+..++=+-|.||-.=
T Consensus 103 v-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASF 167 (1431)
T ss_pred H-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccccc
Confidence 7 458999886543 223333344789999999999997 9999999999999999998999998543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.2e-09 Score=83.55 Aligned_cols=120 Identities=18% Similarity=0.134 Sum_probs=93.9
Q ss_pred EcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHH
Q 048219 49 MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT 128 (183)
Q Consensus 49 ~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~ 128 (183)
...+..+.+...+...........+.+..|+.++||+|++++..++..+..|+|+|.+. .+...+.... .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 33466676666554433334456667888999999999999999999999999999883 6777775532 33334
Q ss_pred HHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 129 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 129 ~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
..+.||+.||.|||+. +.++|+++.-+.+++++.|.-||.+|-.+.
T Consensus 108 ~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred HHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 4578999999999975 499999999999999999999999988774
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-08 Score=74.93 Aligned_cols=135 Identities=19% Similarity=0.170 Sum_probs=92.7
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchh----------------------hHHHHHHHHHHHHHhhcCCC--c
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL----------------------DEREREFQTEIKVIGRTHHR--N 85 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--~ 85 (183)
+.+.+.||-|.-+.||.|....+..+++|.=.-.. ......+.+|.+.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44557899999999999999888888887532110 11123467899999988644 5
Q ss_pred eeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
+++++++ +...++||++.|..|...-- ...+... +...|+.-+.-.... |++|+|+++=||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---~~en~~~---il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---DVENPDE---ILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---cccCHHH---HHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 6665543 67789999999876654321 1122222 334444444444343 999999999999999999
Q ss_pred cccccceecccc
Q 048219 166 CAKNFRLWIGKV 177 (183)
Q Consensus 166 ~~~i~dfg~a~~ 177 (183)
.+.++||=-+.-
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999966553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-08 Score=73.68 Aligned_cols=107 Identities=24% Similarity=0.281 Sum_probs=79.3
Q ss_pred HHHHHHHHHHhhcCCCc--eeeeeceEEeCC----eEEEEEeccCCC-CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHh
Q 048219 69 REFQTEIKVIGRTHHRN--LVRLLGYSLEVS----KKILVYEYMSNG-SLADILFNAEKQPNWIERTGIARDIARGILYL 141 (183)
Q Consensus 69 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~----~~~lv~e~~~~~-~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 141 (183)
.+...|...+..+.... .+++.++.+... ..++++|.+++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 34667777776664333 444555554322 458999999874 78888755222 34445567889999999999
Q ss_pred hhCCCCCceecCCCCCCEEecCCC---cccccceecccccc
Q 048219 142 HDECETQIIHCDIKPQNILMDENR---CAKNFRLWIGKVDE 179 (183)
Q Consensus 142 h~~~~~~i~H~dl~~~nil~~~~~---~~~i~dfg~a~~~~ 179 (183)
|++ +++|+|+++.|||++..+ .+.++||+-+++..
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 998 999999999999999887 78899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.9e-10 Score=94.40 Aligned_cols=147 Identities=20% Similarity=0.271 Sum_probs=110.7
Q ss_pred hchhcccCcCcCceEEEEEEc--CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI--NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~--~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+...+|+|+|+.+...... ....++.+.+.... .....++..|..+-..+. |.|++...+........+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 445567899999987766532 23445555544332 223344556777777776 9999999999999999999999
Q ss_pred ccCCCCHHHHH-hcCCCCCChHHHHHHHHHHHHHHHHhh-hCCCCCceecCCCCCCEEecCCC-cccccceecccccc
Q 048219 105 YMSNGSLADIL-FNAEKQPNWIERTGIARDIARGILYLH-DECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~~ 179 (183)
+..+++++..+ ............-.+..|+..++.|+| .. ++.|+|++|+|.+++..+ ..++.|||+|..+.
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999998877 333213334445557899999999999 66 999999999999999999 99999999998653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.5e-08 Score=79.52 Aligned_cols=141 Identities=17% Similarity=0.146 Sum_probs=89.2
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHH----------------------------------HH------HHH
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERE----------------------------------RE------FQT 73 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~----------------------------------~~------~~~ 73 (183)
+-++.++-|.||+|...+|+.|++|...+...... +. +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 35788999999999999999999998754221110 01 233
Q ss_pred HHHHHhhc----CCCceeeeeceE-EeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCC
Q 048219 74 EIKVIGRT----HHRNLVRLLGYS-LEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148 (183)
Q Consensus 74 e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 148 (183)
|...+..+ +...-+.+...| ...+.-.++|||++|-.+.+.........+...+.....+..--..+ + . +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~-~-d---g 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL-R-D---G 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-h-c---C
Confidence 44444433 222233333333 44667789999999988877643332333333322222221111112 2 2 9
Q ss_pred ceecCCCCCCEEecCCCcccccceecccccc
Q 048219 149 IIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 149 i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|.|.+|.||+++.++.+.+.|||+....+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.2e-07 Score=65.61 Aligned_cols=137 Identities=17% Similarity=0.104 Sum_probs=93.1
Q ss_pred cCcCcCceEEEEEEcCCcEEEEEEccchh------hHHHHHHHHHHHHHhhcCCCc--eeeeeceEE-eC----CeEEEE
Q 048219 36 VGRGSSGTVYKGAMINRQLVAVNRLEKVL------DEREREFQTEIKVIGRTHHRN--LVRLLGYSL-EV----SKKILV 102 (183)
Q Consensus 36 lg~g~~g~v~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~-~~----~~~~lv 102 (183)
-++|+.+.|+.... +++.+-+|+-.+-. +--...+.+|...+..+...+ ++++. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 35588888887543 33367777765211 112346888999888875333 44444 222 11 136799
Q ss_pred EeccCC-CCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc--ccccceecccc
Q 048219 103 YEYMSN-GSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC--AKNFRLWIGKV 177 (183)
Q Consensus 103 ~e~~~~-~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~--~~i~dfg~a~~ 177 (183)
+|-+++ -+|.+++.... ...+......+..+++..+.-||+. ++.|+|+.+.||+++..+. +.++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 58887774432 2334444557889999999999998 9999999999999986666 89999987763
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.4e-07 Score=67.51 Aligned_cols=142 Identities=10% Similarity=0.120 Sum_probs=82.6
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCc--eeeeeceEEeCCeEEEEEeccCCCC-
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN--LVRLLGYSLEVSKKILVYEYMSNGS- 110 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~- 110 (183)
..+++|..+.+|+.. +..+.+|...... ....+.+|.++++.+.... +++++.+....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 468999999999732 3345566654322 2344677888888775333 4566666666777789999998863
Q ss_pred HHHHH--------------hc-----CC---CCCChHHH-HHHHHH----------HHH-HHHHhhhC-CCCCceecCCC
Q 048219 111 LADIL--------------FN-----AE---KQPNWIER-TGIARD----------IAR-GILYLHDE-CETQIIHCDIK 155 (183)
Q Consensus 111 l~~~l--------------~~-----~~---~~~~~~~~-~~i~~~----------i~~-~l~~lh~~-~~~~i~H~dl~ 155 (183)
+...+ .. .. ........ ..+..+ +.. ...++... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 11111 10 00 00010100 001000 001 11222111 12356899999
Q ss_pred CCCEEecCCCcccccceecccccccc
Q 048219 156 PQNILMDENRCAKNFRLWIGKVDEAR 181 (183)
Q Consensus 156 ~~nil~~~~~~~~i~dfg~a~~~~~~ 181 (183)
|.|+++++++ +.++||+.|..++..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~Gdp~ 186 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGYGNPL 186 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCcCCHH
Confidence 9999999888 899999999887653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.7e-08 Score=66.51 Aligned_cols=60 Identities=27% Similarity=0.106 Sum_probs=52.2
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+|.+++......+++..+..++.|++.||.|+|++ + ||+||+++.++.+++ ||++++..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence 578888876556688999999999999999999987 4 999999999999998 99998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.2e-07 Score=72.36 Aligned_cols=141 Identities=17% Similarity=0.125 Sum_probs=86.5
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHH-------------------------------HHH------HHHHHH
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDER-------------------------------ERE------FQTEIK 76 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~-------------------------------~~~------~~~e~~ 76 (183)
+-|+.-+.+.|++|+.++|..|++|.-.+..... .+. +..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4688899999999999999999999765422111 011 222333
Q ss_pred HHh----hcCCCc---eeeeeceEE-eCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCC
Q 048219 77 VIG----RTHHRN---LVRLLGYSL-EVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148 (183)
Q Consensus 77 ~l~----~l~h~~---i~~~~~~~~-~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 148 (183)
... .+.|-+ -+.+..++. -...-.++|||++|..+.+.-.-.....+...+..-..+...-+-+.| |
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~-----G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT-----G 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc-----C
Confidence 332 234444 222333443 234567999999998666544322233344443333333222222333 8
Q ss_pred ceecCCCCCCEEecC----CCcccccceecccccc
Q 048219 149 IIHCDIKPQNILMDE----NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 149 i~H~dl~~~nil~~~----~~~~~i~dfg~a~~~~ 179 (183)
++|.|..|.||++.. +..+.+.|||+.....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 5678899999988654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.1e-08 Score=76.46 Aligned_cols=154 Identities=18% Similarity=0.120 Sum_probs=114.1
Q ss_pred CHHHHHHHHhchhcccCc--CcCceEEEEEE--c-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhc-CCCceeeeece
Q 048219 21 SYAELKKITDGFKEKVGR--GSSGTVYKGAM--I-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRT-HHRNLVRLLGY 92 (183)
Q Consensus 21 ~~~~~~~~~~~~~~~lg~--g~~g~v~~~~~--~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (183)
...++......+.+.+|. |.+|.+|.+.- . ....+++|.-+... +....+=.+|+.-...+ .|.+.++.+..
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 445556666777788999 99999998875 3 35566666633221 12222234455555566 48899998888
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHH----HHHHhhhCCCCCceecCCCCCCEEecCC-Ccc
Q 048219 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR----GILYLHDECETQIIHCDIKPQNILMDEN-RCA 167 (183)
Q Consensus 93 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~ 167 (183)
+...+..++-+|.+ +.++.++.......+..........+... |+.++|.. .++|.|++|.||+...+ ...
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 89999999999988 56888877665555566666667777777 99999998 99999999999999988 889
Q ss_pred cccceeccccc
Q 048219 168 KNFRLWIGKVD 178 (183)
Q Consensus 168 ~i~dfg~a~~~ 178 (183)
++.|||+....
T Consensus 263 ~~~df~~v~~i 273 (524)
T KOG0601|consen 263 KLTDFGLVSKI 273 (524)
T ss_pred ecCCcceeEEc
Confidence 99999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.1e-07 Score=76.01 Aligned_cols=142 Identities=18% Similarity=0.161 Sum_probs=102.7
Q ss_pred chhcccCcCcCceEEEEEEc--CCcEEEEEEccchhhHHHHH--HHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEec
Q 048219 31 GFKEKVGRGSSGTVYKGAMI--NRQLVAVNRLEKVLDERERE--FQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~--~~~~~~ik~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
++...||.|.|+.++.+..+ ++..+++|-+.+.......+ -+.|+-+...+ .|.+.+++...|....+.++-.|+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34457899999988886643 45677777766544332222 23445545444 488888888888777777788899
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceeccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGK 176 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~ 176 (183)
|.+++....... ..-+.+...+.+..|++.++.++|+. .++|.|++|+||++..+ +..++.|||.+.
T Consensus 348 ~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 348 CEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred hcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 988877665522 12234445566788999999999987 99999999999999875 778899999885
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.8e-06 Score=63.54 Aligned_cols=141 Identities=16% Similarity=0.075 Sum_probs=80.8
Q ss_pred cCcCcC-ceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccCCCCHHH
Q 048219 36 VGRGSS-GTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLAD 113 (183)
Q Consensus 36 lg~g~~-g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 113 (183)
|..|.. ..||+.... +..+.+|...... ...+..|+.+++.+. +.-+++++.+....+..+++||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444554 568887543 3456667654331 234556888877774 3345566666665567889999999877654
Q ss_pred HHh-------------------cCCC---CCChH--HHHHHHHH--------------------HHHHHHHhhhC----C
Q 048219 114 ILF-------------------NAEK---QPNWI--ERTGIARD--------------------IARGILYLHDE----C 145 (183)
Q Consensus 114 ~l~-------------------~~~~---~~~~~--~~~~i~~~--------------------i~~~l~~lh~~----~ 145 (183)
... .... ..... ....-... ....+..+-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 320 0000 00000 00000000 11111222111 1
Q ss_pred CCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 146 ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 146 ~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
...++|+|+.|.|++++.++...|+||+.|.+++.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gdp 196 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVADR 196 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccccccH
Confidence 23589999999999999977788999999988764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.4e-07 Score=80.11 Aligned_cols=106 Identities=25% Similarity=0.319 Sum_probs=69.6
Q ss_pred hcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 33 KEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
.+.+..|++|.||..+++. .+..+.|. .+. ..+++. ++....+|+++ |+.
T Consensus 88 IklisngAygavylvrh~~trqrfa~ki-Nkq-----~lilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ-----NLILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcc-ccc-----chhhhc--cccccCCccee---------------------chh
Confidence 3578899999999998764 45566633 221 011111 22222333333 344
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
...+..-+... .+++.+++|+|.- +|+|+|+||+|.++..-|.+|+.|||+++.+-
T Consensus 139 ~tllk~~g~lP---------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 139 ATLLKNIGPLP---------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred hhhcccCCCCc---------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 44443322221 1226789999997 99999999999999999999999999999764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.1e-06 Score=68.39 Aligned_cols=133 Identities=17% Similarity=0.179 Sum_probs=98.5
Q ss_pred eEEEEEE-cCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe----CCeEEEEEeccCC-CCHHHHHh
Q 048219 43 TVYKGAM-INRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE----VSKKILVYEYMSN-GSLADILF 116 (183)
Q Consensus 43 ~v~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~~l~~~l~ 116 (183)
+-|++.. .+|..+.+|++.............-.+.++++.|+|++++.++|.. ...+++|++|.|+ ++|.+.-.
T Consensus 291 Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F 370 (655)
T KOG3741|consen 291 TTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYF 370 (655)
T ss_pred eeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHc
Confidence 4577764 4678889999843322222233445778899999999999999873 4568899999985 46666543
Q ss_pred cC--------------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 117 NA--------------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 117 ~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.. +...++..++.++.|+..||.++|+. |+..+-|.+.+|++.....++|..-|+..+.
T Consensus 371 ~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 371 ANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred cCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 21 12234567777899999999999998 8888999999999998888888877776654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.9e-06 Score=59.89 Aligned_cols=143 Identities=16% Similarity=0.173 Sum_probs=79.4
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCC--ceeeeeceEE---eCCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHR--NLVRLLGYSL---EVSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~e~~~~ 108 (183)
+.++.|..+.+|.....+ ..+.+|..... .....+..|..++..+... .+++++.... .....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 357888899999988777 47888886544 3445677888888777432 2455555332 23356899999998
Q ss_pred CCHHH----------------HHh---cC--C-CCCChHHH--HH-------H------------HHHHHH-HHHHhhh-
Q 048219 109 GSLAD----------------ILF---NA--E-KQPNWIER--TG-------I------------ARDIAR-GILYLHD- 143 (183)
Q Consensus 109 ~~l~~----------------~l~---~~--~-~~~~~~~~--~~-------i------------~~~i~~-~l~~lh~- 143 (183)
.++.. .+. .. . ........ .. . ...+.. .+..+.+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 77766 111 11 0 00111000 00 0 001111 2223322
Q ss_pred ---CCCCCceecCCCCCCEEec-CCCcccccceecccccc
Q 048219 144 ---ECETQIIHCDIKPQNILMD-ENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 144 ---~~~~~i~H~dl~~~nil~~-~~~~~~i~dfg~a~~~~ 179 (183)
.....++|+|+.+.||+++ +++.+-++||+.+..+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~~ 199 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWGD 199 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceECC
Confidence 1234689999999999999 45555799999987664
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.7e-06 Score=59.72 Aligned_cols=136 Identities=18% Similarity=0.217 Sum_probs=86.5
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchhhHHH------------------------HHHHHHHHHHhhcCC--Cceee
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERE------------------------REFQTEIKVIGRTHH--RNLVR 88 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~------------------------~~~~~e~~~l~~l~h--~~i~~ 88 (183)
.|++|.-..||+|....+..+++|+......... .....|...|.++.. -.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 4566777789999887788888888754221110 113446666666643 33444
Q ss_pred eeceEEeCCeEEEEEeccCCC-CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 89 LLGYSLEVSKKILVYEYMSNG-SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~-~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
.+.+. +..++||++... ...-.+... .........+..++++.+.-|... .++||+||+.=|||+. .+.+
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence 44432 456899998542 122222221 122223445567778888777762 2999999999999999 8889
Q ss_pred cccceecccccc
Q 048219 168 KNFRLWIGKVDE 179 (183)
Q Consensus 168 ~i~dfg~a~~~~ 179 (183)
.|+|||-|...+
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.9e-06 Score=59.88 Aligned_cols=68 Identities=26% Similarity=0.319 Sum_probs=51.6
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 97 SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
...+++|||++|..+.+... .++ .+...+.+++.-+|+. |+.|+|+.|.|+++..++ ++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 34568999999987765431 111 2345667788999998 999999999999998554 8999998776
Q ss_pred c
Q 048219 177 V 177 (183)
Q Consensus 177 ~ 177 (183)
-
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 4
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-06 Score=66.40 Aligned_cols=93 Identities=27% Similarity=0.337 Sum_probs=74.3
Q ss_pred HHhhcCCCceeeeeceEEe-----CCeEEEEEeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCC
Q 048219 77 VIGRTHHRNLVRLLGYSLE-----VSKKILVYEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQ 148 (183)
Q Consensus 77 ~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 148 (183)
.+.++-|.||++.+.+|-+ .....+++||+..+++.+++.+ ....+.......++.||+.||.|||+- -.+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 3445568899999888754 3357889999999999999964 234456667778999999999999984 568
Q ss_pred ceecCCCCCCEEecCCCccccc
Q 048219 149 IIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 149 i~H~dl~~~nil~~~~~~~~i~ 170 (183)
|+|+++.-+.|++..++-+|+.
T Consensus 199 iihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cccCCcchhheeecCCceEEec
Confidence 9999999999999987777754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.5e-05 Score=67.12 Aligned_cols=148 Identities=14% Similarity=0.241 Sum_probs=86.0
Q ss_pred cccCcCcCceEEEEEEcCC---cEEEEEEccchh-hHHHHHHHHHHHHHhhcC-CCce--eeeeceEEeC---CeEEEEE
Q 048219 34 EKVGRGSSGTVYKGAMINR---QLVAVNRLEKVL-DEREREFQTEIKVIGRTH-HRNL--VRLLGYSLEV---SKKILVY 103 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~---~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~ 103 (183)
+.++.|.++.+|......+ ..+.+|+..... ......+.+|..+++.+. |.++ ++++.++.+. +..|+||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4577888888888765443 345666543211 112345778999999885 5654 6666666543 4678999
Q ss_pred eccCCCCHHH--------------------HHh---cCC-C---------CCCh--HHHHHHHH---------------H
Q 048219 104 EYMSNGSLAD--------------------ILF---NAE-K---------QPNW--IERTGIAR---------------D 133 (183)
Q Consensus 104 e~~~~~~l~~--------------------~l~---~~~-~---------~~~~--~~~~~i~~---------------~ 133 (183)
|+++|..+.+ .+. ... . ...+ .....+.. .
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 9998753211 111 100 0 0000 01111111 1
Q ss_pred HHHHHHHhhhCCC--------CCceecCCCCCCEEecCC-C-cccccceecccccccc
Q 048219 134 IARGILYLHDECE--------TQIIHCDIKPQNILMDEN-R-CAKNFRLWIGKVDEAR 181 (183)
Q Consensus 134 i~~~l~~lh~~~~--------~~i~H~dl~~~nil~~~~-~-~~~i~dfg~a~~~~~~ 181 (183)
+...+.|+..+.+ ..++|+|+++.|++++.. . ..-++||.+|.+++..
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdPl 261 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQM 261 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCChH
Confidence 2233556644322 259999999999999853 3 3578999999988654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.17 E-value=7.7e-05 Score=53.22 Aligned_cols=133 Identities=17% Similarity=0.215 Sum_probs=83.5
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchh----------------hHHHHHHHHHHHHHhhcC------CCceeeeec
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL----------------DEREREFQTEIKVIGRTH------HRNLVRLLG 91 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~~ 91 (183)
..||+|+.-.||.--... ...+|...... ........+|+.....+. +..|.+++|
T Consensus 7 ~~i~~G~~R~cy~HP~dp--~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDDP--NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEECCCCC--CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 368999999898643323 33444443322 011234556666555544 778999999
Q ss_pred eEEeCCeEEEEEeccC------CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 92 YSLEVSKKILVYEYMS------NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 92 ~~~~~~~~~lv~e~~~------~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
+.++.-...+|+|.+. ..+|.+++... .++. . +...+-.-..++-++ .|+.+|++|.||++....
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEEecC
Confidence 9999888999998763 34777777443 2333 2 222333344667766 899999999999997542
Q ss_pred ----cccccc-eecccc
Q 048219 166 ----CAKNFR-LWIGKV 177 (183)
Q Consensus 166 ----~~~i~d-fg~a~~ 177 (183)
.+.++| ||-..+
T Consensus 156 ~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEKEL 172 (199)
T ss_pred CCceEEEEEeCCCCccc
Confidence 355554 555444
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.2e-05 Score=57.01 Aligned_cols=102 Identities=25% Similarity=0.283 Sum_probs=77.1
Q ss_pred HHHHHHhhcCC-CceeeeeceEEeCCeEEEEEeccCCCCHHHH---HhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCC
Q 048219 73 TEIKVIGRTHH-RNLVRLLGYSLEVSKKILVYEYMSNGSLADI---LFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148 (183)
Q Consensus 73 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~---l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 148 (183)
+|..+++.+++ +++++++|+| .-++++|+...+++... +.. -....|..+..++.+++..+.+++......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 46777888875 5889999988 33568899876655321 101 123568899999999999999998744446
Q ss_pred ceecCCCCCCEEecCCCcccccceecccccc
Q 048219 149 IIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 149 i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+.-.|++++|+.+++++.+|++|...+-+.+
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 6679999999999999999999998876653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.4e-06 Score=69.08 Aligned_cols=73 Identities=21% Similarity=0.251 Sum_probs=61.3
Q ss_pred eEEEEEeccCCCCHHHHHhcCC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 98 KKILVYEYMSNGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
.+||.|++|...+|.+++...+ ..........+..|++.++.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 4789999999999999996432 234456667788999999999 4 8999999999999999999999999987
Q ss_pred c
Q 048219 176 K 176 (183)
Q Consensus 176 ~ 176 (183)
.
T Consensus 404 t 404 (516)
T KOG1033|consen 404 T 404 (516)
T ss_pred e
Confidence 5
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.88 E-value=8.2e-05 Score=54.48 Aligned_cols=34 Identities=21% Similarity=0.315 Sum_probs=28.8
Q ss_pred CCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
..++|+|+.+.|++++..+..-++||+.|.+++.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gDp 197 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGDP 197 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCcCCh
Confidence 3589999999999998766567999999988764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00013 Score=50.76 Aligned_cols=128 Identities=15% Similarity=0.242 Sum_probs=78.2
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCcee-eeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLV-RLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
+.|+.|.+|.||++.+..+ .+++|.-..+ .....+..|+.+|..+.-.++. +++.+ +..++.|||+.|.+|.
T Consensus 28 ~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~L~ 100 (201)
T COG2112 28 KELAKGTTSVVYLGEWRGG-EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhcccccEEEEeeccCc-eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcchh
Confidence 5699999999999987765 4555553332 2345678899988877654433 33332 2334559999998888
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCC-CCCEEecCCCcccccceecccccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIK-PQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~-~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+..... +..... .++.. .|.-+. .+|-|+.++ |...++-..+.+-|+||--|++-.
T Consensus 101 ~~~~~~----~rk~l~----~vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 101 KLEIGG----DRKHLL----RVLEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhcc----cHHHHH----HHHHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 766421 122222 22222 222221 166666664 455555555688999999998653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00011 Score=54.44 Aligned_cols=33 Identities=12% Similarity=0.141 Sum_probs=28.5
Q ss_pred CCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
..++|+|+.+.||++++++ +.++||..|..++.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~gdp 178 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASDGDI 178 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCcCCH
Confidence 3579999999999999877 78999999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00024 Score=51.86 Aligned_cols=34 Identities=18% Similarity=0.172 Sum_probs=29.1
Q ss_pred CCceecCCCCCCEEecC-CCcccccceeccccccc
Q 048219 147 TQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~~~ 180 (183)
..++|+|+.+.||+++. ++.+.++||-.|.....
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~~ 204 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNYR 204 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCch
Confidence 36899999999999997 57899999998876643
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00083 Score=51.06 Aligned_cols=75 Identities=9% Similarity=-0.008 Sum_probs=49.8
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCC---CceeeeeceEEe---CCeEEEEEeccC
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH---RNLVRLLGYSLE---VSKKILVYEYMS 107 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e~~~ 107 (183)
+.||.|..+.+|.....+++ +.+|..+... ....+..|...++.+.. ..++++++.+.. .+..+++||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 36899999999987655453 4455533211 12356778888888753 356777776643 366899999998
Q ss_pred CCCH
Q 048219 108 NGSL 111 (183)
Q Consensus 108 ~~~l 111 (183)
+.++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 7643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0046 Score=47.34 Aligned_cols=33 Identities=21% Similarity=0.413 Sum_probs=28.0
Q ss_pred CCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 146 ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 146 ~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+.++||+|+.+.|++++.+...-++||+.|...
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 347999999999999997665689999998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0028 Score=50.10 Aligned_cols=74 Identities=14% Similarity=0.164 Sum_probs=48.9
Q ss_pred cccCcCcCceEEEEEEcCC-cEEEEEEccchh-------hHHHHHHHHHHHHHhhcC---CCceeeeeceEEeCCeEEEE
Q 048219 34 EKVGRGSSGTVYKGAMINR-QLVAVNRLEKVL-------DEREREFQTEIKVIGRTH---HRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~-~~~~ik~~~~~~-------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 102 (183)
+.+|.|.++.||+....++ +.+.+|+-.+.. +....+...|.+.|..+. ...+++++.+ ++...+++
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 3689999999999987765 478888743110 122345666777777652 2345565554 45667899
Q ss_pred EeccCCC
Q 048219 103 YEYMSNG 109 (183)
Q Consensus 103 ~e~~~~~ 109 (183)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0009 Score=47.77 Aligned_cols=124 Identities=23% Similarity=0.295 Sum_probs=81.0
Q ss_pred HhchhcccCcCcC-ceEEEEEEcCCcEEEEEEccchh---------------h------HHHHHHHHHHHHHhhcC---C
Q 048219 29 TDGFKEKVGRGSS-GTVYKGAMINRQLVAVNRLEKVL---------------D------EREREFQTEIKVIGRTH---H 83 (183)
Q Consensus 29 ~~~~~~~lg~g~~-g~v~~~~~~~~~~~~ik~~~~~~---------------~------~~~~~~~~e~~~l~~l~---h 83 (183)
...+.+.||.|.- |.||++... +..+|+|...... . .....+.+|.+...+++ +
T Consensus 38 ~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 38 DIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred cEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 3445678999999 999997654 4489999832100 0 11234778888777774 3
Q ss_pred Cce--eeeeceEEeC------------------CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhh
Q 048219 84 RNL--VRLLGYSLEV------------------SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143 (183)
Q Consensus 84 ~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 143 (183)
..+ ++++|+..-. ..-.||.||++... ..... =+.++..-+..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 355 8888887421 01256777776542 11111 23566667778888
Q ss_pred CCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 144 ECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 144 ~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
. +|+-+|+++.|..= -+|+|||.+
T Consensus 183 ~---gI~~~Dv~~~ny~~-----G~lvDfs~~ 206 (207)
T PF13095_consen 183 L---GIVPRDVKPRNYRG-----GKLVDFSSS 206 (207)
T ss_pred C---CeeeccCccccccC-----CEEEecccC
Confidence 6 99999999999883 388999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0011 Score=50.22 Aligned_cols=141 Identities=18% Similarity=0.217 Sum_probs=77.0
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCc--eeeeece------EEeCCeEEEEEecc
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN--LVRLLGY------SLEVSKKILVYEYM 106 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e~~ 106 (183)
.+..|....+|+....++ .+.+|..... ....+..|+.++..+.+.. +++++.. ....+..+.+++++
T Consensus 21 ~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 21 GISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred cccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 456676677888765443 5777776531 2234556777776664322 3333221 12345678999999
Q ss_pred CCCCHHH-----------HHh---cC--C--C------CCChHHHH----------HHHHHHHHHHHHhhh----CCCCC
Q 048219 107 SNGSLAD-----------ILF---NA--E--K------QPNWIERT----------GIARDIARGILYLHD----ECETQ 148 (183)
Q Consensus 107 ~~~~l~~-----------~l~---~~--~--~------~~~~~~~~----------~i~~~i~~~l~~lh~----~~~~~ 148 (183)
+|.++.. .+. .. . . ...+.... .....+..++.++.. ..+.+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 8765421 110 00 0 0 00111000 000112223333332 12347
Q ss_pred ceecCCCCCCEEecCCCcccccceecccccc
Q 048219 149 IIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 149 i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|+|+.|.|++++.++...++||+.|..+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g~ 207 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACTDA 207 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcCch
Confidence 9999999999999987777899999988664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0017 Score=50.63 Aligned_cols=139 Identities=12% Similarity=0.124 Sum_probs=87.1
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchh------------------------h--HHHHHHHHHHHHHhhcCCCcee
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL------------------------D--EREREFQTEIKVIGRTHHRNLV 87 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~------------------------~--~~~~~~~~e~~~l~~l~h~~i~ 87 (183)
..|..|.-.-||.|...+|..+|||+.+... + ......-.|++.|.++....|+
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3577777778999998888889998875311 0 0011234577788887766655
Q ss_pred eeeceEEeCCeEEEEEeccCCCCHH--HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 88 RLLGYSLEVSKKILVYEYMSNGSLA--DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~l~--~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
.+.-... ....|||+++. .+-+ ..+. ...+....+..+-.+++.-+..|... +++||.||+-=|+|+. +|
T Consensus 230 ~PePIlL--k~hVLVM~FlG-rdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLG-RDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCceee--ecceEeeeecc-CCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-CC
Confidence 4333322 23468999984 2221 1221 12333334444446666667777665 4999999999999985 46
Q ss_pred cccccceeccccccc
Q 048219 166 CAKNFRLWIGKVDEA 180 (183)
Q Consensus 166 ~~~i~dfg~a~~~~~ 180 (183)
.+-++|.+-+...+.
T Consensus 302 ~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEEccccccCCC
Confidence 678888887765543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0018 Score=48.66 Aligned_cols=34 Identities=26% Similarity=0.417 Sum_probs=28.5
Q ss_pred CceecCCCCCCEEecCCCc-ccccceecccccccc
Q 048219 148 QIIHCDIKPQNILMDENRC-AKNFRLWIGKVDEAR 181 (183)
Q Consensus 148 ~i~H~dl~~~nil~~~~~~-~~i~dfg~a~~~~~~ 181 (183)
.++|+|+.+.|++++.++. .-|+||+.|.+++..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDPa 220 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDPA 220 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCHH
Confidence 5799999999999997554 469999999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0033 Score=48.14 Aligned_cols=37 Identities=19% Similarity=0.406 Sum_probs=32.8
Q ss_pred CCceecCCCCCCEEecCCCcccccceecccccccccC
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEARSD 183 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~~~~ 183 (183)
..++|+|+.+.|++++..+-+-++||+++.+++...|
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~D 234 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLED 234 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHH
Confidence 5689999999999999998899999999999876543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0017 Score=49.82 Aligned_cols=130 Identities=13% Similarity=0.136 Sum_probs=82.5
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEcc--c--------------------hhhHHHHHHHHHHHHHhhcC-CCc-
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLE--K--------------------VLDEREREFQTEIKVIGRTH-HRN- 85 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~--~--------------------~~~~~~~~~~~e~~~l~~l~-h~~- 85 (183)
+.+..+||-|.-+-+|.+-+..|...++|.=. + |..-..-.+..|...|..+. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 44556899999999999988777666555311 0 00111123567888888874 332
Q ss_pred eeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
+++.+ +-+..++|||++.|-++.+.-. ..+...++ ..+..-+--|-.+ |++|+|..-=||++++++
T Consensus 174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly---~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPI----DHNRHCVVMELVDGYPLRQVRH----VEDPPTLY---DDLMGLIVRLANH---GLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCcc----cccceeeHHHhhcccceeeeee----cCChHHHH---HHHHHHHHHHHHc---CceecccchheeEEecCC
Confidence 33333 4467889999998877765432 12233332 1222222233333 999999999999999999
Q ss_pred ccccccee
Q 048219 166 CAKNFRLW 173 (183)
Q Consensus 166 ~~~i~dfg 173 (183)
.++++||=
T Consensus 240 ~i~vIDFP 247 (465)
T KOG2268|consen 240 KIVVIDFP 247 (465)
T ss_pred CEEEeech
Confidence 99999994
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.019 Score=44.60 Aligned_cols=33 Identities=21% Similarity=0.283 Sum_probs=28.1
Q ss_pred CCceecCCCCCCEEecC-CCcccccceecccccc
Q 048219 147 TQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~~ 179 (183)
..++|+|+++.||++++ ++.+.++||..|....
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 46799999999999986 4689999999887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0012 Score=57.15 Aligned_cols=93 Identities=22% Similarity=0.186 Sum_probs=70.6
Q ss_pred CCCceeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe
Q 048219 82 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM 161 (183)
Q Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~ 161 (183)
.+|.+++.+..+....+.+++++++.++++...+...+..-.+..+. +...+.+++++||.. .+.|+|++|.|.+.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs-~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARS-PILERVQSLESLHSS---LRKHRDLKPDSLLI 937 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccc-hhHHHHhhhhccccc---hhhcccccccchhh
Confidence 45666665555556678899999999999999887655332233333 445678899999986 68999999999999
Q ss_pred cCCCccccccee-ccccc
Q 048219 162 DENRCAKNFRLW-IGKVD 178 (183)
Q Consensus 162 ~~~~~~~i~dfg-~a~~~ 178 (183)
..++..++.||| +.+++
T Consensus 938 ~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cccCCcccCccccccccc
Confidence 999999999999 44444
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.052 Score=42.44 Aligned_cols=72 Identities=15% Similarity=0.140 Sum_probs=45.1
Q ss_pred ccCcCcCceEEEEEEcCC-cEEEEEEccchh-------hHHHHHHHHHHHHHhhcC--CC-ceeeeeceEEeCCeEEEEE
Q 048219 35 KVGRGSSGTVYKGAMINR-QLVAVNRLEKVL-------DEREREFQTEIKVIGRTH--HR-NLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~-~~~~ik~~~~~~-------~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 103 (183)
.+|.|....||++....+ +.+.+|+-..-. +-...+..-|.+.|.... -| .+++++ +.++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 479999999999987643 567787743211 122345566777776543 23 344443 34566667899
Q ss_pred eccCC
Q 048219 104 EYMSN 108 (183)
Q Consensus 104 e~~~~ 108 (183)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.02 Score=41.75 Aligned_cols=85 Identities=19% Similarity=0.249 Sum_probs=53.2
Q ss_pred HHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCc
Q 048219 70 EFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149 (183)
Q Consensus 70 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 149 (183)
-+.++.+++.++. .|+++..- ..-.+.++.|.|-.... . .. .++.-=+.+|.-.|+. ..+.
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~-~~---N~i~agi~~L~~fH~~-~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------N-FS---NFITAGIKDLMDFHSE-NQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------c-hh---HHHHHhHHHHHHhhcc-CCCe
Confidence 3456677776553 35666533 33456788888843211 0 00 1111113456667854 2489
Q ss_pred eecCCCCCCEEecCCCccccccee
Q 048219 150 IHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 150 ~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
+|+|..|+||+-|..|.+|+.|=+
T Consensus 165 lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred ecCCCChhheeecCCCCEEecChh
Confidence 999999999999999999998843
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.045 Score=41.52 Aligned_cols=71 Identities=13% Similarity=0.164 Sum_probs=40.3
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhc---CCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRT---HHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.++.|.-..+|... .+++.+.+|.-.... ...+..|.+-|+.+ ....+++++++....+..++++||++.+
T Consensus 24 ~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 24 PVSGGDINEAYRLD-TDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EE--SSSSEEEEEE-TTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred ecCCCChhheEEEE-CCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 56777777777755 566778888765322 22355566666666 3345778888877777779999998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0098 Score=45.14 Aligned_cols=35 Identities=14% Similarity=0.100 Sum_probs=30.0
Q ss_pred CCCceecCCCCCCEEecCC----Ccccccceeccccccc
Q 048219 146 ETQIIHCDIKPQNILMDEN----RCAKNFRLWIGKVDEA 180 (183)
Q Consensus 146 ~~~i~H~dl~~~nil~~~~----~~~~i~dfg~a~~~~~ 180 (183)
+..++|+|+.+.||+++.+ +.+.++||..|.....
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p 216 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYR 216 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCc
Confidence 4578999999999999974 7899999999987643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.018 Score=45.03 Aligned_cols=72 Identities=13% Similarity=0.092 Sum_probs=46.3
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 97 SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
...|++|++- |+++.. + +.-.+.....++-+....+.-+.. ..++-|||+.-.||+++ +|++.|+||.+|+
T Consensus 299 ~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeee
Confidence 3456777754 444422 1 122344445554443333333333 35889999999999999 9999999999998
Q ss_pred c
Q 048219 177 V 177 (183)
Q Consensus 177 ~ 177 (183)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 3
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.0015 Score=53.88 Aligned_cols=131 Identities=18% Similarity=0.086 Sum_probs=83.4
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCc-eeeeeceEEeCCeEEEEEeccCCC-CHH
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN-LVRLLGYSLEVSKKILVYEYMSNG-SLA 112 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~l~ 112 (183)
..++++++.+++++....+....+.+... ....-++++|.+++||| .+..++.+..+...++.++++.++ +..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 45778888899887655555555555432 33455789999999999 667777777788889999998765 111
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.........+.......+...-..+++++|+. .=+|+| ||+..+ +..+..||+.+.-.
T Consensus 324 ~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 324 LEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred ccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCccc
Confidence 11101111122223333455556788899874 447777 665544 66788888877644
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.31 Score=38.88 Aligned_cols=72 Identities=10% Similarity=0.142 Sum_probs=43.5
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchh-------hHHHHHHHHHHHHHhhcC---CCceeeeeceEEeCCeEEEEE
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-------DEREREFQTEIKVIGRTH---HRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+.+|.|....||+.... +..+.+|+-.... +....+...|...|+... ...+++++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 36788999999987764 4457777643110 112333444566665442 245667766654 5567889
Q ss_pred eccCC
Q 048219 104 EYMSN 108 (183)
Q Consensus 104 e~~~~ 108 (183)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99965
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.005 Score=43.49 Aligned_cols=32 Identities=9% Similarity=0.130 Sum_probs=27.8
Q ss_pred CceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 148 QIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 148 ~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
..+|+|+.|.|+++.+++ ++++||+-|..++.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp 109 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGDI 109 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCCCH
Confidence 568999999999998777 88999999987764
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.006 Score=43.46 Aligned_cols=33 Identities=12% Similarity=0.166 Sum_probs=28.2
Q ss_pred CceecCCCCCCEEecCCC-----cccccceeccccccc
Q 048219 148 QIIHCDIKPQNILMDENR-----CAKNFRLWIGKVDEA 180 (183)
Q Consensus 148 ~i~H~dl~~~nil~~~~~-----~~~i~dfg~a~~~~~ 180 (183)
.++|+|+.+.|+++..++ .+.++||..++.+..
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g~p 158 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYGSP 158 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCcCCh
Confidence 689999999999998543 588999999998764
|
subfamily of choline kinases |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.0082 Score=45.76 Aligned_cols=34 Identities=24% Similarity=0.486 Sum_probs=29.1
Q ss_pred CCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 146 ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 146 ~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+.+++|+|+.+.|++++.++...++||+.+....
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~~ 219 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACTDA 219 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccCcc
Confidence 3589999999999999988767899999986553
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.3 Score=35.97 Aligned_cols=58 Identities=17% Similarity=0.244 Sum_probs=37.6
Q ss_pred CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCC---CceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 51 NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH---RNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 51 ~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
...++.+|.-.+ .....+..|+.-|..+.- ..+.+++.+-...++.|+|+||++-+.+
T Consensus 38 g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 38 GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 355677776443 233456667776665543 3456666666678899999999986443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.013 Score=42.14 Aligned_cols=32 Identities=22% Similarity=0.320 Sum_probs=22.2
Q ss_pred CCceecCCCCCCEEe-cCCCcccccceeccccc
Q 048219 147 TQIIHCDIKPQNILM-DENRCAKNFRLWIGKVD 178 (183)
Q Consensus 147 ~~i~H~dl~~~nil~-~~~~~~~i~dfg~a~~~ 178 (183)
..++|+|+.+.||++ +.++.++++||--|...
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n 175 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGYN 175 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EEE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhhc
Confidence 367999999999999 78899999999887653
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.011 Score=45.08 Aligned_cols=35 Identities=17% Similarity=0.223 Sum_probs=30.6
Q ss_pred CCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 146 ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 146 ~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
+.++||+|+.+.|++++.++.+.++||..|.....
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~~ 229 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASFASP 229 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcccCCc
Confidence 34799999999999999988899999999887643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.089 Score=40.69 Aligned_cols=30 Identities=27% Similarity=0.405 Sum_probs=26.9
Q ss_pred ceecCCCCCCEEecCCCc-ccccceeccccc
Q 048219 149 IIHCDIKPQNILMDENRC-AKNFRLWIGKVD 178 (183)
Q Consensus 149 i~H~dl~~~nil~~~~~~-~~i~dfg~a~~~ 178 (183)
+||+|+.+.|++++.+.. ..++||+-|..+
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~~ 229 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGYG 229 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccccc
Confidence 899999999999998875 889999988754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.021 Score=43.49 Aligned_cols=31 Identities=19% Similarity=0.191 Sum_probs=26.7
Q ss_pred CCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++|+|+.+.|++++. +.+.++||+.+...
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~~ 217 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTID 217 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccccC
Confidence 47899999999999987 66789999977654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.032 Score=46.53 Aligned_cols=44 Identities=23% Similarity=0.422 Sum_probs=38.3
Q ss_pred HHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 133 DIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 133 ~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++..|+.|+|... ++||+++.|++|.++..+..||+.|+.+..-
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~ 150 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNA 150 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhcc
Confidence 4458999999863 9999999999999999999999999887643
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.12 Score=38.89 Aligned_cols=32 Identities=16% Similarity=0.225 Sum_probs=28.7
Q ss_pred CceecCCCCCCEEecCCCcccccceecccccc
Q 048219 148 QIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 148 ~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
-+||+|+.+.|++.++.+.+.++||-=|...+
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~D 185 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGLND 185 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCCcc
Confidence 48999999999999999999999998877654
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.027 Score=42.57 Aligned_cols=33 Identities=15% Similarity=0.177 Sum_probs=28.0
Q ss_pred CceecCCCCCCEEecCC--C---cccccceeccccccc
Q 048219 148 QIIHCDIKPQNILMDEN--R---CAKNFRLWIGKVDEA 180 (183)
Q Consensus 148 ~i~H~dl~~~nil~~~~--~---~~~i~dfg~a~~~~~ 180 (183)
-++|+|+.+.||++..+ + .++++||..++.+..
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g~p 253 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYGSP 253 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccCCCc
Confidence 57999999999999765 2 589999999998754
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.81 E-value=0.04 Score=42.48 Aligned_cols=32 Identities=25% Similarity=0.235 Sum_probs=26.5
Q ss_pred CCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
.+++|+|+.+.|++++ + .+.++||+-+..+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g~~ 227 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARMGPA 227 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCCCCH
Confidence 4689999999999995 3 578999999886643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.2 Score=44.73 Aligned_cols=33 Identities=24% Similarity=0.223 Sum_probs=26.6
Q ss_pred CCCceecCCCCCCEEecCCC--ccc-ccceeccccc
Q 048219 146 ETQIIHCDIKPQNILMDENR--CAK-NFRLWIGKVD 178 (183)
Q Consensus 146 ~~~i~H~dl~~~nil~~~~~--~~~-i~dfg~a~~~ 178 (183)
+..++|+|+.+.||+++.++ .+. |+|||-+...
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 34799999999999999774 444 8999987643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.56 E-value=0.9 Score=36.01 Aligned_cols=31 Identities=16% Similarity=0.022 Sum_probs=24.9
Q ss_pred CCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
..++|.|+-+.||+.++ +.+.++||--|...
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~n 257 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGFN 257 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccCC
Confidence 46799999999998754 45899999877643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.92 E-value=0.1 Score=40.32 Aligned_cols=32 Identities=16% Similarity=0.184 Sum_probs=26.9
Q ss_pred CceecCCCCCCEEecC-CCcccccceecccccc
Q 048219 148 QIIHCDIKPQNILMDE-NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 148 ~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~~ 179 (183)
-++|+|+.+.||++++ ++.++++||.-|....
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 4799999999999975 4789999999887543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.23 E-value=0.41 Score=38.43 Aligned_cols=70 Identities=14% Similarity=0.176 Sum_probs=51.6
Q ss_pred EEEEEeccCCC-CHHHHHhc---CC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccc
Q 048219 99 KILVYEYMSNG-SLADILFN---AE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFR 171 (183)
Q Consensus 99 ~~lv~e~~~~~-~l~~~l~~---~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~d 171 (183)
+.+.|..+++- .+..+..- .+ -...|...+.....++.+..-+|.+ |.+-+|+.++|+|+++.+.+.+.|
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 56777777653 22222211 11 2246777788899999999999998 888999999999999988888775
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.23 E-value=0.42 Score=42.50 Aligned_cols=32 Identities=16% Similarity=0.059 Sum_probs=25.5
Q ss_pred CCCceecCCCCCCEEecCCC--c---ccccceecccc
Q 048219 146 ETQIIHCDIKPQNILMDENR--C---AKNFRLWIGKV 177 (183)
Q Consensus 146 ~~~i~H~dl~~~nil~~~~~--~---~~i~dfg~a~~ 177 (183)
+.+++|+|+++.||+++.+. . .-++|||.+..
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 45899999999999998653 3 36899998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 183 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-23 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 183 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-61 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-59 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 9e-58 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-41 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-40 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-39 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-39 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 9e-39 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-38 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-37 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-37 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-36 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-35 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-34 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-32 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-32 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-31 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-25 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-25 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-24 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-24 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-23 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-23 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-23 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-23 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-23 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-23 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-23 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-23 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 9e-23 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-22 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-22 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-22 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-22 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-22 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-22 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-22 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-22 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-22 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-22 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-22 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-21 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-21 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-21 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-21 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-21 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-21 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-21 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-21 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-21 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-21 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-20 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-20 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-20 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-20 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-20 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-20 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-20 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-20 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-20 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-20 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-20 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-20 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-20 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-20 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-19 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-19 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-19 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-19 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-19 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-19 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-19 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-19 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-19 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-19 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-19 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-19 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-19 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-19 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 8e-19 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-18 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-18 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-18 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-18 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-18 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-18 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-18 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-18 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 8e-18 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-17 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-17 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-17 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-17 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-16 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-16 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-16 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-16 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-16 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-16 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 7e-16 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-16 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-15 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-15 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-15 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-15 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-15 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-15 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-15 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-15 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 6e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 6e-15 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 7e-15 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 8e-15 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-14 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-14 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-14 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-14 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-14 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-14 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-14 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-14 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 7e-14 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 8e-14 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 9e-14 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-13 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-13 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-13 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-13 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-13 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-13 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-13 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-13 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-13 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-13 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-13 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-12 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-12 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-12 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-12 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-12 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-12 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-12 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-12 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-12 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-12 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-12 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-12 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-12 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-12 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-12 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-12 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-12 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-12 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-12 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 8e-12 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 9e-12 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 9e-12 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-11 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-11 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-11 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-10 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-10 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-10 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-10 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-10 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-10 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-10 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-09 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-09 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-09 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-09 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 7e-09 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-08 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-08 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-08 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-08 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-08 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-08 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 7e-08 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 7e-08 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 9e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-07 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-07 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-07 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-07 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-07 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-07 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-07 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-07 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-06 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-06 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-06 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-05 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-05 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 2e-05 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-05 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-05 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-05 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-05 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-05 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-05 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-04 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 6e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-61
Identities = 67/160 (41%), Positives = 93/160 (58%), Gaps = 14/160 (8%)
Query: 19 SFSYAELKKITDGFKE--KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE-----REREF 71
FS EL+ +D F +GRG G VYKG + + LVAV K L E E +F
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAV----KRLKEERTQGGELQF 74
Query: 72 QTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP---NWIERT 128
QTE+++I HRNL+RL G+ + ++++LVY YM+NGS+A L + +W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 129 GIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
IA ARG+ YLHD C+ +IIH D+K NIL+DE A
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-59
Identities = 69/164 (42%), Positives = 90/164 (54%), Gaps = 18/164 (10%)
Query: 19 SFSYAELKKITDGFKE--------KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDER--- 67
SFS+ ELK +T+ F E K+G G G VYKG +N VAV +L ++D
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEE 72
Query: 68 -EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP--NW 124
+++F EIKV+ + H NLV LLG+S + LVY YM NGSL D L + P +W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 125 IERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
R IA+ A GI +LH+ IH DIK NIL+DE AK
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAK 173
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 9e-58
Identities = 57/165 (34%), Positives = 87/165 (52%), Gaps = 8/165 (4%)
Query: 9 SNYSTLTTPFSFSYAELKKITDGFKEK--VGRGSSGTVYKGAMINRQLVAVNRLEKVLDE 66
S+Y + +L++ T+ F K +G G G VYKG + + VA+ R +
Sbjct: 18 SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77
Query: 67 REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP---N 123
EF+TEI+ + H +LV L+G+ E ++ IL+Y+YM NG+L L+ ++ +
Sbjct: 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 124 WIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
W +R I ARG+ YLH IIH D+K NIL+DEN K
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-41
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 23/170 (13%)
Query: 15 TTPFSFSYAELKKITDGFK--EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERER--- 69
++ L + + E RG G V+K + + VAV K+ +++
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKA-QLLNEYVAV----KIFPIQDKQSW 63
Query: 70 EFQTEIKVIGRTHHRNLVRLLGYSLEVSK----KILVYEYMSNGSLADILFNAEKQPNWI 125
+ + E+ + H N+++ +G + L+ + GSL+D L +W
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWN 121
Query: 126 ERTGIARDIARGILYLHDECETQ-------IIHCDIKPQNILMDENRCAK 168
E IA +ARG+ YLH++ I H DIK +N+L+ N A
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-40
Identities = 47/141 (33%), Positives = 74/141 (52%), Gaps = 6/141 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVRL 89
KEK+G GS GTV++ + VAV L + ER EF E+ ++ R H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECET 147
+G + +V EY+S GSL +L + +Q + R +A D+A+G+ YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158
Query: 148 QIIHCDIKPQNILMDENRCAK 168
I+H ++K N+L+D+ K
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVK 179
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-39
Identities = 45/150 (30%), Positives = 63/150 (42%), Gaps = 7/150 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE----REREFQTEIKVIGRTHHRNLV 87
+E +G G G VY+ VAV DE + E K+ H N++
Sbjct: 11 LEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
L G L+ LV E+ G L +L + K+ A IARG+ YLHDE
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 148 QIIHCDIKPQNILMDENRCAKNFRLWIGKV 177
IIH D+K NIL+ + + I K+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKI 157
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-39
Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINR-QLVAVNRL-------EKVLDEREREFQTEIKVIGRTHH 83
+++++G+G G V+KG ++ +VA+ L E + E+ +EFQ E+ ++ +H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
N+V+L G +V E++ G L L + W + + DIA GI Y+ +
Sbjct: 83 PNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 144 ECETQIIHCDIKPQNILMDENRCAKNFRL 172
I+H D++ NI +
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCA 168
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-39
Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 4/138 (2%)
Query: 32 FKEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
E +G+G G K +++ + L + +E +R F E+KV+ H N+++ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
G + + + EY+ G+L I+ + + Q W +R A+DIA G+ YLH II
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 151 HCDIKPQNILMDENRCAK 168
H D+ N L+ EN+
Sbjct: 131 HRDLNSHNCLVRENKNVV 148
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-38
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 22 YAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRT 81
Y E++ +E VGRG+ G V K + VA+ ++E + + F E++ + R
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRV 58
Query: 82 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP--NWIERTGIARDIARGIL 139
+H N+V+L G L LV EY GSL ++L AE P ++G+
Sbjct: 59 NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 140 YLHDECETQIIHCDIKPQNILMDEN-RCAK 168
YLH +IH D+KP N+L+ K
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-37
Identities = 33/142 (23%), Positives = 60/142 (42%), Gaps = 7/142 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVRL 89
F K+ SG ++KG + V L + R+F E + H N++ +
Sbjct: 14 FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 90 LGYSLE--VSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECE 146
LG L+ +M GSL ++L + + A D+ARG+ +LH E
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LE 131
Query: 147 TQIIHCDIKPQNILMDENRCAK 168
I + +++++DE+ A+
Sbjct: 132 PLIPRHALNSRSVMIDEDMTAR 153
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-37
Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 20 FSYAELKKITDGFK--EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERER-EFQTEIK 76
+ +E D K E +GRG G VYKG++ + + VAV KV R F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAV----KVFSFANRQNFINEKN 57
Query: 77 V--IGRTHHRNLVRLLGYSLEVS-----KKILVYEYMSNGSLADILFNAEKQPNWIERTG 129
+ + H N+ R + V+ + +LV EY NGSL L +W+
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCR 115
Query: 130 IARDIARGILYLHDE------CETQIIHCDIKPQNILMDENRCAK 168
+A + RG+ YLH E + I H D+ +N+L+ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-36
Identities = 32/137 (23%), Positives = 66/137 (48%), Gaps = 7/137 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVRL 89
E +G+G G VY G VA+ + E+ +++ + F+ E+ +T H N+V
Sbjct: 37 IGELIGKGRFGQVYHG--RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
+G + ++ +L ++ +A+ + + IA++I +G+ YLH + I
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 150 IHCDIKPQNILMDENRC 166
+H D+K +N+ D +
Sbjct: 152 LHKDLKSKNVFYDNGKV 168
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-34
Identities = 46/139 (33%), Positives = 69/139 (49%), Gaps = 8/139 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVRL 89
+++G GS GTVYKG VAV L ++ + F+ E+ V+ +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
+GYS I V ++ SL L +E + + IAR ARG+ YLH + I
Sbjct: 86 MGYSTAPQLAI-VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 150 IHCDIKPQNILMDENRCAK 168
IH D+K NI + E+ K
Sbjct: 142 IHRDLKSNNIFLHEDNTVK 160
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-32
Identities = 38/149 (25%), Positives = 61/149 (40%), Gaps = 19/149 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERERE---FQTEIKVIGRTHHRNLVR 88
E VG+G G V++G+ + VAV K+ R+ + +TE+ H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQG-ENVAV----KIFSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 89 LLGYSLEVSKKI----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
+ + L+ Y GSL D L + + I IA G+ +LH E
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 145 CETQ-----IIHCDIKPQNILMDENRCAK 168
I H D+K +NIL+ +N
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCC 153
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-32
Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 19/149 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVR 88
+++G+G G V+ G + VAV KV +E +TEI H N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWRG-EKVAV----KVFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 89 LLGYSLEVSKKI----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
+ ++ + L+ +Y NGSL D L + + +A G+ +LH E
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 145 CETQ-----IIHCDIKPQNILMDENRCAK 168
+ I H D+K +NIL+ +N
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCC 182
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-31
Identities = 38/149 (25%), Positives = 60/149 (40%), Gaps = 19/149 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERERE---FQTEIKVIGRTHHRNLVR 88
+E +G+G G V++G + VAV K+ RE + EI H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAV----KIFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 89 LLGYSLEVSKKI----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
+ + + LV +Y +GSL D L +A A G+ +LH E
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 145 CETQ-----IIHCDIKPQNILMDENRCAK 168
I H D+K +NIL+ +N
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCC 187
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-27
Identities = 40/142 (28%), Positives = 61/142 (42%), Gaps = 13/142 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMINR---QLVAVN--RLEKVLDEREREFQTEIKVIGRTHHRNL 86
F ++GRGS TVYKG ++ VA + K+ + F+ E +++ H N+
Sbjct: 30 FDIEIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 87 VRLLGYSLEVSKK----ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
VR K +LV E M++G+L L K R I +G+ +LH
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 143 DECETQIIHCDIKPQNILMDEN 164
IIH D+K NI +
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGP 167
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-25
Identities = 32/136 (23%), Positives = 60/136 (44%), Gaps = 6/136 (4%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
K+G GS+G V + + VAV ++ +R E+ ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L + ++ E++ G+L DI+ I + + + + YLH + +IH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI--ATVCEAVLQALAYLHAQ---GVIHR 165
Query: 153 DIKPQNILMDENRCAK 168
DIK +IL+ + K
Sbjct: 166 DIKSDSILLTLDGRVK 181
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-25
Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 6/136 (4%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
EK+G+G+SGTVY + Q VA+ ++ ++ EI V+ + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L + +V EY++ GSL D++ I + R+ + + +LH Q+IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSN---QVIHR 140
Query: 153 DIKPQNILMDENRCAK 168
DIK NIL+ + K
Sbjct: 141 DIKSDNILLGMDGSVK 156
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-24
Identities = 32/136 (23%), Positives = 62/136 (45%), Gaps = 4/136 (2%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
++G G+ G VYK L A +E +E ++ EI+++ H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
K ++ E+ G++ I+ ++ + + R + + +LH + +IIH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHR 141
Query: 153 DIKPQNILMDENRCAK 168
D+K N+LM +
Sbjct: 142 DLKAGNVLMTLEGDIR 157
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-24
Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 33 KEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
+ +G+G+ G VY G + +A+ + + + EI + H+N+V+
Sbjct: 27 RVVLGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT--GIARDIARGILYLHDECET 147
LG E + E + GSL+ +L + E+T + I G+ YLHD
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 148 QIIHCDIKPQNILMD 162
QI+H DIK N+L++
Sbjct: 142 QIVHRDIKGDNVLIN 156
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-23
Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 14/141 (9%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNR--LEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
E +G G++ V ++ VA+ R LEK + E EI+ + + HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYY 79
Query: 91 GYSLEVSKKILVYEYMSNGSLADIL----FNAEKQPNWIERTGIA---RDIARGILYLHD 143
+ + LV + +S GS+ DI+ E + ++ + IA R++ G+ YLH
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 144 ECETQIIHCDIKPQNILMDEN 164
IH D+K NIL+ E+
Sbjct: 140 N---GQIHRDVKAGNILLGED 157
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-23
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 4/154 (2%)
Query: 15 TTPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTE 74
T + E+ F +++G G G V G + VA+ + K E EF E
Sbjct: 11 TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEE 69
Query: 75 IKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDI 134
KV+ H LV+L G + ++ EYM+NG L + L + + + +D+
Sbjct: 70 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ YL + Q +H D+ +N L+++ K
Sbjct: 130 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVK 160
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-23
Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 5/139 (3%)
Query: 32 FKEKVGRGSSGTVYKGAM-INRQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHRNLVRL 89
E++GRG+ G V+ G + + LVAV E + + + +F E +++ + H N+VRL
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
+G + +V E + G L + + D A G+ YL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 150 IHCDIKPQNILMDENRCAK 168
IH D+ +N L+ E K
Sbjct: 235 IHRDLAARNCLVTEKNVLK 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-23
Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 4/137 (2%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
F +++G G G V+ G +N+ VA+ + + E +F E +V+ + H LV+L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
LE + LV E+M +G L+D L G+ D+ G+ YL + +IH
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 127
Query: 152 CDIKPQNILMDENRCAK 168
D+ +N L+ EN+ K
Sbjct: 128 RDLAARNCLVGENQVIK 144
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-23
Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMINR----QLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNL 86
F E +GRG G VY G +++ AV L ++ D E +F TE ++ H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 87 VRLLGYSLEVSKKIL-VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ LLG L L V YM +G L + + N P + G +A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--- 145
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+ +H D+ +N ++DE K
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVK 168
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-23
Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 4/137 (2%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+++G G G V G + VAV + K E EF E + + + H LV+ G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
+ +V EY+SNG L + L + K + + D+ G+ +L Q IH
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 152 CDIKPQNILMDENRCAK 168
D+ +N L+D + C K
Sbjct: 128 RDLAARNCLVDRDLCVK 144
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-23
Identities = 48/137 (35%), Positives = 77/137 (56%), Gaps = 15/137 (10%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNR--LEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
EK+G+GS G V+KG +++VA+ LE+ DE E + Q EI V+ + + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYY 86
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDECET 147
G L+ +K ++ EY+ GS D+L +P ++ T IA R+I +G+ YLH E
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE--- 138
Query: 148 QIIHCDIKPQNILMDEN 164
+ IH DIK N+L+ E+
Sbjct: 139 KKIHRDIKAANVLLSEH 155
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-23
Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
EK+G GS G+VYK Q+VA+ ++ ++ +E EI ++ + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
+ + +V EY GS++DI+ K E I + +G+ YLH + IH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHR 149
Query: 153 DIKPQNILMDENRCAK 168
DIK NIL++ AK
Sbjct: 150 DIKAGNILLNTEGHAK 165
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-23
Identities = 30/135 (22%), Positives = 51/135 (37%), Gaps = 14/135 (10%)
Query: 33 KEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
+ +VGRGS G V++ ++ AV K + + E+ +V L
Sbjct: 63 QPRVGRGSFGEVHRM--KDKQTGFQCAV----KKVRLEVFRVE-ELVACAGLSSPRIVPL 115
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
G E + E + GSL ++ P G+ YLH +I
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY-YLGQALEGLEYLHTR---RI 171
Query: 150 IHCDIKPQNILMDEN 164
+H D+K N+L+ +
Sbjct: 172 LHGDVKADNVLLSSD 186
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-22
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 14/158 (8%)
Query: 34 EKVGRGSSGTVYKGAMINR---QLVAVNRLEK-VLDEREREFQ-TEIKVIGR-THHRNLV 87
EK+G G G+V+K + R + A+ R +K + + + E+ H ++V
Sbjct: 17 EKIGSGEFGSVFKC--VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDE 144
R E ++ EY + GSLAD + + ++ + + + RG+ Y+H
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 145 CETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEARS 182
++H DIKP NI + + D A +
Sbjct: 135 ---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-22
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMINR----QLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNL 86
F E +GRG G VY G +++ AV L ++ D E +F TE ++ H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 87 VRLLGYSLEVSKKIL-VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ LLG L L V YM +G L + + N P + G +A+G+ +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--- 209
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+ +H D+ +N ++DE K
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVK 232
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-22
Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 9/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRN 85
++ +G G G VYKG + VA+ L+ E++R +F E ++G+ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
++RL G + +++ EYM NG+L L + + + ++ G+ R IA G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--- 164
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+H D+ +NIL++ N K
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCK 187
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-22
Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNL 86
++ +G G SG V G + VA+ L+ ER+R +F +E ++G+ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
+RL G ++V EYM NGSL L + Q ++ G+ R + G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---D 169
Query: 147 TQIIHCDIKPQNILMDENRCAK 168
+H D+ +N+L+D N K
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCK 191
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-22
Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 10/144 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNL 86
F +++G+G+ G+V ++VAV +L+ +E R+F+ EI+++ H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 87 VRLLGYSLEVSKK--ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
V+ G ++ L+ EY+ GSL D L +++ + I+ I +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
+ IH D+ +NIL++ K
Sbjct: 132 -TKRYIHRDLATRNILVENENRVK 154
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-22
Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 8/142 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNL 86
+ VG G G V G + VA+ L+ E++R +F E ++G+ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
+RL G + ++V EYM NGSL L + Q I+ G+ R IA G+ YL D
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 147 TQIIHCDIKPQNILMDENRCAK 168
+H D+ +NIL++ N K
Sbjct: 167 -GYVHRDLAARNILINSNLVCK 187
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-22
Identities = 33/145 (22%), Positives = 61/145 (42%), Gaps = 11/145 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHRN 85
+G G G V + VAV L + + + EI+++ +H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 86 LVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
+V+ G E L+ E++ +GSL + L + + N ++ A I +G+ YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG- 143
Query: 144 ECETQIIHCDIKPQNILMDENRCAK 168
Q +H D+ +N+L++ K
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVK 166
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-22
Identities = 36/144 (25%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNL 86
+ ++G+G+ G+V LVAV +L+ +++R+FQ EI+++ H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 87 VRLLGYSLEVSKK--ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
V+ G S ++ LV EY+ +G L D L + + + I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-- 144
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
+ +H D+ +NIL++ K
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVK 167
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-22
Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 10/144 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNL 86
F +++G+G+ G+V ++VAV +L+ +E R+F+ EI+++ H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 87 VRLLGYSLEVSKK--ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
V+ G ++ L+ EY+ GSL D L +++ + I+ I +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
+ IH D+ +NIL++ K
Sbjct: 163 -TKRYIHRDLATRNILVENENRVK 185
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 5e-22
Identities = 29/139 (20%), Positives = 56/139 (40%), Gaps = 13/139 (9%)
Query: 34 EKVGRGSS--GTVYKGAMI-NRQLVAVNR--LEKVLDEREREFQTEIKVIGRTHHRNLVR 88
+G+G TV + V V R LE +E Q E+ V +H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIA---RDIARGILYLHDEC 145
+ ++ +V +M+ GS D++ + + IA + + + + Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 146 ETQIIHCDIKPQNILMDEN 164
+H +K +IL+ +
Sbjct: 148 --GYVHRSVKASHILISVD 164
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-22
Identities = 50/145 (34%), Positives = 75/145 (51%), Gaps = 23/145 (15%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVR 88
E VG G+ G VYKG + QL A+ KV+D + E E + EI ++ + HHRN+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAI----KVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 89 LLGYSLEVSKKI------LVYEYMSNGSLADILFNAEKQP---NWIERTGIARDIARGIL 139
G ++ + LV E+ GS+ D++ N + WI I R+I RG+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLS 143
Query: 140 YLHDECETQIIHCDIKPQNILMDEN 164
+LH ++IH DIK QN+L+ EN
Sbjct: 144 HLHQH---KVIHRDIKGQNVLLTEN 165
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-21
Identities = 40/141 (28%), Positives = 63/141 (44%), Gaps = 12/141 (8%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRL 89
+ +G+G G V G VAV K + D + F E V+ + H NLV+L
Sbjct: 197 LLQTIGKGEFGDVMLG-DYRGNKVAV----KCIKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 90 LGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECET 147
LG +E + +V EYM+ GSL D L + + + D+ + YL
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 308
Query: 148 QIIHCDIKPQNILMDENRCAK 168
+H D+ +N+L+ E+ AK
Sbjct: 309 NFVHRDLAARNVLVSEDNVAK 329
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-21
Identities = 35/155 (22%), Positives = 64/155 (41%), Gaps = 18/155 (11%)
Query: 18 FSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERERE-FQT 73
+L+ I ++GRG+ G V K M + Q++AV R+ ++ +E++
Sbjct: 2 MEVKADDLEPI-----MELGRGAYGVVEK--MRHVPSGQIMAVKRIRATVNSQEQKRLLM 54
Query: 74 EIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT---G 129
++ + RT V G + E M + SL + I
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK 113
Query: 130 IARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
IA I + + +LH + +IH D+KP N+L++
Sbjct: 114 IAVSIVKALEHLHSK--LSVIHRDVKPSNVLINAL 146
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-21
Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 10/140 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
E++G G G V+ G VAV L K F E ++ + H+ LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 92 YSLEVSKK--ILVYEYMSNGSLADIL-FNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
V+++ ++ EYM NGSL D L + + + +A IA G+ ++ +
Sbjct: 76 ---VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 149 IIHCDIKPQNILMDENRCAK 168
IH D++ NIL+ + K
Sbjct: 130 YIHRDLRAANILVSDTLSCK 149
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-21
Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 12/146 (8%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
++K+G G G V+ VAV + K F E V+ H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 92 YSLEVSKK--ILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQ 148
V+K+ ++ E+M+ GSL D L + E + + IA G+ ++ +
Sbjct: 251 V---VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRN 304
Query: 149 IIHCDIKPQNILMDENRCAK--NFRL 172
IH D++ NIL+ + K +F L
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGL 330
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-21
Identities = 27/136 (19%), Positives = 58/136 (42%), Gaps = 9/136 (6%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKV-LDERERE-FQTEIKVIG--RTHHRNLVRL 89
+++G G S V++ +Q+ A+ + D + + ++ EI + + H ++RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
Y + +V E N L L + W ++ +++ + +H I
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQH---GI 148
Query: 150 IHCDIKPQNILMDENR 165
+H D+KP N L+ +
Sbjct: 149 VHSDLKPANFLIVDGM 164
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-21
Identities = 43/140 (30%), Positives = 63/140 (45%), Gaps = 10/140 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+ K+G+G G V+ G VA+ L K F E +V+ + H LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 92 YSLEVSKK--ILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQ 148
VS++ +V EYMS GSL D L K + +A IA G+ Y+
Sbjct: 330 V---VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 383
Query: 149 IIHCDIKPQNILMDENRCAK 168
+H D++ NIL+ EN K
Sbjct: 384 YVHRDLRAANILVGENLVCK 403
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-21
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 6/162 (3%)
Query: 9 SNYSTLTTPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQL-VAVNRLEKVLDER 67
+ + ++ E+++ K K+G G G VY+G L VAV L K
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME 259
Query: 68 EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIE 126
EF E V+ H NLV+LLG ++ E+M+ G+L D L +Q + +
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319
Query: 127 RTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+A I+ + YL + IH ++ +N L+ EN K
Sbjct: 320 LLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVK 358
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-21
Identities = 35/143 (24%), Positives = 65/143 (45%), Gaps = 9/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRNL 86
+G+G G VY G I NR A+ L ++ + ++ F E ++ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 87 VRLLGYSLEVSKKIL-VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ L+G L + YM +G L + + ++ P + +ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
E + +H D+ +N ++DE+ K
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVK 164
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-21
Identities = 27/136 (19%), Positives = 58/136 (42%), Gaps = 9/136 (6%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKV-LDERERE-FQTEIKVIG--RTHHRNLVRL 89
+++G G S V++ +Q+ A+ + D + + ++ EI + + H ++RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
Y + +V E N L L + W ++ +++ + +H I
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQH---GI 129
Query: 150 IHCDIKPQNILMDENR 165
+H D+KP N L+ +
Sbjct: 130 VHSDLKPANFLIVDGM 145
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 4e-21
Identities = 43/140 (30%), Positives = 63/140 (45%), Gaps = 10/140 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+ K+G+G G V+ G VA+ L K F E +V+ + H LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 92 YSLEVSKK--ILVYEYMSNGSLADIL-FNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
VS++ +V EYMS GSL D L K + +A IA G+ Y+
Sbjct: 247 V---VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 300
Query: 149 IIHCDIKPQNILMDENRCAK 168
+H D++ NIL+ EN K
Sbjct: 301 YVHRDLRAANILVGENLVCK 320
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-21
Identities = 33/142 (23%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQL----VAVNRL-EKVLDEREREFQTEIKVIGRTHHRNL 86
+G G G VY+G N + VAV + + + +F +E ++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
V+L+G E I + E G L L + + + I + + YL
Sbjct: 76 VKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 131
Query: 147 TQIIHCDIKPQNILMDENRCAK 168
+H DI +NIL+ C K
Sbjct: 132 INCVHRDIAVRNILVASPECVK 153
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-20
Identities = 27/136 (19%), Positives = 58/136 (42%), Gaps = 9/136 (6%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKV-LDERERE-FQTEIKVIG--RTHHRNLVRL 89
+++G G S V++ +Q+ A+ + D + + ++ EI + + H ++RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
Y + +V E N L L + W ++ +++ + +H I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQH---GI 176
Query: 150 IHCDIKPQNILMDENR 165
+H D+KP N L+ +
Sbjct: 177 VHSDLKPANFLIVDGM 192
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-20
Identities = 32/149 (21%), Positives = 63/149 (42%), Gaps = 8/149 (5%)
Query: 27 KITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRN 85
KI+ K+ +G G+ GT+ M + + VAV R+ E E++++ H N
Sbjct: 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPN 79
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
++R + + + E + +L + + + +E + + G+ +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 146 ETQIIHCDIKPQNILMDENRCAKNFRLWI 174
I+H D+KP NIL+ + I
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMI 164
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-20
Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVA---VNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
++G GS G VY + N ++VA ++ K +E+ ++ E++ + + H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
G L LV EY GS +D+L +K +E + +G+ YLH +
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 175
Query: 150 IHCDIKPQNILMDEN 164
IH D+K NIL+ E
Sbjct: 176 IHRDVKAGNILLSEP 190
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-20
Identities = 40/141 (28%), Positives = 64/141 (45%), Gaps = 12/141 (8%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRL 89
+ +G+G G V G + VAV K + D + F E V+ + H NLV+L
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNK-VAV----KCIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 90 LGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECET 147
LG +E + +V EYM+ GSL D L + + + D+ + YL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 148 QIIHCDIKPQNILMDENRCAK 168
+H D+ +N+L+ E+ AK
Sbjct: 137 NFVHRDLAARNVLVSEDNVAK 157
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-20
Identities = 33/158 (20%), Positives = 68/158 (43%), Gaps = 20/158 (12%)
Query: 18 FSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDEREREF-QT 73
+ +KI ++G G+ G V+K + ++ ++A + + R
Sbjct: 28 GELKDDDFEKI-----SELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 74 EIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT---GI 130
E++V+ + +V G + + E+M GSL +L K+ I +
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKV 136
Query: 131 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ + +G+ YL ++ +I+H D+KP NIL++ K
Sbjct: 137 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIK 172
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-20
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 19/153 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHR 84
++G+GS G VY+G VA+ + + RER EF E V+ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------FNAEKQPNWIERTGIARDIA 135
++VRLLG + +++ E M+ G L L P+ + +A +IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
G+ YL+ + +H D+ +N ++ E+ K
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 178
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-20
Identities = 39/161 (24%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 18 FSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERERE-FQT 73
+ F+ +LK + ++GRG+ G+V K M+++ Q++AV R+ +DE+E++
Sbjct: 17 WDFTAEDLKDL-----GEIGRGAYGSVNK--MVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69
Query: 74 EIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-FNAEKQPNWIERTGIA 131
++ V+ R+ +V+ G + E M + S + + I +
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128
Query: 132 RDIARGIL----YLHDECETQIIHCDIKPQNILMDENRCAK 168
+ I + +L + +IIH DIKP NIL+D + K
Sbjct: 129 K-ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIK 166
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-20
Identities = 29/144 (20%), Positives = 58/144 (40%), Gaps = 13/144 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMIN----RQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHRNL 86
+G G G V++G ++ VA+ D +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 87 VRLLGYSLEVSKK--ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
V+L+G +++ ++ E + G L L + + A ++ + YL
Sbjct: 79 VKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 133
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
+ +H DI +N+L+ N C K
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVK 156
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-20
Identities = 29/140 (20%), Positives = 57/140 (40%), Gaps = 8/140 (5%)
Query: 33 KEKVGRGSSGTVYKG---AMINRQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHRNLVR 88
++G G+ G+V +G + VA+ L + E E +++ + + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L+G + + V E G L L ++ + ++ G+ YL E
Sbjct: 75 LIGVCQAEALML-VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 149 IIHCDIKPQNILMDENRCAK 168
+H D+ +N+L+ AK
Sbjct: 131 FVHRDLAARNVLLVNRHYAK 150
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-20
Identities = 33/142 (23%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVN--RLEKVLDEREREF-QTEIKVIGRTHHRNLVRL 89
+K+GRG VY+ +++ VA+ ++ ++D + R EI ++ + +H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWI-ERT--GIARDIARGILYLHDECE 146
+E ++ +V E G L+ ++ + +KQ I ERT + + ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-- 155
Query: 147 TQIIHCDIKPQNILMDENRCAK 168
+++H DIKP N+ + K
Sbjct: 156 -RVMHRDIKPANVFITATGVVK 176
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-20
Identities = 33/154 (21%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 32 FKEKVGRGSSGTVYKG--------AMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH 83
F E +G+G+ ++KG ++ V + L+K F ++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
++LV G + + ILV E++ GSL L + N + + +A+ +A + +L +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 144 ECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177
+IH ++ +NIL+ K K+
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-20
Identities = 35/143 (24%), Positives = 60/143 (41%), Gaps = 10/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHRN 85
+ +G G GTV+KG I + V + + +K + + + IG H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+VRLLG S LV +Y+ GSL D + IA+G+ YL
Sbjct: 77 IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
E ++H ++ +N+L+ +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQ 155
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-20
Identities = 35/143 (24%), Positives = 64/143 (44%), Gaps = 10/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHRN 85
+ +G G+ GTVYKG I + VA+ L E + +E E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ RLLG L + ++ + + M G L D + + IA+G+ YL
Sbjct: 79 VCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+ +++H D+ +N+L+ + K
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVK 157
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-19
Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN 85
K ++G G+ G V+ N + LVAV L++ + ++FQ E +++ H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADIL--------------FNAEKQPNWIERTGIA 131
+VR G E ++V+EYM +G L L A + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+A G++YL +H D+ +N L+ + K
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVK 198
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-19
Identities = 32/139 (23%), Positives = 61/139 (43%), Gaps = 9/139 (6%)
Query: 32 FKEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRL 89
+ +G+G++ V++G L A+ + R + E +V+ + +H+N+V+L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 90 LGY--SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTG--IARDIARGILYLHDEC 145
K+L+ E+ GSL +L E + RD+ G+ +L +
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 146 ETQIIHCDIKPQNILMDEN 164
I+H +IKP NI+
Sbjct: 132 --GIVHRNIKPGNIMRVIG 148
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-19
Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 24/158 (15%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN 85
K ++G G+ G V+ N + LVAV L+ ++FQ E +++ H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNAEKQPNWIERTGI 130
+V+ G + I+V+EYM +G L L A+ + + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 131 ARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A IA G++YL +H D+ +N L+ N K
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVK 173
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-19
Identities = 43/148 (29%), Positives = 59/148 (39%), Gaps = 19/148 (12%)
Query: 32 FKEKVGRGSSGTVYKG----AMINRQLVAVNRLEKVL-------DEREREFQTEIKVIGR 80
EK+G GS G V +G VAV K L E +F E+ +
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----KCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 81 THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILY 140
HRNL+RL G L K+ V E GSL D L + + A +A G+ Y
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 141 LHDECETQIIHCDIKPQNILMDENRCAK 168
L + IH D+ +N+L+ K
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVK 161
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-19
Identities = 44/139 (31%), Positives = 63/139 (45%), Gaps = 6/139 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQL-VAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
K K+G G G VY+G L VAV L K EF E V+ H NLV+LL
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQI 149
G ++ E+M+ G+L D L +Q + + +A I+ + YL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 150 IHCDIKPQNILMDENRCAK 168
IH D+ +N L+ EN K
Sbjct: 133 IHRDLAARNCLVGENHLVK 151
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-19
Identities = 35/145 (24%), Positives = 58/145 (40%), Gaps = 13/145 (8%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-----RQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHRN 85
+G G G V ++VAV L + ++ EI ++ +H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 86 LVRLLGYSLEVSKK--ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
+++ G + LV EY+ GSL D L + A+ I G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH- 151
Query: 144 ECETQIIHCDIKPQNILMDENRCAK 168
IH D+ +N+L+D +R K
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVK 174
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-19
Identities = 33/173 (19%), Positives = 66/173 (38%), Gaps = 9/173 (5%)
Query: 1 MPVKYKIDSNYSTLTTPFSFSYAELKKITDGFKEKV-GRGSSGTVYKGAMINRQ---LVA 56
MP+ + + + LK+ + G G+ G+V +G R+ VA
Sbjct: 308 MPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVA 367
Query: 57 VNRL-EKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL 115
+ L + E E +++ + + +VRL+G + + V E G L L
Sbjct: 368 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFL 426
Query: 116 FNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
++ + ++ G+ YL E +H ++ +N+L+ AK
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAK 476
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-19
Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 10/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-----NRQLVAVNRL-EKVLDEREREFQTEIKVIGRTHHRN 85
+ +G G+ GTVYKG I + VA+ L E + +E E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ RLLG L S L+ + M G L D + + IA+G+ YL
Sbjct: 79 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+ +++H D+ +N+L+ + K
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVK 157
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-19
Identities = 35/144 (24%), Positives = 51/144 (35%), Gaps = 18/144 (12%)
Query: 34 EKVGRGSSGTVYKGAMINR---QLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLV 87
++G GS G V+K ++ +L AV R +R R+ H V
Sbjct: 63 SRLGHGSYGEVFKV--RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWI-ERT--GIARDIARGILYLHDE 144
RL E L E SL E + E G RD + +LH +
Sbjct: 121 RLEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
++H D+KP NI + K
Sbjct: 177 ---GLVHLDVKPANIFLGPRGRCK 197
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 83.2 bits (205), Expect = 4e-19
Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 13/143 (9%)
Query: 32 FKEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRL 89
KE++G G G V + + VA+ + + L + RE + EI+++ + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 90 L------GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT--GIARDIARGILYL 141
+L EY G L L E E + DI+ + YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 142 HDECETQIIHCDIKPQNILMDEN 164
H+ +IIH D+KP+NI++
Sbjct: 138 HEN---RIIHRDLKPENIVLQPG 157
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-19
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 25/159 (15%)
Query: 32 FKEKVGRGSSGTVYKGAMINR------QLVAVNRLEKVLDERER-EFQTEIKVIGRTHHR 84
F E++G G VYKG + Q VA+ L+ + R EF+ E + R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNAEKQPNWIERTG 129
N+V LLG + +++ Y S+G L + L + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 130 IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ IA G+ YL ++H D+ +N+L+ + K
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVK 168
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-19
Identities = 31/153 (20%), Positives = 68/153 (44%), Gaps = 17/153 (11%)
Query: 18 FSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERERE-FQT 73
+ +L+ + ++G G+ G V+K M R ++AV ++ + ++ E +
Sbjct: 20 YQAEINDLENL-----GEMGSGTCGQVWK--MRFRKTGHVIAVKQMRRSGNKEENKRILM 72
Query: 74 EIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIA 131
++ V+ ++H +V+ G + + + E M + P + + +
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MT 130
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
I + + YL ++ +IH D+KP NIL+DE
Sbjct: 131 VAIVKALYYLKEK--HGVIHRDVKPSNILLDER 161
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 6e-19
Identities = 32/139 (23%), Positives = 61/139 (43%), Gaps = 9/139 (6%)
Query: 32 FKEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRL 89
+ +G+G++ V++G L A+ + R + E +V+ + +H+N+V+L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 90 LGY--SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTG--IARDIARGILYLHDEC 145
K+L+ E+ GSL +L E + RD+ G+ +L +
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 146 ETQIIHCDIKPQNILMDEN 164
I+H +IKP NI+
Sbjct: 132 --GIVHRNIKPGNIMRVIG 148
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 8e-19
Identities = 37/169 (21%), Positives = 68/169 (40%), Gaps = 14/169 (8%)
Query: 7 IDSNYSTLTTPFSFSYAEL--KKITDGFKEKVGRGSSGTVYKGAMINR----QLVAVNRL 60
I T T P + Y E+ ++I +G G G V++G ++ VA+
Sbjct: 370 IIDEEDTYTMPSTRDY-EIQRERIE--LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 61 -EKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAE 119
D +F E + + H ++V+L+G E + ++ E + G L L +
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK 485
Query: 120 KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ A ++ + YL + +H DI +N+L+ N C K
Sbjct: 486 FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 531
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-19
Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 19/153 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMINR----QLVAVNRL-EKVLDERER-EFQTEIKVIGRTHHRN 85
+ +G G G+V +G + VAV + +RE EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 86 LVRLLGYSLE-----VSKKILVYEYMSNGSLADIL-----FNAEKQPNWIERTGIARDIA 135
++RLLG +E + K +++ +M G L L K DIA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
G+ YL +H D+ +N ++ ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVC 187
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-18
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHR 84
+G G+ G VY+G + VAV L +V E++ +F E +I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNAEKQPNWIERTGIARDIARGI 138
N+VR +G SL+ + ++ E M+ G L L + ++ +ARDIA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 139 LYLHDECETQIIHCDIKPQNILMD---ENRCAK 168
YL E IH DI +N L+ R AK
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-18
Identities = 32/145 (22%), Positives = 59/145 (40%), Gaps = 11/145 (7%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
F +K+G G V + + A+ R+ + E Q E + +H N++RL+
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 91 GYSLEVSKK----ILVYEYMSNGSLADILFNAEKQPNWI-ERT--GIARDIARGILYLHD 143
Y L L+ + G+L + + + + N++ E + I RG+ +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 144 ECETQIIHCDIKPQNILMDENRCAK 168
H D+KP NIL+ +
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPV 174
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-18
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 23/157 (14%)
Query: 32 FKEKVGRGSSGTVYKGAMIN---RQLVAVNRLEKVLDERER-EFQTEIKVIGR-THHRNL 86
F++ +G G+ G V K + R A+ R+++ + + +F E++V+ + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNAEKQPNWIERTGIA 131
+ LLG L EY +G+L D L + + + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
D+ARG+ YL + Q IH D+ +NIL+ EN AK
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 182
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-18
Identities = 31/154 (20%), Positives = 56/154 (36%), Gaps = 20/154 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMINR----QLVAVNRL-EKVLDERERE-FQTEIKVIGRTHHRN 85
+G+G G+V + + VAV L ++ + E F E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 86 LVRLLGYSLE------VSKKILVYEYMSNGSLADIL-----FNAEKQPNWIERTGIARDI 134
+ +L+G SL + +++ +M +G L L DI
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A G+ YL IH D+ +N ++ E+
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-18
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHR 84
+G G+ G VY+G + VAV L +V E++ +F E +I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADIL------FNAEKQPNWIERTGIARDIARGI 138
N+VR +G SL+ + ++ E M+ G L L + ++ +ARDIA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 139 LYLHDECETQIIHCDIKPQNILMD---ENRCAK 168
YL E IH DI +N L+ R AK
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-18
Identities = 33/140 (23%), Positives = 61/140 (43%), Gaps = 9/140 (6%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKV-LDEREREF-QTEIKVIGRTHHRNLVRLL 90
+K+G GS G + + + + + + +ERE + E+ V+ H N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT--GIARDIARGILYLHDECETQ 148
E +V +Y G L + NA+K + E I + ++HD +
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 149 IIHCDIKPQNILMDENRCAK 168
I+H DIK QNI + ++ +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQ 165
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-18
Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 18/141 (12%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLL 90
++ +G GSSGTV + VAV R+ + EIK++ + H N++R
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRY- 74
Query: 91 GYSLEVSKK--ILVYEYMSNGSLADIL----FNAEKQPNWIERT--GIARDIARGILYLH 142
Y E + + + E N +L D++ + E E + R IA G+ +LH
Sbjct: 75 -YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 143 DECETQIIHCDIKPQNILMDE 163
+IIH D+KPQNIL+
Sbjct: 133 ---SLKIIHRDLKPQNILVST 150
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-18
Identities = 29/147 (19%), Positives = 59/147 (40%), Gaps = 12/147 (8%)
Query: 33 KEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLL 90
+ + G VY+ + + + A+ RL +E+ R E+ + + + H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 91 GYSLEVSKK-------ILVYEYMSNGSLADILFNAEKQPNWIERT--GIARDIARGILYL 141
+ ++ L+ + G L + L E + T I R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 142 HDECETQIIHCDIKPQNILMDENRCAK 168
H + IIH D+K +N+L+ K
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIK 178
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 8e-18
Identities = 28/157 (17%), Positives = 54/157 (34%), Gaps = 17/157 (10%)
Query: 32 FKEKVGRGSSGTVYKG------AMINRQLVAVNRLEK-VLDEREREFQTEIKVIGRTHHR 84
+G G+ VY+ N+Q + + E Q ++ + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQH 127
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNW-----IERTGIARDIARGIL 139
++ L + +LV E S G+L + + N K A + I
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 140 YLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176
+H + +IIH DIKP N ++ ++ +
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-17
Identities = 33/151 (21%), Positives = 67/151 (44%), Gaps = 18/151 (11%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
+G+G+ G V K ++ + A+ ++ ++ +E+ ++ +H+ +VR
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST-ILSEVMLLASLNHQYVVRYY 68
Query: 91 G------------YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARG 137
+++ + + EY NG+L D++ + E + R I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ Y+H + IIH D+KP NI +DE+R K
Sbjct: 129 LSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-17
Identities = 39/167 (23%), Positives = 67/167 (40%), Gaps = 33/167 (19%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHR 84
+ +G G+ G V++ +VAV L++ + +FQ E ++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADIL-----------------------FNAEKQ 121
N+V+LLG L++EYM+ G L + L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 122 PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ E+ IAR +A G+ YL E + +H D+ +N L+ EN K
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 214
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-17
Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 32/164 (19%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKV---IGRT 81
F + +G G+ G V + VAV L+ ER +E+KV +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 82 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-------FNAEKQPNWIERTG----- 129
H N+V LLG +++ EY G L + L ++ P +E
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 130 -----IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ +A+G+ +L IH D+ +NIL+ R K
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITK 185
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-17
Identities = 30/145 (20%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKV-LDEREREF-QTEIKVIGRTHHRNLVRLL 90
+G GS G K + +++ L+ + E E++ +E+ ++ H N+VR
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 91 GYSLEVSKKIL--VYEYMSNGSLADILFNAEKQPNWI-ERT--GIARDIARGILYLHDEC 145
++ + L V EY G LA ++ K+ ++ E + + + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 146 ET--QIIHCDIKPQNILMDENRCAK 168
+ ++H D+KP N+ +D + K
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVK 156
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-16
Identities = 34/151 (22%), Positives = 58/151 (38%), Gaps = 19/151 (12%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRLLG 91
+ +GRG G V++ ++ A+ R+ E RE E+K + + H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 92 YSLE---------VSKKILVY---EYMSNGSLADILFNAEKQPNWIERT--GIARDIARG 137
LE S K+ +Y + +L D + I IA
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 138 ILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ +LH + ++H D+KP NI + K
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-16
Identities = 20/155 (12%), Positives = 49/155 (31%), Gaps = 12/155 (7%)
Query: 34 EKVGRGSSGTVYKG--AMINRQLVAVN--RLEKVLDERERE-FQTEIKVIGRTHHRNLVR 88
G ++ ++RQ VA+ + VL + + + + R + R
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQ-VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
+L + ++V E++ GSL ++ + P+ + + +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 149 IIHCDIKPQNILMDENRCAKNFRLWIGKVDEARSD 183
+ P + + + + D
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDD 184
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-16
Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 20/144 (13%)
Query: 35 KVGRGSSGTVYKGAMINRQL---VAVNRLEKVL------DEREREFQTEIKVIGRTHHRN 85
++G G+ GTV KG +++ VAV K+L + E E V+ + +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAV----KILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+VR++G +LV E G L L + + ++ G+ YL
Sbjct: 80 IVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYL---- 133
Query: 146 ETQ-IIHCDIKPQNILMDENRCAK 168
E +H D+ +N+L+ AK
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAK 157
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-16
Identities = 28/145 (19%), Positives = 56/145 (38%), Gaps = 24/145 (16%)
Query: 34 EKVGRGSSGTVYKG--AMINRQLVAVNRLEKVL----DERERE-FQTEIKVIGRTHHRNL 86
+ G G +Y +N + V + K L D + E + + H ++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVL----KGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 87 VRLLGYSLEVSKKI-----LVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILY 140
V++ + + +V EY+ SL +K P + +I + Y
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLP--VAEAIAYLLEILPALSY 197
Query: 141 LHDECETQIIHCDIKPQNILMDENR 165
LH +++ D+KP+NI++ E +
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEEQ 219
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-16
Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 28/162 (17%)
Query: 32 FKEKVGRGSSGTVYKG--------AMINRQLVAVNRLEKVLDERER-EFQTEIKVIGR-T 81
+ +G G+ G V VAV L+ E++ + +E++++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 82 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNAEKQPNWIE 126
H+N++ LLG + ++ EY S G+L + L E+Q + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 127 RTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ARG+ YL + IH D+ +N+L+ EN K
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMK 197
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-16
Identities = 34/161 (21%), Positives = 65/161 (40%), Gaps = 27/161 (16%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKVIGR-THH 83
+ +GRG+ G V + + VAV L++ E +E+K++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 84 RNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG------------- 129
N+V LLG + + ++ E+ G+L+ L + + +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 130 --IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ +A+G+ +L + IH D+ +NIL+ E K
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVK 188
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-16
Identities = 43/189 (22%), Positives = 75/189 (39%), Gaps = 32/189 (16%)
Query: 7 IDSNYSTLTTPFSFSYAELKKITD-GFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLD 65
I SNYS L + + K I D + +G + + + A+ + EK L
Sbjct: 9 ILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIIL-CEKDNKFYALKKYEKSLL 67
Query: 66 EREREF-----------------QTEIKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMS 107
E++R+F + E+++I + + G + ++ ++YEYM
Sbjct: 68 EKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYME 126
Query: 108 NGSLADIL--------FNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNI 159
N S+ P + + I + + Y+H+E I H D+KP NI
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIKC-IIKSVLNSFSYIHNE--KNICHRDVKPSNI 183
Query: 160 LMDENRCAK 168
LMD+N K
Sbjct: 184 LMDKNGRVK 192
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-16
Identities = 39/188 (20%), Positives = 67/188 (35%), Gaps = 31/188 (16%)
Query: 7 IDSNYSTLTTPFSFSYAEL-----KKITDGFKEKVGRGSSGTVYKGAMI------NRQLV 55
+ N T P Y E + F + +G G+ G V + V
Sbjct: 22 YEGNSYTFIDPTQLPYNEKWEFPRNNLQ--FGKTLGAGAFGKVVEATAFGLGKEDAVLKV 79
Query: 56 AVNRLEKVLDERER-EFQTEIKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD 113
AV L+ E+ +E+K++ H N+V LLG +++ EY G L +
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 114 IL-------------FNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160
L A + + + +A+G+ +L IH D+ +N+L
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL 196
Query: 161 MDENRCAK 168
+ AK
Sbjct: 197 LTNGHVAK 204
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-16
Identities = 30/154 (19%), Positives = 62/154 (40%), Gaps = 27/154 (17%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
E +G G G V+K I+ + + K + + + E+K + + H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVI----KRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 93 -------------SLEVSKKILVY---EYMSNGSLADILFNAEKQPNWIERT--GIARDI 134
+ SK ++ E+ G+L + + + + I
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQI 131
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+G+ Y+H + ++I+ D+KP NI + + + K
Sbjct: 132 TKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-16
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 28/162 (17%)
Query: 32 FKEKVGRGSSGTVYKG--------AMINRQLVAVNRLEKVLDERER-EFQTEIKVIGR-T 81
+ +G G G V VAV L+ E++ + +E++++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 82 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNAEKQPNWIE 126
H+N++ LLG + ++ EY S G+L + L E+Q + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 127 RTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ARG+ YL + IH D+ +N+L+ EN K
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMK 243
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-15
Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 18/141 (12%)
Query: 37 GRGSSGTVYKG-AMINRQLVAVNRLEKVLDER-------EREFQTEIKVIGRTHHRNLVR 88
G+G G VY ++ ++A+ KVL + E + + E+++ H N++R
Sbjct: 18 GKGKFGNVYLAREKQSKFILAL----KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
L GY + ++ L+ EY G++ L K T ++A + Y H
Sbjct: 74 LYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-YITELANALSYCH---SK 128
Query: 148 QIIHCDIKPQNILMDENRCAK 168
++IH DIKP+N+L+ K
Sbjct: 129 RVIHRDIKPENLLLGSAGELK 149
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-15
Identities = 39/169 (23%), Positives = 62/169 (36%), Gaps = 37/169 (21%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKV---IGRT 81
F + +G G+ G V VAV L++ D ER +E+K+ +G
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS- 107
Query: 82 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL-----------FNAEKQPNWIERTG- 129
H N+V LLG L++EY G L + L E Q E
Sbjct: 108 -HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 130 ----------IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A +A+G+ +L +H D+ +N+L+ + K
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVK 212
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-15
Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 20/147 (13%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDERE---REFQTEIKVIGRTHHRNLVRL 89
G+G+ GTV G VA ++KV+ + RE Q ++ + HH N+V+L
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVA---IKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQL 84
Query: 90 LGYSLEVSKK-------ILVYEYMSNGSLADILFNAEKQPNWIERTGI---ARDIARGIL 139
Y + ++ +V EY+ + +L N ++ I + R I
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143
Query: 140 YLHDECETQIIHCDIKPQNILMDENRC 166
LH + H DIKP N+L++E
Sbjct: 144 CLHLPS-VNVCHRDIKPHNVLVNEADG 169
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-15
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 20/145 (13%)
Query: 34 EKVGRGSSGTVYKG--AMINRQLVAVNRLEKVLDE--------REREFQTEIKVIGRTHH 83
+K+G G TVY ++N + VA+ K + +R F+ E+ + H
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIK-VAI----KAIFIPPREKEETLKR-FEREVHNSSQLSH 70
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
+N+V ++ E LV EY+ +L++ + + + I GI + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH- 128
Query: 144 ECETQIIHCDIKPQNILMDENRCAK 168
+ +I+H DIKPQNIL+D N+ K
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLK 151
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-15
Identities = 38/167 (22%), Positives = 66/167 (39%), Gaps = 33/167 (19%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHR 84
+ +G G G V K + VAV L++ E + +E V+ + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTG--------------- 129
++++L G + +L+ EY GSL L + K +G
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 130 --------IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
A I++G+ YL E +++H D+ +NIL+ E R K
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMK 190
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-15
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 32/164 (19%)
Query: 32 FKEKVGRGSSGTVYKGAMIN--------RQLVAVNRLEKVLDERER-EFQTEIKV---IG 79
+ +G G+ G V I VAV L+ E++ + +E+++ IG
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADIL---------------FNAEKQPNW 124
+ H+N++ LLG + ++ EY S G+L + L N E+Q +
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 125 IERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ A +ARG+ YL + IH D+ +N+L+ E+ K
Sbjct: 191 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMK 231
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-15
Identities = 31/137 (22%), Positives = 59/137 (43%), Gaps = 10/137 (7%)
Query: 37 GRGSSGTVYKGA-MINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVRLLGY 92
G+G ++ + +++ A + K +L +RE EI + H+++V G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 93 SLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
E + + +V E SL ++ + R R I G YLH ++IH
Sbjct: 110 -FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIH 164
Query: 152 CDIKPQNILMDENRCAK 168
D+K N+ ++E+ K
Sbjct: 165 RDLKLGNLFLNEDLEVK 181
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-15
Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 34 EKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDEREREF--QT---EIKVIGRTHHRN 85
K+G GS G V+K NR Q+VA ++K L+ + + EI+++ + H N
Sbjct: 9 GKIGEGSYGVVFKC--RNRDTGQIVA---IKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
LV LL + LV+EY + ++ L ++ I + + + H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
IH D+KP+NIL+ ++ K
Sbjct: 122 --NCIHRDVKPENILITKHSVIK 142
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-15
Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 31/146 (21%)
Query: 34 EKVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERERE---FQT--EIKVIGRTHHRN 85
VG GS G V K N+ ++VA ++K L+ + + EIK++ + H N
Sbjct: 31 GLVGEGSYGMVMKC--RNKDTGRIVA---IKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 86 LVRLLGYSLEV---SKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGI---ARDIARGI 138
LV LL EV K+ LV+E++ + IL + E PN ++ + I GI
Sbjct: 86 LVNLL----EVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 139 LYLHDECETQIIHCDIKPQNILMDEN 164
+ H IIH DIKP+NIL+ ++
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQS 160
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 6e-15
Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 17/141 (12%)
Query: 37 GRGSSGTVYKG-AMINRQLVAVNRLEKVLDER-------EREFQTEIKVIGRTHHRNLVR 88
G+GS VY+ ++ VA+ K++D++ + Q E+K+ + H +++
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAI----KMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
L Y E S + LV E NG + L N K + E I G+LYLH
Sbjct: 76 LYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 148 QIIHCDIKPQNILMDENRCAK 168
I+H D+ N+L+ N K
Sbjct: 132 GILHRDLTLSNLLLTRNMNIK 152
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 6e-15
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 12/140 (8%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERERE---FQT--EIKVIGRTHHRNLVR 88
EKVG G+ G VYK ++VA L+++ + E E EI ++ HH N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVA---LKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L+ LV+E+M L +L + + + RG+ + H +
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---R 139
Query: 149 IIHCDIKPQNILMDENRCAK 168
I+H D+KPQN+L++ + K
Sbjct: 140 ILHRDLKPQNLLINSDGALK 159
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 7e-15
Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 18/141 (12%)
Query: 37 GRGSSGTVYKG-AMINRQLVAVNRLEKVLDER-------EREFQTEIKVIGRTHHRNLVR 88
G+G G VY N+ ++A+ KVL + E + + EI++ H N++R
Sbjct: 23 GKGKFGNVYLAREKQNKFIMAL----KVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
+ Y K+I L+ E+ G L L + T ++A + Y H E
Sbjct: 79 MYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT-FMEELADALHYCH---ER 133
Query: 148 QIIHCDIKPQNILMDENRCAK 168
++IH DIKP+N+LM K
Sbjct: 134 KVIHRDIKPENLLMGYKGELK 154
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-15
Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 17/140 (12%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS 93
+ +G GS G V++ ++ VA ++KVL ++ + + E++++ H N+V L +
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVA---IKKVLQDKRFKNR-ELQIMRIVKHPNVVDLKAFF 101
Query: 94 LEVSKKI------LVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGILYLHDE 144
K LV EY+ ++ + K + I + R + Y+H
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 145 CETQIIHCDIKPQNILMDEN 164
I H DIKPQN+L+D
Sbjct: 161 ---GICHRDIKPQNLLLDPP 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-15
Identities = 35/141 (24%), Positives = 70/141 (49%), Gaps = 18/141 (12%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
+ +G GS G VY+ + + +LVA ++KVL ++ + + E++++ + H N+VRL +
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVA---IKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYF 115
Query: 93 SLEVSKKI------LVYEYMSNGSLADILFNAEKQPNWIERTGIAR---DIARGILYLHD 143
+K LV +Y+ ++ + + + + + + R + Y+H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 173
Query: 144 ECETQIIHCDIKPQNILMDEN 164
I H DIKPQN+L+D +
Sbjct: 174 --SFGICHRDIKPQNLLLDPD 192
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-14
Identities = 31/137 (22%), Positives = 59/137 (43%), Gaps = 10/137 (7%)
Query: 37 GRGSSGTVYKGA-MINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVRLLGY 92
G+G ++ + +++ A + K +L +RE EI + H+++V G+
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 93 SLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
E + + +V E SL ++ + R R I G YLH ++IH
Sbjct: 84 -FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIH 138
Query: 152 CDIKPQNILMDENRCAK 168
D+K N+ ++E+ K
Sbjct: 139 RDLKLGNLFLNEDLEVK 155
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-14
Identities = 29/132 (21%), Positives = 60/132 (45%), Gaps = 8/132 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
E++G G+ G V++ A + + + + EI+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIARGILYLHDECETQ 148
+ ++ +++YE+MS G L + A++ E R + +G+ ++H+
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 149 IIHCDIKPQNIL 160
+H D+KP+NI+
Sbjct: 276 YVHLDLKPENIM 287
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-14
Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 13/141 (9%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE---FQT--EIKVIGRTHHRNLV 87
EK+G G+ GTV+K ++VA L++V + + E EI ++ H+N+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVA---LKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
RL K LV+E+ L + + + +G+ + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--- 120
Query: 148 QIIHCDIKPQNILMDENRCAK 168
++H D+KPQN+L++ N K
Sbjct: 121 NVLHRDLKPQNLLINRNGELK 141
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-14
Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 12/140 (8%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERERE---FQT--EIKVIGRTHHRNLVR 88
EK+G G+ G VYK + A L+K+ E+E E T EI ++ H N+V+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFA---LKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L + +LV+E++ L +L E + + GI Y HD +
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 149 IIHCDIKPQNILMDENRCAK 168
++H D+KPQN+L++ K
Sbjct: 121 VLHRDLKPQNLLINREGELK 140
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-14
Identities = 35/150 (23%), Positives = 58/150 (38%), Gaps = 26/150 (17%)
Query: 34 EKVGRGSSGTVYKG--AMINRQLVAVNRLEKVLDE--------REREFQTEIKVIGRTHH 83
E +G G V+ +R VAV KVL R F+ E + +H
Sbjct: 18 EILGFGGMSEVHLARDLRDHRD-VAV----KVLRADLARDPSFYLR-FRREAQNAAALNH 71
Query: 84 RNLVRLLGYSLEVSKKI----LVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGI 138
+V + + +V EY+ +L DI+ + P +R + D + +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQAL 129
Query: 139 LYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ H + IIH D+KP NI++ K
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVK 156
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-14
Identities = 36/146 (24%), Positives = 57/146 (39%), Gaps = 22/146 (15%)
Query: 34 EKVGRGSSGTVYKGA--MINRQLVAVNRLEKVLDE--------REREFQTEIKVIGRTHH 83
VGRG G VY+ + R VA+ K++ E R R Q E + GR
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERI-VAL----KLMSETLSSDPVFRTR-MQREARTAGRLQE 93
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLH 142
++V + + + + ++ LA +L + P R I R I + H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 143 DECETQIIHCDIKPQNILMDENRCAK 168
H D+KP+NIL+ + A
Sbjct: 152 ---AAGATHRDVKPENILVSADDFAY 174
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 3e-14
Identities = 37/143 (25%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE---FQT--EIKVIGRTHHRNLV 87
EK+G G+ G VYK + ++VA L+K+ + E E EI ++ +H N+V
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVA---LKKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 88 RLLGYSLEVSKKILVYEYMSN--GSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+LL +K LV+E++ D I+ + +G+ + H
Sbjct: 66 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH- 122
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+++H D+KPQN+L++ K
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIK 143
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-14
Identities = 35/147 (23%), Positives = 65/147 (44%), Gaps = 18/147 (12%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE---FQT--EIKVIGRTHHRNLV 87
K+G G+ G VYK + + VA ++++ E E E E+ ++ HRN++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVA---IKRIRLEHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT--GIARDIARGILYLHDEC 145
L + L++EY N L + +K P+ R + G+ + H
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 146 ETQIIHCDIKPQNILMDENRCAKNFRL 172
+ +H D+KPQN+L+ + ++ L
Sbjct: 152 --RCLHRDLKPQNLLLSVSDASETPVL 176
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-14
Identities = 29/137 (21%), Positives = 57/137 (41%), Gaps = 10/137 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRL 89
FK K+G G+ G V+ + + + K + + EI+V+ H N++++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 90 LGYSLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDEC 145
E + +V E G L + I+ + E + + + + Y H +
Sbjct: 86 FEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 146 ETQIIHCDIKPQNILMD 162
++H D+KP+NIL
Sbjct: 144 --HVVHKDLKPENILFQ 158
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-14
Identities = 31/140 (22%), Positives = 51/140 (36%), Gaps = 12/140 (8%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAV-----NRLEKVLDEREREFQTEIKVIGRTHHRN 85
E +G+G V + Q AV + + + E + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLH 142
+V LL +V+E+M L I+ A+ + E + R I + Y H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 143 DECETQIIHCDIKPQNILMD 162
D IIH D+KP +L+
Sbjct: 148 DN---NIIHRDVKPHCVLLA 164
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-14
Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 18/135 (13%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRL 89
KE +G GS + AV K++D+ +R+ EI+++ R H N++ L
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAV----KIIDKSKRDPTEEIEILLRYGQHPNIITL 81
Query: 90 LGYSLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDEC 145
+ K + +V E M G L D IL +Q + ER + + I + + YLH +
Sbjct: 82 KDV-YDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ- 135
Query: 146 ETQIIHCDIKPQNIL 160
++H D+KP NIL
Sbjct: 136 --GVVHRDLKPSNIL 148
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 9e-14
Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
F E +G G+ V+ +L A+ ++K R+ + EI V+ + H N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 91 GYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDECET 147
+ LV + +S G L D IL E+ + E+ + + + + + YLH+
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRIL---ERG-VYTEKDASLVIQQVLSAVKYLHEN--- 125
Query: 148 QIIHCDIKPQNILM 161
I+H D+KP+N+L
Sbjct: 126 GIVHRDLKPENLLY 139
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 1e-13
Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 27/154 (17%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQT--------EIKV---IGRT 81
++G G+ GTVYK + VA L+ V E+ + +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 82 HHRNLVRLL----GYSLEVSKKI-LVYEYMSN--GSLADILFNAEKQPNWIERTGIARDI 134
H N+VRL+ + K+ LV+E++ + D I+ + R
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD--LMRQF 129
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
RG+ +LH I+H D+KP+NIL+ K
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-13
Identities = 44/149 (29%), Positives = 69/149 (46%), Gaps = 25/149 (16%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKV-LDERE-------REFQTEIKVIGRTHHR 84
EK+G G+ TVYKG VA L++V LD E RE I ++ H
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVA---LKEVKLDSEEGTPSTAIRE----ISLMKELKHE 63
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADIL--FNAEKQPNWIERTGIA---RDIARGIL 139
N+VRL +K LV+E+M N L + P +E + + +G+
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 140 YLHDECETQIIHCDIKPQNILMDENRCAK 168
+ H+ +I+H D+KPQN+L+++ K
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLK 148
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-13
Identities = 37/152 (24%), Positives = 65/152 (42%), Gaps = 25/152 (16%)
Query: 34 EKVGRGSSGTVYKG--AMINRQLVAVNRLEKVLDERERE---FQT--EIKV---IGRTHH 83
++G G+ G V+K + VA L++V + E T E+ V + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 84 RNLVRLL----GYSLEVSKKI-LVYEYMSN--GSLADILFNAEKQPNWIERTGIARDIAR 136
N+VRL + K+ LV+E++ + D + I+ + + R
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--MMFQLLR 131
Query: 137 GILYLHDECETQIIHCDIKPQNILMDENRCAK 168
G+ +LH ++H D+KPQNIL+ + K
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIK 160
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-13
Identities = 27/142 (19%), Positives = 62/142 (43%), Gaps = 13/142 (9%)
Query: 26 KKITDGF--KEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH 82
K++ + + E +GRG G V++ +++ ++ ++ + EI ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIAR 59
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGIL 139
HRN++ L + + ++++E++S + + I ER + +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQ 116
Query: 140 YLHDECETQIIHCDIKPQNILM 161
+LH I H DI+P+NI+
Sbjct: 117 FLHSH---NIGHFDIRPENIIY 135
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-13
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 21/149 (14%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-F-QT---EIKVIGRTHHRNLV 87
K+G+G+ G V+K Q VA L+KVL E E+E F T EIK++ H N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 88 RLLG--------YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGIL 139
L+ Y+ LV+++ + LA +L N + E + + + G+
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 140 YLHDECETQIIHCDIKPQNILMDENRCAK 168
Y+H +I+H D+K N+L+ + K
Sbjct: 139 YIHRN---KILHRDMKAANVLITRDGVLK 164
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-13
Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 12/140 (8%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKV-LDEREREFQT---EIKVIGRTHHRNLVR 88
+K+G G+ TVYKG + + LVA L+++ L+ E T E+ ++ H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVA---LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L LV+EY+ L L + N + RG+ Y H + +
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---K 120
Query: 149 IIHCDIKPQNILMDENRCAK 168
++H D+KPQN+L++E K
Sbjct: 121 VLHRDLKPQNLLINERGELK 140
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-13
Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 15/156 (9%)
Query: 15 TTPFSFSYAELKKITDG--FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK--VLDERER 69
TP F ++ +++ +K+G G+ G V A+ + K V
Sbjct: 22 ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS 81
Query: 70 EFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIERT 128
+ E+ V+ H N+++L + + LV E G L D I+ + + E
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVD 137
Query: 129 --GIARDIARGILYLHDECETQIIHCDIKPQNILMD 162
I + + G+ YLH I+H D+KP+N+L++
Sbjct: 138 AAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLE 170
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-13
Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 23/148 (15%)
Query: 32 FKEKVGRGSSGTVYKG---------AM--INRQLVAVNRLEKVLDEREREFQTEIKVIGR 80
KE +GRG S V + A+ I+ E+V + RE E+ ++ +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA-TLKEVDILRK 79
Query: 81 -THHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIAR 136
+ H N+++L E + LV++ M G L D L EK E+ I R +
Sbjct: 80 VSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYL--TEKV-TLSEKETRKIMRALLE 135
Query: 137 GILYLHDECETQIIHCDIKPQNILMDEN 164
I LH I+H D+KP+NIL+D++
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDD 160
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-13
Identities = 30/133 (22%), Positives = 59/133 (44%), Gaps = 8/133 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
E++G G+ G V++ ++ + + + EI ++ + HH L+ L
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIARGILYLHDECETQ 148
+ + +L+ E++S G L D + A + E R G+ ++H+
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH---S 169
Query: 149 IIHCDIKPQNILM 161
I+H DIKP+NI+
Sbjct: 170 IVHLDIKPENIMC 182
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-13
Identities = 39/144 (27%), Positives = 61/144 (42%), Gaps = 16/144 (11%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQT--------EIKVIGRTHHR 84
+ +G G TVYK Q+VA ++K+ E + EIK++ H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVA---IKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
N++ LL S LV+++M L I+ + +G+ YLH
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
I+H D+KP N+L+DEN K
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLK 152
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-13
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 16 TPFSFSYAELKKITDG--FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK---VLDERER 69
TP F +D + +G+GS G V Q AV + K +
Sbjct: 12 TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 70 EFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIERT 128
E++++ + H N+++L + + LV E + G L D I+ + + E
Sbjct: 72 SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVD 127
Query: 129 --GIARDIARGILYLHDECETQIIHCDIKPQNILMD 162
I R + GI Y+H +I+H D+KP+N+L++
Sbjct: 128 AARIIRQVLSGITYMHKN---KIVHRDLKPENLLLE 160
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-13
Identities = 37/134 (27%), Positives = 61/134 (45%), Gaps = 10/134 (7%)
Query: 31 GFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
E +G G G V+K +A ++ + + E + EI V+ + H NL++L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 90 LGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDECE 146
+ +LV EY+ G L D I+ ++ N E + I GI ++H
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQM-- 206
Query: 147 TQIIHCDIKPQNIL 160
I+H D+KP+NIL
Sbjct: 207 -YILHLDLKPENIL 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-13
Identities = 36/139 (25%), Positives = 64/139 (46%), Gaps = 13/139 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK--VLDEREREFQTEIKVIGRTHHRNLVR 88
+G+GS G V K +Q AV + K ++ E++++ + H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 89 LLGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIERT--GIARDIARGILYLHDEC 145
L + S +V E + G L D I+ K+ + E I + + GI Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH- 140
Query: 146 ETQIIHCDIKPQNILMDEN 164
I+H D+KP+NIL++
Sbjct: 141 --NIVHRDLKPENILLESK 157
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-12
Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 22/147 (14%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK--------VLDEREREFQTEIKVIGR-T 81
K+ +GRG S V + AV +E L+E + E ++ +
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 82 HHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARG 137
H +++ L+ E S + LV++ M G L D + ++ E+ I R +
Sbjct: 158 GHPHIITLIDS-YESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEA 212
Query: 138 ILYLHDECETQIIHCDIKPQNILMDEN 164
+ +LH I+H D+KP+NIL+D+N
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDN 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-12
Identities = 32/137 (23%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV-LDERERE-FQTEIKVIGRTHHRNLVR 88
KE++G+G+ V + A + L R+ + + E ++ + H N+VR
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 89 LLGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDEC 145
L E S LV++ ++ G L + I+ ++ + E + + I I Y H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIV---ARE-FYSEADASHCIQQILESIAYCHSN- 124
Query: 146 ETQIIHCDIKPQNILMD 162
I+H ++KP+N+L+
Sbjct: 125 --GIVHRNLKPENLLLA 139
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-12
Identities = 36/170 (21%), Positives = 65/170 (38%), Gaps = 15/170 (8%)
Query: 3 VKYKIDSNYSTLTTPFSFSYAELKKITDGF---KEKVGRGSSGTVYKGAMI-NRQLVAVN 58
+ + + + + ++ + + +++GRG V + Q A
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 59 RLEK--VLDEREREFQTEIKVIGR-THHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-I 114
L+K + E EI V+ ++ L S+ IL+ EY + G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 115 LFNAEKQPNWIER--TGIARDIARGILYLHDECETQIIHCDIKPQNILMD 162
L E E + + I G+ YLH + I+H D+KPQNIL+
Sbjct: 121 L--PELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLS 165
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-12
Identities = 30/146 (20%), Positives = 62/146 (42%), Gaps = 22/146 (15%)
Query: 32 FKEKVGRGSSGTVYKG---------AM--INRQLVAVNRLEKVLDEREREFQTEIKVIGR 80
+ +G G+ G V A+ I+++ A+ + +TEI+++ +
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN--VETEIEILKK 196
Query: 81 THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT--GIARDIARGI 138
+H ++++ + + +V E M G L D + ++ E T + +
Sbjct: 197 LNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAV 252
Query: 139 LYLHDECETQIIHCDIKPQNILMDEN 164
YLH+ IIH D+KP+N+L+
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQ 275
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-12
Identities = 36/134 (26%), Positives = 67/134 (50%), Gaps = 14/134 (10%)
Query: 33 KEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLL 90
++ +G G+ V +I Q AV +EK E++++ + HRN++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 91 GYSLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDECE 146
+ E + LV+E M GS+ I K+ ++ E + + +D+A + +LH++
Sbjct: 78 EF-FEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNK-- 130
Query: 147 TQIIHCDIKPQNIL 160
I H D+KP+NIL
Sbjct: 131 -GIAHRDLKPENIL 143
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-12
Identities = 42/203 (20%), Positives = 70/203 (34%), Gaps = 52/203 (25%)
Query: 10 NYSTLTTPFSFSYAELKKITDG--FKEKVGRGSSGTVYKGAMI-NRQLVAV-----NRLE 61
++S+ F L ++ K +G+GS G V R + A+ N++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 62 KVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNAE 119
++ + +TE++++ + HH N+ RL E + I LV E G L D + +
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFID 124
Query: 120 KQPNWIERTG--------------------------------------IARDIARGILYL 141
I R I + YL
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184
Query: 142 HDECETQIIHCDIKPQNILMDEN 164
H++ I H DIKP+N L N
Sbjct: 185 HNQ---GICHRDIKPENFLFSTN 204
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-12
Identities = 34/158 (21%), Positives = 66/158 (41%), Gaps = 13/158 (8%)
Query: 12 STLTTPFSFSYAELKKITDG--FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV-LDER 67
+ F K +D KE++G+G+ V + A + L R
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70
Query: 68 ERE-FQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIE 126
+ + + E ++ + H N+VRL E S LV++ ++ G L + + ++ + E
Sbjct: 71 DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VARE-FYSE 127
Query: 127 R--TGIARDIARGILYLHDECETQIIHCDIKPQNILMD 162
+ + I I Y H I+H ++KP+N+L+
Sbjct: 128 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLA 162
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 3e-12
Identities = 17/172 (9%), Positives = 37/172 (21%), Gaps = 46/172 (26%)
Query: 32 FKEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERERE-------FQTEIKVIGRTHH 83
E + G V+ + + A+ KV R
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFAL----KVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 84 RNLVRLLGY--------------------------SLEVSKKILVYEYMS-----NGSLA 112
+ V+ +L+ S S
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
D ++ + + + R L + ++H P N+ + +
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPD 230
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-12
Identities = 37/134 (27%), Positives = 70/134 (52%), Gaps = 13/134 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
+ ++GRG++ VY+ ++ A+ L+K +D++ +TEI V+ R H N+++L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLK 114
Query: 91 GYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDECET 147
++ LV E ++ G L D I+ ++ + ER + I + YLH+
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN--- 167
Query: 148 QIIHCDIKPQNILM 161
I+H D+KP+N+L
Sbjct: 168 GIVHRDLKPENLLY 181
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-12
Identities = 35/136 (25%), Positives = 58/136 (42%), Gaps = 13/136 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
+ +GRGS G V R A ++ K E F+ EI+++ H N++RL
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 91 GYSLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDECE 146
E + I LV E + G L + ++ + + E I +D+ + Y H
Sbjct: 73 ET-FEDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKL-- 125
Query: 147 TQIIHCDIKPQNILMD 162
+ H D+KP+N L
Sbjct: 126 -NVAHRDLKPENFLFL 140
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-12
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 22/156 (14%)
Query: 23 AELKKITDGFK---EKVGRGSSGTVYKG---AMINRQLVAVNRLEKVLDEREREFQTEIK 76
+E +++ D F+ KVGRG+ G VYK + + A+ ++E EI
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIA 70
Query: 77 VIGRTHHRNLVRLLGYSLE-VSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARD- 133
++ H N++ L L +K+ L+++Y + L I+ + + R
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129
Query: 134 -------IARGILYLHDECETQIIHCDIKPQNILMD 162
I GI YLH ++H D+KP NIL+
Sbjct: 130 VKSLLYQILDGIHYLHAN---WVLHRDLKPANILVM 162
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-12
Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK--VLDEREREFQTEIKVIGRTHHRNLVR 88
+G+GS G V K +Q AV + K ++ E++++ + H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIERT--GIARDIARGILYLHDE 144
L LE S +V E + G L D I+ K+ + E I + + GI Y+H
Sbjct: 86 LFEI-LEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 145 CETQIIHCDIKPQNILMD 162
I+H D+KP+NIL++
Sbjct: 141 ---NIVHRDLKPENILLE 155
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-12
Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 19/138 (13%)
Query: 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDERERE-FQTEIKVIGR-THHRNL 86
D + +G GS K + Q AV K++ +R Q EI + H N+
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV----KIISKRMEANTQKEITALKLCEGHPNI 68
Query: 87 VRLLGYSLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLH 142
V+L LV E ++ G L + I K+ ++ E + I R + + ++H
Sbjct: 69 VKLHEV-FHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMH 123
Query: 143 DECETQIIHCDIKPQNIL 160
D ++H D+KP+N+L
Sbjct: 124 DV---GVVHRDLKPENLL 138
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-12
Identities = 34/136 (25%), Positives = 53/136 (38%), Gaps = 17/136 (12%)
Query: 33 KEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
K+ +G G +G V + Q A+ L R +E + G ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QEVDHHWQASG---GPHIVCILD 89
Query: 92 Y---SLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDE 144
+ + ++ E M G L I + ER I RDI I +LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 145 CETQIIHCDIKPQNIL 160
I H D+KP+N+L
Sbjct: 148 ---NIAHRDVKPENLL 160
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-12
Identities = 38/141 (26%), Positives = 62/141 (43%), Gaps = 19/141 (13%)
Query: 32 FKEKVGRGSSGTVYKGAMINR---QLVAV-----NRLEKVLDERERE-FQTEIKVIGRTH 82
E++G G V K + + A RL RE + E+ ++
Sbjct: 9 MGEELGSGQFAIVRKC--RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIARGILY 140
H N++ L + +L+ E +S G L D L AEK+ + E T + I G+ Y
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKE-SLTEDEATQFLKQILDGVHY 123
Query: 141 LHDECETQIIHCDIKPQNILM 161
LH + +I H D+KP+NI++
Sbjct: 124 LHSK---RIAHFDLKPENIML 141
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-12
Identities = 32/138 (23%), Positives = 60/138 (43%), Gaps = 19/138 (13%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRL 89
+ +G G +G V + ++ A+ K+L + + + E+++ R + ++VR+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFAL----KMLQDCPK-ARREVELHWRASQCPHIVRI 120
Query: 90 LGY---SLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLH 142
+ K + +V E + G L I + ER + I + I I YLH
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 143 DECETQIIHCDIKPQNIL 160
I H D+KP+N+L
Sbjct: 179 SI---NIAHRDVKPENLL 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-12
Identities = 35/141 (24%), Positives = 61/141 (43%), Gaps = 19/141 (13%)
Query: 32 FKEKVGRGSSGTVYKGAMINR---QLVAV-----NRLEKVLDERERE-FQTEIKVIGRTH 82
E++G G V K + A + RE + E+ ++ +
Sbjct: 16 IGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIARGILY 140
H N++ L + +L+ E +S G L D L A+K+ + E T + I G+ Y
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKE-SLSEEEATSFIKQILDGVNY 130
Query: 141 LHDECETQIIHCDIKPQNILM 161
LH + +I H D+KP+NI++
Sbjct: 131 LHTK---KIAHFDLKPENIML 148
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-12
Identities = 35/139 (25%), Positives = 65/139 (46%), Gaps = 15/139 (10%)
Query: 37 GRGSSGTVYKGA-MINRQLVAVNRLEKV-LDERERE-FQTEIKVIGRTHHRNLVRLLGYS 93
G+G+ V ++ + VA+ ++K L+ + E++++ +H N+V+L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF--- 80
Query: 94 LEV---SKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
EV K + L+ EY S G + D L + R+ R I + Y H + I
Sbjct: 81 -EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS-KFRQIVSAVQYCHQKR---I 135
Query: 150 IHCDIKPQNILMDENRCAK 168
+H D+K +N+L+D + K
Sbjct: 136 VHRDLKAENLLLDADMNIK 154
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-12
Identities = 32/138 (23%), Positives = 57/138 (41%), Gaps = 19/138 (13%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRL 89
+ +G G +G V + ++ A+ L+ R E+++ R + ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRI 76
Query: 90 LGY---SLEVSKKI-LVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLH 142
+ K + +V E + G L I + ER + I + I I YLH
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 143 DECETQIIHCDIKPQNIL 160
I H D+KP+N+L
Sbjct: 135 SI---NIAHRDVKPENLL 149
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 8e-12
Identities = 17/167 (10%), Positives = 56/167 (33%), Gaps = 39/167 (23%)
Query: 34 EKVGRGSSGTVYKG---------AM----------------INRQLVAVNRLEKVLDERE 68
+G+ + + + +++ + L + ++++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 69 ----REFQTEIKVIGRTHHRNLVRLLGY--SLEVSKKILVYEYM--SNGSLADILFN--- 117
F ++ + ++R+ + V + +Y M + + ++L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 118 AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
K R + + R + LH ++H ++P +I++D+
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 242
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-12
Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 26/168 (15%)
Query: 16 TPFSFSYAELKKITDG--FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK---------- 62
P + + KI + K+G G+ G V A+ ++K
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81
Query: 63 ---VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLAD-ILFNA 118
+++ E EI ++ H N+++L + LV E+ G L + I+
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII--- 138
Query: 119 EKQPNWIERT--GIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
+ + E I + I GI YLH I+H DIKP+NIL++
Sbjct: 139 -NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENK 182
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-12
Identities = 30/148 (20%), Positives = 61/148 (41%), Gaps = 26/148 (17%)
Query: 32 FKEKVGRGSSGTVYKG---------AM--INRQLVAVNRLEKVLDEREREFQTEIKVIGR 80
+ +G G+ G V A+ I+++ A+ + +TEI+++ +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN--VETEIEILKK 71
Query: 81 THHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNA--EKQPNWIERT--GIARDIAR 136
+H ++++ + + +V E M G L F+ + E T +
Sbjct: 72 LNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNK-RLKEATCKLYFYQMLL 125
Query: 137 GILYLHDECETQIIHCDIKPQNILMDEN 164
+ YLH+ IIH D+KP+N+L+
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQ 150
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-11
Identities = 35/139 (25%), Positives = 59/139 (42%), Gaps = 15/139 (10%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAV-----NRLEKVLDERERE-FQTEIKVIGRTHHR 84
E++G G V K A + RE + E+ ++ + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIARGILYLH 142
N++ L + +L+ E +S G L D L A+K+ + E T + I G+ YLH
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFL--AQKE-SLSEEEATSFIKQILDGVNYLH 132
Query: 143 DECETQIIHCDIKPQNILM 161
+I H D+KP+NI++
Sbjct: 133 ---TKKIAHFDLKPENIML 148
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-11
Identities = 28/135 (20%), Positives = 60/135 (44%), Gaps = 13/135 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV-LDERERE-FQTEIKVIGRTHHRNLVR 88
E++G+G+ V + + Q A + L R+ + + E ++ H N+VR
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 89 LLGYSLEVSKKILVYEYMSNGSLAD-ILFNAEKQPNWIER--TGIARDIARGILYLHDEC 145
L E L+++ ++ G L + I+ + + E + + I +L+ H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQM- 129
Query: 146 ETQIIHCDIKPQNIL 160
++H ++KP+N+L
Sbjct: 130 --GVVHRNLKPENLL 142
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 4e-11
Identities = 16/167 (9%), Positives = 55/167 (32%), Gaps = 39/167 (23%)
Query: 34 EKVGRGSSGTVYKG---------AM----------------INRQLVAVNRLEKVLDERE 68
+G+ + + + +++ + L + ++++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 69 ----REFQTEIKVIGRTHHRNLVRLL--GYSLEVSKKILVYEYM--SNGSLADILFNAEK 120
F ++ + ++R+ + V + +Y M + + ++L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 121 Q---PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
R + + R + LH ++H ++P +I++D+
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 247
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-11
Identities = 38/138 (27%), Positives = 58/138 (42%), Gaps = 15/138 (10%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAV-----NRLEKVLDERERE-FQTEIKVIGRTHHR 84
E++G G V K A R + RE + E+ ++ H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIER--TGIARDIARGILYLH 142
N++ L + IL+ E ++ G L D L AEK+ + E T + I G+ YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFL--AEKE-SLTEEEATEFLKQILNGVYYLH 131
Query: 143 DECETQIIHCDIKPQNIL 160
QI H D+KP+NI+
Sbjct: 132 ---SLQIAHFDLKPENIM 146
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-10
Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 26/147 (17%)
Query: 37 GRGSSGTVYKGA-MINRQLVAVNRLEKVLDER--------EREFQTEIKVIGRTHHRNLV 87
G GS G V + AV K+L ++ E + EI+++ R H+N++
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAV----KILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 88 RLLG-YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARD----IARGILYL 141
+L+ E +K+ +V EY G + ++ + + A + G+ YL
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQ--AHGYFCQLIDGLEYL 125
Query: 142 HDECETQIIHCDIKPQNILMDENRCAK 168
H + I+H DIKP N+L+ K
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLK 149
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-10
Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 26/144 (18%)
Query: 37 GRGSSGTVYKGA-MINRQLVAV---NRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
G G+ G V + + VAV + ++ +D E + EI + +H N+V+ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPEN-IKKEICINKMLNHENVVKFYGH 73
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR--------GILYLHDE 144
E + + L EY S G L D + G+ A+ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
I H DIKP+N+L+DE K
Sbjct: 125 ---GITHRDIKPENLLLDERDNLK 145
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-10
Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 46/171 (26%)
Query: 33 KEKVGRGSSGTVYKGA-MINRQLVAV-----NRLEKVLDEREREFQT------------- 73
K+++G+GS G V + A+ +L + R
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 74 --------EIKVIGRTHHRNLVRLLGYSLEV-----SKKI-LVYEYMSNGSLADILFNAE 119
EI ++ + H N+V+L+ EV + +V+E ++ G + ++
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVP---T 130
Query: 120 KQPNWIERTG--IARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+P E +D+ +GI YLH +IIH DIKP N+L+ E+ K
Sbjct: 131 LKP-LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIK 177
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-10
Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 26/144 (18%)
Query: 37 GRGSSGTVYKGA-MINRQLVAV---NRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
G G+ G V + + VAV + ++ +D E + EI + +H N+V+ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPEN-IKKEICINKMLNHENVVKFYGH 73
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR--------GILYLHDE 144
E + + L EY S G L D + G+ A+ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
I H DIKP+N+L+DE K
Sbjct: 125 ---GITHRDIKPENLLLDERDNLK 145
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 3e-10
Identities = 31/155 (20%), Positives = 70/155 (45%), Gaps = 43/155 (27%)
Query: 33 KEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVR 88
+ +G GS G V + + +++VA+ ++ +V ++ +R + EI ++ R +H ++V+
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVK 116
Query: 89 LL----GYSLEVSKKI-LVYEYM---------SNGSLAD-----ILFNAEKQPNWIERTG 129
+L +E ++ +V E + L + +L+N
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN------------ 164
Query: 130 IARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
+ G+ Y+H I+H D+KP N L++++
Sbjct: 165 ----LLVGVKYVH---SAGILHRDLKPANCLVNQD 192
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 6e-10
Identities = 34/154 (22%), Positives = 69/154 (44%), Gaps = 31/154 (20%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQT---EIKVI----------- 78
K+G G TV+ M+N VA+ K++ + + EIK++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAM----KIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 79 GRTHHRNLVRLLGY----SLEVSKKILVYEYMSNGSLADILFNAEKQP---NWIERTGIA 131
++++LL + ++V+E + +L ++ E + ++++ I+
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--IS 137
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDENR 165
+ + G+ Y+H C IIH DIKP+N+LM+
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 7e-10
Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 20/148 (13%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEK--------VLDEREREFQTEIKVIGRTHHR 84
+G G+ G V+ + V V ++K + D + + EI ++ R H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 85 NLVRLLGYSLEVSKKI-LVYEYMSNGS-LADILFNAEKQPNWIERTG--IARDIARGILY 140
N++++L E LV E +G L + ++ P E I R + + Y
Sbjct: 90 NIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVSAVGY 145
Query: 141 LHDECETQIIHCDIKPQNILMDENRCAK 168
L + IIH DIK +NI++ E+ K
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIK 170
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-09
Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 18/141 (12%)
Query: 37 GRGSSGTVYKGA-MINRQLVAV---NRLEKVLDERERE-FQTEIKVIGRTHHRNLVRLLG 91
G G+ G V G + VAV NR +K+ + EI+ + H ++++L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 92 YS-LEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIA--RDIARGILYLHDECET 147
Y + I +V EY+S G L D + + E+ + I G+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLD---EKESRRLFQQILSGVDYCHRHM-- 136
Query: 148 QIIHCDIKPQNILMDENRCAK 168
++H D+KP+N+L+D + AK
Sbjct: 137 -VVHRDLKPENVLLDAHMNAK 156
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-09
Identities = 40/141 (28%), Positives = 61/141 (43%), Gaps = 28/141 (19%)
Query: 37 GRGSSGTVYKGA-MINRQLVAVNRLEK--VLDER-EREFQTEIKVIGRTHHRNLVRLLGY 92
G G+ G + ++LVAV +E+ +DE +RE I H N+VR
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFK-- 82
Query: 93 SLEV---SKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARD----IARGILYLHDE 144
EV + ++ EY S G L + + NA + E AR + G+ Y H
Sbjct: 83 --EVILTPTHLAIIMEYASGGELYERICNAGRFS---EDE--ARFFFQQLLSGVSYCHSM 135
Query: 145 CETQIIHCDIKPQNILMDENR 165
QI H D+K +N L+D +
Sbjct: 136 ---QICHRDLKLENTLLDGSP 153
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-09
Identities = 34/138 (24%), Positives = 60/138 (43%), Gaps = 12/138 (8%)
Query: 37 GRGSSGTVYKGA-MINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVRLLGY 92
G G+ G V G + VAV L + + + EI+ + H ++++L Y
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL--Y 77
Query: 93 S-LEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
+ +V EY+S G L D + + R + + I + Y H ++
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR-LFQQILSAVDYCHRHM---VV 133
Query: 151 HCDIKPQNILMDENRCAK 168
H D+KP+N+L+D + AK
Sbjct: 134 HRDLKPENVLLDAHMNAK 151
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-09
Identities = 38/154 (24%), Positives = 57/154 (37%), Gaps = 34/154 (22%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAV-----NRLEKVLDER-----EREFQTEIKVIGRTH 82
+G+G GTV+ G + +R VA+ NR+ E KV
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 83 HRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG---------IAR 132
H ++RLL + E + LV E D LF+ +I G
Sbjct: 97 HPGVIRLLDW-FETQEGFMLVLERPLPA--QD-LFD------YITEKGPLGEGPSRCFFG 146
Query: 133 DIARGILYLHDECETQIIHCDIKPQNILMDENRC 166
+ I + H ++H DIK +NIL+D R
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-09
Identities = 27/174 (15%), Positives = 54/174 (31%), Gaps = 48/174 (27%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
+ +G GS G V + I + + A+ +KVL + + + E+ ++ H N+++L+ Y
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFAL---KKVLQDPRYKNR-ELDIMKVLDHVNIIKLVDY 68
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARD------------------- 133
+ + N +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 134 ---------------------IARGILYLHDECETQIIHCDIKPQNILMDENRC 166
+ R + ++H I H DIKPQN+L++
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDN 179
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-08
Identities = 30/144 (20%), Positives = 59/144 (40%), Gaps = 28/144 (19%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLLG 91
K+GRG V++ + N + V V L+ V ++++ + EIK++ N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 98
Query: 92 YSLEVSKK--ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIA-------RGILYLH 142
+ + LV+E+++N + DI + + Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-----------DIRFYMYEILKALDYCH 147
Query: 143 DECETQIIHCDIKPQNILMDENRC 166
I+H D+KP N+++D
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHR 168
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 2e-08
Identities = 30/148 (20%), Positives = 59/148 (39%), Gaps = 17/148 (11%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERER-EFQTEIKV-IGRTHH 83
+ +GRG+ G V + + VAV L++ E +E+K+ I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 84 RNLVRLLGYSLEVSKKILV-YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
N+V LLG + ++V E+ G+L+ L + +R +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS--------KRNEFVPYKTKGARFRQ 137
Query: 143 DECETQIIHCDIKPQNILMDENRCAKNF 170
+ I D+K + + ++ + +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASS 165
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-08
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 8/82 (9%)
Query: 92 YSLEVSKKILVY---EYMSNGSLADIL--FNAEKQPNWIERTGIARDIARGILYLHDECE 146
S K+ +Y + +L D + + + I IA + +LH +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 147 TQIIHCDIKPQNILMDENRCAK 168
++H D+KP NI + K
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVK 204
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-08
Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 32/152 (21%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEK------VLDEREREFQTEIKVIGRTHHR-- 84
+G G G+VY G + + VA+ +EK E+ ++ +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 85 NLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG---------IARDI 134
++RLL + E L+ E D LF+ +I G +
Sbjct: 109 GVIRLLDW-FERPDSFVLILERPEPV--QD-LFD------FITERGALQEELARSFFWQV 158
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDENRC 166
+ + H+ ++H DIK +NIL+D NR
Sbjct: 159 LEAVRHCHNCG---VLHRDIKDENILIDLNRG 187
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-08
Identities = 33/143 (23%), Positives = 65/143 (45%), Gaps = 19/143 (13%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREF---QTEIKVI------GRTHH 83
+ +G+GS G V K Q VA+ K++ +R EI+++ + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVAL----KMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLH 142
N++ +L + + +E +S +L +++ + Q + A I + + LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 143 DECETQIIHCDIKPQNILMDENR 165
+IIHCD+KP+NIL+ +
Sbjct: 218 KN---RIIHCDLKPENILLKQQG 237
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-08
Identities = 36/139 (25%), Positives = 60/139 (43%), Gaps = 15/139 (10%)
Query: 37 GRGSSGTVYKGA-MINRQLVAV---NRLEKVLDERERE-FQTEIKVIGRTHHRNLVRLLG 91
G GS G V +Q VA+ +R + + + EI + H ++++L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 92 YS-LEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
Y + I +V EY + G L D + ++ R + I I Y H I
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRR-FFQQIICAIEYCHRHK---I 129
Query: 150 IHCDIKPQNILMDENRCAK 168
+H D+KP+N+L+D+N K
Sbjct: 130 VHRDLKPENLLLDDNLNVK 148
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 6e-08
Identities = 37/134 (27%), Positives = 61/134 (45%), Gaps = 10/134 (7%)
Query: 36 VGRGSSGTVYKGAMI-NRQLVAVNRLEK--VLDEREREF-QTEIKVIGRTHHRNLVRLLG 91
+G GS TV + + A+ LEK ++ E + + E V+ R H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 92 YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
++ + +K+ Y NG L + R A +I + YLH + II
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK---GII 152
Query: 151 HCDIKPQNILMDEN 164
H D+KP+NIL++E+
Sbjct: 153 HRDLKPENILLNED 166
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-08
Identities = 35/142 (24%), Positives = 66/142 (46%), Gaps = 20/142 (14%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERE---REFQTEIKVIGRTHHRNLVRL 89
+ +G G+ G V I + VA+ +L + + R ++ E+ ++ +H+N++ L
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 90 L-----GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG-IARDIARGILYLH 142
L SLE + + +V E M +L ++ + ER + + GI +LH
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSYLLYQMLCGIKHLH 144
Query: 143 DECETQIIHCDIKPQNILMDEN 164
IIH D+KP NI++ +
Sbjct: 145 S---AGIIHRDLKPSNIVVKSD 163
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 7e-08
Identities = 36/157 (22%), Positives = 63/157 (40%), Gaps = 26/157 (16%)
Query: 35 KVGRGSSGTVYKGA-MINRQLVAVNRLEKVL---------DEREREFQTEIKVIGRTHH- 83
K+G G TV+ + ++ VA+ KV+ E ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAM----KVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 84 RNLVRLLGYSLEVSKKI-----LVYEYMSNGSLADIL--FNAEKQPNWIERTGIARDIAR 136
R +V L ++S +V+E + + L + N + P + I + + +
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK-IIQQVLQ 157
Query: 137 GILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173
G+ YLH +C +IIH DIKP+NIL+ N
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-08
Identities = 30/141 (21%), Positives = 58/141 (41%), Gaps = 18/141 (12%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQT--EIKVIGRTHHRNLVRLL 90
VG G+ G+V + + VA+ +L + + E+ ++ H N++ LL
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 91 -----GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG-IARDIARGILYLHD 143
SL LV +M L I+ E+ + + +G+ Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-QTDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 144 ECETQIIHCDIKPQNILMDEN 164
++H D+KP N+ ++E+
Sbjct: 145 ---AGVVHRDLKPGNLAVNED 162
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-08
Identities = 31/153 (20%), Positives = 52/153 (33%), Gaps = 32/153 (20%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDERE--REFQT---------EIKVIGRTH 82
+ GS G V G VA+ R+ + + EI+++ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 83 HRNLVRLLG----YSLEVSKKI-LVYEYMSN------GSLADILFNAEKQPNWIERTGIA 131
H N++ L + K+ LV E M ++ Q
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-------FM 140
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
I G+ LH+ ++H D+ P NIL+ +N
Sbjct: 141 YHILLGLHVLHE---AGVVHRDLHPGNILLADN 170
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-07
Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 21/175 (12%)
Query: 2 PVKYKIDSNYSTLTTPFSFSYAELKKIT-DGFKE-KV-GRGSSGTVY----KGAMINRQL 54
P +DS Y + + E + +T + F++ +V G+G G V + ++
Sbjct: 157 PFADYLDSIYFNRFLQWKWL--ERQPVTKNTFRQYRVLGKGGFGEVCACQVRA---TGKM 211
Query: 55 VAVNRLEK---VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGS 110
A +LEK + E E +++ + + R +V L Y+ E + LV M+ G
Sbjct: 212 YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGD 270
Query: 111 LADILFNAEKQPNWIERTGI-ARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
L +++ + R A +I G+ LH E +I++ D+KP+NIL+D++
Sbjct: 271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-07
Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 2 PVKYKIDSNYSTLTTPFSFSYAELKKIT-DGFKE-KV-GRGSSGTVY----KGAMINRQL 54
P + +DS Y + + E + + D F + +V GRG G V+ K +L
Sbjct: 158 PFQEFLDSLYFLRFLQWK--WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKA---TGKL 212
Query: 55 VAVNRLEK---VLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI-LVYEYMSNGS 110
A +L K + + E K++ + H R +V L Y+ E + LV M+ G
Sbjct: 213 YACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGD 271
Query: 111 L-ADILFNAEKQPNWIERTGI--ARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
+ I E P + E I I G+ +LH II+ D+KP+N+L+D++
Sbjct: 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDD 325
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-07
Identities = 34/155 (21%), Positives = 63/155 (40%), Gaps = 43/155 (27%)
Query: 33 KEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERE---REFQTEIKVIGRTHHRNLVR 88
K +GRGS G VY + VA+ ++ ++ ++ R + EI ++ R ++R
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIR 89
Query: 89 LLG----YSLEVSKKI-LVYEYM---------SNGSLAD-----ILFNAEKQPNWIERTG 129
L L ++ +V E + L + IL+N
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN------------ 137
Query: 130 IARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
+ G ++H E+ IIH D+KP N L++++
Sbjct: 138 ----LLLGENFIH---ESGIIHRDLKPANCLLNQD 165
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 2e-07
Identities = 27/203 (13%), Positives = 54/203 (26%), Gaps = 57/203 (28%)
Query: 15 TTPFSFSYAELKKITDGFK--EKVGRGSSGTVYKGAMINRQLVAV--------NRLEKVL 64
P FS+ T+ + EK+G G G V++ + + VA+ + +
Sbjct: 8 KGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQ-TIADHTPVAIKIIAIEGPDLVNGSH 63
Query: 65 DEREREFQTEIKV---------IGRTHHRNLVRLLG------------------------ 91
+ E EI + + L
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 92 ------YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ + +V E+ G D+ K + I + +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASL 181
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+ H D+ N+L+ + K
Sbjct: 182 --RFEHRDLHWGNVLLKKTSLKK 202
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-07
Identities = 30/140 (21%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQT--EIKVIGRTHHRNLVRLL 90
+ VG G+ G V VA+ +L + + E++++ H N++ LL
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 91 -----GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
+L+ LV +M L ++ + + + I+ + + +G+ Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQF--LVYQMLKGLRYIHA- 146
Query: 145 CETQIIHCDIKPQNILMDEN 164
IIH D+KP N+ ++E+
Sbjct: 147 --AGIIHRDLKPGNLAVNED 164
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-07
Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 18/146 (12%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREF---QTEIKVI------GRTHH 83
+G+GS G V K + ++ VA+ K++ ++ Q E++++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAI----KIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLH 142
+V L + + + LV+E +S +L D+L N + + T A+ + +L+L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 143 DECETQIIHCDIKPQNILM-DENRCA 167
E IIHCD+KP+NIL+ + R A
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSA 199
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 3e-07
Identities = 34/141 (24%), Positives = 63/141 (44%), Gaps = 18/141 (12%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQT--EIKVIGRTHHRNLVRLL 90
+ +G G+ G V + + VA+ +L + + + E+ ++ +H+N++ LL
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 91 -----GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTG-IARDIARGILYLHD 143
+LE + + LV E M A+ L + ER + + GI +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMD----AN-LCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 144 ECETQIIHCDIKPQNILMDEN 164
IIH D+KP NI++ +
Sbjct: 183 ---AGIIHRDLKPSNIVVKSD 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-07
Identities = 36/145 (24%), Positives = 58/145 (40%), Gaps = 31/145 (21%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVR 88
+GRG+ V K Q+ A+ + K +L E F+ E V+ R + +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR--------GIL 139
L ++ + + LV EY G L +L ++ I ++AR I
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGER--------IPAEMARFYLAEIVMAID 176
Query: 140 YLHDECETQIIHCDIKPQNILMDEN 164
+H +H DIKP NIL+D
Sbjct: 177 SVH---RLGYVHRDIKPDNILLDRC 198
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-07
Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 17/138 (12%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVR 88
+GRG+ G V K ++ A+ L K +L E F+ E V+ + +
Sbjct: 82 IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQ-PNWIERTGIARDIARGILYLHDECE 146
L Y+ + + LV +Y G L +L E + P + R +A ++ I +H +
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---Q 193
Query: 147 TQIIHCDIKPQNILMDEN 164
+H DIKP NILMD N
Sbjct: 194 LHYVHRDIKPDNILMDMN 211
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-07
Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 33/145 (22%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVR 88
+GRG+ G V K R++ A+ L K ++ + F E ++ + +V+
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR--------GIL 139
L Y+ + + + +V EYM G L +++ + AR +
Sbjct: 134 LF-YAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVVLALD 182
Query: 140 YLHDECETQIIHCDIKPQNILMDEN 164
+H IH D+KP N+L+D++
Sbjct: 183 AIH---SMGFIHRDVKPDNMLLDKS 204
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-06
Identities = 33/145 (22%), Positives = 63/145 (43%), Gaps = 18/145 (12%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREF---QTEIKVIGR-----THHR 84
K+G G+ G V + N++ AV KV+ ++ + E ++ + ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAV----KVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLHD 143
N+V+ G + L++E + SL +I+ IE +I + + YL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 144 ECETQIIHCDIKPQNILMDENRCAK 168
+ H D+KP+NIL+D+ K
Sbjct: 156 M---SLTHTDLKPENILLDDPYFEK 177
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-06
Identities = 33/159 (20%), Positives = 61/159 (38%), Gaps = 43/159 (27%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
+ +G G +G V+ + VA+ ++ + + EIK+I R H N+V++
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK-HALR-EIKIIRRLDHDNIVKVF 74
Query: 91 -------------GYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARD--- 133
SL + +V EYM LA++L G +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-----------EQGPLLEEHA 122
Query: 134 ------IARGILYLHDECETQIIHCDIKPQNILMDENRC 166
+ RG+ Y+H ++H D+KP N+ ++
Sbjct: 123 RLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDL 158
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-06
Identities = 30/147 (20%), Positives = 62/147 (42%), Gaps = 20/147 (13%)
Query: 34 EKVGRGSSGTVYKG--AMINRQLVAVNRLEKVLDEREREF---QTEIKVI------GRTH 82
+ +G G+ G V + + VAV K++ +R ++EI+V+
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAV----KIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYL 141
V++L + +V+E + S D + P ++ +A I + + +L
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 142 HDECETQIIHCDIKPQNILMDENRCAK 168
H ++ H D+KP+NIL ++ +
Sbjct: 135 HSN---KLTHTDLKPENILFVQSDYTE 158
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-06
Identities = 30/142 (21%), Positives = 62/142 (43%), Gaps = 23/142 (16%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK---VLDEREREFQTEIKV---IGRTHHRN 85
+GRG G VY ++ A+ L+K + + E E + +
Sbjct: 197 IGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 86 LVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGI--ARDIARGILYLH 142
+V + Y+ K+ + + M+ G D+ ++ + + E A +I G+ ++H
Sbjct: 254 IVCM-SYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 143 DECETQIIHCDIKPQNILMDEN 164
+ +++ D+KP NIL+DE+
Sbjct: 310 NR---FVVYRDLKPANILLDEH 328
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-06
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 25/145 (17%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQT--EIKVIGRTHHRNLVRLL 90
VG G+ G+V VAV +L + +T E++++ H N++ LL
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 91 -----GYSLEVSKKI-LVYEYMSNGSLADI-----LFNAEKQPNWIERTGIARDIARGIL 139
SLE + LV M L +I L + Q + I RG+
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF-------LIYQILRGLK 146
Query: 140 YLHDECETQIIHCDIKPQNILMDEN 164
Y+H IIH D+KP N+ ++E+
Sbjct: 147 YIHS---ADIIHRDLKPSNLAVNED 168
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-06
Identities = 26/147 (17%), Positives = 55/147 (37%), Gaps = 20/147 (13%)
Query: 34 EKVGRGSSGTVYKGA--MINRQLVAVNRLEKVLDEREREF---QTEIKVI------GRTH 82
+G G+ G V + + VA+ K++ + + EI V+ + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVAL----KIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYL 141
V + + + +E + + + L QP + +A + + +L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 142 HDECETQIIHCDIKPQNILMDENRCAK 168
H+ Q+ H D+KP+NIL +
Sbjct: 140 HEN---QLTHTDLKPENILFVNSEFET 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-06
Identities = 28/131 (21%), Positives = 59/131 (45%), Gaps = 10/131 (7%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH-RNLVRLLG 91
+K+G G+ G + G + + VA+ +LE + R + E + + + ++
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAI-KLEPM-KSRAPQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLHDECETQII 150
+ +V E + SL D LF+ + ++ IA + + Y+H + +I
Sbjct: 73 FGPCGKYNAMVLELLGP-SLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LI 127
Query: 151 HCDIKPQNILM 161
+ D+KP+N L+
Sbjct: 128 YRDVKPENFLI 138
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-05
Identities = 33/149 (22%), Positives = 62/149 (41%), Gaps = 35/149 (23%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVA---VNRLEKVLDEREREFQTEIKVIGRTHHRNLVRL 89
+G G+ G V +N+ VA ++ E + R + EIK++ R H N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLR-EIKILLRFRHENIIGI 90
Query: 90 LG----YSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARD---------IA 135
++E K + +V + M L +L +T + I
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-----------KTQHLSNDHICYFLYQIL 138
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDEN 164
RG+ Y+H ++H D+KP N+L++
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTT 164
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-05
Identities = 34/150 (22%), Positives = 58/150 (38%), Gaps = 33/150 (22%)
Query: 32 FKEKVGRGSSGTVYKGA-MINRQLVA---VNRLEKVLDEREREFQTEIKVIGRTHHRNLV 87
K +G G+ G V ++VA + +K L R + EIK++ H N++
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTLR-EIKILKHFKHENII 72
Query: 88 RLL----GYSLEVSKKI-LVYEYM--------SNGSLADILFNAEKQPNWIERTGIARDI 134
+ S E ++ ++ E M S L+D Q
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD----HIQY-------FIYQT 121
Query: 135 ARGILYLHDECETQIIHCDIKPQNILMDEN 164
R + LH + +IH D+KP N+L++ N
Sbjct: 122 LRAVKVLHG---SNVIHRDLKPSNLLINSN 148
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-05
Identities = 35/140 (25%), Positives = 65/140 (46%), Gaps = 20/140 (14%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDEREREFQTEIKVIGRTHHRNLVRL 89
+G+GS G V+ RQL A+ L+K + + E ++ +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 90 LGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIAR----DIARGILYLHDE 144
Y+ + K+ L+ +++ G L K+ + E + ++A + +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEED--VKFYLAELALALDHLH-- 143
Query: 145 CETQIIHCDIKPQNILMDEN 164
II+ D+KP+NIL+DE
Sbjct: 144 -SLGIIYRDLKPENILLDEE 162
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-05
Identities = 28/165 (16%), Positives = 66/165 (40%), Gaps = 19/165 (11%)
Query: 7 IDSNYSTLTTPFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEK---- 62
I NY T ++ K + +G+G+ + + + ++ ++ R++K
Sbjct: 315 IIPNYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRD 374
Query: 63 -VLDEREREFQT--EIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAE 119
LDE R+ +T E + + + + +++ K ++ Y++ D++
Sbjct: 375 ERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVI---- 430
Query: 120 KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
+ IA I + LH + +IH D+ N + D++
Sbjct: 431 -----EDNLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDKD 467
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-05
Identities = 35/138 (25%), Positives = 71/138 (51%), Gaps = 18/138 (13%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVR 88
+G GS G V+ + N + A+ L+K V+ ++ E E ++ H ++R
Sbjct: 14 LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGI-ARDIARGILYLHDECE 146
+ + + +++I ++ +Y+ G L +L +++ PN A ++ + YLH +
Sbjct: 71 MW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN--PVAKFYAAEVCLALEYLHSK-- 125
Query: 147 TQIIHCDIKPQNILMDEN 164
II+ D+KP+NIL+D+N
Sbjct: 126 -DIIYRDLKPENILLDKN 142
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-05
Identities = 34/136 (25%), Positives = 59/136 (43%), Gaps = 14/136 (10%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVR 88
+G GS G V K + A+ L+K V+ ++ E E +++ + LV+
Sbjct: 49 LGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 89 LLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ 148
L + S +V EY++ G + L + R A I YLH
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSL---D 161
Query: 149 IIHCDIKPQNILMDEN 164
+I+ D+KP+N+L+D+
Sbjct: 162 LIYRDLKPENLLIDQQ 177
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 4e-05
Identities = 33/142 (23%), Positives = 70/142 (49%), Gaps = 22/142 (15%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK---VLDEREREF-QTEIKVIGRTHHRNLV 87
+G+G G V+ ++ A+ L+K V + ++ + E ++ H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 88 RLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIAR----DIARGILYLH 142
L+ Y+ + K+ L+ EY+S G ++ E++ ++E T A +I+ + +LH
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGG---ELFMQLEREGIFMEDT--ACFYLAEISMALGHLH 138
Query: 143 DECETQIIHCDIKPQNILMDEN 164
+ II+ D+KP+NI+++
Sbjct: 139 QK---GIIYRDLKPENIMLNHQ 157
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-05
Identities = 34/141 (24%), Positives = 66/141 (46%), Gaps = 24/141 (17%)
Query: 36 VGRGSSGTV----YKGAMINRQLVAVNRLEK--VLDEREREF-QTEIKVIGRTHHRNLVR 88
+G+G+ G V K + A+ L K ++ + E TE +V+ T H L
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIAR----DIARGILYLHD 143
L Y+ + ++ V EY + G ++ F+ ++ + E AR +I + YLH
Sbjct: 70 LK-YAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEER--ARFYGAEIVSALEYLH- 122
Query: 144 ECETQIIHCDIKPQNILMDEN 164
+++ DIK +N+++D++
Sbjct: 123 --SRDVVYRDIKLENLMLDKD 141
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-05
Identities = 34/141 (24%), Positives = 68/141 (48%), Gaps = 23/141 (16%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDEREREF-QTEIKVIGRTHHRNLVR 88
+G+G+ G V K + A+ L+K ++ + E TE +V+ + H L
Sbjct: 156 LGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 89 LLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIAR----DIARGILYLHD 143
L YS + ++ V EY + G ++ F+ ++ + E AR +I + YLH
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDR--ARFYGAEIVSALDYLHS 266
Query: 144 ECETQIIHCDIKPQNILMDEN 164
E +++ D+K +N+++D++
Sbjct: 267 EKN--VVYRDLKLENLMLDKD 285
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-05
Identities = 26/131 (19%), Positives = 58/131 (44%), Gaps = 10/131 (7%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIG-RTHHRNLVRLLG 91
++G GS G +++G ++N Q VA+ + E + + E + + +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAI-KFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLHDECETQII 150
+ E +LV + + SL D L + + ++ A+ + + +H++ ++
Sbjct: 74 FGQEGLHNVLVIDLLGP-SLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 128
Query: 151 HCDIKPQNILM 161
+ DIKP N L+
Sbjct: 129 YRDIKPDNFLI 139
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-05
Identities = 35/142 (24%), Positives = 62/142 (43%), Gaps = 10/142 (7%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLLG 91
K+G GS G +Y G + + VA+ +LE V + + E K+ + +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAI-KLENV-KTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERT-GIARDIARGILYLHDECETQII 150
+ +E +LV + + SL D LFN + ++ +A + + ++H + +
Sbjct: 71 FGVEGDYNVLVMDLLGP-SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 151 HCDIKPQNILMDENRCAKNFRL 172
H DIKP N LM R A +
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYI 147
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-05
Identities = 37/142 (26%), Positives = 59/142 (41%), Gaps = 26/142 (18%)
Query: 36 VGRGSSGTVY----KG-----AM--INRQ-LVAVNRLEKVLDEREREFQTEIKVIGRTHH 83
+G+GS G V AM +N+Q V N + V E +++ H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL--------QIMQGLEH 74
Query: 84 RNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
LV L YS + + + +V + + G L L + I ++ + YL
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQ 132
Query: 143 DECETQIIHCDIKPQNILMDEN 164
+IIH D+KP NIL+DE+
Sbjct: 133 ---NQRIIHRDMKPDNILLDEH 151
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 37/147 (25%), Positives = 63/147 (42%), Gaps = 28/147 (19%)
Query: 32 FKEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQT--EIKVIGR-THHRNLV 87
+K+G+G+ G V+K ++VAV ++ +T EI ++ + H N+V
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 88 RLLGYSLEVSKK--ILVYEYMSNGSLAD--------ILFNAEKQPNWIERTGIARDIARG 137
LL + + LV++YM D IL KQ + + +
Sbjct: 73 NLLNVLRADNDRDVYLVFDYME----TDLHAVIRANILEPVHKQY-------VVYQLIKV 121
Query: 138 ILYLHDECETQIIHCDIKPQNILMDEN 164
I YLH ++H D+KP NIL++
Sbjct: 122 IKYLHS---GGLLHRDMKPSNILLNAE 145
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 1e-04
Identities = 32/141 (22%), Positives = 56/141 (39%), Gaps = 8/141 (5%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLLG 91
K+G GS G +Y G + + VA+ +LE V + + E K+ + +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAI-KLECV-KTKHPQLHIESKIYKMMQGGVGIPTIRW 72
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
E ++V E + SL D+ ++ + +A + I Y+H IH
Sbjct: 73 CGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 128
Query: 152 CDIKPQNILMDENRCAKNFRL 172
D+KP N LM + +
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYI 149
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 5e-04
Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 25/142 (17%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDEREREF-QTEIKVIGR-THHRNLV 87
+GRGS V K ++ A+ ++K V D+ + ++ QTE V + ++H LV
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 88 RLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIAR----DIARGILYLH 142
L + ++ V EY++ G D++F+ ++Q E AR +I+ + YLH
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEH--ARFYSAEISLALNYLH 127
Query: 143 DECETQIIHCDIKPQNILMDEN 164
E II+ D+K N+L+D
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSE 146
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 38.4 bits (90), Expect = 6e-04
Identities = 39/142 (27%), Positives = 72/142 (50%), Gaps = 25/142 (17%)
Query: 36 VGRGSSGTVY----KGAMINRQLVAVNRLEK--VLDEREREF-QTEIKVIGR-THHRNLV 87
+G+GS G V K AV L+K +L ++E + +E V+ + H LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 88 RLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIAR----DIARGILYLH 142
L +S + + K+ V +Y++ G ++ ++ +++ ++E AR +IA + YLH
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPR--ARFYAAEIASALGYLH 156
Query: 143 DECETQIIHCDIKPQNILMDEN 164
I++ D+KP+NIL+D
Sbjct: 157 ---SLNIVYRDLKPENILLDSQ 175
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 183 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.98 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.95 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.95 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.94 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.92 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.92 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.92 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.91 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.9 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.18 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.51 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.94 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.17 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.19 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 88.49 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=233.62 Aligned_cols=148 Identities=20% Similarity=0.206 Sum_probs=125.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.|.+.+.||+|+||.||+|... +++.||+|.+.+. .......+.+|+.+++.++||||+++++++.+.+.+||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4677789999999999999976 5889999998653 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+||+|.+++.... ..+++..+..++.|++.||.|+|++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999997543 3467788888999999999999998 99999999999999999999999999999764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=230.16 Aligned_cols=147 Identities=27% Similarity=0.443 Sum_probs=129.1
Q ss_pred HhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
.+.+.+.||+|+||.||+|... ++..||+|.++.......+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3556789999999999999864 3678999999876555667899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC------------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccc
Q 048219 103 YEYMSNGSLADILFNA------------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~ 170 (183)
|||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999653 24578889999999999999999998 99999999999999999999999
Q ss_pred ceeccccc
Q 048219 171 RLWIGKVD 178 (183)
Q Consensus 171 dfg~a~~~ 178 (183)
|||+|+..
T Consensus 171 DFGla~~~ 178 (299)
T 4asz_A 171 DFGMSRDV 178 (299)
T ss_dssp CCSCHHHH
T ss_pred Ccccceec
Confidence 99999854
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=234.16 Aligned_cols=144 Identities=23% Similarity=0.315 Sum_probs=129.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+|+.++||||++++++|.+.+.+|||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 555678999999999999976 5889999998754433445678999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 156 g~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 156 GALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceec
Confidence 999998865 3578888899999999999999998 9999999999999999999999999999865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=228.04 Aligned_cols=146 Identities=25% Similarity=0.254 Sum_probs=131.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+.+|+.+|+.++||||+++++++++.+.+|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3778889999999999999976 588999999976432 224568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++||+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 113 y~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 113 YAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 99999999999764 3577888888999999999999998 9999999999999999999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=229.10 Aligned_cols=145 Identities=24% Similarity=0.399 Sum_probs=125.4
Q ss_pred chhcccCcCcCceEEEEEEc------CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 31 GFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+|.+++||||+++++++.+.+..++|||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 44578999999999999864 367899999987655666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC--------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccc
Q 048219 105 YMSNGSLADILFNAE--------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~ 170 (183)
|+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 999999999986532 2477888899999999999999998 99999999999999999999999
Q ss_pred ceeccccc
Q 048219 171 RLWIGKVD 178 (183)
Q Consensus 171 dfg~a~~~ 178 (183)
|||+|+..
T Consensus 201 DFGla~~~ 208 (329)
T 4aoj_A 201 DFGMSRDI 208 (329)
T ss_dssp CCC-----
T ss_pred ccccceec
Confidence 99999854
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=235.48 Aligned_cols=144 Identities=23% Similarity=0.317 Sum_probs=129.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+|+.++||||++++++|.+.+.+|||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 556678999999999999976 5889999998654333445688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 233 G~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 233 GALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999998653 478888899999999999999998 9999999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=224.55 Aligned_cols=144 Identities=32% Similarity=0.451 Sum_probs=125.0
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.+.||+|+||.||+|.... .+|+|.++.. .......+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCC
Confidence 3466789999999999998654 5888887632 2345567999999999999999999999874 567899999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|+|.+++......+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999977666788999999999999999999998 99999999999999999999999999998653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=224.22 Aligned_cols=147 Identities=26% Similarity=0.378 Sum_probs=127.4
Q ss_pred HhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
...+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3567789999999999999853 35789999986532 2334678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc
Q 048219 102 VYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC 166 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~ 166 (183)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999996431 3477888899999999999999998 9999999999999999999
Q ss_pred ccccceeccccc
Q 048219 167 AKNFRLWIGKVD 178 (183)
Q Consensus 167 ~~i~dfg~a~~~ 178 (183)
+||+|||+|+..
T Consensus 184 ~Ki~DFGlar~~ 195 (308)
T 4gt4_A 184 VKISDLGLFREV 195 (308)
T ss_dssp EEECCSCCBCGG
T ss_pred EEECCcccceec
Confidence 999999999854
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=219.50 Aligned_cols=147 Identities=28% Similarity=0.354 Sum_probs=124.8
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe----CCeEEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE----VSKKILVY 103 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~ 103 (183)
.+.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+.+++.++||||++++++|.+ ...+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45668999999999999976 4788999998643 23345678999999999999999999999875 34589999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~~ 179 (183)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++. ++.+||+|||+|++..
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999754 4577888888999999999999997 113999999999999984 7899999999998654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=217.12 Aligned_cols=146 Identities=23% Similarity=0.322 Sum_probs=123.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4778889999999999999965 588999999865422 224568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+ +|+|.+.+... ..+++..+..++.|++.||.|+|++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 94 y~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 94 YA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp CC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred CC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99 67999988764 4578888889999999999999998 99999999999999999999999999998653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=219.35 Aligned_cols=147 Identities=19% Similarity=0.236 Sum_probs=120.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC----------
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS---------- 97 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---------- 97 (183)
|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+|+.++||||++++++|.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 567789999999999999976 57899999986543 233467889999999999999999999997654
Q ss_pred --eEEEEEeccCCCCHHHHHhcCCC--CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 98 --KKILVYEYMSNGSLADILFNAEK--QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 98 --~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
.+|++||||++++|.+++..... ...+..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999975432 233455677899999999999998 99999999999999999999999999
Q ss_pred cccccc
Q 048219 174 IGKVDE 179 (183)
Q Consensus 174 ~a~~~~ 179 (183)
+|+..+
T Consensus 164 la~~~~ 169 (299)
T 4g31_A 164 LVTAMD 169 (299)
T ss_dssp CC----
T ss_pred cceecC
Confidence 998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=222.92 Aligned_cols=140 Identities=21% Similarity=0.180 Sum_probs=123.9
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+.+.||+|+||.||+|.+. ++..||+|.+.... ...+|+.+++.++||||+++++++.+.+.+||||||++|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 445568999999999999976 57899999986532 124699999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~ 178 (183)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 135 g~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 135 GSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 9999999764 3578888889999999999999998 999999999999999887 6999999999865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=222.65 Aligned_cols=146 Identities=25% Similarity=0.241 Sum_probs=123.0
Q ss_pred HhchhcccCcCcCceEEEEEEc----CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
.|.+.+.||+|+||.||+|+.. .++.+|+|.+.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4778899999999999999863 35789999986432 11223577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|||++||+|.+++... ..+++..+..++.|++.||.|+|++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999764 3577888888999999999999998 9999999999999999999999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=213.74 Aligned_cols=146 Identities=25% Similarity=0.275 Sum_probs=120.8
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC----eEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS----KKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|.+ ++..||+|.+...... ......|+..+..++||||+++++++...+ ..++||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 45668899999999999987 5778999998754322 122334666667889999999999997654 57999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCC-----CCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC-----ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++|+|.+++... .+++..+..++.|++.||.|+|++. ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 ~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999999753 4778888889999999999999741 2389999999999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=220.80 Aligned_cols=153 Identities=22% Similarity=0.313 Sum_probs=129.2
Q ss_pred HHHHHHHhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCC-CceeeeeceEE
Q 048219 23 AELKKITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHH-RNLVRLLGYSL 94 (183)
Q Consensus 23 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~ 94 (183)
+++....+.+.+.||+|+||.||+|.... .+.||+|.+.... ......+.+|+.+|.++.| |||++++++|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 34455567778899999999999998543 3579999987543 3345678999999999976 89999999987
Q ss_pred eC-CeEEEEEeccCCCCHHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCC
Q 048219 95 EV-SKKILVYEYMSNGSLADILFNA---------------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQN 158 (183)
Q Consensus 95 ~~-~~~~lv~e~~~~~~l~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~n 158 (183)
.+ +.+++|||||++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 64 5689999999999999999643 13367888888999999999999998 99999999999
Q ss_pred EEecCCCcccccceeccccc
Q 048219 159 ILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 159 il~~~~~~~~i~dfg~a~~~ 178 (183)
||+++++.+||+|||+|+..
T Consensus 216 ILl~~~~~vKi~DFGlar~~ 235 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDI 235 (353)
T ss_dssp EEECGGGCEEECCCGGGSCT
T ss_pred eeeCCCCCEEECcchhhhhc
Confidence 99999999999999999865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=213.40 Aligned_cols=144 Identities=22% Similarity=0.325 Sum_probs=125.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEe------CCeEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLE------VSKKI 100 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~ 100 (183)
|.+.+.||+|+||.||+|... +++.||+|.+.+.. ......+.+|+.+|+.++||||+++++++.. .+.+|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 666789999999999999976 58899999986532 3345678899999999999999999998764 35789
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||||++ |+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 136 ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 9999996 6899988653 4678888899999999999999998 9999999999999999999999999999865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=222.08 Aligned_cols=148 Identities=20% Similarity=0.311 Sum_probs=132.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.|.+.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+|+.++||||++++++|.+.+.++++|||++
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 3667789999999999999976 588999999876555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC--Ccccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN--RCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~--~~~~i~dfg~a~~~~ 179 (183)
||+|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||+|+...
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999976555678888889999999999999998 99999999999999854 789999999998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=211.14 Aligned_cols=141 Identities=16% Similarity=0.254 Sum_probs=123.7
Q ss_pred HhchhcccCcCcCceEEEEEEc----CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.|.+.+.||+|+||.||+|..+ .++.||+|.+.+.. ...++.+|+.++..+ +||||+++++++.+.+++++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 3677789999999999999854 36789999886542 234577899999988 6999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~~~ 178 (183)
||+++++|.+.+. .+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 100 E~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 100 PYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp ECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999883 477888889999999999999998 99999999999999877 79999999999854
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-32 Score=219.10 Aligned_cols=146 Identities=20% Similarity=0.177 Sum_probs=124.1
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHH---HHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQT---EIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
+.+.+.||+|+||.||+|... +++.+|+|.+.+.... ....+.+ ++.++..++||||++++++|.+.+.+|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 445578999999999999976 5889999998754211 1122333 45667778999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|||++||+|.+.+... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+|+...
T Consensus 271 mEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp ECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999764 3577888888999999999999998 99999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=191.07 Aligned_cols=147 Identities=27% Similarity=0.447 Sum_probs=133.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+.++..++||||+++++++.+.+..+++||+++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 4566789999999999999976 478899998876655666788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++......+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999987666788888899999999999999998 9999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=190.63 Aligned_cols=146 Identities=22% Similarity=0.308 Sum_probs=129.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.+. .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 3667789999999999999974 6889999998654 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++.+++... ..+++.....++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 96 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 96 ASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp CTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999988654 3467788888999999999999998 9999999999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=190.89 Aligned_cols=149 Identities=29% Similarity=0.453 Sum_probs=130.9
Q ss_pred HHhchhcccCcCcCceEEEEEEc----CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 34566688999999999999875 34469999987542 33456788999999999999999999999988899999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|||+++++|.+++......+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+|+...
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999976656788888999999999999999998 99999999999999999999999999998653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=197.65 Aligned_cols=146 Identities=23% Similarity=0.178 Sum_probs=128.1
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHH---HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|.... ++.+|+|.+.+..... ...+.+|..++..++||||+++++++.+.+..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4556789999999999999775 6789999987532221 12378899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 999999999977556688888888999999999999998 9999999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=187.60 Aligned_cols=145 Identities=27% Similarity=0.361 Sum_probs=129.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 4666789999999999999864 578899999865544445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 101 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 101 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp TCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 99999998653 477888888999999999999998 9999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=192.83 Aligned_cols=148 Identities=32% Similarity=0.489 Sum_probs=124.8
Q ss_pred HhchhcccCcCcCceEEEEEEc----CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++..++||||+++++++...+..+++|
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 4566689999999999999865 46679999987542 334567899999999999999999999999889999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||+++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+...
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999977666688888889999999999999998 99999999999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=183.87 Aligned_cols=146 Identities=28% Similarity=0.419 Sum_probs=131.0
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.+.||+|+||.||+|...++..+++|.+..... ....+.+|+.+++.++||||+++++++.+.+..+++||++++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 4667789999999999999988888899999875432 235688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.+++......+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccc
Confidence 999999977666678888889999999999999998 9999999999999999999999999999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-29 Score=186.95 Aligned_cols=147 Identities=25% Similarity=0.342 Sum_probs=127.5
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhH--HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE--REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||+|+||.||+|...++..+++|.+...... ....+.+|+.+++.++||||+++++++.+....+++||++
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 46667899999999999999988899999998643221 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++ ++.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+...
T Consensus 102 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 102 EK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 75 88888876666678888888999999999999998 99999999999999999999999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=188.42 Aligned_cols=146 Identities=21% Similarity=0.200 Sum_probs=128.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... +++.+++|.+.+... .....+..|+.+++.++||||+++++++.+.+..+++||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 3566789999999999999976 578899999875421 224567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|...+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 86 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 86 YANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp CCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 99999999988653 3567788888999999999999998 9999999999999999999999999999853
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=187.78 Aligned_cols=149 Identities=27% Similarity=0.415 Sum_probs=130.0
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-----CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKK 99 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 99 (183)
...+.+.+.||+|+||.||+|... .+..+++|.+..........+.+|+.++..++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 345777889999999999999842 478899999877655666778999999999999999999999864 4568
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++||++++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999977655578888889999999999999998 9999999999999999999999999999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-29 Score=193.31 Aligned_cols=146 Identities=22% Similarity=0.134 Sum_probs=128.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH---HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||++... +++.+|+|.+.+..... ...+.+|..++..+.|++|+++++++.+.+..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 445578999999999999976 58899999987542211 23477899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheec
Confidence 999999999976555677888888999999999999998 9999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=189.30 Aligned_cols=147 Identities=23% Similarity=0.367 Sum_probs=126.8
Q ss_pred HhchhcccCcCcCceEEEEEEc--------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI--------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~--------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
.+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 4556678999999999999853 24569999987543 33456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC
Q 048219 99 KILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE 163 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~ 163 (183)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 999999999999999997543 2367778888999999999999998 9999999999999999
Q ss_pred CCcccccceeccccc
Q 048219 164 NRCAKNFRLWIGKVD 178 (183)
Q Consensus 164 ~~~~~i~dfg~a~~~ 178 (183)
++.+||+|||+|+..
T Consensus 239 ~~~~kl~DFG~a~~~ 253 (370)
T 2psq_A 239 NNVMKIADFGLARDI 253 (370)
T ss_dssp TCCEEECCCSSCEET
T ss_pred CCCEEEccccCCccc
Confidence 999999999999844
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=190.38 Aligned_cols=148 Identities=23% Similarity=0.268 Sum_probs=128.3
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 101 (183)
...+.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+..|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 345677789999999999999976 478899999876421 2235577899999887 69999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||||+++++|...+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999988654 3477888888999999999999998 9999999999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=190.47 Aligned_cols=148 Identities=20% Similarity=0.316 Sum_probs=130.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+.++..++||||+++++++.+....+++|||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4667789999999999999976 578899999876555555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC--CCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE--NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~--~~~~~i~dfg~a~~~~ 179 (183)
+++|.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++. .+.+||+|||+|+...
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999876555678888899999999999999998 9999999999999974 4679999999998653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-28 Score=184.72 Aligned_cols=146 Identities=18% Similarity=0.269 Sum_probs=129.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..+++||+++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 3567788999999999999976 47788999886442 344567899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC--CCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE--NRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~--~~~~~i~dfg~a~~~ 178 (183)
+++|.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++. ++.+||+|||+|+..
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999976555678888899999999999999998 9999999999999987 789999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=193.17 Aligned_cols=148 Identities=24% Similarity=0.376 Sum_probs=130.0
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
..+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++|||+
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34556688999999999999986 67889999987543 23345678899999999999999999999988899999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++......+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999976555577888888999999999999998 9999999999999999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=192.92 Aligned_cols=144 Identities=21% Similarity=0.192 Sum_probs=125.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH---HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... +++.+|+|.+.+..... ...+.+|..++..++||||+++++++.+....++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 445578999999999999976 47889999987532211 23477899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... .+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 151 ~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 151 MPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp CTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999988653 467888888999999999999998 9999999999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-28 Score=184.92 Aligned_cols=148 Identities=19% Similarity=0.230 Sum_probs=124.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC---------
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS--------- 97 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 97 (183)
.+.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 4667789999999999999976 68899999986432 234467889999999999999999999986543
Q ss_pred ------------------------------------------------eEEEEEeccCCCCHHHHHhcCCC--CCChHHH
Q 048219 98 ------------------------------------------------KKILVYEYMSNGSLADILFNAEK--QPNWIER 127 (183)
Q Consensus 98 ------------------------------------------------~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~ 127 (183)
..+++||++++++|.+++..... ...+..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 27999999999999999976432 2344456
Q ss_pred HHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 128 TGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 128 ~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+...
T Consensus 167 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 215 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215 (332)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECS
T ss_pred HHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccc
Confidence 77999999999999998 99999999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=182.29 Aligned_cols=147 Identities=25% Similarity=0.329 Sum_probs=131.1
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.+.+.||+|+||.||+|...++..+++|.+..... ....+.+|+.++..++||||+++++++...+..+++||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 35667789999999999999988888899999875432 23567889999999999999999999998999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceec
Confidence 9999999976555678888899999999999999998 9999999999999999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=181.95 Aligned_cols=148 Identities=24% Similarity=0.337 Sum_probs=128.8
Q ss_pred HHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
...+.+.+.||+|+||.||++....+..+++|.+..... ....+.+|+.++..++|+||+++++++...+..+++||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 345667789999999999999988888899999875422 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999976555678888899999999999999998 9999999999999999999999999999854
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=183.17 Aligned_cols=148 Identities=22% Similarity=0.296 Sum_probs=130.2
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-C-------cEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-R-------QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~-------~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
..+.+.+.||+|+||.||+|.... + ..+++|.+..........+.+|+.+++.++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 356677899999999999998653 2 46899998766555567789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc--------ccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC--------AKNFR 171 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~--------~~i~d 171 (183)
+++||++++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++. ++|+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999977655578888888999999999999998 9999999999999998876 99999
Q ss_pred eeccccc
Q 048219 172 LWIGKVD 178 (183)
Q Consensus 172 fg~a~~~ 178 (183)
||+|...
T Consensus 165 fg~~~~~ 171 (289)
T 4fvq_A 165 PGISITV 171 (289)
T ss_dssp CCSCTTT
T ss_pred Ccccccc
Confidence 9999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-28 Score=184.56 Aligned_cols=146 Identities=23% Similarity=0.281 Sum_probs=128.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... +++.+++|.+.+... .....+.+|..++..++||||+++++++.+....+++||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 3566789999999999999976 578899999875432 123567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+++... ..+++.....++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 87 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 87 YIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp CCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceec
Confidence 99999999999764 3467778888999999999999998 9999999999999999999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-28 Score=182.11 Aligned_cols=147 Identities=28% Similarity=0.356 Sum_probs=128.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+|.+.+.||+|+||.||+|... .+..+++|.+... .......+.+|+.++..++||||+++++++...+..+++||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 4667789999999999999975 5788999987432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+++++|.+++... ..+++.....++.|++.||.|+|++ +++|+||||+||+++.++.++|+|||+|+...
T Consensus 92 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 92 YIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999998654 3567888888999999999999998 99999999999999999999999999998653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-28 Score=185.09 Aligned_cols=146 Identities=25% Similarity=0.261 Sum_probs=127.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||+|... +++.+++|.+.+.. ......+..|..++..+ +||||+++++++.+.+..+++|
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3566789999999999999976 47889999987542 23345678899999887 8999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+++++|.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 90 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999988653 3467888888999999999999998 9999999999999999999999999999853
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=186.05 Aligned_cols=146 Identities=37% Similarity=0.558 Sum_probs=129.1
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
+.+.+.||+|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++...+..+++||+++++
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 44556899999999999998788899999887654445567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC---CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 110 SLADILFNAE---KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 110 ~l~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999885432 2467888888999999999999998 9999999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=184.67 Aligned_cols=148 Identities=32% Similarity=0.459 Sum_probs=124.4
Q ss_pred HHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
...+.+.+.||+|+||.||+|.. .+..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 34566778999999999999976 56779999876432 3344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCC--CCChHHHHHHHHHHHHHHHHhhhCCCCC--ceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEK--QPNWIERTGIARDIARGILYLHDECETQ--IIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+++..... .+++..+..++.|++.||.|||++ + ++|+||||+||+++.++.+||+|||+|+..
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 9999999999975431 267788888999999999999997 7 999999999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=190.37 Aligned_cols=145 Identities=25% Similarity=0.244 Sum_probs=125.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+..|..++..+ +||||+++++++.+.+..++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 4566789999999999999976 477899999876432 2224577888888776 7999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
||+++++|...+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 133 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999988654 3577888888999999999999998 999999999999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-28 Score=188.08 Aligned_cols=147 Identities=21% Similarity=0.231 Sum_probs=129.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
..+.+.+.||+|+||.||++... +++.+|+|.+.+... .....+.+|+.++..++||||+++++++.+....+++|
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34667789999999999999976 478899999865431 22356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+++++|...+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+|+..
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 999999999988653 4577888888999999999999998 9999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-28 Score=188.18 Aligned_cols=143 Identities=24% Similarity=0.344 Sum_probs=122.0
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
+.||+|+||.||+|... ++..+++|.+..........+.+|+.++..++||||+++++++...+..++||||+++++|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 56999999999999875 57889999987655455667899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe--cCCCcccccceecccccc
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM--DENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~--~~~~~~~i~dfg~a~~~~ 179 (183)
+.+......+++..+..++.|++.||.|||+. +|+|+||||+||++ +.++.+||+|||+|+...
T Consensus 175 ~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 175 DRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp HHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 98876555677888888999999999999998 99999999999999 566789999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-28 Score=183.82 Aligned_cols=155 Identities=21% Similarity=0.274 Sum_probs=133.2
Q ss_pred eeCHHHHHHHHh------------chhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCc
Q 048219 19 SFSYAELKKITD------------GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN 85 (183)
Q Consensus 19 ~~~~~~~~~~~~------------~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~ 85 (183)
.++..+++.... ...+.||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 355666655543 33457999999999999976 68899999987544444567889999999999999
Q ss_pred eeeeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
|+++++++...+..+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence 99999999999999999999999999998854 4577888889999999999999998 999999999999999999
Q ss_pred cccccceeccccc
Q 048219 166 CAKNFRLWIGKVD 178 (183)
Q Consensus 166 ~~~i~dfg~a~~~ 178 (183)
.+||+|||+|+..
T Consensus 179 ~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 179 RVKLSDFGFCAQI 191 (321)
T ss_dssp CEEECCCTTCEEC
T ss_pred cEEEeeeeeeeec
Confidence 9999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=187.36 Aligned_cols=148 Identities=22% Similarity=0.278 Sum_probs=127.9
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 101 (183)
...+.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+..|..++..+ +||||+++++++.+....++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 345667789999999999999976 578899999876421 2234577888888876 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||||+++++|.+++... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 96 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999998653 3467888888999999999999998 9999999999999999999999999999853
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-28 Score=185.41 Aligned_cols=146 Identities=21% Similarity=0.179 Sum_probs=128.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... ++..+++|.+.+... .....+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 455678999999999999976 578999999865432 1235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 123 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 123 VAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp CTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999998754 3467888888999999999999998 99999999999999999999999999998543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=185.24 Aligned_cols=155 Identities=23% Similarity=0.297 Sum_probs=129.9
Q ss_pred HHHHHHHHhchhcccCcCcCceEEEEEE-----cCCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEe
Q 048219 22 YAELKKITDGFKEKVGRGSSGTVYKGAM-----INRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLE 95 (183)
Q Consensus 22 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (183)
...+....+.+.+.||+|+||.||+|.. ..+..+++|.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3334445577788999999999999983 3578899999875322 223568899999999999999999999986
Q ss_pred C--CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 96 V--SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 96 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
. ...+++||++++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence 6 668999999999999999966556678888899999999999999998 99999999999999999999999999
Q ss_pred cccccc
Q 048219 174 IGKVDE 179 (183)
Q Consensus 174 ~a~~~~ 179 (183)
+|+...
T Consensus 172 ~~~~~~ 177 (302)
T 4e5w_A 172 LTKAIE 177 (302)
T ss_dssp TCEECC
T ss_pred cccccc
Confidence 998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-28 Score=185.82 Aligned_cols=150 Identities=19% Similarity=0.201 Sum_probs=128.0
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH-----HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE-----REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
...|.+.+.||+|+||.||+|... +++.+++|.+...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 346788899999999999999876 5788999998643211 2456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc---ccccceec
Q 048219 101 LVYEYMSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC---AKNFRLWI 174 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~---~~i~dfg~ 174 (183)
++|||+++++|.+.+... ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877542 23467888888999999999999998 9999999999999987654 99999999
Q ss_pred ccccc
Q 048219 175 GKVDE 179 (183)
Q Consensus 175 a~~~~ 179 (183)
|+...
T Consensus 180 a~~~~ 184 (351)
T 3c0i_A 180 AIQLG 184 (351)
T ss_dssp CEECC
T ss_pred eeEec
Confidence 97653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=183.15 Aligned_cols=145 Identities=23% Similarity=0.342 Sum_probs=127.5
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
|.+.+.||+|+||.||+|....++.+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..+++||+++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 566788999999999999987788999998864321 123567789999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ ++.+.+......+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 5 89988876656678888888999999999999998 9999999999999999999999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=180.18 Aligned_cols=146 Identities=23% Similarity=0.314 Sum_probs=126.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 566788999999999999976 47889999886432 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++ ++.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+...
T Consensus 84 ~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 84 DQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 75 67666666556688888899999999999999998 99999999999999999999999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=186.41 Aligned_cols=146 Identities=23% Similarity=0.316 Sum_probs=127.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH------HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE------REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.+.... ....+.+|+.++..++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 3667789999999999999976 5788999998653221 23568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC----cccccceecccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR----CAKNFRLWIGKV 177 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~----~~~i~dfg~a~~ 177 (183)
+||++++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .+||+|||+|+.
T Consensus 93 v~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 93 ILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999998653 4577888889999999999999998 999999999999998776 799999999986
Q ss_pred c
Q 048219 178 D 178 (183)
Q Consensus 178 ~ 178 (183)
.
T Consensus 169 ~ 169 (361)
T 2yab_A 169 I 169 (361)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=184.35 Aligned_cols=146 Identities=21% Similarity=0.231 Sum_probs=121.4
Q ss_pred HHhchhcccCcCcCceEEEEEEc----CCcEEEEEEccchh----hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL----DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
..+.+.+.||+|+||.||++... .++.+++|.+.+.. ......+.+|+.+++.++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 45777789999999999999863 67889999987542 12234577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
+++|||+++++|.+.+... ..+.+.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999988653 3466777888999999999999998 999999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=183.78 Aligned_cols=149 Identities=25% Similarity=0.356 Sum_probs=130.7
Q ss_pred HHhchhcccCcCcCceEEEEEE-----cCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEE--eCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAM-----INRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSL--EVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 100 (183)
..+.+.+.||+|+||.||+|.. ..+..+++|.+..........+.+|+.+++.++|+||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4567778999999999999984 257889999987765566677899999999999999999999887 456689
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++||++++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 99999999999999976445578888889999999999999998 99999999999999999999999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=187.87 Aligned_cols=148 Identities=18% Similarity=0.254 Sum_probs=127.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 45778889999999999999875 57889999886432 3344568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~~ 179 (183)
++++++|.+.+... ..+++.....++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+|+...
T Consensus 91 ~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 91 LVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999988764 4577888889999999999999998 9999999999999984 5789999999997653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=185.07 Aligned_cols=146 Identities=19% Similarity=0.194 Sum_probs=129.6
Q ss_pred HhchhcccCcC--cCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRG--SSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g--~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.|.+.+.||+| +||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 57778899999 99999999976 58899999986542 334466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 104 EYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|++++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||.+..
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999987642 4577888888999999999999998 999999999999999999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=186.01 Aligned_cols=159 Identities=42% Similarity=0.644 Sum_probs=132.7
Q ss_pred eCHHHHHHH--HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhH-HHHHHHHHHHHHhhcCCCceeeeeceEEeC
Q 048219 20 FSYAELKKI--TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE-REREFQTEIKVIGRTHHRNLVRLLGYSLEV 96 (183)
Q Consensus 20 ~~~~~~~~~--~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (183)
++..++... .+.+.+.||+|+||.||+|...++..+++|.+...... ....+.+|+.++..++||||+++++++...
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 444544444 45556789999999999998777889999998754322 223578899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 97 SKKILVYEYMSNGSLADILFNAE---KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
+..+++||++++++|.+++.... ..+++..+..++.|++.||.|||+.+..+++|+||||+||+++.++.++|+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999997643 237788888999999999999998644589999999999999999999999999
Q ss_pred ccccc
Q 048219 174 IGKVD 178 (183)
Q Consensus 174 ~a~~~ 178 (183)
+|+..
T Consensus 180 ~~~~~ 184 (326)
T 3uim_A 180 LAKLM 184 (326)
T ss_dssp SCEEC
T ss_pred ccccc
Confidence 99865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-28 Score=185.98 Aligned_cols=152 Identities=24% Similarity=0.341 Sum_probs=130.4
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc--------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI--------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSL 94 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (183)
+....+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 33456677789999999999999853 23568999987543 33446788999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCE
Q 048219 95 EVSKKILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNI 159 (183)
Q Consensus 95 ~~~~~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ni 159 (183)
..+..+++||++++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 9999999999999999999997643 2477888899999999999999998 999999999999
Q ss_pred EecCCCcccccceecccccc
Q 048219 160 LMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 160 l~~~~~~~~i~dfg~a~~~~ 179 (183)
+++.++.+||+|||+|+...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~ 242 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIH 242 (382)
T ss_dssp EECTTCCEEECSCSCCCCSS
T ss_pred EEcCCCcEEEcccCcccccc
Confidence 99999999999999998553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=186.36 Aligned_cols=145 Identities=21% Similarity=0.191 Sum_probs=122.1
Q ss_pred HHhchhcccCcCcCceEEEEE------EcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC---CCceeeeeceEEeCCe
Q 048219 28 ITDGFKEKVGRGSSGTVYKGA------MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH---HRNLVRLLGYSLEVSK 98 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~ 98 (183)
..+.+.+.||+|+||.||+|. ...++.+++|.+..... ..+..|+.++..+. |++++++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345566789999999999994 34578899999876432 34556666666665 8999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhc----CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-----------
Q 048219 99 KILVYEYMSNGSLADILFN----AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE----------- 163 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~----------- 163 (183)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999964 235578888999999999999999998 9999999999999998
Q ss_pred CCcccccceeccccc
Q 048219 164 NRCAKNFRLWIGKVD 178 (183)
Q Consensus 164 ~~~~~i~dfg~a~~~ 178 (183)
++.+||+|||+|+..
T Consensus 219 ~~~~kl~DFG~a~~~ 233 (365)
T 3e7e_A 219 SAGLALIDLGQSIDM 233 (365)
T ss_dssp CTTEEECCCTTCEEG
T ss_pred cCCEEEeeCchhhhh
Confidence 899999999999643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=188.90 Aligned_cols=152 Identities=23% Similarity=0.338 Sum_probs=128.1
Q ss_pred HHHHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEe
Q 048219 24 ELKKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLE 95 (183)
Q Consensus 24 ~~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (183)
++....+.+.+.||+|+||.||+|.+. +++.+++|.+.... ......+.+|+.++..+ .||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 344456777889999999999999742 35789999987543 33446788999999999 78999999999987
Q ss_pred CC-eEEEEEeccCCCCHHHHHhcCCC------------------------------------------------------
Q 048219 96 VS-KKILVYEYMSNGSLADILFNAEK------------------------------------------------------ 120 (183)
Q Consensus 96 ~~-~~~lv~e~~~~~~l~~~l~~~~~------------------------------------------------------ 120 (183)
.+ ..+++|||+++++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 55 48999999999999999875432
Q ss_pred -----------CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 121 -----------QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 121 -----------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 166777888999999999999998 9999999999999999999999999999854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=183.42 Aligned_cols=148 Identities=20% Similarity=0.269 Sum_probs=128.7
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45778889999999999999976 4788999998643 23344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC---cccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR---CAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~---~~~i~dfg~a~~~~ 179 (183)
++++++|.+.+... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++..+ .+||+|||+|+...
T Consensus 109 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 109 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999988653 4577888888999999999999998 999999999999998654 59999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=181.98 Aligned_cols=147 Identities=23% Similarity=0.325 Sum_probs=126.4
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC--eEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS--KKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++||||+++++++.... ..+++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 36677899999999999999764 7889999987543 223456778999999999999999999988655 7899999
Q ss_pred ccCCCCHHHHHhcCC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe----cCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM----DENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~----~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||++ +..+.+||+|||+|+..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999997643 2378888889999999999999998 99999999999998 77788999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=185.46 Aligned_cols=147 Identities=22% Similarity=0.238 Sum_probs=127.8
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+.+.||+|+||.||+|.... ++.+|+|.+.+... .....+..|..++..+ .||+|+++++++.+.+..+++
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 346677899999999999999875 67899999876422 2235677899999887 799999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|||+++++|.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 100 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999988654 3467888888999999999999998 9999999999999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=181.15 Aligned_cols=147 Identities=23% Similarity=0.300 Sum_probs=128.7
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH------HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE------REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45778889999999999999976 4788999988653211 2456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC----cccccceeccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR----CAKNFRLWIGK 176 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~----~~~i~dfg~a~ 176 (183)
++||++++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||+|+
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999998653 4577888889999999999999998 999999999999998877 79999999998
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 167 ~~ 168 (326)
T 2y0a_A 167 KI 168 (326)
T ss_dssp EC
T ss_pred EC
Confidence 65
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=184.19 Aligned_cols=146 Identities=25% Similarity=0.310 Sum_probs=125.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 3567789999999999999976 678899999864322 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+|+..
T Consensus 88 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 88 SGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp TTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecccee
Confidence 999999988543 3577888889999999999999998 9999999999999999999999999999754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=178.41 Aligned_cols=147 Identities=20% Similarity=0.301 Sum_probs=121.4
Q ss_pred HHhchhcccCcCcCceEEEEEEcC----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++||||+++++++ ..+..+++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence 456777899999999999998653 4568899876532 33446788999999999999999999987 45678999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||++++++|.+++......+++..+..++.|++.||.|+|++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999976655678888888999999999999998 9999999999999999999999999999865
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=182.30 Aligned_cols=147 Identities=26% Similarity=0.376 Sum_probs=127.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+...+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 3566678999999999999974 6788999998642 23334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+. |++.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+...
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 997 588887765556678888889999999999999998 99999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=186.18 Aligned_cols=147 Identities=29% Similarity=0.438 Sum_probs=125.4
Q ss_pred HHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..+.+.+.||+|+||.||+|... .+..+++|.+.... ......+..|+.++..++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 44666788999999999999843 35679999986532 334456888999999999999999999999989999
Q ss_pred EEEeccCCCCHHHHHhcCC------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC---cccccc
Q 048219 101 LVYEYMSNGSLADILFNAE------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR---CAKNFR 171 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~---~~~i~d 171 (183)
+|||++++++|.+++.... ..+.+..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997532 3467788888999999999999998 999999999999999554 599999
Q ss_pred eecccc
Q 048219 172 LWIGKV 177 (183)
Q Consensus 172 fg~a~~ 177 (183)
||+|+.
T Consensus 228 FG~a~~ 233 (367)
T 3l9p_A 228 FGMARD 233 (367)
T ss_dssp CHHHHH
T ss_pred Cccccc
Confidence 999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=177.55 Aligned_cols=146 Identities=28% Similarity=0.403 Sum_probs=130.6
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.+.||+|+||.||++...++..+++|.+..... ....+.+|+.++..++||||+++++++...+..+++||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 4566788999999999999988888899999875432 235688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|.+++......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccc
Confidence 999999977656678888888999999999999998 9999999999999999999999999999854
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=183.01 Aligned_cols=147 Identities=26% Similarity=0.419 Sum_probs=128.0
Q ss_pred HhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
.+.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.++..++||||+++++++...+..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 45566789999999999998753 4789999987543 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC-----------------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCC
Q 048219 102 VYEYMSNGSLADILFNAE-----------------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQN 158 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~n 158 (183)
+|||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 999999999999987532 3567788888999999999999998 99999999999
Q ss_pred EEecCCCcccccceeccccc
Q 048219 159 ILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 159 il~~~~~~~~i~dfg~a~~~ 178 (183)
|+++.++.+||+|||+|+..
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~ 224 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNI 224 (343)
T ss_dssp EEECGGGCEEECCCSCHHHH
T ss_pred EEECCCCeEEEeecCCCccc
Confidence 99999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=190.11 Aligned_cols=146 Identities=24% Similarity=0.324 Sum_probs=129.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.+.... ....+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4667789999999999999976 6889999998754322 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 97 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 97 YVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp CCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999988653 4577888888999999999999998 9999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=185.19 Aligned_cols=144 Identities=26% Similarity=0.302 Sum_probs=125.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+|.+.+.||+|+||.||++... ++..+++|.+.+... ....+.+|+.+++.++||||+++++++.+....+++|||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4778889999999999999976 578899999865322 23457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc--ccccceecccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC--AKNFRLWIGKV 177 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~--~~i~dfg~a~~ 177 (183)
+++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++. +||+|||+|+.
T Consensus 100 ~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 100 GGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999988653 3477888888999999999999998 9999999999999987765 99999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=193.30 Aligned_cols=149 Identities=27% Similarity=0.388 Sum_probs=131.0
Q ss_pred HHHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
....+.+.+.||+|+||.||+|.... +..+++|.+.... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34456677899999999999999875 7789999987542 234578899999999999999999999998899999999
Q ss_pred ccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++.... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999997643 4577888888999999999999998 9999999999999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=193.47 Aligned_cols=149 Identities=23% Similarity=0.344 Sum_probs=128.9
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+....+.+.+.||+|+||.||+|....+..+++|.+.... .....+.+|+.+++.++||||+++++++. ....+++||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3344566778999999999999998888889999987542 23567889999999999999999999875 667899999
Q ss_pred ccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++.... ...+......++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999996432 2466777888999999999999998 9999999999999999999999999999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=183.18 Aligned_cols=145 Identities=25% Similarity=0.359 Sum_probs=126.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH---HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.+..... ...+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 3667789999999999999975 57889999987543221 2468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+ ++++.+.+... ..+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 90 ~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 90 YA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp CC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred CC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 99 67888887654 3577888888999999999999998 9999999999999999999999999999865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=191.82 Aligned_cols=148 Identities=14% Similarity=0.154 Sum_probs=118.0
Q ss_pred HHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchh--------hHHHHHHHHHHHHHhhcC---------CCceee
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL--------DEREREFQTEIKVIGRTH---------HRNLVR 88 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~ 88 (183)
....|.+.+.||+|+||.||+|.. ++..+|+|.+.... ......+.+|+.+++.++ |+|+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345677888999999999999987 67889999987532 112356778888887775 555555
Q ss_pred eece-----------------EEe-------------CCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHH
Q 048219 89 LLGY-----------------SLE-------------VSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGI 138 (183)
Q Consensus 89 ~~~~-----------------~~~-------------~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l 138 (183)
+.+. +.+ .+..++||||+++|++.+.+.. ..+++..+..++.|++.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 5444 433 6789999999999876665533 4567888899999999999
Q ss_pred HHhh-hCCCCCceecCCCCCCEEecCCC--------------------cccccceecccccc
Q 048219 139 LYLH-DECETQIIHCDIKPQNILMDENR--------------------CAKNFRLWIGKVDE 179 (183)
Q Consensus 139 ~~lh-~~~~~~i~H~dl~~~nil~~~~~--------------------~~~i~dfg~a~~~~ 179 (183)
.||| ++ +|+||||||+||+++.++ .+||+|||+|+...
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~ 233 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER 233 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC
Confidence 9999 87 999999999999999887 89999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=176.21 Aligned_cols=148 Identities=25% Similarity=0.313 Sum_probs=130.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH---HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+....... ...+.+|+.++..++||||+++++++.+.+..+++||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 3566788999999999999975 67889999986543221 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++|.+++......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999976656678888899999999999999998 99999999999999999999999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=189.79 Aligned_cols=146 Identities=18% Similarity=0.328 Sum_probs=117.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----CeEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-----SKKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 100 (183)
.|.+.+.||+|+||.||+|... ++..||+|.+.+. .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4667789999999999999876 5788999988653 233456788999999999999999999998543 5689
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|||++ +++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 134 lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 999988 56898888653 4577888888999999999999998 99999999999999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=191.70 Aligned_cols=146 Identities=23% Similarity=0.216 Sum_probs=127.9
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
+.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 445578999999999999976 588999999875422 1234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+.+.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999887643 3477888888999999999999998 9999999999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=181.24 Aligned_cols=148 Identities=27% Similarity=0.423 Sum_probs=129.4
Q ss_pred HHhchhcccCcCcCceEEEEEE-----cCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC--eEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAM-----INRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS--KKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 100 (183)
..+.+.+.||+|+||.||+|.. .++..+++|.+..........+.+|+.+++.++|+||+++.+++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3466778999999999999984 257889999987655556677899999999999999999999886543 789
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++||++++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999987666678888888999999999999998 9999999999999999999999999999865
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=181.79 Aligned_cols=150 Identities=21% Similarity=0.333 Sum_probs=126.8
Q ss_pred HHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCC
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVS 97 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 97 (183)
....+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++..+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3445677789999999999999862 34579999986542 22345788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCC----------------------CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCC
Q 048219 98 KKILVYEYMSNGSLADILFNAEK----------------------QPNWIERTGIARDIARGILYLHDECETQIIHCDIK 155 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~ 155 (183)
..+++||++++++|.+++..... .+++..+..++.|++.||.|||++ +++|+|||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999976432 257778888999999999999998 99999999
Q ss_pred CCCEEecCCCcccccceeccccc
Q 048219 156 PQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 156 ~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+||+++.++.++|+|||+|+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~ 222 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDI 222 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCG
T ss_pred hhhEEEcCCCcEEeCCCccCccc
Confidence 99999999999999999999855
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=177.69 Aligned_cols=147 Identities=27% Similarity=0.470 Sum_probs=125.6
Q ss_pred HhchhcccCcCcCceEEEEEEcC----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEE-eCCeEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSL-EVSKKILV 102 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 102 (183)
.+.+.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++||||+++++++. ..+..+++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 35566789999999999998543 2357888876532 334567889999999999999999999865 45678999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||++++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999977666678888888999999999999998 9999999999999999999999999999854
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=188.62 Aligned_cols=144 Identities=27% Similarity=0.369 Sum_probs=125.3
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-eEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS-KKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~ 107 (183)
.+.+.+.||+|+||.||+|... +..+++|.++... ....+.+|+.+++.++||||+++++++.... ..+++||+++
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 3455678999999999999875 5689999987543 3456889999999999999999999987654 7899999999
Q ss_pred CCCHHHHHhcCCC-CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEK-QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++..... .++......++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999976543 357788888999999999999998 9999999999999999999999999999854
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=178.95 Aligned_cols=149 Identities=24% Similarity=0.360 Sum_probs=128.7
Q ss_pred HHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
...+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 445677789999999999999863 34779999986542 34456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCC-----------------------CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCC
Q 048219 100 ILVYEYMSNGSLADILFNAEK-----------------------QPNWIERTGIARDIARGILYLHDECETQIIHCDIKP 156 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~ 156 (183)
+++||++++++|.+++..... .+++..+..++.|++.||.|||++ +++|+||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999976432 256778888999999999999998 999999999
Q ss_pred CCEEecCCCcccccceeccccc
Q 048219 157 QNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 157 ~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||+++.++.++|+|||+|+..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~ 200 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDV 200 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEEC
T ss_pred heEEEcCCCCEEEccccccccc
Confidence 9999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=179.52 Aligned_cols=152 Identities=21% Similarity=0.129 Sum_probs=127.2
Q ss_pred HHHHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeE
Q 048219 24 ELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 24 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (183)
++-...+.+.+.||+|+||.||+|... ++..+|+|.+.... .........|+..+..+ .|+|++++++++...+..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344466788889999999999999987 68899999875422 22333445555555544 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++||++ ++++.+.+......+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||+|+...
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999 6799888876666688899999999999999999998 99999999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=175.42 Aligned_cols=147 Identities=22% Similarity=0.312 Sum_probs=129.6
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..|.+.+.||+|+||.||+|.... +..+++|.+.+........+.+|+.+++.++||||+++++++.+....+++||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 457778899999999999999764 6688999887654445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe---cCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~---~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+.+... ..+++..+..++.|++.||.|||++ +++|+||+|+||++ +.++.++|+|||+|...
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 89 TGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999888653 3467888888999999999999998 99999999999999 77889999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=190.57 Aligned_cols=146 Identities=20% Similarity=0.200 Sum_probs=119.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... ++..+|+|.+.+.. ......+..|+.+++.++||||+++++++...+..++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 3566689999999999999975 57889999987532 2233557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+.+... ..+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+|+..
T Consensus 229 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 229 YANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp CCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred eCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999988654 356788888899999999999998 6 9999999999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=179.80 Aligned_cols=145 Identities=25% Similarity=0.317 Sum_probs=121.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--------------------------HHHHHHHHHHHHhhc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--------------------------REREFQTEIKVIGRT 81 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--------------------------~~~~~~~e~~~l~~l 81 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.+++.+
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4677789999999999999875 5788999988643211 124578899999999
Q ss_pred CCCceeeeeceEEe--CCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCE
Q 048219 82 HHRNLVRLLGYSLE--VSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNI 159 (183)
Q Consensus 82 ~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ni 159 (183)
+||||+++++++.+ ....+++||+++++++.++.. ...+++.....++.|++.||.|||++ +++|+||||+||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 99999999999986 567899999999998877543 24577888888999999999999998 999999999999
Q ss_pred EecCCCcccccceeccccc
Q 048219 160 LMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 160 l~~~~~~~~i~dfg~a~~~ 178 (183)
+++.++.+||+|||+|+..
T Consensus 169 l~~~~~~~kl~Dfg~~~~~ 187 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEF 187 (298)
T ss_dssp EECTTSCEEECCCTTCEEC
T ss_pred EECCCCCEEEecCCCcccc
Confidence 9999999999999999854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=178.64 Aligned_cols=150 Identities=23% Similarity=0.343 Sum_probs=129.9
Q ss_pred HHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
...+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++..+ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 345777889999999999999852 35789999987543 23456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCC-----------------CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe
Q 048219 99 KILVYEYMSNGSLADILFNAEK-----------------QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM 161 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~ 161 (183)
.+++||++++++|.+++..... .+++..+..++.|++.||.|||++ +++|+||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999976432 367888888999999999999998 99999999999999
Q ss_pred cCCCcccccceecccccc
Q 048219 162 DENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 162 ~~~~~~~i~dfg~a~~~~ 179 (183)
+.++.++|+|||+|+...
T Consensus 179 ~~~~~~kl~Dfg~~~~~~ 196 (313)
T 1t46_A 179 THGRITKICDFGLARDIK 196 (313)
T ss_dssp ETTTEEEECCCGGGSCTT
T ss_pred cCCCCEEEcccccccccc
Confidence 999999999999998653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=180.46 Aligned_cols=146 Identities=27% Similarity=0.459 Sum_probs=124.5
Q ss_pred hchhcccCcCcCceEEEEEEcC-----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.++..++||||+++++++...+..+++|
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence 3445789999999999998653 2458999986543 234456889999999999999999999999889999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 126 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 126 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999977656678888899999999999999998 9999999999999999999999999999865
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-27 Score=189.50 Aligned_cols=144 Identities=24% Similarity=0.264 Sum_probs=126.1
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.||+|+||.||+|... +++.+++|.+.+.... ....+..|+.++..++||||+++++++.+....+++|||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3357999999999999976 5889999998754322 23567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC---CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAE---KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+.+.... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999886542 3577888888999999999999998 9999999999999999999999999999854
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=184.92 Aligned_cols=146 Identities=26% Similarity=0.256 Sum_probs=118.7
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh---hHHHHHHHHHHHH-HhhcCCCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL---DEREREFQTEIKV-IGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+.+.||+|+||.||+|.... +..+++|.+.+.. ......+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 346677899999999999999764 7789999986543 1223445666665 5678999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|||+++++|.+.+... ..+.+.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 118 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999988654 3466777788999999999999998 999999999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=179.67 Aligned_cols=150 Identities=27% Similarity=0.391 Sum_probs=131.4
Q ss_pred HHHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
....+.+.+.||+|+||.||+|.... +..+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34556777899999999999999775 7789999986543 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+...
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999997643 4477888888999999999999998 99999999999999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=178.95 Aligned_cols=146 Identities=22% Similarity=0.350 Sum_probs=127.0
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+..........+..|+.++..++||||+++++++...+..+++||++
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 34667789999999999999976 47889999887654444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
+++++.+++......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+|.
T Consensus 99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 99999998876556678888899999999999999998 99999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=180.68 Aligned_cols=146 Identities=24% Similarity=0.322 Sum_probs=114.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..+++||++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 3556678999999999999865 578899998864322 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-----CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-----KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ ++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 7 59988875421 3467778888999999999999998 9999999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=191.91 Aligned_cols=148 Identities=28% Similarity=0.382 Sum_probs=127.1
Q ss_pred HHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
....+.+.+.||+|+||.||+|....+..+++|.+.... .....+.+|+.+++.++||||+++++++.. +..+++||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 334566778999999999999998887889999987542 224568899999999999999999998765 678999999
Q ss_pred cCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 9999999999642 24577888889999999999999998 9999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=180.41 Aligned_cols=148 Identities=22% Similarity=0.309 Sum_probs=117.5
Q ss_pred HHhchhcccCcCcCceEEEEEEcCC----cEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE--
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINR----QLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK-- 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-- 99 (183)
..+.+.+.||+|+||.||+|..... ..+++|.+... .......+.+|+.+++.++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 4577788999999999999986543 27899988653 233456788999999999999999999999876554
Q ss_pred ----EEEEeccCCCCHHHHHhcCC-----CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccc
Q 048219 100 ----ILVYEYMSNGSLADILFNAE-----KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNF 170 (183)
Q Consensus 100 ----~lv~e~~~~~~l~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~ 170 (183)
+++||++++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 89999999999999885421 2467888889999999999999998 99999999999999999999999
Q ss_pred ceeccccc
Q 048219 171 RLWIGKVD 178 (183)
Q Consensus 171 dfg~a~~~ 178 (183)
|||+|+..
T Consensus 180 Dfg~a~~~ 187 (323)
T 3qup_A 180 DFGLSRKI 187 (323)
T ss_dssp CCCC----
T ss_pred eccccccc
Confidence 99999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=181.01 Aligned_cols=151 Identities=23% Similarity=0.360 Sum_probs=129.1
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS 97 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (183)
+....+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++|+||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34456778889999999999999754 35679999986543 233456889999999999999999999999889
Q ss_pred eEEEEEeccCCCCHHHHHhcCC---------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccc
Q 048219 98 KKILVYEYMSNGSLADILFNAE---------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~ 168 (183)
..+++||++++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence 9999999999999999886421 3456778888999999999999998 999999999999999999999
Q ss_pred ccceeccccc
Q 048219 169 NFRLWIGKVD 178 (183)
Q Consensus 169 i~dfg~a~~~ 178 (183)
|+|||+|+..
T Consensus 179 l~Dfg~~~~~ 188 (322)
T 1p4o_A 179 IGDFGMTRDI 188 (322)
T ss_dssp ECCTTCCCGG
T ss_pred ECcCcccccc
Confidence 9999999854
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=186.33 Aligned_cols=146 Identities=21% Similarity=0.280 Sum_probs=126.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----CeEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-----SKKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 100 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+.+. .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4667789999999999999976 4778999998653 233456788999999999999999999998765 5689
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|||++. ++|.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 107 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9999986 5999988653 4578888889999999999999998 99999999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=181.34 Aligned_cols=144 Identities=17% Similarity=0.218 Sum_probs=125.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+.... ....+..|+.+++.+ +|+||+++++++......+++||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 3566789999999999999964 67889999876432 123577899999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc-----ccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC-----AKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~-----~~i~dfg~a~~~ 178 (183)
+++|.+++......+++..+..++.|++.||.|||+. +++||||||+||+++.++. ++|+|||+|+..
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 8999999987656788889999999999999999998 9999999999999998887 999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=177.22 Aligned_cols=148 Identities=21% Similarity=0.226 Sum_probs=127.1
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe----CCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE----VSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 102 (183)
..|.+.+.||+|+||.||++... ++..+++|.+..........+.+|+.+++.++||||+++++++.. ....+++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 35677789999999999999974 678899998866555566778899999999999999999999873 3478899
Q ss_pred EeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||++++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++..
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999998865 345678888889999999999999998 9999999999999999999999999988754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-27 Score=178.58 Aligned_cols=150 Identities=23% Similarity=0.358 Sum_probs=128.3
Q ss_pred HHHHhchhcccCcCcCceEEEEEEc--------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEe
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMI--------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLE 95 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (183)
....+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3456777889999999999999864 35679999987543 33456788999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEE
Q 048219 96 VSKKILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160 (183)
Q Consensus 96 ~~~~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil 160 (183)
.+..+++||++++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 999999999999999999997543 1367778888999999999999998 9999999999999
Q ss_pred ecCCCcccccceeccccc
Q 048219 161 MDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 161 ~~~~~~~~i~dfg~a~~~ 178 (183)
++.++.+||+|||+|+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~ 207 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDI 207 (334)
T ss_dssp ECTTCCEEECCCTTCEEC
T ss_pred EcCCCCEEEccccccccc
Confidence 999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-27 Score=175.62 Aligned_cols=158 Identities=42% Similarity=0.648 Sum_probs=135.5
Q ss_pred CceeCHHHHHHHHhchh--------cccCcCcCceEEEEEEcCCcEEEEEEccchh----hHHHHHHHHHHHHHhhcCCC
Q 048219 17 PFSFSYAELKKITDGFK--------EKVGRGSSGTVYKGAMINRQLVAVNRLEKVL----DEREREFQTEIKVIGRTHHR 84 (183)
Q Consensus 17 ~~~~~~~~~~~~~~~~~--------~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~ 84 (183)
...+...++.....++. +.||+|+||.||+|.. ++..+++|.+.... ......+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 34578888888887775 4599999999999976 56789999876421 23346788999999999999
Q ss_pred ceeeeeceEEeCCeEEEEEeccCCCCHHHHHhcC--CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec
Q 048219 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNA--EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD 162 (183)
Q Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~ 162 (183)
||+++++++...+..+++||++++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999988643 23477888888999999999999998 999999999999999
Q ss_pred CCCcccccceeccccc
Q 048219 163 ENRCAKNFRLWIGKVD 178 (183)
Q Consensus 163 ~~~~~~i~dfg~a~~~ 178 (183)
.++.++|+|||+|+..
T Consensus 168 ~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 168 EAFTAKISDFGLARAS 183 (307)
T ss_dssp TTCCEEECCCTTCEEC
T ss_pred CCCcEEEeeccccccc
Confidence 9999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=181.03 Aligned_cols=146 Identities=21% Similarity=0.266 Sum_probs=124.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe----EE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK----KI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~ 100 (183)
.|.+.+.||+|+||.||+|.+. +++.+++|.+.... ......+.+|+.++..++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 4677889999999999999974 57889999986532 2334568899999999999999999999875443 49
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++|||+++++|.+++... ..+++.....++.|++.||.|+|++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 93 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 999999999999998654 3567888888999999999999998 9999999999999999999999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=180.27 Aligned_cols=147 Identities=25% Similarity=0.347 Sum_probs=122.7
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-Cc----EEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQ----LVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~----~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
..+.+.+.||+|+||.||+|.... +. .+++|.+.... ......+.+|+.++..++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 346677899999999999998653 33 35777775432 23346788999999999999999999998765 4778
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++++++.+++......+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999987666788888899999999999999998 9999999999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-27 Score=176.15 Aligned_cols=146 Identities=23% Similarity=0.409 Sum_probs=125.1
Q ss_pred hchhcccCcCcCceEEEEEEcC----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE-EEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK-ILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~ 103 (183)
+.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+.. +++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 3345789999999999998543 2368899886533 33456788999999999999999999999876655 8999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++.+++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999999999977666778888888999999999999998 9999999999999999999999999999744
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-27 Score=176.46 Aligned_cols=146 Identities=23% Similarity=0.289 Sum_probs=127.2
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++||++
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 5667889999999999999764 7889999875432 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++++..++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+...
T Consensus 85 ~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 85 DHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp SEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 998888877543 4577888888999999999999998 99999999999999999999999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-27 Score=174.88 Aligned_cols=149 Identities=19% Similarity=0.273 Sum_probs=127.4
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
..+.+.+.||+|+||.||++... .+..+++|.+.... ......+..|+.+++.++||||+++++++.+....+++||+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45778889999999999999975 47789999886543 22346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec---CCCcccccceecccccc
Q 048219 106 MSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD---ENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~---~~~~~~i~dfg~a~~~~ 179 (183)
+++++|.+.+... ...+++..+..++.|++.||.|||+. +++|+||||+||+++ .++.++|+|||+|+...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888542 35577888889999999999999998 999999999999994 45789999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=183.73 Aligned_cols=146 Identities=26% Similarity=0.469 Sum_probs=119.9
Q ss_pred hchhcccCcCcCceEEEEEEc--C--CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI--N--RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~--~--~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 103 (183)
+.+.+.||+|+||.||+|... + ...+++|.+.... ......+.+|+.+++.++||||+++++++.. .+..+++|
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 345578999999999999854 2 2457888876432 3445678899999999999999999998754 56789999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+++++|.+++......+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999977666677888888999999999999998 9999999999999999999999999999854
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-27 Score=174.21 Aligned_cols=146 Identities=26% Similarity=0.380 Sum_probs=127.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe------------
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE------------ 95 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------ 95 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+... ......+.+|+.+++.++|||++++++++..
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 4667789999999999999975 6788999998653 3345678899999999999999999998865
Q ss_pred -CCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceec
Q 048219 96 -VSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWI 174 (183)
Q Consensus 96 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~ 174 (183)
.+..+++||++++++|.+++.......++.....++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 3567999999999999999976555566777788999999999999998 999999999999999999999999999
Q ss_pred cccc
Q 048219 175 GKVD 178 (183)
Q Consensus 175 a~~~ 178 (183)
|+..
T Consensus 163 ~~~~ 166 (303)
T 1zy4_A 163 AKNV 166 (303)
T ss_dssp CSCT
T ss_pred hhhc
Confidence 9865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=184.38 Aligned_cols=147 Identities=23% Similarity=0.324 Sum_probs=126.1
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCC--eEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVS--KKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|.... +..+++|.+..... .....+.+|+.+++.++||||+++++++...+ ..+++||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 46677899999999999999764 78999999875432 22456778999999999999999999988655 7799999
Q ss_pred ccCCCCHHHHHhcCC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe----cCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM----DENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~----~~~~~~~i~dfg~a~~~ 178 (183)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||++ +..+.+||+|||+|+..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999986533 2378888889999999999999998 99999999999998 77778999999999865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-27 Score=173.74 Aligned_cols=145 Identities=21% Similarity=0.336 Sum_probs=125.9
Q ss_pred hchhc-ccCcCcCceEEEEEEc---CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKE-KVGRGSSGTVYKGAMI---NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~-~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+.+ .||+|+||.||+|... .+..+++|.+.... ......+.+|+.++..++||||+++++++ ..+..+++||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 34444 8999999999999854 46779999987642 34456788999999999999999999998 5567899999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+|+..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999976556678888899999999999999998 9999999999999999999999999999855
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-27 Score=177.52 Aligned_cols=146 Identities=26% Similarity=0.369 Sum_probs=122.9
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC----eEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS----KKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... +..+|+|.+..... .......|+.++..++||||+++++++.... ..+++||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 4667789999999999999865 67899999865432 2334556888999999999999999998644 3699999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCC-------CCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC-------ETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-------~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|+++++|.+++... .+++..+..++.|++.||.|||+.. ..+++|+||||+||+++.++.+||+|||+|+.
T Consensus 103 ~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 103 FHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 99999999999663 4778888899999999999999741 12899999999999999999999999999975
Q ss_pred c
Q 048219 178 D 178 (183)
Q Consensus 178 ~ 178 (183)
.
T Consensus 181 ~ 181 (322)
T 3soc_A 181 F 181 (322)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-26 Score=174.59 Aligned_cols=144 Identities=25% Similarity=0.353 Sum_probs=125.7
Q ss_pred chhcccCcCcCceEEEEEEc-----CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-----NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILV 102 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-----~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 102 (183)
.+.+.||+|+||.||++.+. ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+ ....+++
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67789999999999988643 46789999987543 3345678899999999999999999999987 4678999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||++++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+|+...
T Consensus 114 ~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp ECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999653 477888888999999999999998 99999999999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-27 Score=175.20 Aligned_cols=141 Identities=26% Similarity=0.340 Sum_probs=118.7
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhh--cCCCceeeeeceEEe----CCeEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGR--THHRNLVRLLGYSLE----VSKKILV 102 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv 102 (183)
.+.+.+.||+|+||.||+|.. ++..+++|.+.... ......|.+++.. ++||||+++++++.. ....+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 466778999999999999987 57789999986542 2344556666655 789999999998754 2457899
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhh--------hCCCCCceecCCCCCCEEecCCCcccccceec
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH--------DECETQIIHCDIKPQNILMDENRCAKNFRLWI 174 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~ 174 (183)
|||+++++|.+++.. ..+++.....++.|++.||.||| +. +++|+||||+||+++.++.+||+|||+
T Consensus 85 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 85 THYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp ECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred hhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999999999943 45778888899999999999999 76 999999999999999999999999999
Q ss_pred cccc
Q 048219 175 GKVD 178 (183)
Q Consensus 175 a~~~ 178 (183)
|+..
T Consensus 160 a~~~ 163 (301)
T 3q4u_A 160 AVMH 163 (301)
T ss_dssp CEEE
T ss_pred eeec
Confidence 9754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=176.68 Aligned_cols=138 Identities=25% Similarity=0.331 Sum_probs=121.1
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
+.||+|+||.||+|... ++..+++|.+.+. ......+|+.++..+. ||||+++++++.+....+++||++++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 57999999999999976 5788999998754 2345678999999997 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC---cccccceeccccc
Q 048219 112 ADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR---CAKNFRLWIGKVD 178 (183)
Q Consensus 112 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~---~~~i~dfg~a~~~ 178 (183)
.+.+... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||+|+..
T Consensus 94 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 94 FERIKKK-KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp HHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9998764 4577888889999999999999998 999999999999998765 7999999999854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=181.32 Aligned_cols=155 Identities=21% Similarity=0.297 Sum_probs=129.6
Q ss_pred eCHHHHHHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-----CCceeeeeceE
Q 048219 20 FSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-----HRNLVRLLGYS 93 (183)
Q Consensus 20 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~ 93 (183)
...+.+....|.+.+.||+|+||.||+|... ++..+++|.+... .........|+.+++.+. |+||+++++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3333333456777889999999999999975 5788999998643 233445677899998886 99999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---------
Q 048219 94 LEVSKKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE--------- 163 (183)
Q Consensus 94 ~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~--------- 163 (183)
...+..+++||++ +++|.+++.... ..++...+..++.|++.||.|||+. +|+|+||||+||+++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccc
Confidence 9999999999999 889999997644 3477888888999999999999998 9999999999999975
Q ss_pred ----------------CCcccccceecccccc
Q 048219 164 ----------------NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 164 ----------------~~~~~i~dfg~a~~~~ 179 (183)
++.+||+|||+|+...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~ 213 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred hhcccccccccccccCCCCEEEEeccCceecC
Confidence 7889999999998543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=181.69 Aligned_cols=146 Identities=25% Similarity=0.350 Sum_probs=124.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH-HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER-EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
|.+.+.||+|+||.||+|... ++..+++|.+....... ...+.+|+.+++.++||||+++++++.+.+..+++||+++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 556788999999999999976 57889999886432211 1234579999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++.+++......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+|+...
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 84 -KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp -EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 589998877666788888888999999999999998 99999999999999999999999999998553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=172.43 Aligned_cols=149 Identities=25% Similarity=0.274 Sum_probs=127.1
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
..+.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+..+..+ +||||+++++++.+.+..+++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 45677789999999999999976 6889999988653 233456678899999888 8999999999999999999999
Q ss_pred eccCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC----------------
Q 048219 104 EYMSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---------------- 164 (183)
Q Consensus 104 e~~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---------------- 164 (183)
|++++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999998653 14567888889999999999999998 99999999999999844
Q ss_pred ---Ccccccceecccccc
Q 048219 165 ---RCAKNFRLWIGKVDE 179 (183)
Q Consensus 165 ---~~~~i~dfg~a~~~~ 179 (183)
..++|+|||.|....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~ 185 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRIS 185 (289)
T ss_dssp --CCCEEECCCTTCEETT
T ss_pred CCceEEEEcccccccccC
Confidence 478999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-27 Score=191.92 Aligned_cols=140 Identities=21% Similarity=0.346 Sum_probs=123.6
Q ss_pred ccCcCcCceEEEEEEc---CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMI---NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.. +..++||||+++++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6899999999999864 35679999987542 2345678899999999999999999999875 56899999999999
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999976556688888899999999999999998 9999999999999999999999999999865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=192.32 Aligned_cols=148 Identities=28% Similarity=0.382 Sum_probs=128.2
Q ss_pred HHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
....+.+.+.||+|+||.||+|....+..+++|.+.... .....+.+|+.+++.++|+||+++++++.. ...++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 334566778999999999999998887889999987542 224568899999999999999999998765 678999999
Q ss_pred cCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 9999999999642 24477888889999999999999998 9999999999999999999999999999865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=179.68 Aligned_cols=151 Identities=23% Similarity=0.342 Sum_probs=127.2
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV 96 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (183)
+....+.+.+.||+|+||.||+|... +++.+++|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 33456777889999999999999742 35789999987543 23345788999999999 689999999998765
Q ss_pred C-eEEEEEeccCCCCHHHHHhcCCCC---------------CChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEE
Q 048219 97 S-KKILVYEYMSNGSLADILFNAEKQ---------------PNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160 (183)
Q Consensus 97 ~-~~~lv~e~~~~~~l~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil 160 (183)
+ ..+++||++++++|.+++...... +++..+..++.|++.||.|||++ +++|+||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence 4 589999999999999999764321 56778888999999999999998 9999999999999
Q ss_pred ecCCCcccccceeccccc
Q 048219 161 MDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 161 ~~~~~~~~i~dfg~a~~~ 178 (183)
++.++.++|+|||+|+..
T Consensus 181 ~~~~~~~kl~Dfg~~~~~ 198 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDI 198 (316)
T ss_dssp ECGGGCEEECCCGGGSCT
T ss_pred ECCCCCEEECCCcccccc
Confidence 999999999999999854
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-27 Score=176.15 Aligned_cols=145 Identities=25% Similarity=0.361 Sum_probs=123.9
Q ss_pred hchh-cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFK-EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~-~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+. +.||+|+||.||+|... ++..+++|.+..........+.+|+.++.++ +||||+++++++.+.+..+++||++
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 4443 57999999999999865 5788999998765434456788899999885 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc---ccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC---AKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~---~~i~dfg~a~~~ 178 (183)
++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++. +||+|||+++..
T Consensus 94 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 94 RGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred CCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999998654 3467788888999999999999998 9999999999999998765 999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=179.79 Aligned_cols=143 Identities=24% Similarity=0.365 Sum_probs=116.2
Q ss_pred hchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+.+.||+|+||.||+|.... +..+++|.+.... ....+.+|+.++..++||||+++++++...+..+++|||+++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 5566789999999999999764 6789999987542 334677899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~ 178 (183)
++|.+.+... ..+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+|+..
T Consensus 133 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 133 GELFDRIVEK-GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999988653 4467888888999999999999998 9999999999999975 789999999999865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=185.82 Aligned_cols=149 Identities=23% Similarity=0.338 Sum_probs=129.0
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
...|.+.+.||+|+||.||+|... ++..+++|.+.+.. ......+.+|+.+++.++||||+++++++.+....+++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888899999999999999976 57889999986432 123456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~~ 179 (183)
|++++++|.+.+... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++. ++.+||+|||+|+...
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999888654 3577888889999999999999998 9999999999999954 4679999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=171.92 Aligned_cols=146 Identities=23% Similarity=0.360 Sum_probs=126.8
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHH---HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDER---EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|.... +..+++|.+.+..... ...+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 35667889999999999998764 6689999886543221 3568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++++.+.+... ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||+|...
T Consensus 90 ~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 90 YAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999988654 3467788888999999999999998 9999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=179.48 Aligned_cols=148 Identities=27% Similarity=0.321 Sum_probs=123.6
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-----hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-----DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
..|.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 45777889999999999999875 57789999886532 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC---------------------------------------CCCCChHHHHHHHHHHHHHHHHhh
Q 048219 102 VYEYMSNGSLADILFNA---------------------------------------EKQPNWIERTGIARDIARGILYLH 142 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh 142 (183)
||||+++++|.+++... ...+++..+..++.|++.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988421 001134455678999999999999
Q ss_pred hCCCCCceecCCCCCCEEecCCC--cccccceeccccc
Q 048219 143 DECETQIIHCDIKPQNILMDENR--CAKNFRLWIGKVD 178 (183)
Q Consensus 143 ~~~~~~i~H~dl~~~nil~~~~~--~~~i~dfg~a~~~ 178 (183)
+. +++|+||||+||+++.++ .+||+|||+|+..
T Consensus 186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~ 220 (345)
T 3hko_A 186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF 220 (345)
T ss_dssp HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred HC---CccccCCChhhEEEecCCCceEEEeeccccccc
Confidence 98 999999999999998776 8999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=173.99 Aligned_cols=148 Identities=24% Similarity=0.347 Sum_probs=126.9
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
..+.+.+.||+|+||.||++... +++.+++|.+..........+.+|+.++..++||||+++++++.+.+..+++||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45777889999999999999976 57889999987654444556889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe---cCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~---~~~~~~~i~dfg~a~~~~ 179 (183)
++++|.+.+... ..+++..+..++.|++.||.|||++ +++|+||+|+||++ +.++.++|+|||+++...
T Consensus 89 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 89 SGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999988653 3467788888999999999999998 99999999999999 677899999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=186.17 Aligned_cols=148 Identities=23% Similarity=0.333 Sum_probs=123.8
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
..|.+.+.||+|+||.||+|... .+..+++|.+.+.. ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45778889999999999999976 57789999986542 1224568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---Ccccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---~~~~i~dfg~a~~~~ 179 (183)
|+++++|.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.. +.+||+|||+|+...
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999888654 3467788888999999999999998 99999999999999764 459999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=176.23 Aligned_cols=146 Identities=20% Similarity=0.229 Sum_probs=128.1
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||++.... +..+++|.+.... ......+..|+.+++.++|+||+++++++.+.+..+++||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 46667899999999999999764 6788999876532 3345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 122 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 122 LCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp CCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 99999999988653 4567888888999999999999998 9999999999999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=173.18 Aligned_cols=146 Identities=26% Similarity=0.454 Sum_probs=124.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---H----HHHHHHHHHHHhhcCCCceeeeeceEEeCCeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---R----EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (183)
..+.+.+.||+|+||.||+|... ++..+++|.+...... . ...+.+|+.+++.++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 34667789999999999999975 5788999998542211 1 156889999999999999999999886554
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCC--ceecCCCCCCEEecCCCc-----ccccce
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ--IIHCDIKPQNILMDENRC-----AKNFRL 172 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dl~~~nil~~~~~~-----~~i~df 172 (183)
+++||++++++|.+.+......+++.....++.|++.||.|||++ + ++|+||||+||+++.++. ++|+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 699999999999998877666788888899999999999999997 7 999999999999988776 999999
Q ss_pred eccccc
Q 048219 173 WIGKVD 178 (183)
Q Consensus 173 g~a~~~ 178 (183)
|+|+..
T Consensus 174 g~~~~~ 179 (287)
T 4f0f_A 174 GLSQQS 179 (287)
T ss_dssp TTCBCC
T ss_pred Cccccc
Confidence 999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=172.71 Aligned_cols=148 Identities=19% Similarity=0.298 Sum_probs=122.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 4677789999999999999875 5788999988642 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++...
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999998864 235577888888999999999999998 99999999999999999999999999997643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=180.26 Aligned_cols=145 Identities=23% Similarity=0.344 Sum_probs=116.9
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCC--eEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVS--KKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~l 101 (183)
..|.+.+.||+|+||.||+|.+. ++..+|+|.+.+. .......+.+|+.++..+. |+||+++++++...+ ..++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 35677789999999999999975 5788999988543 2334566788999999997 999999999997544 6899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|||+++ +++...+.. ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 999997 589888865 3567778888999999999999998 9999999999999999999999999999854
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-27 Score=185.63 Aligned_cols=144 Identities=21% Similarity=0.290 Sum_probs=119.4
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------CeE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SKK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 99 (183)
+|.+.+.||+|+||.||+|... .+..+|+|.+.+. .......+.+|+.+++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 3556678999999999999876 4788999998754 233456788999999999999999999998654 357
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++||||+++ ++.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 143 ~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 999999975 56666632 367788888999999999999998 99999999999999999999999999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=180.08 Aligned_cols=147 Identities=27% Similarity=0.315 Sum_probs=123.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH-----HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER-----EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+....... ...+.+|+.+++.++||||+++++++...+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45777789999999999999976 47889999986432211 2357789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||++++ ++.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999975 88888866555577778888999999999999998 9999999999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=172.36 Aligned_cols=146 Identities=23% Similarity=0.327 Sum_probs=125.9
Q ss_pred HhchhcccCcCcCceEEEEEEcC----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++||||+++++++.. +..+++|
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence 46677899999999999998543 3458999987542 3445678899999999999999999998754 4578999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++++|.+++......+++.....++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999976656678888888999999999999998 9999999999999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=180.87 Aligned_cols=146 Identities=23% Similarity=0.298 Sum_probs=121.4
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcE----EEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQL----VAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~----~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
.+.+.+.||+|+||.||+|.... +.. +++|.+.... ......+.+|+.++..++||||+++++++. .+..+++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 45667889999999999998653 333 6777764322 112234667899999999999999999875 5678899
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||++++++|.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999976545677778888999999999999998 9999999999999999999999999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=177.93 Aligned_cols=146 Identities=23% Similarity=0.318 Sum_probs=124.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEe--------CC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLE--------VS 97 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~ 97 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|+||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 5777789999999999999975 578999998754321 123456789999999999999999999876 34
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
..++|||++++ ++.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 68999999975 88887766656688888999999999999999998 999999999999999999999999999975
Q ss_pred c
Q 048219 178 D 178 (183)
Q Consensus 178 ~ 178 (183)
.
T Consensus 174 ~ 174 (351)
T 3mi9_A 174 F 174 (351)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=186.32 Aligned_cols=149 Identities=23% Similarity=0.330 Sum_probs=129.6
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
...|.+.+.||+|+||.||+|... ++..+++|.+.+.. ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 346778889999999999999976 67889999985432 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe---cCCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~---~~~~~~~i~dfg~a~~~~ 179 (183)
||++.+++|.+.+... ..+++..+..++.|++.||.|||++ +|+|+||||+||++ +.++.+||+|||+|+...
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999988654 4577888888999999999999998 99999999999999 456889999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=185.29 Aligned_cols=148 Identities=24% Similarity=0.324 Sum_probs=125.1
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-------------HHHHHHHHHHHHHhhcCCCceeeeeceE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-------------EREREFQTEIKVIGRTHHRNLVRLLGYS 93 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+.+... .....+.+|+.+++.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34667789999999999999976 467899999865321 1235688999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC---ccccc
Q 048219 94 LEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR---CAKNF 170 (183)
Q Consensus 94 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~---~~~i~ 170 (183)
.+....++||||+++++|.+.+... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++ .+||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999888654 4577888889999999999999998 999999999999998775 69999
Q ss_pred ceecccccc
Q 048219 171 RLWIGKVDE 179 (183)
Q Consensus 171 dfg~a~~~~ 179 (183)
|||+|+...
T Consensus 192 Dfg~a~~~~ 200 (504)
T 3q5i_A 192 DFGLSSFFS 200 (504)
T ss_dssp CCTTCEECC
T ss_pred ECCCCEEcC
Confidence 999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-27 Score=192.43 Aligned_cols=144 Identities=23% Similarity=0.240 Sum_probs=125.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+..|..++..+ .|++|+++++++.+.+.+++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 555678999999999999976 477899999875421 2235577889999887 69999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
|+++++|...+... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 423 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 423 YVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred CcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999998764 3477888888999999999999998 999999999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=177.17 Aligned_cols=147 Identities=26% Similarity=0.379 Sum_probs=126.8
Q ss_pred HHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
...+.+.+.||+|+||.||+|....+..+++|.+.... .....+.+|+.+++.++|+|++++++++. .+..+++||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 34567788999999999999998888889999886542 23456888999999999999999998875 55689999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 9999999885432 2467788888999999999999998 9999999999999999999999999999865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=171.91 Aligned_cols=146 Identities=20% Similarity=0.229 Sum_probs=127.7
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||++.... +..+++|.+.... ......+..|+.+++.++|+||+++++++.+.+..+++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 45667899999999999999764 6788999876432 3345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++++.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 96 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 96 LCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp CCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 99999999988653 3567888888999999999999998 9999999999999999999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=176.42 Aligned_cols=148 Identities=29% Similarity=0.448 Sum_probs=124.9
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcE--EEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQL--VAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~--~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+.+.||+|+||.||+|... ++.. +++|.+.... ......+.+|+.++..+ +||||+++++++...+..+++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 34667789999999999999865 3443 4888876432 23345688899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcc
Q 048219 103 YEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~ 167 (183)
||++++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999986543 3577888889999999999999998 99999999999999999999
Q ss_pred cccceeccccc
Q 048219 168 KNFRLWIGKVD 178 (183)
Q Consensus 168 ~i~dfg~a~~~ 178 (183)
+|+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=175.25 Aligned_cols=147 Identities=23% Similarity=0.311 Sum_probs=128.3
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH------HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE------REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.++..++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45778889999999999999976 5788999988653211 2456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC----cccccceeccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR----CAKNFRLWIGK 176 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~----~~~i~dfg~a~ 176 (183)
++||++++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||+|+
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999998653 4567788888999999999999998 999999999999999887 79999999997
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 168 ~~ 169 (321)
T 2a2a_A 168 EI 169 (321)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=178.90 Aligned_cols=148 Identities=22% Similarity=0.227 Sum_probs=126.7
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--------HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--------EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 45777789999999999999965 578899998865321 112346679999999999999999999999999
Q ss_pred EEEEEeccCCC-CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 99 KILVYEYMSNG-SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 99 ~~lv~e~~~~~-~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
.+++||++.++ ++.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 99999998766 999988654 3577888888999999999999998 999999999999999999999999999986
Q ss_pred cc
Q 048219 178 DE 179 (183)
Q Consensus 178 ~~ 179 (183)
..
T Consensus 180 ~~ 181 (335)
T 3dls_A 180 LE 181 (335)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=172.69 Aligned_cols=146 Identities=12% Similarity=0.035 Sum_probs=125.5
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+|.+.+.||+|+||.||+|.+.. ++.+++|.+.... ......+.+|+..+..++|+||+++++++...+..+++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3457788899999999999999864 7889999987542 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|||+++++|.+++... ........++.|++.||.|+|++ +|+|+||||+||+++.++.++|++++.....
T Consensus 110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~~~~ 179 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMPDA 179 (286)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCCTTC
T ss_pred EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccccCCC
Confidence 9999999999998442 34556777899999999999998 9999999999999999999999987765433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=178.59 Aligned_cols=148 Identities=24% Similarity=0.326 Sum_probs=114.4
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
..+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.++..++||||+++++++...+..+++||+
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 45677789999999999999854 57889999886432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-------CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFN-------AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999998864 234477888889999999999999998 9999999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=171.61 Aligned_cols=147 Identities=31% Similarity=0.375 Sum_probs=117.6
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhH----HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDE----REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... +..+++|.+...... ....+.+|+.+++.++||||+++++++...+..+++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 3566789999999999999875 678999988654322 23568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC--------CCcccccceeccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE--------NRCAKNFRLWIGK 176 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~--------~~~~~i~dfg~a~ 176 (183)
+++++++.+++.. ..+++.....++.|++.||.|||++...+++|+||||+||+++. ++.++|+|||+|+
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 87 FARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp CCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred cCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999999998853 45778888889999999999999981112999999999999986 6789999999998
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 165 ~~ 166 (271)
T 3dtc_A 165 EW 166 (271)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=174.68 Aligned_cols=148 Identities=30% Similarity=0.445 Sum_probs=120.5
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
+....+.+.+.||+|+||.||+|.... .+++|.+... .......+.+|+.+++.++|+|+++++++. .....+++
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 334457777899999999999997644 4888887532 234456788999999999999999999854 56678999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||++++++|.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999976666678888889999999999999998 9999999999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-27 Score=177.06 Aligned_cols=149 Identities=21% Similarity=0.354 Sum_probs=127.4
Q ss_pred HHHhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
...+.+.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.++..+ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3456677899999999999998653 2468999886543 33456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-------------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 99 KILVYEYMSNGSLADILFNA-------------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
.+++||++++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 99999999999999988642 23457788888999999999999998 999999999999999999
Q ss_pred cccccceeccccc
Q 048219 166 CAKNFRLWIGKVD 178 (183)
Q Consensus 166 ~~~i~dfg~a~~~ 178 (183)
.++|+|||+|+..
T Consensus 202 ~~kl~Dfg~~~~~ 214 (333)
T 2i1m_A 202 VAKIGDFGLARDI 214 (333)
T ss_dssp EEEBCCCGGGCCG
T ss_pred eEEECcccccccc
Confidence 9999999999854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=176.14 Aligned_cols=144 Identities=20% Similarity=0.307 Sum_probs=124.9
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCC--CceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHH--RNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||++...++..+++|.+... .......+.+|+.++..++| +||+++++++......+++||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 36677899999999999999888889999987643 23344678899999999986 899999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+.+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++ ++.+||+|||+|+..
T Consensus 90 -~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 90 -CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp -CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred -CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 4578999999764 4567788888999999999999998 999999999999997 578999999999865
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-26 Score=169.06 Aligned_cols=146 Identities=23% Similarity=0.317 Sum_probs=128.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.+++.++||||+++++++...+..+++||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4667789999999999999976 6888999998654221 23567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++... ..+++.....++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 92 YVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred ccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999998654 3467788888999999999999998 9999999999999999999999999999865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-27 Score=179.38 Aligned_cols=146 Identities=15% Similarity=0.129 Sum_probs=120.8
Q ss_pred HhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchhhHHH-----------HHHHHHHHHHhhcCCCceeeeec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERE-----------REFQTEIKVIGRTHHRNLVRLLG 91 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~~ 91 (183)
.|.+.+.||+|+||.||+|.... ++.+++|.+........ .....|+..+..++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 56777899999999999998764 36789998764321111 12345666778889999999999
Q ss_pred eEEeC----CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec--CCC
Q 048219 92 YSLEV----SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD--ENR 165 (183)
Q Consensus 92 ~~~~~----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~--~~~ 165 (183)
++... ...+++||++ +++|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 98764 4589999999 9999999987666788999999999999999999998 999999999999999 789
Q ss_pred cccccceeccccc
Q 048219 166 CAKNFRLWIGKVD 178 (183)
Q Consensus 166 ~~~i~dfg~a~~~ 178 (183)
.+||+|||+|+..
T Consensus 192 ~~kl~DFG~a~~~ 204 (364)
T 3op5_A 192 QVYLVDYGLAYRY 204 (364)
T ss_dssp CEEECCCTTCEES
T ss_pred eEEEEECCcceec
Confidence 9999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=174.31 Aligned_cols=146 Identities=26% Similarity=0.325 Sum_probs=124.7
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.|.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++||+
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 46667899999999999999764 7889999875432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++..+... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+|+..
T Consensus 106 ~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 106 VDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp CSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 998888776643 34577888888999999999999998 9999999999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=171.53 Aligned_cols=142 Identities=27% Similarity=0.354 Sum_probs=122.9
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
..||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++||||+++++++...+..+++||++++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 37999999999999975 57789999987654445567889999999999999999999999999999999999999999
Q ss_pred HHHhcCCC--CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-CCcccccceeccccc
Q 048219 113 DILFNAEK--QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-NRCAKNFRLWIGKVD 178 (183)
Q Consensus 113 ~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg~a~~~ 178 (183)
+++..... ..++..+..++.|++.||.|||++ +++|+||+|+||+++. ++.++|+|||+++..
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99876432 345677777899999999999998 9999999999999997 789999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=172.57 Aligned_cols=147 Identities=24% Similarity=0.345 Sum_probs=119.1
Q ss_pred HhchhcccCcCcCceEEEEEEcC----CcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-----
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS----- 97 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 97 (183)
.+.+.+.||+|+||.||+|.... +..+++|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 45666789999999999997542 457999998643 2334467889999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHhc-----CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccce
Q 048219 98 KKILVYEYMSNGSLADILFN-----AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRL 172 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~df 172 (183)
..+++||++++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeec
Confidence 35899999999999998843 224577888889999999999999998 9999999999999999999999999
Q ss_pred eccccc
Q 048219 173 WIGKVD 178 (183)
Q Consensus 173 g~a~~~ 178 (183)
|+|+..
T Consensus 192 g~~~~~ 197 (313)
T 3brb_A 192 GLSKKI 197 (313)
T ss_dssp SCC---
T ss_pred Ccceec
Confidence 999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=169.77 Aligned_cols=147 Identities=20% Similarity=0.272 Sum_probs=126.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++||+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3566789999999999999976 47889999886432 33446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc---ccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC---AKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~---~~i~dfg~a~~~~ 179 (183)
++++++.+.+... ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++. ++|+|||+|....
T Consensus 87 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 87 VTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999998888654 3467888888999999999999998 9999999999999987655 9999999997543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=173.93 Aligned_cols=148 Identities=28% Similarity=0.338 Sum_probs=124.9
Q ss_pred HHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 26 KKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 26 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
....+.+.+.||+|+||.||+|... ++..+++|.+.... ....+.+|+.++..++||||+++++++...+..+++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3445667789999999999999976 47889999886532 23567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999875455678888889999999999999998 9999999999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=172.24 Aligned_cols=147 Identities=21% Similarity=0.269 Sum_probs=126.6
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
..|.+.+.||+|+||.||+|... +++.+++|.+.... ......+.+|+.++..++||||+++++++...+..+++|
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 34677789999999999999976 57889999986542 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp ECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999998653 3467888888999999999999998 9999999999999999999999999998754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=178.73 Aligned_cols=144 Identities=20% Similarity=0.286 Sum_probs=118.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------eE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------KK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 99 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 4666788999999999999975 58899999985432 233467889999999999999999999987653 45
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++||++ +++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 106 ~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp EEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 9999999 7899998865 3567788888999999999999998 9999999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-27 Score=178.78 Aligned_cols=146 Identities=22% Similarity=0.303 Sum_probs=127.9
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHH-----------------HHHHHHHHHHHhhcCCCceeeeec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDER-----------------EREFQTEIKVIGRTHHRNLVRLLG 91 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~~~~ 91 (183)
.|.+.+.||+|+||.||+|.. ++..+++|.+....... ...+.+|+.++..++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 466778999999999999998 88899999986542211 167889999999999999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHH------HhcC-CCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecC
Q 048219 92 YSLEVSKKILVYEYMSNGSLADI------LFNA-EKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDE 163 (183)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~~l~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~ 163 (183)
++...+..+++||++++++|.++ +... ...+++..+..++.|++.||.|||+ . +++|+||+|+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence 99999999999999999999987 5332 3567788888999999999999998 7 9999999999999999
Q ss_pred CCcccccceeccccc
Q 048219 164 NRCAKNFRLWIGKVD 178 (183)
Q Consensus 164 ~~~~~i~dfg~a~~~ 178 (183)
++.++|+|||+++..
T Consensus 188 ~~~~kl~dfg~~~~~ 202 (348)
T 2pml_X 188 NGRVKLSDFGESEYM 202 (348)
T ss_dssp TSCEEECCCTTCEEC
T ss_pred CCcEEEecccccccc
Confidence 999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=176.97 Aligned_cols=146 Identities=20% Similarity=0.262 Sum_probs=126.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 3555678999999999999976 5788999988654 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
++++|.+++... ..+++.....++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||+|+.
T Consensus 114 ~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 114 DGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 999999998654 3467778888999999999999983 1899999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=170.20 Aligned_cols=147 Identities=25% Similarity=0.303 Sum_probs=128.5
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
..+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++++...+..+++||+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45777889999999999999976 57889999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999988754 24567888888999999999999998 9999999999999999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=176.69 Aligned_cols=145 Identities=22% Similarity=0.326 Sum_probs=121.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.+++.++||||+++++++.+....+++||+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 5777789999999999999865 5788999998644322 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec-----CCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-----ENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~-----~~~~~~i~dfg~a~~~ 178 (183)
+++ +|.+++.... .+++..+..++.|++.||.|||++ +|+|+||||+||+++ ..+.+||+|||+|+..
T Consensus 115 ~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 115 AEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp CSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred CCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 974 9999886643 467888888999999999999998 999999999999995 4455999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=180.96 Aligned_cols=146 Identities=25% Similarity=0.215 Sum_probs=125.5
Q ss_pred HhchhcccCcCcCceEEEEEEc----CCcEEEEEEccchh----hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL----DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (183)
.+.+.+.||+|+||.||++... .+..+++|.+.+.. ......+..|+.++..+ .|+||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 4667789999999999999873 57889999886432 11223456788899988 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+|+..
T Consensus 135 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999998654 3467788888999999999999998 9999999999999999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=178.14 Aligned_cols=143 Identities=20% Similarity=0.302 Sum_probs=123.9
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccch--hhHHHHHHHHHHHHHhhcC--CCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKV--LDEREREFQTEIKVIGRTH--HRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|.+.+.||+|+||.||++....+..+++|.+... .......+.+|+.++..+. |+||+++++++...+..+++||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 6677899999999999999877889999988643 2344567889999999996 5999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+.+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++ ++.+||+|||+|+..
T Consensus 137 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 55789999987643 567777888999999999999998 999999999999995 588999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-26 Score=170.08 Aligned_cols=152 Identities=24% Similarity=0.313 Sum_probs=120.5
Q ss_pred HHHHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-----HHHHHHHHHHHHHhhc---CCCceeeeeceEE
Q 048219 24 ELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-----EREREFQTEIKVIGRT---HHRNLVRLLGYSL 94 (183)
Q Consensus 24 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~ 94 (183)
++...+|.+.+.||+|+||.||+|.+. +++.+++|.+..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 334456788899999999999999964 578899999863211 0112445566666555 5999999999998
Q ss_pred eCC-----eEEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccc
Q 048219 95 EVS-----KKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168 (183)
Q Consensus 95 ~~~-----~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~ 168 (183)
... ..+++||++. ++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 654 4789999996 59999887643 3378888889999999999999998 999999999999999999999
Q ss_pred ccceecccccc
Q 048219 169 NFRLWIGKVDE 179 (183)
Q Consensus 169 i~dfg~a~~~~ 179 (183)
|+|||+|+...
T Consensus 161 l~Dfg~a~~~~ 171 (308)
T 3g33_A 161 LADFGLARIYS 171 (308)
T ss_dssp ECSCSCTTTST
T ss_pred EeeCccccccC
Confidence 99999998653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=188.59 Aligned_cols=137 Identities=16% Similarity=0.162 Sum_probs=106.4
Q ss_pred cCcCcCceEEEEE-EcCCcEEEEEEccchh----------hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEE
Q 048219 36 VGRGSSGTVYKGA-MINRQLVAVNRLEKVL----------DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 36 lg~g~~g~v~~~~-~~~~~~~~ik~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.|++|.+..++ ..-++.+++|.+.+.. ....+.+.+|+++|+++ .|+||+++++++++.+..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455555544444 3346678888875421 22345689999999999 6999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||++|++|.+.+.... .++. ..|+.||+.||.|+|++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~~~-~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHTTC-CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHhCC-CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999997643 3443 24789999999999998 99999999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=170.60 Aligned_cols=146 Identities=24% Similarity=0.339 Sum_probs=127.2
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.++..++|+|++++++++.+.+..+++||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4667789999999999999976 4678999988654222 13568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+.+... ..+++.....++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 95 FAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999988654 3467788888999999999999998 9999999999999999999999999998644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-26 Score=169.40 Aligned_cols=146 Identities=28% Similarity=0.348 Sum_probs=123.8
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe----CCeEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE----VSKKILV 102 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 102 (183)
+.+.+.||+|+||.||+|... .+..+++|.+... .......+.+|+.+++.++||||+++++++.. ....+++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 456678999999999999876 4678888887643 23445678899999999999999999999875 3458999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCC--ceecCCCCCCEEec-CCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQ--IIHCDIKPQNILMD-ENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dl~~~nil~~-~~~~~~i~dfg~a~~~~ 179 (183)
||++++++|.+++... ..+++..+..++.|++.||.|||+. + ++|+||+|+||+++ .++.++|+|||+|....
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999998653 3467788888999999999999997 7 99999999999998 78899999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=181.17 Aligned_cols=148 Identities=21% Similarity=0.272 Sum_probs=122.7
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--------HHHHHHHHHHHHHhhcCCCceeeeeceEEeCC
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--------EREREFQTEIKVIGRTHHRNLVRLLGYSLEVS 97 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (183)
...|.+.+.||+|+||.||+|... ++..+|+|.+.+... .....+.+|+.+++.++||||+++++++. ..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 345777789999999999999976 478899999865321 11124778999999999999999999874 55
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC---cccccceec
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR---CAKNFRLWI 174 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~---~~~i~dfg~ 174 (183)
..+++||++++++|.+.+... ..+++.....++.|++.||.|||++ +++|+||||+||+++..+ .+||+|||+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 689999999999998877543 4577888888999999999999998 999999999999997544 599999999
Q ss_pred ccccc
Q 048219 175 GKVDE 179 (183)
Q Consensus 175 a~~~~ 179 (183)
|+...
T Consensus 289 a~~~~ 293 (419)
T 3i6u_A 289 SKILG 293 (419)
T ss_dssp TTSCC
T ss_pred ceecC
Confidence 98753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-27 Score=179.30 Aligned_cols=146 Identities=23% Similarity=0.292 Sum_probs=122.5
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchh-----------hHHHHHHHHHHHHHhhcCCCceeeeeceEEe--
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-----------DEREREFQTEIKVIGRTHHRNLVRLLGYSLE-- 95 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 95 (183)
.|.+.+.||+|+||.||+|....+..+++|.+.... ......+.+|+.++..++||||+++++++..
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 355668999999999999998889999999875421 1223678899999999999999999999854
Q ss_pred ---CCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccce
Q 048219 96 ---VSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRL 172 (183)
Q Consensus 96 ---~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~df 172 (183)
....+++||+++ +++.+.+......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+||
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCT
T ss_pred CCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEec
Confidence 236799999997 588888876655678888889999999999999998 9999999999999999999999999
Q ss_pred eccccc
Q 048219 173 WIGKVD 178 (183)
Q Consensus 173 g~a~~~ 178 (183)
|+|+..
T Consensus 179 g~~~~~ 184 (362)
T 3pg1_A 179 NLARED 184 (362)
T ss_dssp TC----
T ss_pred Cccccc
Confidence 999743
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=170.10 Aligned_cols=147 Identities=24% Similarity=0.312 Sum_probs=128.1
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH------HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE------REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..+.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45778889999999999999976 5788999987653211 2456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC----cccccceeccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR----CAKNFRLWIGK 176 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~----~~~i~dfg~a~ 176 (183)
++||++++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999998653 3567888889999999999999998 999999999999998876 79999999997
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 161 ~~ 162 (283)
T 3bhy_A 161 KI 162 (283)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-26 Score=175.24 Aligned_cols=146 Identities=25% Similarity=0.330 Sum_probs=126.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--------hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--------DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.... ......+..|+.++..+ +||||+++++++...+.
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 3556678999999999999986 58899999875422 12235678899999998 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
.+++|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999988653 3567888888999999999999998 9999999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=175.94 Aligned_cols=147 Identities=25% Similarity=0.349 Sum_probs=121.8
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-Cc----EEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-RQ----LVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~~----~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
..+.+.+.||+|+||.||+|.... +. .+++|.+... .......+.+|+.++..++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 346677899999999999998653 33 3566766432 2233467889999999999999999999987654 788
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++++++.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999987666788888899999999999999998 9999999999999999999999999999865
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-26 Score=169.83 Aligned_cols=146 Identities=25% Similarity=0.272 Sum_probs=126.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---------hHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---------DEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVS 97 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 97 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.+. ||||+++++++...+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4666788999999999999976 57889999985421 122356788999999995 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
..+++||++++++|.+++... ..+++.....++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999998653 3567888888999999999999998 999999999999999999999999999975
Q ss_pred c
Q 048219 178 D 178 (183)
Q Consensus 178 ~ 178 (183)
.
T Consensus 174 ~ 174 (298)
T 1phk_A 174 L 174 (298)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-26 Score=187.46 Aligned_cols=148 Identities=20% Similarity=0.306 Sum_probs=127.2
Q ss_pred HHhchhcccCcCcCceEEEEEEcC----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++||||+++++++ ..+..+++
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceEEE
Confidence 345667789999999999998653 4568899876533 33346788999999999999999999987 45678999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|||+++++|.+++......+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+...
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999976655678888888999999999999998 99999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=175.34 Aligned_cols=143 Identities=24% Similarity=0.275 Sum_probs=121.8
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEec
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+.+... ...+|++++.++ +||||+++++++.+....+++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 45777789999999999999976 578899999865422 234577778777 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC----Ccccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN----RCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~----~~~~i~dfg~a~~~ 178 (183)
+++++|.+.+... ..+++.....++.|++.||.|||++ +|+||||||+||++... +.+||+|||+|+..
T Consensus 98 ~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999988654 4577888889999999999999998 99999999999998543 35999999999854
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=173.51 Aligned_cols=148 Identities=19% Similarity=0.253 Sum_probs=126.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEE--------eCC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSL--------EVS 97 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~ 97 (183)
..+.+.+.||+|+||.||+|... .+..+++|.+..........+.+|+.++..+. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 35677789999999999999975 57889999886655556677889999999996 999999999984 234
Q ss_pred eEEEEEeccCCCCHHHHHhc--CCCCCChHHHHHHHHHHHHHHHHhhhCCCCC--ceecCCCCCCEEecCCCccccccee
Q 048219 98 KKILVYEYMSNGSLADILFN--AEKQPNWIERTGIARDIARGILYLHDECETQ--IIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
..+++||++. ++|.+++.. ....+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 5789999996 688888754 334578888899999999999999997 7 9999999999999999999999999
Q ss_pred cccccc
Q 048219 174 IGKVDE 179 (183)
Q Consensus 174 ~a~~~~ 179 (183)
+|+...
T Consensus 184 ~~~~~~ 189 (337)
T 3ll6_A 184 SATTIS 189 (337)
T ss_dssp TCBCCS
T ss_pred cceecc
Confidence 998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=182.97 Aligned_cols=146 Identities=10% Similarity=0.083 Sum_probs=115.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccch---hhHHHHHHHHHHH---HHhhcCCCceeeee-------ceEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV---LDEREREFQTEIK---VIGRTHHRNLVRLL-------GYSLE 95 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~~~~ 95 (183)
+.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+. .++.++||||++++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 344578999999999999964 5889999998632 2234467888994 55566899999988 55544
Q ss_pred CC-----------------eEEEEEeccCCCCHHHHHhcCCCCCC------hHHHHHHHHHHHHHHHHhhhCCCCCceec
Q 048219 96 VS-----------------KKILVYEYMSNGSLADILFNAEKQPN------WIERTGIARDIARGILYLHDECETQIIHC 152 (183)
Q Consensus 96 ~~-----------------~~~lv~e~~~~~~l~~~l~~~~~~~~------~~~~~~i~~~i~~~l~~lh~~~~~~i~H~ 152 (183)
.+ ..+++||++ +|+|.+++........ +..+..++.|++.||.|||++ +|+|+
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 43 278999999 5799999875322222 356667899999999999998 99999
Q ss_pred CCCCCCEEecCCCcccccceecccccc
Q 048219 153 DIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 153 dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||||+||+++.++.+||+|||+|+...
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999998543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-26 Score=170.53 Aligned_cols=145 Identities=28% Similarity=0.397 Sum_probs=127.4
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.++..++|+|++++++++......+++||++
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 3566788999999999999865 57889999986432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+|...
T Consensus 103 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 103 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp TTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceec
Confidence 99999998854 4577888888999999999999998 9999999999999999999999999999754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=171.66 Aligned_cols=147 Identities=28% Similarity=0.313 Sum_probs=118.8
Q ss_pred HHhchhcccCcCcCceEEEEEEc--CC--cEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI--NR--QLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~--~~--~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..+.+.+.||+|+||.||+|... .+ ..+++|.+.... ......+.+|+.++..++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 35677789999999999999853 22 358898876432 234467889999999999999999999987654 88
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|++++++|.+.+......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999876545577888888999999999999998 9999999999999999999999999999765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-26 Score=172.41 Aligned_cols=147 Identities=25% Similarity=0.300 Sum_probs=126.0
Q ss_pred HHHHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhh--cCCCceeeeeceEEeCC---
Q 048219 23 AELKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGR--THHRNLVRLLGYSLEVS--- 97 (183)
Q Consensus 23 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~--- 97 (183)
.......+.+.+.||+|+||.||+|.. +++.+++|.+.... ...+..|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344456678889999999999999987 47889999986532 3456678888876 78999999999998765
Q ss_pred -eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhh--------hCCCCCceecCCCCCCEEecCCCccc
Q 048219 98 -KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH--------DECETQIIHCDIKPQNILMDENRCAK 168 (183)
Q Consensus 98 -~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dl~~~nil~~~~~~~~ 168 (183)
..+++||++++++|.+++... .+++.....++.|++.||.||| +. +++|+||||+||+++.++.+|
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred ceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999653 4678888889999999999999 66 999999999999999999999
Q ss_pred ccceeccccc
Q 048219 169 NFRLWIGKVD 178 (183)
Q Consensus 169 i~dfg~a~~~ 178 (183)
|+|||+|+..
T Consensus 188 L~Dfg~~~~~ 197 (342)
T 1b6c_B 188 IADLGLAVRH 197 (342)
T ss_dssp ECCCTTCEEE
T ss_pred EEECCCceec
Confidence 9999999754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=173.47 Aligned_cols=150 Identities=29% Similarity=0.450 Sum_probs=124.5
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS 97 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (183)
+....+.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34456778889999999999999832 45689999986432 334457888999999999999999999999988
Q ss_pred eEEEEEeccCCCCHHHHHhcCC------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---Cccc
Q 048219 98 KKILVYEYMSNGSLADILFNAE------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAK 168 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---~~~~ 168 (183)
..+++||++++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.+ ..++
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999997643 3367778888999999999999998 99999999999999844 4699
Q ss_pred ccceecccc
Q 048219 169 NFRLWIGKV 177 (183)
Q Consensus 169 i~dfg~a~~ 177 (183)
|+|||+|+.
T Consensus 184 l~Dfg~~~~ 192 (327)
T 2yfx_A 184 IGDFGMARD 192 (327)
T ss_dssp ECCCHHHHH
T ss_pred ECccccccc
Confidence 999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=168.56 Aligned_cols=145 Identities=22% Similarity=0.323 Sum_probs=124.9
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC--CeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV--SKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 104 (183)
.+.+.+.||+|+||.||+|... +..+++|.+.... ......+.+|+.+++.++||||+++++++.+. +..+++||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 4667789999999999999875 6778999886432 34456788999999999999999999999876 77899999
Q ss_pred ccCCCCHHHHHhcCCC-CCChHHHHHHHHHHHHHHHHhhhCCCCC--ceecCCCCCCEEecCCCcccccceecccc
Q 048219 105 YMSNGSLADILFNAEK-QPNWIERTGIARDIARGILYLHDECETQ--IIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
++++++|.+++..... .+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+++.|||++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999976543 478888899999999999999997 7 99999999999999999999888877654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-26 Score=171.12 Aligned_cols=144 Identities=23% Similarity=0.332 Sum_probs=118.8
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEE-------------
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSL------------- 94 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------------- 94 (183)
+|.+.+.||+|+||.||+|.... ++.+++|.+..........+.+|+.+++.++|||++++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 35667889999999999999774 7889999887655555677889999999999999999998873
Q ss_pred -eCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec-CCCcccccce
Q 048219 95 -EVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKNFRL 172 (183)
Q Consensus 95 -~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~-~~~~~~i~df 172 (183)
..+..+++||+++ ++|.+++.. ..+++.....++.|++.||.|||++ +++|+||||+||+++ .++.+||+||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999997 599998854 4567788888999999999999998 999999999999998 4579999999
Q ss_pred eccccc
Q 048219 173 WIGKVD 178 (183)
Q Consensus 173 g~a~~~ 178 (183)
|+|+..
T Consensus 166 g~~~~~ 171 (320)
T 2i6l_A 166 GLARIM 171 (320)
T ss_dssp TTCBCC
T ss_pred cccccc
Confidence 999865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=188.36 Aligned_cols=139 Identities=24% Similarity=0.336 Sum_probs=121.0
Q ss_pred ccCcCcCceEEEEEEc---CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMI---NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.||+|+||.||+|.+. .+..+|+|.++.... .....+.+|+.++..++|+||+++++++. ....++||||++++
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELG 454 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCC
Confidence 6999999999999653 357899999875432 23467899999999999999999999886 45688999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 455 ~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 455 PLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred CHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 999999653 4577888889999999999999998 9999999999999999999999999999854
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-26 Score=169.64 Aligned_cols=145 Identities=19% Similarity=0.282 Sum_probs=124.9
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe----------
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE---------- 95 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 95 (183)
...+.+.+.||+|+||.||+|... +++.+++|.+.... ..+.+|+.+++.++|||++++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 345777789999999999999976 68889999986532 245679999999999999999998864
Q ss_pred ------CCeEEEEEeccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccc
Q 048219 96 ------VSKKILVYEYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168 (183)
Q Consensus 96 ------~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~ 168 (183)
....+++||++++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 34578999999999999999653 24577888888999999999999998 999999999999999999999
Q ss_pred ccceeccccc
Q 048219 169 NFRLWIGKVD 178 (183)
Q Consensus 169 i~dfg~a~~~ 178 (183)
|+|||+|+..
T Consensus 163 l~Dfg~~~~~ 172 (284)
T 2a19_B 163 IGDFGLVTSL 172 (284)
T ss_dssp ECCCTTCEES
T ss_pred ECcchhheec
Confidence 9999998754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-26 Score=171.79 Aligned_cols=140 Identities=21% Similarity=0.335 Sum_probs=122.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEe--CCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLE--VSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.... ...+.+|+.+++.++ |+||+++.+++.+ ....+++||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 4566689999999999999865 57889999987532 356788999999997 9999999999987 567899999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~ 178 (183)
+++++++.+++.. +++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||+|+..
T Consensus 114 ~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 114 HVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999988743 66778888999999999999998 999999999999999776 8999999999854
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-26 Score=170.66 Aligned_cols=145 Identities=18% Similarity=0.250 Sum_probs=125.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+.... ....+.+|+..+..+ .|++++.+++++......+++||++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 4667789999999999999964 67889999875432 223567789999998 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc-----ccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC-----AKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~-----~~i~dfg~a~~~~ 179 (183)
+++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++.++. ++|+|||+|+...
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 8999999987666688889999999999999999998 9999999999999987765 9999999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-26 Score=169.25 Aligned_cols=147 Identities=17% Similarity=0.271 Sum_probs=125.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||++... +++.+++|.+... .......+.+|+.+++.++||||+++++++.. ....+++|
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4566789999999999999976 5788999988643 23345678899999999999999999998854 56889999
Q ss_pred eccCCCCHHHHHhcC---CCCCChHHHHHHHHHHHHHHHHhhhCCCCC-----ceecCCCCCCEEecCCCcccccceecc
Q 048219 104 EYMSNGSLADILFNA---EKQPNWIERTGIARDIARGILYLHDECETQ-----IIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 104 e~~~~~~l~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-----i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
|++++++|.+++... ...+++..+..++.|++.||.|||+. + ++|+||+|+||+++.++.++|+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999988653 23477888889999999999999997 6 999999999999999999999999999
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
+..
T Consensus 164 ~~~ 166 (279)
T 2w5a_A 164 RIL 166 (279)
T ss_dssp HHC
T ss_pred eee
Confidence 754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-26 Score=177.16 Aligned_cols=138 Identities=22% Similarity=0.292 Sum_probs=116.8
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHH-hhcCCCceeeeeceEEe----CCeEEEEEeccC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVI-GRTHHRNLVRLLGYSLE----VSKKILVYEYMS 107 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 107 (183)
+.||+|+||.||+|... ++..+++|.+... ..+.+|+.++ +..+|+||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999976 5788999998643 2355677776 44579999999999875 567899999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceecccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~~ 179 (183)
+++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+|+...
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999997643 3578888899999999999999998 9999999999999997 6889999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-26 Score=171.21 Aligned_cols=147 Identities=21% Similarity=0.268 Sum_probs=122.0
Q ss_pred HHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--------HHHHHHHHHHHHHhhcCCCceeeeeceEEeCC
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--------EREREFQTEIKVIGRTHHRNLVRLLGYSLEVS 97 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (183)
...|.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 346788899999999999999976 478899999864321 11234778999999999999999999886554
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc---ccccceec
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC---AKNFRLWI 174 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~---~~i~dfg~ 174 (183)
.+++||++++++|.+.+... ..+++.....++.|++.||.|||++ +++|+||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 89999999999999988543 4577888888999999999999998 9999999999999987654 99999999
Q ss_pred cccc
Q 048219 175 GKVD 178 (183)
Q Consensus 175 a~~~ 178 (183)
|+..
T Consensus 164 ~~~~ 167 (322)
T 2ycf_A 164 SKIL 167 (322)
T ss_dssp CEEC
T ss_pred ceec
Confidence 9864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-26 Score=173.94 Aligned_cols=145 Identities=21% Similarity=0.278 Sum_probs=124.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----CeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-----SKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 101 (183)
+|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.++..++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4677789999999999999976 57789999986533 33346788999999999999999999998754 36899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+||++. ++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+...
T Consensus 108 v~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999997 589988865 3477888888999999999999998 99999999999999999999999999998654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-26 Score=168.63 Aligned_cols=145 Identities=23% Similarity=0.329 Sum_probs=123.2
Q ss_pred Hhchhc-ccCcCcCceEEEEEEc---CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 29 TDGFKE-KVGRGSSGTVYKGAMI---NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 29 ~~~~~~-~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
.+.+.+ .||+|+||.||+|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++++ ..+..+++
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 455556 8999999999999643 35789999986542 22346788999999999999999999998 66778999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||++++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+|+..
T Consensus 96 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999764 3477888888999999999999998 9999999999999999999999999999855
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=170.70 Aligned_cols=145 Identities=29% Similarity=0.401 Sum_probs=118.3
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.+.||+|+||.||++... ++.+++|.+... .....+.+|+.+++.++||||+++++++. +..+++|||+++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 3556788999999999999875 567999998653 23456889999999999999999998876 457899999999
Q ss_pred CCHHHHHhcCCC--CCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc-ccccceeccccc
Q 048219 109 GSLADILFNAEK--QPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC-AKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~-~~i~dfg~a~~~ 178 (183)
++|.+++..... ......+..++.|++.||.|||+....+++|+||||+||+++.++. +||+|||+|+..
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999976432 3567777888999999999999932238999999999999998876 799999999754
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=169.09 Aligned_cols=145 Identities=22% Similarity=0.333 Sum_probs=123.0
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH--HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE--REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+.+.||+|+||.||+|... +++.+++|.+...... ....+.+|+.+++.++||||+++++++...+..+++||++
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (299)
T 2r3i_A 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEcc
Confidence 456678999999999999976 5788999988643221 2256788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
. +++.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+|+..
T Consensus 85 ~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 153 (299)
T 2r3i_A 85 H-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153 (299)
T ss_dssp S-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred c-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchhhhhc
Confidence 7 59998886543 4567778888999999999999998 9999999999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=174.04 Aligned_cols=144 Identities=20% Similarity=0.287 Sum_probs=119.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------eE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------KK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 99 (183)
.|.+.+.||+|+||.||+|... .+..+++|.+... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4667788999999999999876 5788999998653 2334466889999999999999999999987654 68
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++||++++ ++.+.+.. .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+...
T Consensus 106 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 999999975 78777743 467778888999999999999998 99999999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=176.18 Aligned_cols=144 Identities=23% Similarity=0.300 Sum_probs=110.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------CeE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SKK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 99 (183)
+|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 4667789999999999999865 57889999986532 33456788999999999999999999998654 557
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|++ +++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+|+..
T Consensus 110 ~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 9999998 6788887754 4577888888999999999999998 9999999999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=170.63 Aligned_cols=146 Identities=27% Similarity=0.354 Sum_probs=120.0
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-CeEEEEEecc
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-SKKILVYEYM 106 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~ 106 (183)
..+.+.+.||+|+||.||++... +..+++|.+.... ....+.+|+.++..++|||++++++++... +..+++||++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 34667789999999999999764 6789999987542 345688899999999999999999987654 5789999999
Q ss_pred CCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++...
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999886532 2256777888999999999999998 99999999999999999999999999997543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=176.61 Aligned_cols=146 Identities=10% Similarity=-0.015 Sum_probs=106.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhc--CCCceeeee-------ceEEeC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRT--HHRNLVRLL-------GYSLEV 96 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~~~ 96 (183)
+.+.+.||+|+||.||+|.+. ++..+|+|.+.... ......+.+|+.++..+ +|||+++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 456678999999999999976 67889999987632 23345567775444433 699988754 344332
Q ss_pred -----------------CeEEEEEeccCCCCHHHHHhcCCCCCChHHH------HHHHHHHHHHHHHhhhCCCCCceecC
Q 048219 97 -----------------SKKILVYEYMSNGSLADILFNAEKQPNWIER------TGIARDIARGILYLHDECETQIIHCD 153 (183)
Q Consensus 97 -----------------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~lh~~~~~~i~H~d 153 (183)
...++||||++ ++|.+++......+.+..+ ..++.|++.||.|||++ +|+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD 219 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence 34799999998 7999999764333344444 56779999999999998 999999
Q ss_pred CCCCCEEecCCCcccccceecccccc
Q 048219 154 IKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 154 l~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|||+||+++.++.+||+|||+|+...
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~ 245 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVG 245 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETT
T ss_pred CCHHHEEECCCCCEEEEecceeeecC
Confidence 99999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=166.19 Aligned_cols=147 Identities=22% Similarity=0.213 Sum_probs=115.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.+.+.+.||+|+||.||+|... +++.+++|.+.... ......+.++...++.+.|||++++++++...+..+++||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 4667789999999999999975 57889999986532 12223344555567888999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++ ++.+++.. ....+++..+..++.|++.||.|||++ .+++|+||||+||+++.++.++|+|||+|+..
T Consensus 88 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 88 MDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred hcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 974 88776643 345678888889999999999999984 28999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=168.58 Aligned_cols=146 Identities=27% Similarity=0.343 Sum_probs=122.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh----HHHHHHHHHHHHHhhcCCCceeeeeceEE--eCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD----EREREFQTEIKVIGRTHHRNLVRLLGYSL--EVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 101 (183)
.|.+.+.||+|+||.||++... ++..+++|.+..... .....+.+|+.+++.++|+||+++++++. .....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 3667789999999999999975 578899999875421 23467889999999999999999999985 4557899
Q ss_pred EEeccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||+++++ +.+.+... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 99999865 66666543 34577888888999999999999998 9999999999999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=169.43 Aligned_cols=148 Identities=23% Similarity=0.284 Sum_probs=121.7
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhh--cCCCceeeeeceEEeC----Ce
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGR--THHRNLVRLLGYSLEV----SK 98 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~ 98 (183)
.....+.+.+.||+|+||.||+|... +..+++|.+.... ......|.+++.. ++|+||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34456788899999999999999875 7789999986432 2233445555544 4899999999999876 68
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCC-----CCCceecCCCCCCEEecCCCccccccee
Q 048219 99 KILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC-----ETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
.+++|||+++++|.+++... .+++..+..++.|++.||.|||++. ..+++|+||||+||+++.++.+||+|||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 89999999999999999653 4778888889999999999999741 2289999999999999999999999999
Q ss_pred ccccc
Q 048219 174 IGKVD 178 (183)
Q Consensus 174 ~a~~~ 178 (183)
+|+..
T Consensus 188 ~a~~~ 192 (337)
T 3mdy_A 188 LAVKF 192 (337)
T ss_dssp TCEEC
T ss_pred Cceee
Confidence 99654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=171.06 Aligned_cols=148 Identities=23% Similarity=0.286 Sum_probs=125.8
Q ss_pred HHhchh-cccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEE
Q 048219 28 ITDGFK-EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 28 ~~~~~~-~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 102 (183)
..+.+. +.||+|+||.||+|... +++.+++|.+..... .....+.+|+.++..+. ||||+++++++...+..+++
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 345554 78999999999999976 578899998865322 22456888999999885 69999999999999999999
Q ss_pred EeccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~ 178 (183)
||++++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||+++. .+.++|+|||+|+..
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999987543 24577888889999999999999998 9999999999999987 789999999999865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=167.55 Aligned_cols=141 Identities=21% Similarity=0.278 Sum_probs=120.1
Q ss_pred hchh-cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHH-hhcCCCceeeeeceEEe----CCeEEEE
Q 048219 30 DGFK-EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVI-GRTHHRNLVRLLGYSLE----VSKKILV 102 (183)
Q Consensus 30 ~~~~-~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv 102 (183)
+.+. +.||+|+||.||+|... ++..+++|.+... ....+|+.++ +..+||||+++++++.. ....+++
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 3343 67999999999999975 5788999998643 2455677777 55689999999999876 6678999
Q ss_pred EeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~ 178 (183)
||++++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++. ++.++|+|||+|...
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 99999999999997643 3578888889999999999999998 9999999999999998 788999999999765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=172.71 Aligned_cols=146 Identities=14% Similarity=0.084 Sum_probs=116.6
Q ss_pred HHhchhcccCcCcCceEEEEEEc----CCcEEEEEEccchhhHH-----------HHHHHHHHHHHhhcCCCceeeeece
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDER-----------EREFQTEIKVIGRTHHRNLVRLLGY 92 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (183)
..|.+.+.||+|+||.||+|... .+..+++|......... ...+..|+..+..++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 45677789999999999999976 45678888876432110 1235678888999999999999999
Q ss_pred EEe----CCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC--c
Q 048219 93 SLE----VSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR--C 166 (183)
Q Consensus 93 ~~~----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~--~ 166 (183)
+.. ....+++||++ +++|.+++.... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence 987 67889999999 899999886543 577888899999999999999998 999999999999999877 9
Q ss_pred ccccceeccccc
Q 048219 167 AKNFRLWIGKVD 178 (183)
Q Consensus 167 ~~i~dfg~a~~~ 178 (183)
+||+|||+|+..
T Consensus 192 ~kL~Dfg~a~~~ 203 (345)
T 2v62_A 192 VYLADYGLSYRY 203 (345)
T ss_dssp EEECCCTTCEES
T ss_pred EEEEeCCCceec
Confidence 999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=174.13 Aligned_cols=146 Identities=22% Similarity=0.289 Sum_probs=123.3
Q ss_pred HhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhc------CCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRT------HHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~l 101 (183)
+|.+.+.||+|+||.||+|.... +..+|+|.+.... .....+..|+.++..+ .|+|++++++++...+..++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 46677899999999999998764 7889999986542 2334566777777766 57799999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc--ccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC--AKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~--~~i~dfg~a~~~ 178 (183)
+||++. +++.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|||+|+..
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 58998887644 3478888889999999999999998 9999999999999999876 999999999754
Q ss_pred c
Q 048219 179 E 179 (183)
Q Consensus 179 ~ 179 (183)
.
T Consensus 253 ~ 253 (429)
T 3kvw_A 253 H 253 (429)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=170.32 Aligned_cols=146 Identities=32% Similarity=0.449 Sum_probs=124.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEe------CCeEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLE------VSKKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~ 100 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+.... .....+..|+.++..+ .||||+++++++.. .+..+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 4567789999999999999975 57889999876432 2335678899999998 79999999999976 45789
Q ss_pred EEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++||++++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 9999999999999987643 4567778888999999999999998 9999999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=174.59 Aligned_cols=142 Identities=20% Similarity=0.264 Sum_probs=117.4
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----------
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV----------- 96 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----------- 96 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+..... ...+|+.+++.++|+||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4667789999999999999875 578999998864321 223689999999999999999998543
Q ss_pred ---------------------------CeEEEEEeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCC
Q 048219 97 ---------------------------SKKILVYEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECE 146 (183)
Q Consensus 97 ---------------------------~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 146 (183)
...+++|||++ +++.+.+.. ....+++..+..++.|++.||.|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34789999997 487776653 345677888888999999999999998
Q ss_pred CCceecCCCCCCEEec-CCCcccccceeccccc
Q 048219 147 TQIIHCDIKPQNILMD-ENRCAKNFRLWIGKVD 178 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~-~~~~~~i~dfg~a~~~ 178 (183)
+|+|+||||+||+++ .++.+||+|||+|+..
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 192 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEEC
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCccc
Confidence 999999999999998 5789999999999854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.7e-26 Score=176.01 Aligned_cols=142 Identities=22% Similarity=0.293 Sum_probs=116.2
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe------EEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK------KILV 102 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv 102 (183)
.|.+.+.||+|+||.||+|....+..+++|++..... ...+|+.+++.++|+||+++++++...+. .+++
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 4677789999999999999988777788888754321 12358999999999999999999865433 7899
Q ss_pred EeccCCCCHHHHHh---cCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec-CCCcccccceeccccc
Q 048219 103 YEYMSNGSLADILF---NAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~-~~~~~~i~dfg~a~~~ 178 (183)
|||+++ ++...+. .....+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||+|+..
T Consensus 117 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999976 4443332 2245677888888999999999999998 999999999999999 7899999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=174.40 Aligned_cols=141 Identities=16% Similarity=0.175 Sum_probs=120.1
Q ss_pred HhchhcccCcCcCceEEEEEEcC---------CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceee-----------
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN---------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVR----------- 88 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~----------- 88 (183)
.|.+.+.||+|+||.||+|.... +..+++|.+... ..+.+|+.+++.++|+|+++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 56677899999999999998764 678999998653 35678999999999998887
Q ss_pred ----eeceEEe-CCeEEEEEeccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec
Q 048219 89 ----LLGYSLE-VSKKILVYEYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD 162 (183)
Q Consensus 89 ----~~~~~~~-~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~ 162 (183)
+++++.. ....+++||++ +++|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||+++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 5666655 67889999999 99999999764 24678888999999999999999998 999999999999999
Q ss_pred CCC--cccccceeccccc
Q 048219 163 ENR--CAKNFRLWIGKVD 178 (183)
Q Consensus 163 ~~~--~~~i~dfg~a~~~ 178 (183)
.++ .++|+|||+|+..
T Consensus 194 ~~~~~~~kl~Dfg~a~~~ 211 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRY 211 (352)
T ss_dssp TTEEEEEEECCGGGCBCS
T ss_pred CCCCceEEEecCcceeec
Confidence 988 8999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-25 Score=164.10 Aligned_cols=151 Identities=23% Similarity=0.320 Sum_probs=129.0
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
....+|.+.+.||+|+||.||+|... +++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 33456788899999999999999976 57889999986532 2234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---Ccccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---~~~~i~dfg~a~~~ 178 (183)
+||+++++++.+.+... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.. +.++|+|||+++..
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999998887653 3467888888999999999999998 99999999999999764 46999999999865
Q ss_pred c
Q 048219 179 E 179 (183)
Q Consensus 179 ~ 179 (183)
.
T Consensus 175 ~ 175 (287)
T 2wei_A 175 Q 175 (287)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-26 Score=186.37 Aligned_cols=145 Identities=20% Similarity=0.220 Sum_probs=122.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc--CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe-----E
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI--NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK-----K 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~ 99 (183)
..|.+.+.||+|+||.||++.+. ++..|++|.+.... ......+..|+.++..++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45777789999999999999976 57889999886432 3344568899999999999999999999987655 7
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++||||+++++|.+.+.. .+++..+..++.|++.||.|+|++ +|+|+||||+||+++.+ .+||+|||+|+...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999887643 577888889999999999999998 99999999999999875 89999999998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=174.41 Aligned_cols=140 Identities=27% Similarity=0.319 Sum_probs=110.2
Q ss_pred cccCcCcCceEEEEEEc---CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMI---NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 108 (183)
+.||+|+||.||+|... .+..+++|.+.... ....+.+|+.+++.++||||+++++++.. ....+++|||+.
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 47999999999999865 46789999987532 12357789999999999999999999965 668999999996
Q ss_pred CCHHHHHhcC--------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe----cCCCcccccceeccc
Q 048219 109 GSLADILFNA--------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM----DENRCAKNFRLWIGK 176 (183)
Q Consensus 109 ~~l~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~----~~~~~~~i~dfg~a~ 176 (183)
+++.+.+... ...+++..+..++.|++.||.|||++ +|+|+||||+||++ +..+.+||+|||+|+
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 4887777421 12377788888999999999999998 99999999999999 677899999999998
Q ss_pred ccc
Q 048219 177 VDE 179 (183)
Q Consensus 177 ~~~ 179 (183)
...
T Consensus 181 ~~~ 183 (405)
T 3rgf_A 181 LFN 183 (405)
T ss_dssp ---
T ss_pred ecC
Confidence 654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=169.63 Aligned_cols=144 Identities=19% Similarity=0.270 Sum_probs=123.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----CeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-----SKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 101 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 3566788999999999999976 57889999986432 33445678999999999999999999887653 67899
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||++. ++|.+.+.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+..
T Consensus 92 v~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 999997 589888865 3577888888999999999999998 9999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=172.21 Aligned_cols=144 Identities=21% Similarity=0.310 Sum_probs=120.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeE------
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKK------ 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 99 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3556678999999999999976 57889999987532 23346788999999999999999999999876654
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++||++. +++.+.+. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+...
T Consensus 123 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 58877663 3477888889999999999999998 99999999999999999999999999998543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=165.46 Aligned_cols=146 Identities=21% Similarity=0.275 Sum_probs=121.0
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceE-EeCCeEEEEEec
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS-LEVSKKILVYEY 105 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~ 105 (183)
..|.+.+.||+|+||.||+|... .+..+++|.+.... ....+..|+.++..++|++++..+..+ ...+..+++||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 35677889999999999999974 57889999764321 223467899999999988766665555 567788999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe---cCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~---~~~~~~~i~dfg~a~~~~ 179 (183)
+ +++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||++ +.++.+||+|||+|+...
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9 8999999976566788889999999999999999998 99999999999999 788999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=168.52 Aligned_cols=144 Identities=27% Similarity=0.426 Sum_probs=114.7
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHH--HHhhcCCCceeeeeceEEe-----CCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIK--VIGRTHHRNLVRLLGYSLE-----VSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~--~l~~l~h~~i~~~~~~~~~-----~~~~~l 101 (183)
.+.+.+.||+|+||.||+|.. ++..+++|.+..... ..+..|.+ .+..++|+||+++++.+.. ....++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 456778999999999999965 577899999865432 22333444 4456899999999876542 235689
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCC------CCCceecCCCCCCEEecCCCcccccceecc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC------ETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
+|||+++++|.+++... ..++.....++.|++.||.|||+.. ..+++|+||||+||+++.++.+||+|||+|
T Consensus 90 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 99999999999999654 3467778889999999999999741 128999999999999999999999999999
Q ss_pred ccc
Q 048219 176 KVD 178 (183)
Q Consensus 176 ~~~ 178 (183)
+..
T Consensus 168 ~~~ 170 (336)
T 3g2f_A 168 MRL 170 (336)
T ss_dssp EEC
T ss_pred eec
Confidence 754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-26 Score=172.98 Aligned_cols=146 Identities=22% Similarity=0.344 Sum_probs=121.7
Q ss_pred HHHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
...+.+.+.||+|+||.||+|.... .+++|.+.... ......+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3446677899999999999998765 47888875421 1122346678999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++|.+++......+++..+..++.|++.||.|||++ +++|+||+|+||+++ ++.++|+|||+|+..
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 9999999999976655678888889999999999999998 999999999999998 679999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=169.40 Aligned_cols=144 Identities=21% Similarity=0.305 Sum_probs=121.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe------E
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK------K 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~ 99 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3556678999999999999976 57889999986532 2334678899999999999999999999876554 4
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++||++. +++.+.+. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+|+...
T Consensus 105 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 99999997 57777663 2477888888999999999999998 99999999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=165.53 Aligned_cols=146 Identities=21% Similarity=0.266 Sum_probs=123.3
Q ss_pred HhchhcccCcCcCceEEEEEE-c-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCC------ceeeeeceEEeCCeEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAM-I-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHR------NLVRLLGYSLEVSKKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~-~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~ 100 (183)
.|.+.+.||+|+||.||+|.. . ++..+++|.+.... .....+.+|+.++..++|+ +++++++++...+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 567788999999999999987 3 57889999986542 3345677888888887655 4899999999999999
Q ss_pred EEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC----------------
Q 048219 101 LVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---------------- 163 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---------------- 163 (183)
++||++ ++++.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 789999887644 3467788888999999999999998 9999999999999987
Q ss_pred ---CCcccccceecccccc
Q 048219 164 ---NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 164 ---~~~~~i~dfg~a~~~~ 179 (183)
++.++|+|||+|+...
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~ 188 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDD 188 (339)
T ss_dssp EESCCCEEECCCSSCEETT
T ss_pred cccCCCceEeeCcccccCc
Confidence 5679999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=170.53 Aligned_cols=134 Identities=24% Similarity=0.334 Sum_probs=109.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC--------CCceeeeeceEE----
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH--------HRNLVRLLGYSL---- 94 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---- 94 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+... ......+.+|+.+++.++ |+|++++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 45777789999999999999875 5788999998754 234456788999998885 788999999987
Q ss_pred eCCeEEEEEeccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC
Q 048219 95 EVSKKILVYEYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR 165 (183)
Q Consensus 95 ~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~ 165 (183)
.....+++||++ ++++.+.+... ...+++..+..++.|++.||.|||++ .+|+||||||+||+++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccc
Confidence 455789999999 55666666543 35578888889999999999999985 2899999999999999775
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=174.68 Aligned_cols=145 Identities=20% Similarity=0.278 Sum_probs=121.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCC-ceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHR-NLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||+|+||.||+|... .+..|++|.+..... ...+..|+.++..+.|. ++..+..++......+++||++
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4567789999999999999975 578899998654321 23467899999999874 5555666666788899999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe---cCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~---~~~~~~~i~dfg~a~~~~ 179 (183)
+++|.+++......+++..+..++.|++.||.|||++ +|+|+||||+||++ +..+.+||+|||+|+...
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 8999999986666788999999999999999999998 99999999999999 578899999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=167.07 Aligned_cols=147 Identities=24% Similarity=0.344 Sum_probs=120.0
Q ss_pred HhchhcccCcCcCceEEEEEEc--CCcEEEEEEccchhhH--HHHHHHHHHHHHhhc---CCCceeeeeceEE-----eC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI--NRQLVAVNRLEKVLDE--REREFQTEIKVIGRT---HHRNLVRLLGYSL-----EV 96 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~--~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~ 96 (183)
.|.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.+++.+ .||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 4667789999999999999974 5778999987643211 112345666666655 8999999999987 45
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecc
Q 048219 97 SKKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIG 175 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a 175 (183)
...+++||+++ ++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+|
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence 67899999997 59999887643 3477888888999999999999998 9999999999999999999999999999
Q ss_pred cccc
Q 048219 176 KVDE 179 (183)
Q Consensus 176 ~~~~ 179 (183)
+...
T Consensus 168 ~~~~ 171 (326)
T 1blx_A 168 RIYS 171 (326)
T ss_dssp CCCC
T ss_pred cccc
Confidence 8653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=173.32 Aligned_cols=142 Identities=25% Similarity=0.327 Sum_probs=115.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------CeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~l 101 (183)
.|.+.+.||+|+||.||+|... ++..|++|.+.... ....+|+.+++.++|+||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3566678999999999999986 58899999886432 1234689999999999999999988542 23678
Q ss_pred EEeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceecccc
Q 048219 102 VYEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGKV 177 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~~ 177 (183)
+|||+++ ++.+.+.. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||+|+.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 66655532 345677888888999999999999998 99999999999999965 6789999999985
Q ss_pred c
Q 048219 178 D 178 (183)
Q Consensus 178 ~ 178 (183)
.
T Consensus 207 ~ 207 (420)
T 1j1b_A 207 L 207 (420)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=169.67 Aligned_cols=150 Identities=22% Similarity=0.285 Sum_probs=119.1
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh------HHHHHHHHHHHHHhhc----CCCceeeeeceE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD------EREREFQTEIKVIGRT----HHRNLVRLLGYS 93 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~~~~~~ 93 (183)
.-...|.+.+.||+|+||.||+|... ++..+++|.+..... .....+..|+.++..+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 33456788889999999999999865 578899999865321 1122355688888888 899999999999
Q ss_pred EeCCeEEEEEec-cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec-CCCcccccc
Q 048219 94 LEVSKKILVYEY-MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKNFR 171 (183)
Q Consensus 94 ~~~~~~~lv~e~-~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~-~~~~~~i~d 171 (183)
...+..++++|+ +.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++ .++.++|+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence 988899999999 7889999998653 3477888888999999999999998 999999999999999 789999999
Q ss_pred eeccccc
Q 048219 172 LWIGKVD 178 (183)
Q Consensus 172 fg~a~~~ 178 (183)
||+|+..
T Consensus 184 fg~~~~~ 190 (312)
T 2iwi_A 184 FGSGALL 190 (312)
T ss_dssp CSSCEEC
T ss_pred cchhhhc
Confidence 9999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.8e-25 Score=163.31 Aligned_cols=145 Identities=21% Similarity=0.272 Sum_probs=121.3
Q ss_pred HhchhcccCcCcCceEEEEEE-cCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceE-EeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAM-INRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYS-LEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~ 106 (183)
.+.+.+.||+|+||.||+|.. .+++.+++|.+.... ....+.+|+.++..++|++++..+..+ ......+++||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 356678999999999999997 468889999875432 123577899999999988766655554 5677889999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe---cCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM---DENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~---~~~~~~~i~dfg~a~~~~ 179 (183)
+++|.+++......+++..+..++.|++.||.|||++ +++|+||||+||++ +.++.+||+|||+|+...
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 8899999976566788888999999999999999998 99999999999999 478899999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=164.16 Aligned_cols=145 Identities=20% Similarity=0.297 Sum_probs=124.3
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccch--hhHHHHHHHHHHHHHhhcC--CCceeeeeceEEeCCeEEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKV--LDEREREFQTEIKVIGRTH--HRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 103 (183)
..|.+.+.||+|+||.||++...++..+++|.+... .......+.+|+.++..++ |+|++++++++...+..+++|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 346677899999999999999888889999988542 2334567889999999997 599999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
| +.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++. +.+||+|||+|+..
T Consensus 108 e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 108 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp C-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred e-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9 5578999998764 3567778888999999999999998 9999999999999965 88999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-25 Score=167.75 Aligned_cols=147 Identities=24% Similarity=0.250 Sum_probs=108.0
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCe-------E
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSK-------K 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~ 99 (183)
..+.+.+.||+|+||.||+|... ++..+++|.+.... ........++..+..++||||+++++++...+. .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 35677789999999999999976 57889999875432 122345567777888899999999999876443 7
Q ss_pred EEEEeccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhh--hCCCCCceecCCCCCCEEecC-CCccccccee
Q 048219 100 ILVYEYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLH--DECETQIIHCDIKPQNILMDE-NRCAKNFRLW 173 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~~i~H~dl~~~nil~~~-~~~~~i~dfg 173 (183)
+++|||+++ ++...+.. ....+++..+..++.|++.|+.|+| +. +|+|+||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 899999976 55444432 3345677788889999999999999 76 9999999999999997 8999999999
Q ss_pred cccccc
Q 048219 174 IGKVDE 179 (183)
Q Consensus 174 ~a~~~~ 179 (183)
+|+...
T Consensus 178 ~a~~~~ 183 (360)
T 3e3p_A 178 SAKKLS 183 (360)
T ss_dssp TCBCCC
T ss_pred CceecC
Confidence 998653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=162.73 Aligned_cols=146 Identities=20% Similarity=0.244 Sum_probs=112.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHH-HHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-ERE-REFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+..... ... ..+.++..+++.++||||+++++++...+..+++||+
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 4566678999999999999976 578899999865422 222 3344555567888999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+ ++.+..+.......+++..+..++.|++.||.|||+ + +++|+||+|+||+++.++.++|+|||+++..
T Consensus 106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9 556666554434567788888899999999999998 5 8999999999999999999999999999754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.2e-25 Score=172.08 Aligned_cols=144 Identities=21% Similarity=0.255 Sum_probs=116.5
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.+.+.+.||+|+||.|+.....++..||+|.+..... ..+.+|+.+++.+ +||||+++++++.+....+++||++.
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 4556678999999997765566788999999864321 2245689999988 79999999999999999999999996
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---C--Ccccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---N--RCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~--~~~~i~dfg~a~~~~ 179 (183)
++|.+++........+.....++.|++.||.|||++ +|+||||||+||+++. + ..++|+|||+|+...
T Consensus 102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 599999976554444445567899999999999998 9999999999999953 2 257799999998653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=170.93 Aligned_cols=140 Identities=26% Similarity=0.263 Sum_probs=113.3
Q ss_pred hhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
..+.||+|+||.||.+...++..||+|.+.... ...+..|+.++..+ +||||+++++++.+....+++||++. ++
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 346799999999987766778999999986532 23467899999876 89999999999999999999999996 59
Q ss_pred HHHHHhcCCCCC------ChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-------------Ccccccc
Q 048219 111 LADILFNAEKQP------NWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-------------RCAKNFR 171 (183)
Q Consensus 111 l~~~l~~~~~~~------~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-------------~~~~i~d 171 (183)
|.+++....... .+..+..++.|++.||.|||++ +|+|+||||+||+++.. ..+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999986543211 1122356899999999999998 99999999999999754 4799999
Q ss_pred eeccccc
Q 048219 172 LWIGKVD 178 (183)
Q Consensus 172 fg~a~~~ 178 (183)
||+|+..
T Consensus 172 FG~a~~~ 178 (434)
T 2rio_A 172 FGLCKKL 178 (434)
T ss_dssp CTTCEEC
T ss_pred cccceec
Confidence 9999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=163.59 Aligned_cols=146 Identities=18% Similarity=0.254 Sum_probs=121.4
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-C-cEEEEEEccchhhHHHHHHHHHHHHHhhcCCCc------eeeeeceEEeCCeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-R-QLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN------LVRLLGYSLEVSKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~-~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~ 99 (183)
..|.+.+.||+|+||.||+|.... + ..+++|.+... ......+..|+.+++.++|++ ++.+.+++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 457778899999999999999753 3 68999998654 233456778899888887655 88889999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe-----------------
Q 048219 100 ILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM----------------- 161 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~----------------- 161 (183)
+++||++ ++++.+.+.... ..+++..+..++.|++.||.|||++ +|+|+||||+||++
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 567776665543 4577888889999999999999998 99999999999999
Q ss_pred --cCCCcccccceeccccc
Q 048219 162 --DENRCAKNFRLWIGKVD 178 (183)
Q Consensus 162 --~~~~~~~i~dfg~a~~~ 178 (183)
+.++.+||+|||+|+..
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~ 192 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFD 192 (355)
T ss_dssp EEESCCCEEECCCTTCEET
T ss_pred cccCCCcEEEeecCccccc
Confidence 56789999999999864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=173.44 Aligned_cols=133 Identities=16% Similarity=0.264 Sum_probs=103.6
Q ss_pred hcccCcCcCceEEEEEEcCCcEEEEEEccc-hh-------hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 33 KEKVGRGSSGTVYKGAMINRQLVAVNRLEK-VL-------DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 33 ~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~-~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.||+|+||.||++. ..+..+++|.... .. .....++.+|+.+++.++||||+++..++...+..+++||
T Consensus 341 ~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 4579999999999994 3455666665422 11 1123457899999999999999977777777888899999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
|+++++|.+++.. ...++.|++.+|.|||++ +|+||||||+||+++. .+||+|||+|+....
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999998854 346889999999999998 9999999999999998 999999999997643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-24 Score=161.90 Aligned_cols=147 Identities=22% Similarity=0.269 Sum_probs=120.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHH-HHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIK-VIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.+.+.+.||+|+||.||+|... ++..+++|.+.... ......+..|+. +++.++||||+++++++...+..+++||+
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 4556678999999999999976 57889999986532 223344555555 67788999999999999999999999999
Q ss_pred cCCCCHHHHHhc----CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFN----AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++ ++.+++.. ....+++.....++.|++.||.|||++ .+++|+||||+||+++.++.+||+|||+|+..
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 975 77776642 235577888888999999999999984 28999999999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=164.98 Aligned_cols=148 Identities=24% Similarity=0.313 Sum_probs=120.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CC-----ceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HR-----NLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~l 101 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+.... .....+..|+.++..+. |+ +++++.+++...+..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 4666789999999999999976 57789999987542 23445667888877764 44 48999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec--CCCcccccceeccccc
Q 048219 102 VYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD--ENRCAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~--~~~~~~i~dfg~a~~~ 178 (183)
|||+++ ++|.+++.... ..+++..+..++.|++.||.|||++ ..+|+||||||+||+++ .++.+||+|||+|+..
T Consensus 134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 999996 59999887653 4577888888999999999999952 23899999999999995 4678999999999765
Q ss_pred c
Q 048219 179 E 179 (183)
Q Consensus 179 ~ 179 (183)
.
T Consensus 212 ~ 212 (382)
T 2vx3_A 212 G 212 (382)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-25 Score=178.97 Aligned_cols=149 Identities=24% Similarity=0.293 Sum_probs=125.0
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe------CCeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE------VSKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~ 99 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.++..++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 45788899999999999999865 5788999988653 33445678899999999999999999888754 5678
Q ss_pred EEEEeccCCCCHHHHHhcCC--CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc---ccccceec
Q 048219 100 ILVYEYMSNGSLADILFNAE--KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC---AKNFRLWI 174 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~---~~i~dfg~ 174 (183)
+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++. ++|+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 2466777888999999999999998 9999999999999997764 89999999
Q ss_pred ccccc
Q 048219 175 GKVDE 179 (183)
Q Consensus 175 a~~~~ 179 (183)
|+...
T Consensus 171 a~~~~ 175 (676)
T 3qa8_A 171 AKELD 175 (676)
T ss_dssp CCBTT
T ss_pred ccccc
Confidence 98653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=162.96 Aligned_cols=143 Identities=22% Similarity=0.215 Sum_probs=115.1
Q ss_pred Hhchh-cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe----CCeEEEE
Q 048219 29 TDGFK-EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE----VSKKILV 102 (183)
Q Consensus 29 ~~~~~-~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 102 (183)
.|.+. +.||+|+||.||+|... +++.+++|.+..... . ..+....++.+.|+|++++++++.. ....+++
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-A---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-H---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-H---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 34553 46999999999999976 578999999865321 1 1122233566789999999999875 4458999
Q ss_pred EeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC---Ccccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN---RCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~---~~~~i~dfg~a~~~ 178 (183)
|||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.+ +.++|+|||+|+..
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999997653 3578888899999999999999998 99999999999999864 45999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=165.04 Aligned_cols=147 Identities=20% Similarity=0.240 Sum_probs=123.9
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH------HHHHHHHHHHHHhhcC--CCceeeeeceEEeCCe
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE------REREFQTEIKVIGRTH--HRNLVRLLGYSLEVSK 98 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 98 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+...... ....+..|+.+++.+. |+|++++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 34677789999999999999865 5788999998653211 1134567899999886 5999999999999999
Q ss_pred EEEEEeccCC-CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec-CCCcccccceeccc
Q 048219 99 KILVYEYMSN-GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKNFRLWIGK 176 (183)
Q Consensus 99 ~~lv~e~~~~-~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~-~~~~~~i~dfg~a~ 176 (183)
.++++|++.+ ++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++ .++.+||+|||+|+
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 9999999975 8999988653 3567788888999999999999998 999999999999999 67899999999998
Q ss_pred cc
Q 048219 177 VD 178 (183)
Q Consensus 177 ~~ 178 (183)
..
T Consensus 199 ~~ 200 (320)
T 3a99_A 199 LL 200 (320)
T ss_dssp EC
T ss_pred cc
Confidence 64
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=160.91 Aligned_cols=132 Identities=11% Similarity=0.064 Sum_probs=106.3
Q ss_pred hhcccCcCcCceEEEEEEcCCcEEEEEEccchhh------------------HHHHHHHHHHHHHhhcCCCceeeeeceE
Q 048219 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLD------------------EREREFQTEIKVIGRTHHRNLVRLLGYS 93 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (183)
+.+.||+|+||.||+|...++..+++|.+..... .....+.+|+.++..++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 3478999999999999996688999999864321 13456889999999998 4 6666654
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCccccccee
Q 048219 94 LEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLW 173 (183)
Q Consensus 94 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg 173 (183)
. .+..+++|||+++++|.+ +.. . ....++.|++.|+.|+|+. +++|+||||+||+++ ++.++|+|||
T Consensus 171 ~-~~~~~lvmE~~~g~~L~~-l~~-----~--~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 171 A-WEGNAVLMELIDAKELYR-VRV-----E--NPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp E-EETTEEEEECCCCEEGGG-CCC-----S--CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred e-ccceEEEEEecCCCcHHH-cch-----h--hHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 3 356699999999999988 421 1 1235889999999999998 999999999999999 9999999999
Q ss_pred cccccc
Q 048219 174 IGKVDE 179 (183)
Q Consensus 174 ~a~~~~ 179 (183)
+|+...
T Consensus 238 ~a~~~~ 243 (282)
T 1zar_A 238 QSVEVG 243 (282)
T ss_dssp TCEETT
T ss_pred CCeECC
Confidence 998653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=160.90 Aligned_cols=148 Identities=24% Similarity=0.280 Sum_probs=121.7
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-----------CCceeeeeceEEe
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-----------HRNLVRLLGYSLE 95 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 95 (183)
..|.+.+.||+|+||.||+|... ++..+++|.+.... .....+.+|+.++..+. |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 45778889999999999999975 57889999986532 33456778888888775 7899999999876
Q ss_pred CC----eEEEEEeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC------C
Q 048219 96 VS----KKILVYEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE------N 164 (183)
Q Consensus 96 ~~----~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~------~ 164 (183)
.+ ..+++||++ +++|.+++.... ..+++..+..++.|++.||.|||++ .+|+|+||||+||+++. .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCc
Confidence 44 688999999 889999887643 4477888888999999999999984 28999999999999953 3
Q ss_pred Ccccccceecccccc
Q 048219 165 RCAKNFRLWIGKVDE 179 (183)
Q Consensus 165 ~~~~i~dfg~a~~~~ 179 (183)
+.+||+|||+|+...
T Consensus 175 ~~~kl~Dfg~a~~~~ 189 (373)
T 1q8y_A 175 IQIKIADLGNACWYD 189 (373)
T ss_dssp EEEEECCCTTCEETT
T ss_pred ceEEEcccccccccC
Confidence 479999999998553
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=157.36 Aligned_cols=144 Identities=13% Similarity=0.102 Sum_probs=104.6
Q ss_pred hhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCC-Cceee---------ee-------
Q 048219 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHH-RNLVR---------LL------- 90 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~~---------~~------- 90 (183)
..+.||+|+||.||+|.+. ++..+|+|.+..... .....+.+|+.+++.+.| .+... ..
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 4467999999999999965 578999998873221 124567889999988876 21111 01
Q ss_pred -----ceEEe-----CCeEEEEEeccCCCCHHHHHhc------CCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCC
Q 048219 91 -----GYSLE-----VSKKILVYEYMSNGSLADILFN------AEKQPNWIERTGIARDIARGILYLHDECETQIIHCDI 154 (183)
Q Consensus 91 -----~~~~~-----~~~~~lv~e~~~~~~l~~~l~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl 154 (183)
.++.. ....+++|+.+ +++|.+++.. ....+++..+..++.|++.||.|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 11111 22456777765 6799988842 122344556777889999999999998 9999999
Q ss_pred CCCCEEecCCCcccccceecccccc
Q 048219 155 KPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 155 ~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||+||+++.++.+||+|||+|+...
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~ 262 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDG 262 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETT
T ss_pred ccceEEEecCCeEEEEeccceeecC
Confidence 9999999999999999999988543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=149.49 Aligned_cols=138 Identities=14% Similarity=0.193 Sum_probs=101.0
Q ss_pred chhcccCcCcCceEEEEEE-cCCcE--EEEEEccchhh------------------------HHHHHHHHHHHHHhhcCC
Q 048219 31 GFKEKVGRGSSGTVYKGAM-INRQL--VAVNRLEKVLD------------------------EREREFQTEIKVIGRTHH 83 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~-~~~~~--~~ik~~~~~~~------------------------~~~~~~~~e~~~l~~l~h 83 (183)
.+.+.||+|+||.||+|.. .++.. +|+|.+..... .....+..|+..+..+.|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3456899999999999997 67878 99998643211 112357889999999887
Q ss_pred CceeeeeceEEeCCeEEEEEeccCC-C----CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhh-hCCCCCceecCCCCC
Q 048219 84 RNLVRLLGYSLEVSKKILVYEYMSN-G----SLADILFNAEKQPNWIERTGIARDIARGILYLH-DECETQIIHCDIKPQ 157 (183)
Q Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~-~----~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dl~~~ 157 (183)
+++..+..+.. +..++||||+.+ | ++.+.... .++.....++.|++.++.++| +. +++|+||||+
T Consensus 130 ~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~ 200 (258)
T 1zth_A 130 AGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEY 200 (258)
T ss_dssp TTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTT
T ss_pred CCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHH
Confidence 75432221111 356899999942 2 66665422 112345568899999999999 77 9999999999
Q ss_pred CEEecCCCcccccceecccccc
Q 048219 158 NILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 158 nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||+++. .++|+|||+|....
T Consensus 201 NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SEEESS--SEEECCCTTCEETT
T ss_pred HEEEcC--cEEEEECcccccCC
Confidence 999998 89999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=7.3e-18 Score=129.91 Aligned_cols=136 Identities=13% Similarity=0.058 Sum_probs=95.0
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchh-----------------hHH-----HHHHHHHHHHHhhcCCCcee
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL-----------------DER-----EREFQTEIKVIGRTHHRNLV 87 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~-----------------~~~-----~~~~~~e~~~l~~l~h~~i~ 87 (183)
|.+...||+|++|.||+|...++..+|+|.+.... ... ......|...|.++.+..+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 55667899999999999998889999999764210 000 11123466667666444332
Q ss_pred eeeceEEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCc-
Q 048219 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRC- 166 (183)
Q Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~- 166 (183)
....+.. ...++||||++|.++..+.. .. ....+..|++.++.++|.. +++||||||.|||+++++.
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~-----~~--~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS-----VP--DPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCC-----CS--CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhcc-----cH--HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCc
Confidence 2211111 23479999999888765431 11 2234678999999999998 9999999999999988763
Q ss_pred ---------ccccceecccc
Q 048219 167 ---------AKNFRLWIGKV 177 (183)
Q Consensus 167 ---------~~i~dfg~a~~ 177 (183)
+.|+||+-|.-
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 78999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=6.1e-14 Score=102.95 Aligned_cols=143 Identities=12% Similarity=0.042 Sum_probs=105.0
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
+.+...++.|+.+.||++... +..+++|............+..|+.+++.+. +..++++++++...+..+++||+++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 444556777888889988643 5678888875432122335778899998884 56778888888888899999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCC-------------------------------------------
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC------------------------------------------- 145 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------------------- 145 (183)
.++.+.+.. . .....++.++..++..||+..
T Consensus 95 ~~l~~~~~~---~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 95 VLCSEEYED---E---QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EEHHHHCCT---T---TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred eehhhccCC---c---ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 988775311 1 112346778888899999710
Q ss_pred -------------CCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 146 -------------ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 146 -------------~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
...++|+|+++.||+++..+.+.++||+.|..+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~gd 215 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccCC
Confidence 1358999999999999876666799999987664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.6e-12 Score=92.99 Aligned_cols=131 Identities=15% Similarity=0.075 Sum_probs=91.8
Q ss_pred CcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCc--eeeeeceEEeCCeEEEEEeccCCCCHHHH
Q 048219 37 GRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRN--LVRLLGYSLEVSKKILVYEYMSNGSLADI 114 (183)
Q Consensus 37 g~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 114 (183)
+.|..+.||++...++..+++|..... ....+..|+.+++.+.+.+ +++++.+....+..+++||+++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355668999987666667888886543 1234667888888775433 556777777777889999999998773
Q ss_pred HhcCCCCCChHHHHHHHHHHHHHHHHhhhCC-------------------------------------------------
Q 048219 115 LFNAEKQPNWIERTGIARDIARGILYLHDEC------------------------------------------------- 145 (183)
Q Consensus 115 l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------------------------- 145 (183)
. . .... ..++.+++..+..+|+..
T Consensus 104 ~-~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 104 S-S---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp T-S---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred c-C---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 2 1 1111 135566666777777531
Q ss_pred ------CCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 146 ------ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 146 ------~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
...++|+|++|.||+++.++.+.++||+.|..+.
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 1128999999999999877667799999988764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-11 Score=94.74 Aligned_cols=143 Identities=17% Similarity=0.179 Sum_probs=98.2
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEcc--chh-hHHHHHHHHHHHHHhhcCC--CceeeeeceEEeC---CeEEEEEec
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLE--KVL-DEREREFQTEIKVIGRTHH--RNLVRLLGYSLEV---SKKILVYEY 105 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~--~~~-~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~ 105 (183)
+.++.|.++.+|+....+ ..+.+|... ... ......+..|..+++.+.. ..+++++.++.+. +..+++||+
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 368889999999876544 456677654 221 1123457789999998864 4567777777655 457899999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCC----------------------------------------
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC---------------------------------------- 145 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---------------------------------------- 145 (183)
++|.++.+.. ...++......+..++...|..+|+..
T Consensus 123 v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 123 VSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred cCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9987664311 122445556667788888888888620
Q ss_pred ---------------CCCceecCCCCCCEEecCCCc--ccccceeccccccc
Q 048219 146 ---------------ETQIIHCDIKPQNILMDENRC--AKNFRLWIGKVDEA 180 (183)
Q Consensus 146 ---------------~~~i~H~dl~~~nil~~~~~~--~~i~dfg~a~~~~~ 180 (183)
...++|+|+++.||+++.++. +.++||+.|..+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~p 251 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGHP 251 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEECH
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCCH
Confidence 246899999999999997653 58999999987654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.8e-08 Score=75.37 Aligned_cols=137 Identities=16% Similarity=0.203 Sum_probs=86.0
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCc--eeeeeceEEeCC---eEEEEEeccCC
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRN--LVRLLGYSLEVS---KKILVYEYMSN 108 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~~ 108 (183)
.++.|..+.+|... ..+.+|..... .....+..|..+++.+. +.. ++++.......+ ..|++|++++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 46778888888653 34677765432 33456788999998873 333 333433322222 34789999998
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhC--------------------------------------------
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDE-------------------------------------------- 144 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-------------------------------------------- 144 (183)
.++...... .++......++.+++..+..+|+.
T Consensus 101 ~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 101 VPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp EECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred eECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 777543221 123333444555555555555531
Q ss_pred -----------CCCCceecCCCCCCEEecC--CCcccccceeccccccc
Q 048219 145 -----------CETQIIHCDIKPQNILMDE--NRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 145 -----------~~~~i~H~dl~~~nil~~~--~~~~~i~dfg~a~~~~~ 180 (183)
....++|+|+++.||+++. .+.+.++||+.|..++.
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~ 226 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP 226 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh
Confidence 1235799999999999998 56678999999987653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.2e-07 Score=69.60 Aligned_cols=138 Identities=12% Similarity=0.077 Sum_probs=82.8
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCC---ceeeeeceEE-eCCeEEEEEeccCCCC
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHR---NLVRLLGYSL-EVSKKILVYEYMSNGS 110 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~ 110 (183)
.++.|....+|.. +..+.+|.... ......+..|..+++.+.+. .++++..+.. ..+..+++|++++|.+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 4666777778876 44566776432 23345688899999988642 2455555553 3456789999999877
Q ss_pred HHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhh-----------------------------------------------
Q 048219 111 LADILFNAEKQPNWIERTGIARDIARGILYLHD----------------------------------------------- 143 (183)
Q Consensus 111 l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~----------------------------------------------- 143 (183)
+...... .++......+..++...|..||+
T Consensus 100 l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 100 LGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp CHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred Cchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 7552111 01111111122222222222221
Q ss_pred ----------CCCCCceecCCCCCCEEecC---CCc-ccccceecccccccc
Q 048219 144 ----------ECETQIIHCDIKPQNILMDE---NRC-AKNFRLWIGKVDEAR 181 (183)
Q Consensus 144 ----------~~~~~i~H~dl~~~nil~~~---~~~-~~i~dfg~a~~~~~~ 181 (183)
.....++|+|+.+.|++++. ++. ..++||+.|.+++.-
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~ 228 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPD 228 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGG
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHH
Confidence 02336799999999999987 344 479999999877643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.1e-07 Score=69.60 Aligned_cols=137 Identities=13% Similarity=0.103 Sum_probs=88.7
Q ss_pred cCcCcCc-eEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccCCCCHH
Q 048219 36 VGRGSSG-TVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLA 112 (183)
Q Consensus 36 lg~g~~g-~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 112 (183)
+..|..+ .+|+..... +..+.+|.-.. .....+..|...|+.+. +-.+++++.++.+.+..+++||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3344444 578765443 45677776433 23445777888888774 334677788888889999999999988776
Q ss_pred HHHhcCCCCCChHHHHHHHHHHHHHHHHhhhC------------------------------------------------
Q 048219 113 DILFNAEKQPNWIERTGIARDIARGILYLHDE------------------------------------------------ 144 (183)
Q Consensus 113 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~------------------------------------------------ 144 (183)
+...... .....+..++...+.-||..
T Consensus 109 ~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 6542210 01112333444444444421
Q ss_pred -------CCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 145 -------CETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 145 -------~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
....++|+|+.+.||+++..+.+-|+||+.|..+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gdp 226 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADR 226 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEET
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCCH
Confidence 012378999999999999877777999999987653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.1e-07 Score=70.98 Aligned_cols=34 Identities=9% Similarity=0.075 Sum_probs=28.5
Q ss_pred CCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
..++|+|+.+.||++++.+.+.++||+.|..+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~g~p 255 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVALGPR 255 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEEECH
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccccCCc
Confidence 4789999999999999655578999999987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.1e-05 Score=60.71 Aligned_cols=33 Identities=24% Similarity=0.152 Sum_probs=29.3
Q ss_pred CCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
..++|+|+.+.|++++.++.+.++||+.|..+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~ 254 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDL 254 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEECC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccCC
Confidence 489999999999999878889999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.9e-06 Score=63.50 Aligned_cols=74 Identities=14% Similarity=0.121 Sum_probs=44.8
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhh---H----HHHHHHHHHHHHhhcCC--C-ceeeeeceEEeCCeEEEE
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---E----REREFQTEIKVIGRTHH--R-NLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~----~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~lv 102 (183)
+.+|.|..+.||++... .+..+++|....... . ...++..|.++++.+.. + .+++++. .+....+++
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE--EcCCccEEE
Confidence 46899999999998643 456788887542211 0 12345668888876632 2 3344443 245566899
Q ss_pred EeccCCC
Q 048219 103 YEYMSNG 109 (183)
Q Consensus 103 ~e~~~~~ 109 (183)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00012 Score=57.06 Aligned_cols=32 Identities=9% Similarity=0.215 Sum_probs=28.4
Q ss_pred CCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
..++|+|+++.||+++.++ +.++||+.|..+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 4899999999999998776 8999999988765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00037 Score=52.29 Aligned_cols=73 Identities=16% Similarity=0.138 Sum_probs=52.3
Q ss_pred ccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC---CCceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 35 KVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH---HRNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
.++.|....+|+... ++..+.+|..... ....+..|...|+.+. ...+++++.+....+..+++||++++.++
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 477788888898764 4556777775432 2345677888887773 24577788777777889999999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00015 Score=53.90 Aligned_cols=32 Identities=19% Similarity=0.185 Sum_probs=26.8
Q ss_pred CCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
..++|+|+.+.|++ ..++.+.++||..|..+.
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 35899999999999 556678999999887664
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00061 Score=50.20 Aligned_cols=73 Identities=12% Similarity=0.220 Sum_probs=47.9
Q ss_pred cccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCC---ceeeeeceEEeCCeEEEEEeccCCCC
Q 048219 34 EKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHR---NLVRLLGYSLEVSKKILVYEYMSNGS 110 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (183)
+.+|.|..+.+|+....+|+.+.+|............+..|...|+.+... .+++++.. + ..+++||++++..
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 357889999999999888888999885433222223456788888877432 23333332 2 3468899987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00045 Score=51.93 Aligned_cols=34 Identities=18% Similarity=0.166 Sum_probs=29.0
Q ss_pred CCceecCCCCCCEEecCC----Ccccccceeccccccc
Q 048219 147 TQIIHCDIKPQNILMDEN----RCAKNFRLWIGKVDEA 180 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~----~~~~i~dfg~a~~~~~ 180 (183)
..++|+|+.+.||+++.+ +.+.++||+.|..+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 478999999999999874 6789999999987654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0012 Score=50.85 Aligned_cols=140 Identities=14% Similarity=0.107 Sum_probs=73.8
Q ss_pred ccCcCcCceEEEEEEc--------CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEec
Q 048219 35 KVGRGSSGTVYKGAMI--------NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.+..|....+|++... ++..+.+++.... ......+.+|..+++.+. +.-.+++++.+. + .+++||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence 3445666678887653 2356777775321 112334557888887774 222345554442 3 389999
Q ss_pred cCCCCHH--------------HHHh---cC----CCCCC--hHHHHHHHHHHH-------------------HHHHHh--
Q 048219 106 MSNGSLA--------------DILF---NA----EKQPN--WIERTGIARDIA-------------------RGILYL-- 141 (183)
Q Consensus 106 ~~~~~l~--------------~~l~---~~----~~~~~--~~~~~~i~~~i~-------------------~~l~~l-- 141 (183)
++|.++. ..+. .. .+... +..+..+..++. ..+.++
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 9874332 1111 11 11122 122223333221 112222
Q ss_pred --hh-CCCCCceecCCCCCCEEecCC----Ccccccceecccccc
Q 048219 142 --HD-ECETQIIHCDIKPQNILMDEN----RCAKNFRLWIGKVDE 179 (183)
Q Consensus 142 --h~-~~~~~i~H~dl~~~nil~~~~----~~~~i~dfg~a~~~~ 179 (183)
.. ..+..++|+|+.+.||+++.+ +.+.++||..|..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~ 256 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNY 256 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCC
Confidence 21 123468999999999999876 688999999887653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0015 Score=51.03 Aligned_cols=68 Identities=16% Similarity=0.177 Sum_probs=40.1
Q ss_pred ccCcCcCceEEEEEEcC--------CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCce-eeeeceEEeCCeEEEEEec
Q 048219 35 KVGRGSSGTVYKGAMIN--------RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNL-VRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~--------~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~ 105 (183)
.++.|....+|++.... +..+.+|+...... ...+..|..+++.+...++ +++++.+. + .+++||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 45667777899887542 35677777633111 1234468888877743233 45555432 2 388999
Q ss_pred cCC
Q 048219 106 MSN 108 (183)
Q Consensus 106 ~~~ 108 (183)
++|
T Consensus 154 l~G 156 (429)
T 1nw1_A 154 IPS 156 (429)
T ss_dssp CCE
T ss_pred eCC
Confidence 876
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.98 E-value=0.0026 Score=47.41 Aligned_cols=33 Identities=15% Similarity=0.275 Sum_probs=27.8
Q ss_pred CCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
..++|+|+.+.||+++.++.+.++||+.|..+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g~ 219 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACNDL 219 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccCch
Confidence 468999999999999987666899999887653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.50 E-value=0.0077 Score=44.92 Aligned_cols=32 Identities=22% Similarity=0.113 Sum_probs=27.1
Q ss_pred CCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
..++|+|+++.||+++ + .+.++||+.|..+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~~ 226 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARNGPA 226 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCEECT
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCcCcH
Confidence 3679999999999998 4 789999998876643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.17 E-value=0.0069 Score=45.73 Aligned_cols=34 Identities=15% Similarity=0.119 Sum_probs=29.2
Q ss_pred CCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
..++|+|+.+.|++++.++.+.++||+.+..+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence 4689999999999999878899999988876543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.07 E-value=0.016 Score=44.04 Aligned_cols=32 Identities=13% Similarity=0.138 Sum_probs=26.0
Q ss_pred CCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
..++|+|+.+.||+++.++ +.++||..|..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g~ 243 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGFNF 243 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEEEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCCCc
Confidence 3689999999999998655 7999998887553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.38 E-value=0.042 Score=43.35 Aligned_cols=70 Identities=10% Similarity=0.070 Sum_probs=38.9
Q ss_pred ccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCce-eeeeceEEeCCeEEEEEeccCCC
Q 048219 35 KVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNL-VRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
.|+.|....+|+....+ +..+.+|...... ...-....|..++..+...++ +++++.+ .+ .+++||++|.
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~ 186 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGY 186 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSE
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCc
Confidence 45566667788877654 3566677653211 000112467888887764444 4555554 22 3599999864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.19 E-value=0.11 Score=40.11 Aligned_cols=31 Identities=19% Similarity=0.197 Sum_probs=25.8
Q ss_pred CceecCCCCCCEEe------cCCCcccccceeccccc
Q 048219 148 QIIHCDIKPQNILM------DENRCAKNFRLWIGKVD 178 (183)
Q Consensus 148 ~i~H~dl~~~nil~------~~~~~~~i~dfg~a~~~ 178 (183)
.++|+|+.+.||++ ++.+.+.++||-.|...
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 46899999999999 34567899999988754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=88.49 E-value=0.13 Score=40.10 Aligned_cols=32 Identities=13% Similarity=0.192 Sum_probs=27.5
Q ss_pred CCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 147 ~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
..++|+|+.+.|++ +.++.+.++||..|....
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~~ 293 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAINF 293 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEEEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCcCC
Confidence 46799999999999 777889999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 183 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-31 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-29 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-29 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-28 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-28 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-28 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-27 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-27 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-27 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-26 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-23 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-23 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-23 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-21 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-20 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-20 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-19 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-19 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-18 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-36
Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 4/137 (2%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+++G GS GTVYKG V + + ++ + F+ E+ V+ +T H N++ +G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
YS + +V ++ SL L E + I+ IAR A+G+ YLH + IIH
Sbjct: 72 YSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 152 CDIKPQNILMDENRCAK 168
D+K NI + E+ K
Sbjct: 128 RDLKSNNIFLHEDLTVK 144
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (304), Expect = 1e-34
Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 20 FSYAELKKITDGF-----------KEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL 64
F++ + + F ++ +G G G V G + VA+ L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 65 DERE-REFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPN 123
E++ R+F +E ++G+ H N++ L G + + +++ E+M NGSL L + Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 124 WIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
I+ G+ R IA G+ YL D +H D+ +NIL++ N K
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCK 168
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-34
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 4/137 (2%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
F +++G G G V+ G +N+ VA+ + + E +F E +V+ + H LV+L G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
LE + LV+E+M +G L+D L G+ D+ G+ YL + C +IH
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 152 CDIKPQNILMDENRCAK 168
D+ +N L+ EN+ K
Sbjct: 125 RDLAARNCLVGENQVIK 141
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-33
Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 8/140 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+ +G+G G V G VAV ++ D + F E V+ + H NLV+LLG
Sbjct: 11 LLQTIGKGEFGDVMLG-DYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 92 YSLEVSKKI-LVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQI 149
+E + +V EYM+ GSL D L + + + D+ + YL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 124
Query: 150 IHCDIKPQNILMDENRCAKN 169
+H D+ +N+L+ E+ AK
Sbjct: 125 VHRDLAARNVLVSEDNVAKV 144
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-33
Identities = 36/149 (24%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 24 ELKKITDGFK--EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDERERE-FQTEIKVIG 79
ELK D F+ ++G G+ G V+K + + ++A + + R E++V+
Sbjct: 2 ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGIL 139
+ +V G + + E+M GSL +L A + P ++ + +G+
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLT 118
Query: 140 YLHDECETQIIHCDIKPQNILMDENRCAK 168
YL ++ +I+H D+KP NIL++ K
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIK 145
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 9e-33
Identities = 34/137 (24%), Positives = 62/137 (45%), Gaps = 4/137 (2%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
F +++G G G V G + VA+ +++ E EF E KV+ H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
+ ++ EYM+NG L + L + + + +D+ + YL + +H
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 123
Query: 152 CDIKPQNILMDENRCAK 168
D+ +N L+++ K
Sbjct: 124 RDLAARNCLVNDQGVVK 140
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-32
Identities = 31/138 (22%), Positives = 61/138 (44%), Gaps = 4/138 (2%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
++G G+ G VYK L A ++ +E ++ EI ++ H N+V+LL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
+ ++ E+ + G++ ++ E+ + + + + YLH + +II
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 151 HCDIKPQNILMDENRCAK 168
H D+K NIL + K
Sbjct: 133 HRDLKAGNILFTLDGDIK 150
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-32
Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 6/138 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
E++G G G V+ G VAV L++ + F E ++ + H+ LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYA 75
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQII 150
+ ++ EYM NGSL D L + +A IA G+ ++ + I
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 151 HCDIKPQNILMDENRCAK 168
H D++ NIL+ + K
Sbjct: 132 HRDLRAANILVSDTLSCK 149
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-31
Identities = 28/134 (20%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 35 KVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNLVRLL 90
++G G+ G+V +G R VA+ L++ ++ + E E +++ + + +VRL+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
G + +LV E G L L ++ + ++ G+ YL ++ +
Sbjct: 76 GV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFV 131
Query: 151 HCDIKPQNILMDEN 164
H D+ +N+L+
Sbjct: 132 HRDLAARNVLLVNR 145
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-31
Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 9/149 (6%)
Query: 26 KKITDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVLDERE-REFQTEIKVIGR 80
+ F E +GRG G VY G +++ + AV L ++ D E +F TE ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 81 THHRNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGIL 139
H N++ LLG L +V YM +G L + + N P + G +A+G
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-- 142
Query: 140 YLHDECETQIIHCDIKPQNILMDENRCAK 168
+ + +H D+ +N ++DE K
Sbjct: 143 -MKFLASKKFVHRDLAARNCMLDEKFTVK 170
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 7e-31
Identities = 34/139 (24%), Positives = 63/139 (45%), Gaps = 8/139 (5%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRL 89
++G GS G VY + N ++VA+ ++ +E+ ++ E++ + + H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
G L LV EY + + + +K +E + +G+ YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 150 IHCDIKPQNILMDENRCAK 168
IH D+K NIL+ E K
Sbjct: 137 IHRDVKAGNILLSEPGLVK 155
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 109 bits (274), Expect = 1e-29
Identities = 29/135 (21%), Positives = 62/135 (45%), Gaps = 4/135 (2%)
Query: 32 FKEKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
E++G G+ G V++ A + + + + EI+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
+ ++ +++YE+MS G L + + + + + E R + +G+ ++H+ +
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146
Query: 151 HCDIKPQNILMDENR 165
H D+KP+NI+ R
Sbjct: 147 HLDLKPENIMFTTKR 161
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 1e-29
Identities = 44/139 (31%), Positives = 65/139 (46%), Gaps = 6/139 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
K K+G G G VY+G VAV L++ E E EF E V+ H NLV+LL
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 79
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQI 149
G ++ E+M+ G+L D L +Q + + +A I+ + YL +
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 136
Query: 150 IHCDIKPQNILMDENRCAK 168
IH D+ +N L+ EN K
Sbjct: 137 IHRDLAARNCLVGENHLVK 155
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-29
Identities = 40/137 (29%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGY 92
EK+G+G+SGTVY + Q VA+ ++ ++ EI V+ + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHC 152
L + +V EY++ GSL D++ E + + + R+ + + +LH Q+IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 153 DIKPQNILMDENRCAKN 169
DIK NIL+ + K
Sbjct: 141 DIKSDNILLGMDGSVKL 157
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-29
Identities = 37/146 (25%), Positives = 60/146 (41%), Gaps = 13/146 (8%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+E +G+G G V++G + VAV +ER + EI H N++ +
Sbjct: 7 LQESIGKGRFGEVWRG-KWRGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIA 64
Query: 92 YSLEVSKKI----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC-- 145
+ + LV +Y +GSL D L +A A G+ +LH E
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 146 ---ETQIIHCDIKPQNILMDENRCAK 168
+ I H D+K +NIL+ +N
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCC 148
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-29
Identities = 40/138 (28%), Positives = 61/138 (44%), Gaps = 6/138 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
+ K+G+G G V+ G VA+ L+ E F E +V+ + H LV+L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 79
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQP-NWIERTGIARDIARGILYLHDECETQII 150
+ +V EYMS GSL D L + + +A IA G+ Y+ +
Sbjct: 80 V-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 135
Query: 151 HCDIKPQNILMDENRCAK 168
H D++ NIL+ EN K
Sbjct: 136 HRDLRAANILVGENLVCK 153
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 5e-29
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 28/162 (17%)
Query: 32 FKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVLDERERE-FQTEIKVIGR-THH 83
F + +G G+ G V + VAV L+ ERE +E+KV+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILF-----------------NAEKQPNWIE 126
N+V LLG +++ EY G L + L + E + +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 127 RTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ +A+G+ +L + IH D+ +NIL+ R K
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITK 185
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 107 bits (267), Expect = 1e-28
Identities = 30/146 (20%), Positives = 66/146 (45%), Gaps = 6/146 (4%)
Query: 26 KKITDGFK--EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH 82
+ D + E++G G+ G V++ ++ + + + EI ++ + H
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 84
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
H L+ L + + +L+ E++S G L D + + + + E R G+ ++H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 143 DECETQIIHCDIKPQNILMDENRCAK 168
+ I+H DIKP+NI+ + + +
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASS 167
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-28
Identities = 34/141 (24%), Positives = 63/141 (44%), Gaps = 8/141 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLV 87
+G+G G VY ++ ++A+ L K E + + E+++ H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
RL GY + ++ L+ EY G++ L K ++A + Y H +
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATYITELANALSYCHSK--- 125
Query: 148 QIIHCDIKPQNILMDENRCAK 168
++IH DIKP+N+L+ K
Sbjct: 126 RVIHRDIKPENLLLGSAGELK 146
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-28
Identities = 41/140 (29%), Positives = 59/140 (42%), Gaps = 9/140 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVR 88
F ++GRGS TVYKG VA L K+ + F+ E +++ H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 89 LLGYSLEVSKK----ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
K +LV E M++G+L L K R I +G+ +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 145 CETQIIHCDIKPQNILMDEN 164
IIH D+K NI +
Sbjct: 132 TP-PIIHRDLKCDNIFITGP 150
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-28
Identities = 27/147 (18%), Positives = 59/147 (40%), Gaps = 10/147 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK--VLDEREREFQTEIKVIGRTHHRNLVR 88
+G GS G K + +++ L+ + + ++ +E+ ++ H N+VR
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 89 LLGYSLEVSKKIL--VYEYMSNGSLADILFNAEKQP---NWIERTGIARDIARGILYLHD 143
++ + L V EY G LA ++ K+ + + + + H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 144 --ECETQIIHCDIKPQNILMDENRCAK 168
+ ++H D+KP N+ +D + K
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVK 154
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 6e-28
Identities = 35/166 (21%), Positives = 66/166 (39%), Gaps = 33/166 (19%)
Query: 32 FKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVLDERERE-FQTEIKVIGR-THH 83
F + +G G+ G V VAV L++ D ERE +E+K++ + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPN-------------------- 123
N+V LLG L++EY G L + L + ++ +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 124 --WIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCA 167
+ + A +A+G+ +L + +H D+ +N+L+ +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVV 203
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-27
Identities = 37/139 (26%), Positives = 60/139 (43%), Gaps = 6/139 (4%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK-VLDEREREFQTEIKVIGRTHHRNLVRL 89
+ +G G+ G V + VAV ++ + + EI + +H N+V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
G+ E + + L EY S G L D + P + + G++YLH I
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 150 IHCDIKPQNILMDENRCAK 168
H DIKP+N+L+DE K
Sbjct: 125 THRDIKPENLLLDERDNLK 143
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-27
Identities = 41/144 (28%), Positives = 59/144 (40%), Gaps = 11/144 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHR 84
EK+G GS G V +G VAV L+ + E +F E+ + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
NL+RL G L +V E GSL D L + + A +A G+ YL +
Sbjct: 72 NLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
IH D+ +N+L+ K
Sbjct: 131 R---FIHRDLAARNLLLATRDLVK 151
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-27
Identities = 36/149 (24%), Positives = 56/149 (37%), Gaps = 10/149 (6%)
Query: 26 KKITDGFK--EKVGRGSSGTVYKG-AMINRQLVAVNRLEK---VLDEREREFQTEIKVIG 79
KK + FK + +G GS TV + + A+ LEK + + + E V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 80 RTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGIL 139
R H V+L + K Y NG L + A +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTAEIVS 119
Query: 140 YLHDECETQIIHCDIKPQNILMDENRCAK 168
L IIH D+KP+NIL++E+ +
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQ 148
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-27
Identities = 31/150 (20%), Positives = 62/150 (41%), Gaps = 9/150 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMINRQ----LVAVNRLEKVLDERERE-FQTEIKVIGRTHHRNL 86
+G G G V++G ++ + VA+ + + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
V+L+G E + ++ E + G L L + + A ++ + YL
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 126
Query: 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGK 176
+ +H DI +N+L+ N C K + +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 4e-27
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 33/167 (19%)
Query: 32 FKEKVGRGSSGTVYKG------AMINRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHR 84
+ +G G+ G V++ +VAV L++ + +FQ E ++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP---------------------- 122
N+V+LLG L++EYM+ G L + L +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 123 -NWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ E+ IAR +A G+ YL E + +H D+ +N L+ EN K
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-27
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 32 FKEKVGRGSSGTVYKGAMIN---RQLVAVNRLEKVLDERE-REFQTEIKVIGR-THHRNL 86
F++ +G G+ G V K + R A+ R+++ + + R+F E++V+ + HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQP---------------NWIERTGIA 131
+ LLG L EY +G+L D L + + + A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
D+ARG+ YL + Q IH D+ +NIL+ EN AK
Sbjct: 134 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 167
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-26
Identities = 27/146 (18%), Positives = 66/146 (45%), Gaps = 7/146 (4%)
Query: 26 KKITDGFK--EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH 82
K++ + + E +GRG G V++ +++ ++ ++ + EI ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIAR 59
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
HRN++ L + + ++++E++S + + + + + N E + + +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 143 DECETQIIHCDIKPQNILMDENRCAK 168
I H DI+P+NI+ R +
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSST 142
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 2e-26
Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 9/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHRN 85
++ +G G G VYKG + VA+ L+ E++R +F E ++G+ H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
++RL G + +++ EYM NG+L L + + + ++ G+ R IA G+ YL +
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+H D+ +NIL++ N K
Sbjct: 131 ---YVHRDLAARNILVNSNLVCK 150
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 2e-26
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 10/139 (7%)
Query: 35 KVGRGSSGTVYKGAMINR---QLVAVNRLEKVLDERE--REFQTEIKVIGRTHHRNLVRL 89
++G G+ GTV KG + + VAV L+ ++ E E V+ + + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
+G E +LV E G L L + + ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---F 128
Query: 150 IHCDIKPQNILMDENRCAK 168
+H D+ +N+L+ AK
Sbjct: 129 VHRDLAARNVLLVTQHYAK 147
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 4e-26
Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 32 FKEKVGRGSSGTVYKG------AMINRQLVAVNRLEKVLDERER-EFQTEIKVIGRTHHR 84
++G+GS G VY+G VA+ + + RER EF E V+ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQ---------PNWIERTGIARDIA 135
++VRLLG + +++ E M+ G L L + P+ + +A +IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
G+ YL+ + +H D+ +N ++ E+ K
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 173
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 5e-26
Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 10/143 (6%)
Query: 32 FKEKVGRGSSGTVYKGAMIN-----RQLVAVNRLEKVLDER-EREFQTEIKVIGRTHHRN 85
+ +G G+ GTVYKG I + VA+ L + + +E E V+ + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 86 LVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC 145
+ RLLG L S L+ + M G L D + + IA+G+ YL D
Sbjct: 73 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 146 ETQIIHCDIKPQNILMDENRCAK 168
+++H D+ +N+L+ + K
Sbjct: 131 --RLVHRDLAARNVLVKTPQHVK 151
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 5e-25
Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 24/157 (15%)
Query: 17 PFSFSYAELKKITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEI 75
P SY + K I G GS G VY+ + + +LVA+ K + + +R E+
Sbjct: 17 PQEVSYTDTKVI--------GNGSFGVVYQAKLCDSGELVAI----KKVLQDKRFKNREL 64
Query: 76 KVIGRTHHRNLVRLLGYSLEVSKK------ILVYEYMSNGSLADILFNAEKQP--NWIER 127
+++ + H N+VRL + +K LV +Y+ + + I
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 128 TGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN 164
+ R + Y+H I H DIKPQN+L+D +
Sbjct: 125 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPD 158
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 9e-25
Identities = 37/170 (21%), Positives = 71/170 (41%), Gaps = 28/170 (16%)
Query: 32 FKEKVGRGSSGTVYKG--------AMINRQLVAVNRLEKVLDERE-REFQTEIKVIGR-T 81
+ +G G+ G V VAV L+ E++ + +E++++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 82 HHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILF---------------NAEKQPNWIE 126
H+N++ LLG + ++ EY S G+L + L N E+Q + +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 127 RTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176
A +ARG+ YL + + IH D+ +N+L+ E+ K + +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 183
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.0 bits (238), Expect = 1e-24
Identities = 29/144 (20%), Positives = 58/144 (40%), Gaps = 11/144 (7%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK---VLDEREREFQTE---IKVIGRTHHR 84
+GRG G VY ++ A+ L+K + + E E + ++
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 85 NLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
+V + K + + M+ G L L + + A +I G+ ++H+
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 145 CETQIIHCDIKPQNILMDENRCAK 168
+++ D+KP NIL+DE+ +
Sbjct: 127 F---VVYRDLKPANILLDEHGHVR 147
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.6 bits (232), Expect = 6e-24
Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 8/145 (5%)
Query: 22 YAELKKITDGFK--EKVGRGSSGTVYKG-AMINRQLVAVNRLEK-VLDEREREFQTEIKV 77
+ + + I D + + +G G+ V ++LVA+ + K L+ +E + EI V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 78 IGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARG 137
+ + H N+V L L+ + +S G L D + + + + + +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDA 119
Query: 138 ILYLHDECETQIIHCDIKPQNILMD 162
+ YLHD I+H D+KP+N+L
Sbjct: 120 VKYLHDLG---IVHRDLKPENLLYY 141
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.8 bits (230), Expect = 1e-23
Identities = 34/141 (24%), Positives = 69/141 (48%), Gaps = 8/141 (5%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLV 87
+G GS G V+ + N + A+ L+K + ++ E ++ H ++
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
R+ G + + ++ +Y+ G L +L +++ PN + + A ++ + YLH +
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHSKD-- 124
Query: 148 QIIHCDIKPQNILMDENRCAK 168
II+ D+KP+NIL+D+N K
Sbjct: 125 -IIYRDLKPENILLDKNGHIK 144
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 91.7 bits (227), Expect = 2e-23
Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 15/148 (10%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKV---------LDEREREFQTEIKVIGRT 81
KE +GRG S V + + AV ++ + E E+ ++ +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 82 H-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILY 140
H N+++L + LV++ M G L D L + + E I R + I
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICA 125
Query: 141 LHDECETQIIHCDIKPQNILMDENRCAK 168
LH I+H D+KP+NIL+D++ K
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIK 150
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 91.3 bits (226), Expect = 3e-23
Identities = 31/161 (19%), Positives = 58/161 (36%), Gaps = 14/161 (8%)
Query: 26 KKITDGFK--EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVL---DEREREFQTEIKVIG 79
++D ++ E +G G V+ + + VAV L L F+ E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 80 RTHHRNLVRLLGYSLEVSKKI----LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIA 135
+H +V + + +V EY+ +L DI+ + D
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT-PKRAIEVIADAC 121
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176
+ + + + IIH D+KP NI++ K I +
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIAR 159
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 3e-23
Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 10/141 (7%)
Query: 34 EKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVL-----DEREREFQTEIKVIGRTHHRNLV 87
+ +G G TVYK N Q+VA+ +++ D R EIK++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
LL S LV+++M I+ + +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 148 QIIHCDIKPQNILMDENRCAK 168
I+H D+KP N+L+DEN K
Sbjct: 121 -ILHRDLKPNNLLLDENGVLK 140
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.7 bits (227), Expect = 3e-23
Identities = 34/157 (21%), Positives = 61/157 (38%), Gaps = 9/157 (5%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEK---VLDEREREFQTEIKVIGRT-HHRNL 86
+ +G+GS G V+ Q A+ L+K ++D+ E +V+ H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 87 VRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECE 146
+ V EY++ G L + + K T A +I G+ +L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-LSRATFYAAEIILGLQFL---HS 121
Query: 147 TQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEARSD 183
I++ D+K NIL+D++ K + K +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 6e-23
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 24 ELKK--ITDGFK---EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKV 77
++KK I D +K + +G G +G V + ++ A+ K+L + + + E+++
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL----KMLQDCPK-ARREVEL 57
Query: 78 IGR-THHRNLVRLLGYSLEVSKK----ILVYEYMSNGSLADILFNAEKQP-NWIERTGIA 131
R + ++VR++ + ++V E + G L + + Q E + I
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 132 RDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRL 172
+ I I YLH I H D+KP+N+L R +L
Sbjct: 118 KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL 155
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 8e-23
Identities = 29/149 (19%), Positives = 62/149 (41%), Gaps = 13/149 (8%)
Query: 28 ITDGFK--EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDERERE-FQTEIKVIGRTHH 83
+ + +G G+ G V +N+ VA+ ++ + + EIK++ R H
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 84 RNLVRLLGY----SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGIL 139
N++ + ++E K + + ++ L +L + + I RG+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLK 123
Query: 140 YLHDECETQIIHCDIKPQNILMDENRCAK 168
Y+H ++H D+KP N+L++ K
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLK 149
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 2e-22
Identities = 34/161 (21%), Positives = 64/161 (39%), Gaps = 27/161 (16%)
Query: 32 FKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEK-VLDEREREFQTEIKVIGRT-HH 83
+ +GRG+ G V + + VAV L++ R +E+K++ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 84 RNLVRLLGYSLEVSKKI-LVYEYMSNGSLADILFNAEKQP---------------NWIER 127
N+V LLG + + ++ E+ G+L+ L + +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 128 TGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAK 168
+ +A+G+ +L + IH D+ +NIL+ E K
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVK 174
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 87.2 bits (215), Expect = 9e-22
Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 6/137 (4%)
Query: 34 EKVGRGSSGTVYKGAMINRQLVAVN--RLEKVLDEREREFQTEIKVIGRTHHRNLVRLLG 91
EK+G G+ G VYK + A+ RLEK + EI ++ H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 92 YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIH 151
+ +LV+E++ + E + + GI Y HD ++H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLH 123
Query: 152 CDIKPQNILMDENRCAK 168
D+KPQN+L++ K
Sbjct: 124 RDLKPQNLLINREGELK 140
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 2e-21
Identities = 34/139 (24%), Positives = 63/139 (45%), Gaps = 6/139 (4%)
Query: 34 EKVGRGSSGTVYKGA-MINRQLVAVN--RLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
EK+G G+ G VYK + ++VA+ RL+ + EI ++ +H N+V+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
+K LV+E++ + +A + +G+ + H ++
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VL 124
Query: 151 HCDIKPQNILMDENRCAKN 169
H D+KPQN+L++ K
Sbjct: 125 HRDLKPQNLLINTEGAIKL 143
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 3e-21
Identities = 32/158 (20%), Positives = 61/158 (38%), Gaps = 15/158 (9%)
Query: 34 EKVGRGSSGTVYKGAMI--NRQLVAVNRL--EKVLDEREREFQTEIKV---IGRTHHRNL 86
++G G+ G V+K + + VA+ R+ + + E+ V + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 87 VRLLGYSLEVSKK-----ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYL 141
VRL LV+E++ + E + + RG+ +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 142 HDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179
H ++H D+KPQNIL+ + K + ++
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS 167
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 84.1 bits (207), Expect = 2e-20
Identities = 26/146 (17%), Positives = 55/146 (37%), Gaps = 8/146 (5%)
Query: 27 KITDGFK--EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH 83
++ + ++ K+G GS G +Y G + + VA+ + + E K+
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQG 61
Query: 84 RNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD 143
+ + + ++ + SL D+ ++ + +A + I Y+H
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 144 ECETQIIHCDIKPQNILMDENRCAKN 169
+ IH D+KP N LM +
Sbjct: 122 K---NFIHRDVKPDNFLMGLGKKGNL 144
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 4e-20
Identities = 26/144 (18%), Positives = 49/144 (34%), Gaps = 12/144 (8%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVL------DEREREFQTEIKVIGR--TH 82
+G G G+VY G + + VA+ +EK E+ ++ + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
++RLL + +L+ E + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 126
Query: 143 DECETQIIHCDIKPQNILMDENRC 166
++H DIK +NIL+D NR
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRG 148
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 9e-20
Identities = 29/141 (20%), Positives = 52/141 (36%), Gaps = 8/141 (5%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLV 87
+ + +G+G+ G V + A+ L K + + TE +V+ T H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 88 RLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
L + V EY + G L L R +I L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSA---LEYLHSR 124
Query: 148 QIIHCDIKPQNILMDENRCAK 168
+++ DIK +N+++D++ K
Sbjct: 125 DVVYRDIKLENLMLDKDGHIK 145
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 82.5 bits (203), Expect = 1e-19
Identities = 32/135 (23%), Positives = 58/135 (42%), Gaps = 8/135 (5%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEK--VLDERERE-FQTEIKVIGRTHHRNLVRL 89
+ +G GS G V + A+ L+K V+ ++ E E +++ + LV+L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 90 LGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQI 149
+ S +V EY++ G + L + A I YLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSL---DL 162
Query: 150 IHCDIKPQNILMDEN 164
I+ D+KP+N+L+D+
Sbjct: 163 IYRDLKPENLLIDQQ 177
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 2e-19
Identities = 33/152 (21%), Positives = 62/152 (40%), Gaps = 13/152 (8%)
Query: 26 KKITDGFK--EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDERER------EFQTEIK 76
+ + D + E++G G V K A ++K + R + + E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 77 VIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIAR 136
++ H N++ L + IL+ E ++ G L D L ++ E T + I
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILN 124
Query: 137 GILYLHDECETQIIHCDIKPQNILMDENRCAK 168
G ++ QI H D+KP+NI++ + K
Sbjct: 125 G---VYYLHSLQIAHFDLKPENIMLLDRNVPK 153
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.0 bits (196), Expect = 5e-19
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 7/147 (4%)
Query: 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDERE--REFQTEIKVIGRTHHRNLVRLL 90
EK+G G+ GTV+K ++VA+ R+ D+ EI ++ H+N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
K LV+E+ + + + +G+ + H ++
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 151 HCDIKPQNILMDENRCAKNFRLWIGKV 177
H D+KPQN+L++ N K + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARA 150
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 79.5 bits (195), Expect = 9e-19
Identities = 23/144 (15%), Positives = 58/144 (40%), Gaps = 6/144 (4%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
++G GS G +++G ++N Q VA+ + + + E + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 91 GYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQII 150
Y + ++ + SL D+L ++ + A+ + + +H++ ++
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 151 HCDIKPQNILMDENRCAKNFRLWI 174
+ DIKP N L+ +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYV 147
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (195), Expect = 1e-18
Identities = 30/146 (20%), Positives = 59/146 (40%), Gaps = 15/146 (10%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRL--EKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
K+G+G+ G V+K Q VA+ ++ E + EIK++ H N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 91 GYSLEVSKKI--------LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
+ LV+++ + + N + E + + + G L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNG---LY 131
Query: 143 DECETQIIHCDIKPQNILMDENRCAK 168
+I+H D+K N+L+ + K
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLK 157
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 1e-18
Identities = 35/172 (20%), Positives = 64/172 (37%), Gaps = 21/172 (12%)
Query: 20 FSYAELKKITDGFK------EKVGRGSSGTVYKGA-MINRQLVAVNRLEKVLDERE--RE 70
F E+ K + + VG G+ G V VA+ +L + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 71 FQTEIKVIGRTHHRNLVRLLGYSLE------VSKKILVYEYMSNGSLADILFNAEKQPNW 124
E++++ H N++ LL + LV +M G+ L EK
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG-E 120
Query: 125 IERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176
+ + +G+ Y+H IIH D+KP N+ ++E+ K + +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.6 bits (190), Expect = 6e-18
Identities = 37/170 (21%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 19 SFSYAELKK----ITDGFK--EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDERE--R 69
+F EL K + + ++ VG G+ G+V VAV +L + +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 70 EFQTEIKVIGRTHHRNLVRLLGY-----SLEVSKKILVYEYMSNGSLADILFNAEKQPNW 124
E++++ H N++ LL SLE + + ++ L +I ++
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTD 120
Query: 125 IERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWI 174
+ I RG+ Y+H IIH D+KP N+ ++E+ K +
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 76.0 bits (186), Expect = 2e-17
Identities = 29/139 (20%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 32 FKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRL 89
K+GRG V++ I N + V V L+ ++++ + EIK++ N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITL 95
Query: 90 LGYSLEVSKK--ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECET 147
+ + LV+E+++N + + + +I + + Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG-- 149
Query: 148 QIIHCDIKPQNILMDENRC 166
I+H D+KP N+++D
Sbjct: 150 -IMHRDVKPHNVMIDHEHR 167
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 1e-16
Identities = 34/142 (23%), Positives = 59/142 (41%), Gaps = 13/142 (9%)
Query: 32 FKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVLDERE----REFQTEIKVIGR-TH 82
+ +G G+ G V+ I +L A+ L+K ++ +TE +V+
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 83 HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLH 142
LV L +K L+ +Y++ G L L E+ + + +L L
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIVLALE 143
Query: 143 DECETQIIHCDIKPQNILMDEN 164
+ II+ DIK +NIL+D N
Sbjct: 144 HLHKLGIIYRDIKLENILLDSN 165
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.4 bits (179), Expect = 2e-16
Identities = 31/152 (20%), Positives = 60/152 (39%), Gaps = 16/152 (10%)
Query: 34 EKVGRGSSGTVYKG-AMINRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLL 90
+ +G G+ G V + + VA+ +L + + E+ ++ +H+N++ LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 91 GYSL------EVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDE 144
E LV E M I + + + + + + GI +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 145 CETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176
IIH D+KP NI++ + K + +
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.7 bits (169), Expect = 4e-15
Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 19/154 (12%)
Query: 32 FKEKVGRGSSGTVYKG-AMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLL 90
K+G G TV+ M+N VA+ + E + EIK++ R + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKED 75
Query: 91 GYSLEVSKKILVY---------------EYMSNGSLADILFNAEKQPNWIERTGIARDIA 135
K+L + E + LA I + I I++ +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRCAKN 169
G+ Y+H C IIH DIKP+N+LM+ +N
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 167
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.1 bits (163), Expect = 7e-15
Identities = 20/151 (13%), Positives = 40/151 (26%), Gaps = 25/151 (16%)
Query: 30 DGFKEKVGRGSSGTVYKGAMINRQLVAV----------NRLEKVLDEREREFQTEIKVIG 79
D + +G G V+ V ++++ D + F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 80 RTHHRNLVRLLG----YSLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIA 135
R R L +L G ++ E + + + I
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE--------LYRVRVENPDEVLDMIL 113
Query: 136 RGILYLHDECETQIIHCDIKPQNILMDENRC 166
+ + I+H D+ N+L+ E
Sbjct: 114 EEVAKFYHRG---IVHGDLSQYNVLVSEEGI 141
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 183 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.98 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.98 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.98 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.81 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-36 Score=223.78 Aligned_cols=151 Identities=27% Similarity=0.393 Sum_probs=132.4
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcC-CcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMIN-RQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+....+.+.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 333456677899999999999999764 7789999986543 23457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNA-EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||+++|++.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999998654 35677888888999999999999998 99999999999999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-35 Score=219.49 Aligned_cols=145 Identities=27% Similarity=0.360 Sum_probs=130.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.|.+.+.||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4677789999999999999965 588999999875544445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 101 gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp TCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheee
Confidence 9999998765 3577888889999999999999998 9999999999999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-36 Score=223.02 Aligned_cols=146 Identities=22% Similarity=0.348 Sum_probs=131.7
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
|.+.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 567788999999999999976 5788999998765444556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 999998766556688888889999999999999998 9999999999999999999999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=216.93 Aligned_cols=146 Identities=28% Similarity=0.416 Sum_probs=127.2
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
+.+.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 45667899999999999999888889999987543 23457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|.+++......+++..+..++.|++.||.|+|++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheecc
Confidence 99999877666778888889999999999999998 99999999999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.5e-35 Score=221.66 Aligned_cols=148 Identities=20% Similarity=0.319 Sum_probs=132.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3778889999999999999975 588999999876555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec--CCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD--ENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~--~~~~~~i~dfg~a~~~~ 179 (183)
+++|.+.+......+++..+..++.|++.||.|||++ +|+||||||+|||++ ..+.+||+|||+|+...
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 9999998866556688899999999999999999998 999999999999998 56899999999998654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-35 Score=216.30 Aligned_cols=145 Identities=26% Similarity=0.313 Sum_probs=126.9
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 567789999999999999976 57899999986542 2233568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 87 gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 87 GGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp TEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheee
Confidence 9999998854 34578888889999999999999998 9999999999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-34 Score=210.45 Aligned_cols=146 Identities=23% Similarity=0.349 Sum_probs=129.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH---HHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE---REREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|.+.+.||+|+||.||+|... ++..+|+|.+.+.... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 567789999999999999986 5788999998654322 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 88 ~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 88 APLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred cCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence 9999999998653 3577888889999999999999998 99999999999999999999999999998654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-34 Score=219.35 Aligned_cols=148 Identities=20% Similarity=0.311 Sum_probs=132.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4678889999999999999975 588999999876655556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC--CCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE--NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~--~~~~~i~dfg~a~~~~ 179 (183)
+|+|.+.+......+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+|+...
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999866555688899999999999999999998 9999999999999964 5789999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-34 Score=216.41 Aligned_cols=146 Identities=27% Similarity=0.453 Sum_probs=123.0
Q ss_pred hchhcccCcCcCceEEEEEEcC-C---cEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-R---QLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~---~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+.+.||+|+||.||+|.... + ..+++|.+... .....+.+.+|+.+|+.++||||+++++++...+..+++||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 3445789999999999998653 2 35888887653 23345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|+++|+|.+++......+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999998877666788888999999999999999998 9999999999999999999999999999865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=217.76 Aligned_cols=146 Identities=20% Similarity=0.263 Sum_probs=128.7
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+|+.++||||++++++|.+.+..++||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4567789999999999999976 57889999986432 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhh-CCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHD-ECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+||+++.++.+||+|||+|+..
T Consensus 87 ~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 87 DGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp TTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999998654 347788888899999999999996 5 8999999999999999999999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-35 Score=215.06 Aligned_cols=147 Identities=27% Similarity=0.381 Sum_probs=127.4
Q ss_pred HHhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
..+.+.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 4566778999999999999998888889999987543 23456899999999999999999999764 566799999999
Q ss_pred CCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|+|.+.+.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 999998774432 3478888889999999999999998 99999999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-33 Score=211.66 Aligned_cols=149 Identities=23% Similarity=0.325 Sum_probs=129.8
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
..|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34677789999999999999975 57889999986432 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDEA 180 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~~ 180 (183)
||++++++...+.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999888766544 34678888899999999999999998 999999999999999999999999999997643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-34 Score=208.71 Aligned_cols=146 Identities=24% Similarity=0.341 Sum_probs=131.0
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (183)
+.+.+.||+|+||.||+|..+++..||+|.+.+... ....+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 356688999999999999998888999999875432 3457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 110 SLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 110 ~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++..++........+..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheecc
Confidence 99998876666778888889999999999999998 99999999999999999999999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-34 Score=210.42 Aligned_cols=147 Identities=25% Similarity=0.252 Sum_probs=130.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 3678889999999999999975 578999999875432 123568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+++|+|.+++... ..+++..+..++.|++.||.|+|++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 89 y~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 89 YAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999988654 4577888888999999999999998 99999999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=207.16 Aligned_cols=147 Identities=28% Similarity=0.355 Sum_probs=123.9
Q ss_pred chhcccCcCcCceEEEEEEc-CCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe----CCeEEEEE
Q 048219 31 GFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE----VSKKILVY 103 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~ 103 (183)
.+.+.||+|+||.||+|.+. ++..+|+|.+... .......+.+|+++++.++||||+++++++.+ ...++++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999976 4778999987643 23345678899999999999999999999875 34579999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec-CCCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD-ENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~-~~~~~~i~dfg~a~~~~ 179 (183)
||+++++|.+++... ..+++..+..++.|++.||.|||++ ..+|+||||||+||+++ .++.+||+|||+|++..
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999998654 3567888888999999999999987 11399999999999996 57899999999998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=211.58 Aligned_cols=147 Identities=18% Similarity=0.269 Sum_probs=130.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+|.+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+|+.++||||+++++++.+.+.+|+||||++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3677889999999999999976 57889999987653 334567899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC--Ccccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN--RCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~--~~~~i~dfg~a~~~~ 179 (183)
+++|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.+ ..++|+|||+|+...
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999976555688889999999999999999998 99999999999999854 479999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-33 Score=213.01 Aligned_cols=146 Identities=21% Similarity=0.194 Sum_probs=129.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+.+|+.+|+.++||||+++++++.+.+.+++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 567789999999999999975 588999999876432 2245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++|+|.+++... ..+++..+..++.|++.||.|+|++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 87 ~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 87 ANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp CTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred cCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999988764 3467777888999999999999998 99999999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-34 Score=210.02 Aligned_cols=144 Identities=32% Similarity=0.465 Sum_probs=124.4
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccch--hhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKV--LDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.+.+.||+|+||.||+|.... .+|+|.+... .......+.+|+.++.+++||||+++++++ ..+..+++|||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccEEEEEEecCC
Confidence 4566889999999999997543 5899988643 233456788999999999999999999976 4567899999999
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+|+|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999976666788889999999999999999998 99999999999999999999999999998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-33 Score=207.24 Aligned_cols=144 Identities=21% Similarity=0.348 Sum_probs=125.0
Q ss_pred hhc-ccCcCcCceEEEEEEc---CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 32 FKE-KVGRGSSGTVYKGAMI---NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 32 ~~~-~lg~g~~g~v~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
+.+ +||+|+||.||+|.++ ++..||+|.+.+.. ......+.+|+.++.+++||||+++++++.+ +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 4999999999999764 34579999987543 3445678999999999999999999998864 5689999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|+|.+++......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 91 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 91 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp TTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999998866656788889999999999999999998 99999999999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-34 Score=208.69 Aligned_cols=151 Identities=17% Similarity=0.260 Sum_probs=121.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEe--CCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLE--VSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 103 (183)
.|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+ .+.++++|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 3667789999999999999976 57889999986542 3344568899999999999999999999865 45689999
Q ss_pred eccCCCCHHHHHhc---CCCCCChHHHHHHHHHHHHHHHHhhhCC--CCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFN---AEKQPNWIERTGIARDIARGILYLHDEC--ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
||+++|+|.+++.. ....+++..+..++.|++.||.|+|+.. ..+|+||||||+||+++.++.+||+|||+|+..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 99999999998854 2356788899999999999999999851 124999999999999999999999999999865
Q ss_pred c
Q 048219 179 E 179 (183)
Q Consensus 179 ~ 179 (183)
.
T Consensus 165 ~ 165 (269)
T d2java1 165 N 165 (269)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-33 Score=210.36 Aligned_cols=147 Identities=23% Similarity=0.321 Sum_probs=119.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh-HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD-EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3677889999999999999976 578899999875432 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec---CCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD---ENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~---~~~~~~i~dfg~a~~~~ 179 (183)
+|++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++. .++.+||+|||+|+...
T Consensus 90 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 90 SGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999653 4578888889999999999999998 999999999999995 46889999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-33 Score=205.54 Aligned_cols=147 Identities=25% Similarity=0.276 Sum_probs=129.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---------hHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---------DEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVS 97 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 97 (183)
.|.+.+.||+|+||.||+|+.. +++.+|+|.+.+.. ......+.+|+.++.+++ ||||+++++++.+.+
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 3567789999999999999975 57899999986431 112346789999999997 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccc
Q 048219 98 KKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKV 177 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~ 177 (183)
..+++|||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999999764 3578888999999999999999998 999999999999999999999999999986
Q ss_pred cc
Q 048219 178 DE 179 (183)
Q Consensus 178 ~~ 179 (183)
..
T Consensus 160 ~~ 161 (277)
T d1phka_ 160 LD 161 (277)
T ss_dssp CC
T ss_pred cc
Confidence 53
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-33 Score=206.45 Aligned_cols=145 Identities=28% Similarity=0.467 Sum_probs=124.6
Q ss_pred chhcccCcCcCceEEEEEEcCC-----cEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 31 GFKEKVGRGSSGTVYKGAMINR-----QLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~~-----~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.+.+.||+|+||.||+|..... ..||+|.+.... ......+.+|+.++..++||||+++++++...+..+++||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 4557899999999999986542 468999986543 3334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++.++++.+.+......+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999998877667788888899999999999999998 9999999999999999999999999999865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-33 Score=207.97 Aligned_cols=146 Identities=23% Similarity=0.281 Sum_probs=128.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
|.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 567789999999999999975 588999999875432 2245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|+++...+.... ...+.....++.|++.||.|+|++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 86 ~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 86 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred cCCccccccccccc-cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999886643 456667777899999999999998 99999999999999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-33 Score=209.24 Aligned_cols=149 Identities=21% Similarity=0.331 Sum_probs=124.8
Q ss_pred HHhchhcccCcCcCceEEEEEEcC-C-----cEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN-R-----QLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~-~-----~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (183)
..+.+.+.||+|+||.||+|.... + ..|++|.+.... ......+.+|+.++..+ +||||+++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 346677899999999999998653 2 358888875432 23345688899999988 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC----------------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCC
Q 048219 100 ILVYEYMSNGSLADILFNAE----------------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQ 157 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ 157 (183)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 99999999999999996542 2367778888999999999999998 9999999999
Q ss_pred CEEecCCCcccccceecccccc
Q 048219 158 NILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 158 nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||+++.++.+||+|||+|+...
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~ 215 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIM 215 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGG
T ss_pred ccccccCCeEEEeecccccccc
Confidence 9999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-33 Score=205.74 Aligned_cols=147 Identities=23% Similarity=0.308 Sum_probs=128.8
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh------HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD------EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+.+... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4677889999999999999975 578999999864321 124578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC----cccccceecccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR----CAKNFRLWIGKV 177 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~----~~~i~dfg~a~~ 177 (183)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+|++|||+|+.
T Consensus 91 v~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999998654 3577888888999999999999998 999999999999998776 499999999986
Q ss_pred cc
Q 048219 178 DE 179 (183)
Q Consensus 178 ~~ 179 (183)
..
T Consensus 167 ~~ 168 (293)
T d1jksa_ 167 ID 168 (293)
T ss_dssp CT
T ss_pred cC
Confidence 53
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-32 Score=202.39 Aligned_cols=141 Identities=23% Similarity=0.328 Sum_probs=120.8
Q ss_pred cccCcCcCceEEEEEEcC---CcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 34 EKVGRGSSGTVYKGAMIN---RQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~---~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
++||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 369999999999998643 4679999986432 2334678999999999999999999999864 457899999999
Q ss_pred CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 109 GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 109 ~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||+|+...
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcc
Confidence 9999988654 4577888899999999999999998 99999999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-33 Score=206.12 Aligned_cols=145 Identities=28% Similarity=0.380 Sum_probs=126.8
Q ss_pred HhchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccCC
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMSN 108 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (183)
.+.+.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 577888999999999999999888889999986543 23457899999999999999999999884 5668999999999
Q ss_pred CCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 109 GSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 109 ~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++..++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+|+..
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhc
Confidence 99998875432 4578889999999999999999998 9999999999999999999999999999865
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.3e-32 Score=205.20 Aligned_cols=147 Identities=22% Similarity=0.291 Sum_probs=123.6
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..+++||++
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 556689999999999999975 578999999864322 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
.++.+..........+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||+|+...
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceecc
Confidence 76444433334445678889999999999999999998 99999999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=4.4e-32 Score=206.20 Aligned_cols=147 Identities=21% Similarity=0.178 Sum_probs=129.6
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+.+... .....+.+|+.+++.++||||+++++++.+....+++||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 3566679999999999999976 588999999865322 123568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++.++++.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 122 ~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp CCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 99999999988654 3577888888999999999999998 99999999999999999999999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.4e-32 Score=200.53 Aligned_cols=147 Identities=20% Similarity=0.313 Sum_probs=121.5
Q ss_pred HhchhcccCcCcCceEEEEEEcC----CcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMIN----RQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~~----~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
.+.+.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.+++.++||||+++++++. .+..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 46777899999999999998653 3468888886543 333467899999999999999999999884 56789999
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
||++++++.+++......+++..+..++.|++.||.|+|++ +++||||||+||+++.++.+||+|||+|+...
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999998877666788888999999999999999998 99999999999999999999999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=200.82 Aligned_cols=144 Identities=26% Similarity=0.473 Sum_probs=125.6
Q ss_pred hhcccCcCcCceEEEEEEcCC----cEEEEEEccch-hhHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeEEEEEec
Q 048219 32 FKEKVGRGSSGTVYKGAMINR----QLVAVNRLEKV-LDEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKKILVYEY 105 (183)
Q Consensus 32 ~~~~lg~g~~g~v~~~~~~~~----~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 105 (183)
+.+.||+|+||.||+|..... ..+|+|.+.+. ......++.+|++++.+++||||+++++++.. ++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 456899999999999986532 35889988643 34455789999999999999999999999875 5688999999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
++++++.+++........+..+..++.|++.||.|+|+. +|+||||||+||++++++.+||+|||+|+..
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 999999999877666677888888999999999999998 9999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=9.1e-32 Score=205.45 Aligned_cols=146 Identities=20% Similarity=0.173 Sum_probs=124.2
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH---HHHHH---HHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER---EREFQ---TEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~---~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
|.+.+.||+|+||.||+|... +++.+|+|.+.+..... ...+. .++.+++.+.||||+++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 566789999999999999976 58899999986532211 12233 346777888999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp ECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999998654 3466778888999999999999998 99999999999999999999999999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=200.83 Aligned_cols=146 Identities=23% Similarity=0.271 Sum_probs=125.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhh---HHHHHHHHHHHHH-hhcCCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLD---EREREFQTEIKVI-GRTHHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
|.+.+.||+|+||.||+|... +++.+|+|.+.+... .....+..|..++ +.++||||+++++++.+.+..|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 567789999999999999976 588899999975421 1234556666665 46899999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+|++|||+|+...
T Consensus 84 y~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 84 YLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred ecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999998654 3467778888999999999999998 99999999999999999999999999998654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=5.7e-32 Score=200.50 Aligned_cols=146 Identities=22% Similarity=0.300 Sum_probs=127.2
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhh--HHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLD--EREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
|.+.+.||+|+||.||+|.+.+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++++|++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 566789999999999999998899999999865322 123578899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++.+.... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||.|....
T Consensus 84 ~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 84 QDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp EEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred hhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 65555544 4456688889999999999999999998 99999999999999999999999999998654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=200.25 Aligned_cols=142 Identities=27% Similarity=0.323 Sum_probs=119.3
Q ss_pred cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHH-----HHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEeccC
Q 048219 34 EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDER-----EREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYMS 107 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (183)
+.||+|+||.||+|.+. +++.+|+|.+....... ...+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999975 58899999986532211 2357899999999999999999999999999999999998
Q ss_pred CCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 108 NGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 108 ~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++.... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 84 ~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 84 TDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred chHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccC
Confidence 76655544 3345577778888999999999999998 99999999999999999999999999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.9e-32 Score=197.99 Aligned_cols=146 Identities=28% Similarity=0.318 Sum_probs=119.1
Q ss_pred hchhcccCcCcCceEEEEEEcC--C--cEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN--R--QLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~--~--~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (183)
+.+.+.||+|+||.||+|.... + ..||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+ +..+++
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 5677899999999999998542 2 368899886532 2334678999999999999999999999965 467899
Q ss_pred EeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 103 YEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|||++++++.+.+......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||+|+...
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999988876556688888899999999999999998 99999999999999999999999999999653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=199.51 Aligned_cols=148 Identities=30% Similarity=0.455 Sum_probs=125.2
Q ss_pred hchhcccCcCcCceEEEEEEcC-Cc--EEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCeEEEEEe
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQ--LVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSKKILVYE 104 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~--~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 104 (183)
+.+.+.||+|+||.||+|.... +. .+++|.+.... ......+.+|+.++..+ +||||+++++++.+.+..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 4567899999999999998654 33 47788875432 33445789999999998 69999999999999999999999
Q ss_pred ccCCCCHHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccc
Q 048219 105 YMSNGSLADILFNA---------------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKN 169 (183)
Q Consensus 105 ~~~~~~l~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i 169 (183)
|+++|+|.+++... ...+++..+..++.|++.|+.|+|++ +++||||||+||+++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999998543 24578888899999999999999998 9999999999999999999999
Q ss_pred cceeccccccc
Q 048219 170 FRLWIGKVDEA 180 (183)
Q Consensus 170 ~dfg~a~~~~~ 180 (183)
+|||+|+....
T Consensus 169 ~DfG~a~~~~~ 179 (309)
T d1fvra_ 169 ADFGLSRGQEV 179 (309)
T ss_dssp CCTTCEESSCE
T ss_pred ccccccccccc
Confidence 99999986543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=200.20 Aligned_cols=145 Identities=26% Similarity=0.354 Sum_probs=123.6
Q ss_pred hchhcccCcCcCceEEEEEEcC-Cc----EEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMIN-RQ----LVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVY 103 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~-~~----~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (183)
+.+.+.||+|+||.||+|.... ++ .|++|.+.... ....+.+.+|+.+++.++||||+++++++.+. ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 5667899999999999998653 32 57888876432 22346789999999999999999999998764 567888
Q ss_pred eccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 104 EYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 104 e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
|++.++++.+.+......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 99999999998887777788888899999999999999998 9999999999999999999999999999865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.5e-31 Score=198.35 Aligned_cols=147 Identities=26% Similarity=0.416 Sum_probs=127.2
Q ss_pred HhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (183)
.+.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.++|||++++++++...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 3566789999999999999864 24679999987543 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC-----------------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCC
Q 048219 102 VYEYMSNGSLADILFNAE-----------------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQN 158 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~n 158 (183)
+||++++++|.+++.... ..+++..+..++.|++.||.|+|+. +++||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence 999999999999886421 2356777888999999999999998 99999999999
Q ss_pred EEecCCCcccccceeccccc
Q 048219 159 ILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 159 il~~~~~~~~i~dfg~a~~~ 178 (183)
|+++.++.+||+|||+|+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~ 190 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNI 190 (301)
T ss_dssp EEECGGGCEEECCCSCHHHH
T ss_pred eEECCCCcEEEccchhheec
Confidence 99999999999999999744
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=198.78 Aligned_cols=149 Identities=23% Similarity=0.343 Sum_probs=127.5
Q ss_pred HHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEE
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (183)
..+.+.+.||+|+||.||+|... .+..||+|++.... ......+.+|+.++.+++||||+++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 44567789999999999999854 24679999987543 333456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC---------CCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccc
Q 048219 101 LVYEYMSNGSLADILFNA---------EKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFR 171 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~d 171 (183)
++||++++|++.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999987532 13356777888999999999999998 999999999999999999999999
Q ss_pred eecccccc
Q 048219 172 LWIGKVDE 179 (183)
Q Consensus 172 fg~a~~~~ 179 (183)
||+|+...
T Consensus 177 FGla~~~~ 184 (308)
T d1p4oa_ 177 FGMTRDIY 184 (308)
T ss_dssp TTCCCGGG
T ss_pred cccceecc
Confidence 99998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=199.24 Aligned_cols=152 Identities=22% Similarity=0.323 Sum_probs=117.2
Q ss_pred HHHHHhchhcccCcCcCceEEEEEEcC------CcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeC
Q 048219 25 LKKITDGFKEKVGRGSSGTVYKGAMIN------RQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEV 96 (183)
Q Consensus 25 ~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (183)
+....+.+.+.||+|+||.||+|.... ++.||+|.+.... ......+..|...+.++ .|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 444567788899999999999998542 3679999986533 33345677788877776 588999999887654
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEE
Q 048219 97 -SKKILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNIL 160 (183)
Q Consensus 97 -~~~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil 160 (183)
...+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 46899999999999999986432 2367788888999999999999998 9999999999999
Q ss_pred ecCCCcccccceecccccc
Q 048219 161 MDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 161 ~~~~~~~~i~dfg~a~~~~ 179 (183)
++.++.+||+|||+|+...
T Consensus 167 l~~~~~~Kl~DFGla~~~~ 185 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIY 185 (299)
T ss_dssp ECGGGCEEECC------CC
T ss_pred ECCCCcEEEccCcchhhcc
Confidence 9999999999999998643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=8.8e-31 Score=193.27 Aligned_cols=146 Identities=21% Similarity=0.251 Sum_probs=127.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh---hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC----eEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL---DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS----KKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 100 (183)
+|.+.+.||+|+||.||+|.+. +++.+|+|.+.+.. ......+.+|+.+++.++||||+++++++...+ ..|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 3677889999999999999975 58899999986532 333457889999999999999999999997654 378
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+||||+++++|.+.+... ..+++..+..++.|++.||.|+|++ +|+||||||+||+++.++..+++|||.++..
T Consensus 88 lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 999999999999888654 3577888889999999999999998 9999999999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=195.04 Aligned_cols=144 Identities=27% Similarity=0.364 Sum_probs=120.0
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEe-CCeEEEEEeccCC
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLE-VSKKILVYEYMSN 108 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~ 108 (183)
+.+.+.||+|+||.||+|... +..||+|.+++.. ..+.+.+|+.++++++||||+++++++.+ .+..++||||+++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 346678999999999999875 5679999997642 34568899999999999999999999864 5678999999999
Q ss_pred CCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 109 GSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 109 ~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
|+|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+|++|||+++...
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 99999986532 3467888889999999999999998 99999999999999999999999999999754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-30 Score=194.79 Aligned_cols=150 Identities=23% Similarity=0.337 Sum_probs=129.3
Q ss_pred HHHhchhcccCcCcCceEEEEEEc------CCcEEEEEEccchh-hHHHHHHHHHHHHHhhc-CCCceeeeeceEEeCCe
Q 048219 27 KITDGFKEKVGRGSSGTVYKGAMI------NRQLVAVNRLEKVL-DEREREFQTEIKVIGRT-HHRNLVRLLGYSLEVSK 98 (183)
Q Consensus 27 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (183)
...+.+.+.||+|+||.||+|... .+..+|+|++.... ......+.+|+.++..+ +||||+++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 345677889999999999999853 35689999987543 33455788999999998 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-----------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEe
Q 048219 99 KILVYEYMSNGSLADILFNAE-----------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILM 161 (183)
Q Consensus 99 ~~lv~e~~~~~~l~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~ 161 (183)
.+++|||++++++.+++.... ..+++..+..++.|++.|+.|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999986432 2467788888999999999999998 99999999999999
Q ss_pred cCCCcccccceecccccc
Q 048219 162 DENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 162 ~~~~~~~i~dfg~a~~~~ 179 (183)
+.++.++++|||+|+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~ 196 (311)
T d1t46a_ 179 THGRITKICDFGLARDIK 196 (311)
T ss_dssp ETTTEEEECCCGGGSCTT
T ss_pred cccCcccccccchheecc
Confidence 999999999999999654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-30 Score=197.51 Aligned_cols=142 Identities=22% Similarity=0.281 Sum_probs=119.6
Q ss_pred hchh-cccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhh-cCCCceeeeeceEEe----CCeEEEE
Q 048219 30 DGFK-EKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGR-THHRNLVRLLGYSLE----VSKKILV 102 (183)
Q Consensus 30 ~~~~-~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv 102 (183)
|.+. +.||+|+||.||+|... +++.||+|.+.+. ..+.+|+.++.+ .+||||++++++|.+ ...+|++
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 4554 46999999999999975 5789999998653 245678888655 479999999999875 3568999
Q ss_pred EeccCCCCHHHHHhcCC-CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceeccccc
Q 048219 103 YEYMSNGSLADILFNAE-KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVD 178 (183)
Q Consensus 103 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~ 178 (183)
||||+||+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++. .+.+||+|||+|+..
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeec
Confidence 99999999999997643 4578888899999999999999998 9999999999999986 457999999999865
Q ss_pred c
Q 048219 179 E 179 (183)
Q Consensus 179 ~ 179 (183)
.
T Consensus 165 ~ 165 (335)
T d2ozaa1 165 T 165 (335)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.9e-30 Score=192.72 Aligned_cols=146 Identities=25% Similarity=0.275 Sum_probs=118.5
Q ss_pred hchhcccCcCcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC----eEEEEEec
Q 048219 30 DGFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS----KKILVYEY 105 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~ 105 (183)
+-+.+.||+|+||.||+|+. ++..||+|.+...... ......|+..+..++||||+++++++.+.+ ..++||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 44567899999999999985 5778999998654221 112223555556789999999999997654 57899999
Q ss_pred cCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCC-----CCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 106 MSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDEC-----ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 106 ~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++++|.+++... .+++..+..++.|++.|+.|+|+.. ..+|+||||||+||+++.++.+||+|||+|+...
T Consensus 83 ~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999999763 5778888889999999999999621 1389999999999999999999999999998653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.2e-31 Score=195.13 Aligned_cols=149 Identities=23% Similarity=0.328 Sum_probs=123.2
Q ss_pred HHhchhcccCcCcCceEEEEEEcC--------CcEEEEEEccchhh-HHHHHHHHHHHHHhhc-CCCceeeeeceEEeCC
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMIN--------RQLVAVNRLEKVLD-EREREFQTEIKVIGRT-HHRNLVRLLGYSLEVS 97 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 97 (183)
..+.+.+.||+|+||.||+|+... +..||+|.+.+... .....+.+|...+.++ +||||+++++++.+.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 356677899999999999998543 24689999876543 3346788888888887 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEec
Q 048219 98 KKILVYEYMSNGSLADILFNAE---------------KQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMD 162 (183)
Q Consensus 98 ~~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~ 162 (183)
..+++|||+++|++.+++.... ..+++..+..++.|++.||.|+|++ +++||||||+||+++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999996542 3468888899999999999999998 999999999999999
Q ss_pred CCCcccccceecccccc
Q 048219 163 ENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 163 ~~~~~~i~dfg~a~~~~ 179 (183)
.++.+||+|||+++...
T Consensus 170 ~~~~~kl~dfg~~~~~~ 186 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIH 186 (299)
T ss_dssp TTCCEEECSTTCCCCGG
T ss_pred CCCCeEeccchhhcccc
Confidence 99999999999999664
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4e-30 Score=195.16 Aligned_cols=145 Identities=21% Similarity=0.270 Sum_probs=119.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh-hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC-----eEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL-DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS-----KKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 101 (183)
+|.+.+.||+|+||.||+|... ++..+|+|.+.+.. ......+.+|+.+|+.++|||++++++++.... ..++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 3667789999999999999875 68899999987543 334567889999999999999999999987543 2445
Q ss_pred EEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 102 VYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 102 v~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+ +++.+++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 89 ~-~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 89 V-THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp E-EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred E-EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 4 556689999998653 578888899999999999999998 99999999999999999999999999998653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.2e-30 Score=190.66 Aligned_cols=146 Identities=23% Similarity=0.274 Sum_probs=127.5
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCCeEEEEEecc
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
|.+.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++|+||+++.+++.+....+++++++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 567789999999999999976 57889999985432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
.++++..++.. .....+..+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||.|+...
T Consensus 84 ~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 84 DQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp SEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhccc
Confidence 98888776654 44567788888999999999999998 99999999999999999999999999998654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=4.3e-30 Score=193.69 Aligned_cols=141 Identities=21% Similarity=0.341 Sum_probs=121.4
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeC--CeEEEEEe
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEV--SKKILVYE 104 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 104 (183)
.|.+.+.||+|+||.||+|+.. +++.||+|.+++.. ..++.+|+.+|..++ ||||+++++++... ...+++||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 4677789999999999999975 58889999987542 346788999999995 99999999999754 56899999
Q ss_pred ccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceecccccc
Q 048219 105 YMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVDE 179 (183)
Q Consensus 105 ~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~~ 179 (183)
+++++++.... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .++++|||+|+...
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 99999987653 3577888889999999999999998 999999999999998654 68999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.8e-31 Score=193.50 Aligned_cols=147 Identities=20% Similarity=0.247 Sum_probs=123.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhH------HHHHHHHHHHHHhhcC--CCceeeeeceEEeCCeE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDE------REREFQTEIKVIGRTH--HRNLVRLLGYSLEVSKK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 99 (183)
.|.+.+.||+|+||.||+|... ++..+|+|.+.+.... ...++.+|+.+++.++ ||||+++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4677889999999999999976 5789999998653211 1223567999999886 89999999999999999
Q ss_pred EEEEeccCC-CCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCC-Ccccccceecccc
Q 048219 100 ILVYEYMSN-GSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDEN-RCAKNFRLWIGKV 177 (183)
Q Consensus 100 ~lv~e~~~~-~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~-~~~~i~dfg~a~~ 177 (183)
+++||++.+ +++.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||+|+.
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 999999975 5777777543 4577888888999999999999998 99999999999999865 7899999999986
Q ss_pred cc
Q 048219 178 DE 179 (183)
Q Consensus 178 ~~ 179 (183)
..
T Consensus 161 ~~ 162 (273)
T d1xwsa_ 161 LK 162 (273)
T ss_dssp CC
T ss_pred cc
Confidence 53
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=192.69 Aligned_cols=145 Identities=20% Similarity=0.290 Sum_probs=118.9
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeCC------eE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEVS------KK 99 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 99 (183)
+|.+.+.||+|+||.||+|.+. +++.||+|.+.+.. ......+.+|+.+|+.++|||+++++++|...+ .+
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 4667788999999999999976 58889999987532 234567889999999999999999999997654 46
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 100 ILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 100 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
+++||++ +.++...... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||+|+...
T Consensus 99 ~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp EEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 9999999 5678777654 3578888899999999999999998 99999999999999999999999999998654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.9e-30 Score=193.33 Aligned_cols=143 Identities=25% Similarity=0.304 Sum_probs=116.3
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceeeeeceEEeC------CeEEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVRLLGYSLEV------SKKIL 101 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~l 101 (183)
.|...+.||+|+||.||+|.+. +++.||+|.+.+.. ....+|+.+|+.++|+||++++++|... .++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3556678999999999999986 58899999986532 1234699999999999999999998542 34789
Q ss_pred EEeccCCCCHHHHHh--cCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC-cccccceeccccc
Q 048219 102 VYEYMSNGSLADILF--NAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR-CAKNFRLWIGKVD 178 (183)
Q Consensus 102 v~e~~~~~~l~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~-~~~i~dfg~a~~~ 178 (183)
+|||++++....+.. .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999997653333322 2345678888888999999999999998 999999999999999775 8999999999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.9e-30 Score=191.78 Aligned_cols=146 Identities=25% Similarity=0.217 Sum_probs=125.7
Q ss_pred hchhcccCcCcCceEEEEEEc----CCcEEEEEEccchh----hHHHHHHHHHHHHHhhcCC-CceeeeeceEEeCCeEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI----NRQLVAVNRLEKVL----DEREREFQTEIKVIGRTHH-RNLVRLLGYSLEVSKKI 100 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~----~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 100 (183)
|.+.+.||+|+||.||+|... +++.+|+|.+.+.. ......+.+|+.++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 777889999999999999853 36789999986432 1123457789999999976 79999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++||++.+++|.+.+.... ...+.....++.|++.|+.|+|++ +++||||||+||+++.++.+||+|||+|+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999986644 345677778899999999999998 99999999999999999999999999998653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.3e-29 Score=188.61 Aligned_cols=146 Identities=21% Similarity=0.285 Sum_probs=120.5
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEeC-----CeEE
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLEV-----SKKI 100 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 100 (183)
+|.+.+.||+|+||.||+|.+. +++.||+|.+.+.. ......+.+|+.+|+.++|+|++++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4777789999999999999975 58899999987542 23445788999999999999999999998643 2345
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++++++.+++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||+|....
T Consensus 99 ~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 66677789999998844 4578888899999999999999998 99999999999999999999999999998654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.2e-29 Score=186.19 Aligned_cols=148 Identities=21% Similarity=0.288 Sum_probs=120.2
Q ss_pred HHhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEe--------C
Q 048219 28 ITDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLE--------V 96 (183)
Q Consensus 28 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~ 96 (183)
.+|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+|+.++|+|++++.+++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 35677889999999999999975 68899999875432 1223567899999999999999999988754 3
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 97 SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
+..+++||++.++.+. .............+..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||+|+
T Consensus 90 ~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 4679999999765554 4444445677788888999999999999998 99999999999999999999999999997
Q ss_pred ccc
Q 048219 177 VDE 179 (183)
Q Consensus 177 ~~~ 179 (183)
...
T Consensus 166 ~~~ 168 (318)
T d3blha1 166 AFS 168 (318)
T ss_dssp ECC
T ss_pred ecc
Confidence 543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.9e-29 Score=186.08 Aligned_cols=148 Identities=24% Similarity=0.319 Sum_probs=119.0
Q ss_pred HhchhcccCcCcCceEEEEEEc-C-CcEEEEEEccchhhH--HHHHHHHHHHHHhhc---CCCceeeeeceEEe-----C
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-N-RQLVAVNRLEKVLDE--REREFQTEIKVIGRT---HHRNLVRLLGYSLE-----V 96 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~-~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~ 96 (183)
.|.+.+.||+|+||.||+|.+. + ++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4677789999999999999975 3 567899998643211 122355677766655 79999999999863 2
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceeccc
Q 048219 97 SKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGK 176 (183)
Q Consensus 97 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~ 176 (183)
...+++||++.++++..........+++..+..++.|++.||.|||++ +|+||||||+|||++..+.+||+|||+++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 467899999988766555555556677888888999999999999998 99999999999999999999999999998
Q ss_pred ccc
Q 048219 177 VDE 179 (183)
Q Consensus 177 ~~~ 179 (183)
...
T Consensus 165 ~~~ 167 (305)
T d1blxa_ 165 IYS 167 (305)
T ss_dssp CCC
T ss_pred hhc
Confidence 654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=2e-28 Score=181.90 Aligned_cols=145 Identities=18% Similarity=0.251 Sum_probs=124.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCC-CceeeeeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH-RNLVRLLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~ 106 (183)
.|.+.+.||+|+||.||+|.+. +++.+|+|.+.... ....+..|++.+..++| ++++.+++++......++|||++
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4677889999999999999976 57889999875432 22346678888888875 89999999999999999999998
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC-----CCcccccceecccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE-----NRCAKNFRLWIGKVDE 179 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~-----~~~~~i~dfg~a~~~~ 179 (183)
++++.+.+......++......++.|++.||.|+|+. +|+||||||+||+++. .+.++|+|||+|+...
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 6899998877666788888899999999999999998 9999999999999974 4679999999998753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.5e-28 Score=185.06 Aligned_cols=143 Identities=21% Similarity=0.309 Sum_probs=116.4
Q ss_pred hchhcccCcCcCceEEEEEEc-CCcEEEEEEccchh--hHHHHHHHHHHHHHhhcCCCceeeeeceEEe------CCeEE
Q 048219 30 DGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVL--DEREREFQTEIKVIGRTHHRNLVRLLGYSLE------VSKKI 100 (183)
Q Consensus 30 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~ 100 (183)
|.+.+.||+|+||+||+|.+. ++..+|+|++.+.. .....++.+|+.+++.++||||++++++|.. .+..|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 566789999999999999976 58899999987542 3334568899999999999999999999864 36789
Q ss_pred EEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 101 LVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 101 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
++|||+.+ ++.+.+. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++++|||+++...
T Consensus 99 iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 99 LVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 99999965 4545442 3467888889999999999999998 99999999999999999999999999988654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=1e-27 Score=178.46 Aligned_cols=144 Identities=22% Similarity=0.255 Sum_probs=118.1
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCceee-eeceEEeCCeEEEEEecc
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNLVR-LLGYSLEVSKKILVYEYM 106 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~ 106 (183)
+|.+.+.||+|+||.||+|.+. +++.||+|.+.... ....+..|+++++.++|++++. +..++...+..+++||++
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 3677889999999999999975 57889999875432 2235678999999998776554 455556778889999999
Q ss_pred CCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecC---CCcccccceeccccc
Q 048219 107 SNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDE---NRCAKNFRLWIGKVD 178 (183)
Q Consensus 107 ~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~---~~~~~i~dfg~a~~~ 178 (183)
++++...+......+++..+..++.|++.||.|+|++ +|+||||||+||+++. +..++++|||+|+..
T Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 86 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred -CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 5677777766666788899999999999999999998 9999999999999764 457999999999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=4e-24 Score=149.22 Aligned_cols=133 Identities=11% Similarity=0.088 Sum_probs=101.0
Q ss_pred chhcccCcCcCceEEEEEEcCCcEEEEEEccchh------------------hHHHHHHHHHHHHHhhcCCCceeeeece
Q 048219 31 GFKEKVGRGSSGTVYKGAMINRQLVAVNRLEKVL------------------DEREREFQTEIKVIGRTHHRNLVRLLGY 92 (183)
Q Consensus 31 ~~~~~lg~g~~g~v~~~~~~~~~~~~ik~~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (183)
.+.+.||+|+||.||+|...+++.+|+|.+.... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3567899999999999998889999999764211 0112234568888889999988876644
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhcCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCCcccccce
Q 048219 93 SLEVSKKILVYEYMSNGSLADILFNAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENRCAKNFRL 172 (183)
Q Consensus 93 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~~~~i~df 172 (183)
. ..+++||++++....+ +.......++.|++.++.++|+. +|+|+||||+||++++++ ++++||
T Consensus 83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEECCC
T ss_pred c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEEEC
Confidence 2 2378999998765433 12223345789999999999998 999999999999999655 789999
Q ss_pred ecccccc
Q 048219 173 WIGKVDE 179 (183)
Q Consensus 173 g~a~~~~ 179 (183)
|.|+...
T Consensus 147 G~a~~~~ 153 (191)
T d1zara2 147 PQSVEVG 153 (191)
T ss_dssp TTCEETT
T ss_pred CCcccCC
Confidence 9997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.88 E-value=6.3e-23 Score=155.89 Aligned_cols=149 Identities=23% Similarity=0.246 Sum_probs=112.4
Q ss_pred HhchhcccCcCcCceEEEEEEc-CCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-----------CCceeeeeceEEe-
Q 048219 29 TDGFKEKVGRGSSGTVYKGAMI-NRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-----------HRNLVRLLGYSLE- 95 (183)
Q Consensus 29 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~- 95 (183)
+|.+.+.||+|+||+||+|+.. +++.||+|.+.+.. .....+.+|+.+++.+. |+|++++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3778899999999999999975 58899999987643 22345677888777664 5789999888754
Q ss_pred -CCeEEEEEeccCCCC-HHHHHh-cCCCCCChHHHHHHHHHHHHHHHHhhhCCCCCceecCCCCCCEEecCCC------c
Q 048219 96 -VSKKILVYEYMSNGS-LADILF-NAEKQPNWIERTGIARDIARGILYLHDECETQIIHCDIKPQNILMDENR------C 166 (183)
Q Consensus 96 -~~~~~lv~e~~~~~~-l~~~l~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil~~~~~------~ 166 (183)
....+++++++.... ...... .......+..+..++.|++.|+.|||+. .+|+||||||+||+++..+ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 456666776654433 222222 2334567788888999999999999973 2899999999999998665 3
Q ss_pred ccccceeccccccc
Q 048219 167 AKNFRLWIGKVDEA 180 (183)
Q Consensus 167 ~~i~dfg~a~~~~~ 180 (183)
++++|||.|.....
T Consensus 171 ~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 171 IKIADLGNACWYDE 184 (362)
T ss_dssp EEECCCTTCEETTB
T ss_pred eeEeeccccccccc
Confidence 89999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=3.7e-08 Score=70.10 Aligned_cols=134 Identities=13% Similarity=0.062 Sum_probs=83.5
Q ss_pred CcCceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEeccCCCCHHHHHhc
Q 048219 39 GSSGTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEYMSNGSLADILFN 117 (183)
Q Consensus 39 g~~g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~ 117 (183)
++.+.||+... +++.+.+|+...........+..|...+..+. +-.+++++.+....+..+++|++++|.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 33457887653 44456677765433223334566777777664 33456777777778889999999998777554321
Q ss_pred CCCCCChHHHHHHHHHHHHHHHHhhhC-----------------------------------------------------
Q 048219 118 AEKQPNWIERTGIARDIARGILYLHDE----------------------------------------------------- 144 (183)
Q Consensus 118 ~~~~~~~~~~~~i~~~i~~~l~~lh~~----------------------------------------------------- 144 (183)
. ... ..+..++...+..+|+.
T Consensus 104 ~---~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 104 E---QSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp C---SCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred c---ccH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 1 111 11223333333333321
Q ss_pred ---CCCCceecCCCCCCEEecCCCcccccceecccccc
Q 048219 145 ---CETQIIHCDIKPQNILMDENRCAKNFRLWIGKVDE 179 (183)
Q Consensus 145 ---~~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~~ 179 (183)
....++|+|+.+.||++++++..-++||+.|..+.
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~ 215 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhcccCC
Confidence 01237899999999999987767799999988764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=2.9e-06 Score=59.70 Aligned_cols=73 Identities=16% Similarity=0.121 Sum_probs=47.2
Q ss_pred cCcCcC-ceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCC--CceeeeeceEEeCCeEEEEEeccCCCCH
Q 048219 36 VGRGSS-GTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHH--RNLVRLLGYSLEVSKKILVYEYMSNGSL 111 (183)
Q Consensus 36 lg~g~~-g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~l 111 (183)
+..|.. ..||+.....+..+.+|...... ...+..|...++.+.. ..+++++.+..+.+..+++|++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344443 56888777667677777654321 2235567777766632 2356677777778888999999987544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.92 E-value=2.8e-05 Score=58.33 Aligned_cols=75 Identities=13% Similarity=0.130 Sum_probs=44.3
Q ss_pred cccCcCcCceEEEEEEcC-CcEEEEEEccch---h----hHHHHHHHHHHHHHhhcC-C--CceeeeeceEEeCCeEEEE
Q 048219 34 EKVGRGSSGTVYKGAMIN-RQLVAVNRLEKV---L----DEREREFQTEIKVIGRTH-H--RNLVRLLGYSLEVSKKILV 102 (183)
Q Consensus 34 ~~lg~g~~g~v~~~~~~~-~~~~~ik~~~~~---~----~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv 102 (183)
+.+|.|....||+..... ++.+.+|.-... . +....+...|.+.++.+. + ..+++++. .++...+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 368999999999987544 566777764321 0 111223456777776552 2 23444443 355667899
Q ss_pred EeccCCCC
Q 048219 103 YEYMSNGS 110 (183)
Q Consensus 103 ~e~~~~~~ 110 (183)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.68 E-value=0.0019 Score=47.94 Aligned_cols=69 Identities=13% Similarity=0.077 Sum_probs=39.8
Q ss_pred ccCcCcCceEEEEEEcCC--------cEEEEEEccchhhHHHHHHHHHHHHHhhcC-CCceeeeeceEEeCCeEEEEEec
Q 048219 35 KVGRGSSGTVYKGAMINR--------QLVAVNRLEKVLDEREREFQTEIKVIGRTH-HRNLVRLLGYSLEVSKKILVYEY 105 (183)
Q Consensus 35 ~lg~g~~g~v~~~~~~~~--------~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 105 (183)
.|+.|..-.+|+....++ ..+.++...... ......+|..+++.+. +.-.+++++++. -++++||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 466677778898875432 345555543221 1223456778787764 333445665542 2578898
Q ss_pred cCCC
Q 048219 106 MSNG 109 (183)
Q Consensus 106 ~~~~ 109 (183)
++|.
T Consensus 123 i~g~ 126 (395)
T d1nw1a_ 123 IPSR 126 (395)
T ss_dssp CCEE
T ss_pred eccc
Confidence 8764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.60 E-value=0.004 Score=44.96 Aligned_cols=67 Identities=9% Similarity=-0.019 Sum_probs=40.4
Q ss_pred ceEEEEEEcCCcEEEEEEccchhhHHHHHHHHHHHHHhhcCCCce--e---ee--eceEEeCCeEEEEEeccCCC
Q 048219 42 GTVYKGAMINRQLVAVNRLEKVLDEREREFQTEIKVIGRTHHRNL--V---RL--LGYSLEVSKKILVYEYMSNG 109 (183)
Q Consensus 42 g~v~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~---~~--~~~~~~~~~~~lv~e~~~~~ 109 (183)
..||++...++..+++|.-.... .....+..|...+..+....+ + .. -..+...+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 46899888788888888764432 133456778887776632211 1 11 12233456678888888753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.81 E-value=0.00085 Score=48.23 Aligned_cols=33 Identities=15% Similarity=0.298 Sum_probs=28.5
Q ss_pred CCCceecCCCCCCEEecCCCcccccceeccccc
Q 048219 146 ETQIIHCDIKPQNILMDENRCAKNFRLWIGKVD 178 (183)
Q Consensus 146 ~~~i~H~dl~~~nil~~~~~~~~i~dfg~a~~~ 178 (183)
+.+++|+|+.+.|++++.+...-++||+.|...
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~ 214 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACND 214 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccccccCCcchhhhhcccccceeEecccccccc
Confidence 457899999999999998877789999988643
|